id subject predicate object category relation description has_attribute source uuid:7056bc28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7056ed92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7057151a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:705738ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:70575c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.707']} DrugCentral uuid:705783a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:7057a6f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7057cec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) DrugCentral uuid:7057f5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7057f5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:705823ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:70584b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7058741e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70589bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7058c356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7058eae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:6 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 (S)-nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:70590ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:13 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levdobutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:705931ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:705958d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:70597fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7059a79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48760 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin targets Enzyme (Folylpoly-gamma-glutamate synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7059cee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:21 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopterin is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7059f5dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:705a1cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:705a44ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:705a6c1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:24 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:705a942e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:25 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:705abb48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:25 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:705adeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:705b018e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:705b248e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96J66 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Transporter (ATP-binding cassette sub-family C member 11) DrugCentral uuid:705b4784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:705b6e76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8F0 biolink:molecularly_interacts_with DrugCentral:26 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorouracil targets Enzyme (Uracil phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:705b9630-59f3-11ec-9eaa-0242ac110003 UniProtKB:O26232 biolink:molecularly_interacts_with DrugCentral:27 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:705bbd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03962 biolink:molecularly_interacts_with DrugCentral:27 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:705be4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:705c0bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:705c3630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:705c607e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:705c8aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:705cb2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.276']} DrugCentral uuid:705cd9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:705d009c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:34 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abacavir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:705d28d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:35 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.49']} DrugCentral uuid:705d5786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:705d5786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:705d5786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705da380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:705e08de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.697']} DrugCentral uuid:705e2fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose is inhibitor of Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:705e52d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:705e79b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:705ea122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:705ec828-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:705eef56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P94451 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:705f167a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53051 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Oligo-1,6-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:705f3e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00690 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:705f64fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:39 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:705f8c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:705fb2f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:705fdd3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:40 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acebutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:706006b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:70602db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:706054a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.227']} DrugCentral uuid:70607c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:43 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:70609ee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7060c5ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7060ecb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:44 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acediasulfone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:70611470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:7061375c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:70615a48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:47 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acemetacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:706181d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:48 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acenocoumarol is inhibitor of Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7061a9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:48 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acenocoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.114']} DrugCentral uuid:7061d0cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:49 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:7061f8cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:50 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceprometazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:70621c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:70624386-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:70626668-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:70628954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7062b046-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7062d904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:7063001e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:7063271a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:70634e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:70637616-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:70639d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:7063c42c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:7063eb0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.547']} DrugCentral uuid:70641260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:70643970-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:70646076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02144 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol targets Unclassified (Myoglobin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:70648740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:52 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paracetamol is agonist of GPCR (Cannabinoid receptor 1) DrugCentral uuid:7064aaae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:54 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetanilide targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7064d1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7064f8ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:70651ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:706547d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:70656eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:706595fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7065bd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7065e572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29972 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Transporter (Aquaporin-1) DrugCentral uuid:70660854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:70662f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:70665638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:70667db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7066a4b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:7066cba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7066f3c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:70671b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:70674264-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7067694c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERQ8 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7067902a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7067b8a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7067dfa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:706806a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:70682daa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7068551e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70687c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7068a33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7068ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7068f2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:70691a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:70694168-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7069699a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:70699118-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7069b81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7069e014-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:706a07b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:706a2f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706a7b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:706b3af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:706b3af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:706b3af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:706b3af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:706b8982-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:706b8982-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:706bbca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46510 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:706be3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.08']} DrugCentral uuid:706c0b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:706c3260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HVB9 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:706c5970-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:706c8166-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:706cabdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75493 biolink:molecularly_interacts_with DrugCentral:56 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase-related protein 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:706cd742-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:706cd742-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:706d0a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:706d387c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:706d387c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:706d387c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:706d7030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:706d9736-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0PXQ5 biolink:molecularly_interacts_with DrugCentral:58 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetohydroxamic acid targets Enzyme (Urease subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:706dbe50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:59 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetophenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:706de24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:59 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetophenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:706e0950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:706e3056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril is inhibitor of Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:706e587e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:706e8114-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:706ea7f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08049 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:706ecf5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19621 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:706ef630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42892 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Endothelin-converting enzyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:706f1de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00800 biolink:molecularly_interacts_with DrugCentral:60 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racecadotril targets Enzyme (Thermolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:706f44c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:706f6b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:706f9270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:706fba20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:706fe0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:707007c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:62 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:70702fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:70705836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:70707f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7070a61a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7070cd16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7070f4bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:70711ba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:707142b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:707169a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:707194ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:707194ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7071cb6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7071cb6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:707201c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:707201c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:707239f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:707239f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:707270d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:707270d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7072a730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7072a730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7072e7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7072e7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7072e7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7072e7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7072e7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:70733fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:H6TY12 biolink:molecularly_interacts_with DrugCentral:65 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcholine targets Ion channel (Nicotinic acetylcholine receptor alpha8 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:707366e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P99999 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Enzyme (Cytochrome c) DrugCentral uuid:707389b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Secreted (Vascular endothelial growth factor A) DrugCentral uuid:7073ac8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04179 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine targets Enzyme (Superoxide dismutase [Mn], mitochondrial) DrugCentral uuid:7073cf3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48637 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine is modulator of Enzyme (Glutathione synthetase) DrugCentral uuid:7073f5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:66 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylcysteine is modulator of Transporter (Cystine/glutamate transporter) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70743258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:70749e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:7074c146-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:7074e40a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:73 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acepromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:70750ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7075323e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:70755926-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60045 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Acidic phospholipase A2 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:70758022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19440 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:7075a70a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7075d09a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7075f7d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:70761eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:707645a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:74 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylsalicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:70766df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:76 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acipimox is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:707694da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:7076b7a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7076de90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) DrugCentral uuid:707701c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:78 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:70772896-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:70774f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70777684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:70779e20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:70779e20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:7077d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:7077d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:7077d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:7077d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:7077d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:70782566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:707848b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:70787020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:82 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acrivastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:707896ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7078bddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Kinase (Thymidine kinase) DrugCentral uuid:7078e122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:70790814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7079303c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:70795314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:70797826-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:70799af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04407 biolink:molecularly_interacts_with DrugCentral:85 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:7079bdb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7079e482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:707a0bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:707a3400-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:87 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:707a5af2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil is inhibitor of Polyprotein (Protein P) DrugCentral uuid:707a7dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54098 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil targets Enzyme (DNA polymerase subunit gamma-1) DrugCentral uuid:707aa106-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:88 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adefovir dipivoxil targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:707ac7c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:707af8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:707af8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:707af8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:707af8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:707b45d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:707b6f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.509']} DrugCentral uuid:707b961a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:707bbd02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:707be444-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:707c0b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:707c3228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:707c5906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:707c8052-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:707ca726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9TVW2 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:707cce2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:707cf514-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23526 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.796']} DrugCentral uuid:707d21ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:707d21ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:707d5496-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BTU6 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:707d7b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCG2 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:707da27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04406 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Glyceraldehyde-3-phosphate dehydrogenase liver) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:707dd4b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:707dd4b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:707dd4b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:707dd4b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:707e201a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TEK3 biolink:molecularly_interacts_with DrugCentral:90 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine targets Enzyme (Histone-lysine N-methyltransferase, H3 lysine-79 specific) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:707e4784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49652 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:707e6e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:707e95ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:707ebcdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:707ee55e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:707f0da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:707f348c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:707f5b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:707f8298-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:707fa98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41148 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Membrane other (Endoplasmin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:707fd068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49137 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (MAP kinase-activated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:707ff750-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:70801e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70804552-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:70806c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.836']} DrugCentral uuid:7080932c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12931 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock protein 75 kDa, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7080bb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7080e34a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:70810a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:70813106-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:70815938-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:70818084-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJX6 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7081a776-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7081ce5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7081f5be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51579 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70821c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7082438e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:70826a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:708292f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09467 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7082babc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00636 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7082e1ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:70830882-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:70832fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:708356ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:70838122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:70838122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:7083b43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.19']} DrugCentral uuid:7083db86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A9J4 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (Ketopantoate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.2']} DrugCentral uuid:70840278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7084296a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43598 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:708450c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35820 biolink:molecularly_interacts_with DrugCentral:92 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:70847ac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:7084c9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:70856c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7085a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7085a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7085a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7085a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7085a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7085f768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:70861e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:70864af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:70864af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:708684b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:708684b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:708684b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:7086c3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7086eb3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:70871332-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:70873a4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:70875d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7087857e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:7087ac84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7087d376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alacepril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:7087f9c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:7087f9c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:70882e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:70882e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:70885bb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole targets Structural (Tubulin alpha chain) DrugCentral uuid:70888582-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:70888582-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:70888582-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7088d1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:70893482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:104 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albendazole sulfoxide targets Structural (Tubulin alpha chain) DrugCentral uuid:708957c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.613']} DrugCentral uuid:70897eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:7089a5c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7089ccc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7089f6ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:708a1a5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclofenac targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:708a3d3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:708a641a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.9']} DrugCentral uuid:708a8b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:708ab276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:708ad97c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.721']} DrugCentral uuid:708b01c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:708b2904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:708b5668-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:708b5668-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:708b5668-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:708b9164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:708b9164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:708bc71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:708bf104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:708c1b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:708c41e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldosterone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:708c692c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:708c9014-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:708cb6de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Protein farnesyltransferase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:708cddbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:708d0562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:708d2c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:708d533c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:708d7a4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:708da454-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WUK0 biolink:molecularly_interacts_with DrugCentral:113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alexidine is inhibitor of Enzyme (Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:708dcb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:708df224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.951']} DrugCentral uuid:708e18f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708e403a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:708e710e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708e710e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708e710e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708e710e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708ebd26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:708ee440-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:708f0c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:708f3364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:708f5b1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:708f8242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:708fa920-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfuzosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:708fd012-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.61']} DrugCentral uuid:708ff77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:70901e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:70904510-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9TSZ1 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70906bda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DLS0 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:70909380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08424 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7090ba40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06281 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7090e10a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7M3D2 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:709107e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:70912f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DLW5 biolink:molecularly_interacts_with DrugCentral:119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7091582e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:70917ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7091a5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alizapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7091cd7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7091f464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:70921732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:70923e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:709265fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9FBI2 biolink:molecularly_interacts_with DrugCentral:124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 allopurinol targets Unclassified (Shiga toxin subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:70928d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7092b43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7092db40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70930232-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:70932a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:70935110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:709377e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alosetron targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.218']} DrugCentral uuid:70939f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfacalcidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7093c636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfacalcidol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:7093e8fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Transporter (Sodium- and chloride-dependent GABA transporter 1) DrugCentral uuid:70941276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:70941276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:70941276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7094840e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70956946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70956946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70956946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7095a8a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7095cf76-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7095f64a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70964f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70972c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:7097538c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem targets Unclassified (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:70977a7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpidem is partial agonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) DrugCentral uuid:70979d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:7097c416-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.457']} DrugCentral uuid:7097ebe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:709812a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.61']} DrugCentral uuid:7098403a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7098403a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7098403a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:70988694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:70988694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:70988694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:7098cd52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:7098cd52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:7098cd52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:709912a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:709912a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:709912a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:709951d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:70997888-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:70999f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:7099c75c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:7099ee3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:709a14fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:709a3bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:709a6450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.678']} DrugCentral uuid:709a8d90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.658']} DrugCentral uuid:709ab478-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:709adb60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:709b02ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:709b299e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:709b505e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:709b7732-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:709b9e6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:709bc53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:709bec12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:709c130e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:709c3ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:709c61b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:709c88b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:709caf80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:709cd6f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:709cfdc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:709d24ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:709d4ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.35']} DrugCentral uuid:709d72da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:709d9ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 altretamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:709dc190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:709de88c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:709e117c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:709e3864-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:709e5f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:709e865c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:709eafa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is inhibitor of Ion channel (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709eeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:709f59a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q20MD5 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:709f805c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:709fa726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:709fcddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:709ff140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.34']} DrugCentral uuid:70a01814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:70a03eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:70a065a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.254']} DrugCentral uuid:70a08cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:70a0afcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:147 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambroxol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:70a0d6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:70a1013e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:70a1013e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:70a1013e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:70a1470c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:70a1470c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:70a1470c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:70a185aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifostine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:70a1ad78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifostine targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) DrugCentral uuid:70a1d082-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amikacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.201']} DrugCentral uuid:70a1f760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37088 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Amiloride-sensitive sodium channel subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:70a21e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:70a24580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:70a26c4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.408']} DrugCentral uuid:70a2931e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19634 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:70a2b9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:70a2e09e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:70a3079a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70a32e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:70a355d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:70a384b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70a384b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70a384b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70a3c860-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9W6Q1 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:70a3f056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14940 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:70a41734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26431 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:70a43fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50482 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:70a4669e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06869 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:70a48d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55926 biolink:molecularly_interacts_with DrugCentral:158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:70a4b432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:70a4db60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:70a5023e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:70a528fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amineptine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70a54fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminocaproic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:70a57a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminocaproic acid is inhibitor of Enzyme (Tissue-type plasminogen activator) DrugCentral uuid:70a59d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:70a5c412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:70a5eae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:70a60e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:70a6350a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoglutethimide targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:70a65be8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:70a682bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:70a6a9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:70a6cc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:70a6ef36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminophenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:70a71600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminopicoline is inhibitor of Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70a73f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:70a765f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:70a78cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70a7b394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminoquinuride targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:70a7daea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:70a801b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:70a8295a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:70a8502e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:70a8775c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.177']} DrugCentral uuid:70a89e3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70a8c59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70a8ec6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:70a915b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:70a94010-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70a966e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:70a98da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:70a9b536-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:70a9dc0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:70aa02de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:70aa29a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.989']} DrugCentral uuid:70aa50ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:70aa78fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.674']} DrugCentral uuid:70aa9ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.045']} DrugCentral uuid:70aac6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:70aaf02c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:70ab1700-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.984']} DrugCentral uuid:70ab3dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:70ab649e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:70ab8c6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.168']} DrugCentral uuid:70abb34a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.296']} DrugCentral uuid:70abda0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.968']} DrugCentral uuid:70ac01ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.498']} DrugCentral uuid:70ac2906-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:70ac4fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.004']} DrugCentral uuid:70ac7686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:70ac9d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.176']} DrugCentral uuid:70acc67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.549']} DrugCentral uuid:70aced50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:70ad13fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.284']} DrugCentral uuid:70ad3ae4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.791']} DrugCentral uuid:70ad6244-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:70ad890e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:70adafe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.039']} DrugCentral uuid:70add698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37268 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:70adfdb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.368']} DrugCentral uuid:70ae24ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:70ae4b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:70ae724c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:70ae9a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.347']} DrugCentral uuid:70aec0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70aee812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.407']} DrugCentral uuid:70af0ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:70af366e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.879']} DrugCentral uuid:70af5d38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:70af840c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:70afaaea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.943']} DrugCentral uuid:70afd326-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.932']} DrugCentral uuid:70affa04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:70b020ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:70b047ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:70b071d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70b09b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75151 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase PHF2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:70b0c2ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:70b0eb44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZMT4 biolink:molecularly_interacts_with DrugCentral:176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:70b11218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.953']} DrugCentral uuid:70b138f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:70b15ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:70b18716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.382']} DrugCentral uuid:70b1adea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:70b1d4be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.758']} DrugCentral uuid:70b1fb7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:70b22248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:70b24bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:70b2728e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70b2996c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:70b2c0d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:70b2e7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:70b30e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:70b3352a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:70b35c4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:70b38340-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:70b3aadc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70b3d1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.367']} DrugCentral uuid:70b3f92e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.456']} DrugCentral uuid:70b42354-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:70b44a78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:70b4714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70b498c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:70b4bfbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:70b4e686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:70b50d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:70b5346a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:70b55bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:70b5828a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:70b5a968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:70b5d136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:70b5fa8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:70b62172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.83']} DrugCentral uuid:70b64832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:70b6706e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:70b69738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:70b6be2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:70b6e4e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:70b70c04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.066']} DrugCentral uuid:70b73300-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:70b759de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70b782d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:70b7ab0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:70b7d224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70b7f8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:70b81fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:70b8470e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:70b86dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:70b894ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:70b8bb62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70b8e286-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:70b90928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:70b92ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:70b9569e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70b97ea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:70b9a5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:70b9cc82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:70b9f356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70ba1aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:70ba4ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70ba4ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70ba4ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70ba4ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70ba4ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70baa54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptyline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:70bacc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amitriptylinoxide targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70baf454-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70bb1b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70bb4210-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:70bb756e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:70bb756e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:70bb756e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:70bb756e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:70bbb754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.646']} DrugCentral uuid:70bbde3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:70bc063c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:70bc2d06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:70bc53bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:70bc7a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.358']} DrugCentral uuid:70bca1d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70bcc8a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:70bcef84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70bd1676-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:70bd3d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:70bd6022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70bd8714-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70bdadf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.507']} DrugCentral uuid:70bdd570-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:70bdfc3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70be230e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:70be49ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:70be70e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50135 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:70be98b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y251 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Enzyme (Heparanase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.28']} DrugCentral uuid:70bebf80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amodiaquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:70bee672-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:70bf0dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:70bf34c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:70bf5b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:70bf7e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:70bfa620-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:70bfcd08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:70bff3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:70c01ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.182']} DrugCentral uuid:70c0422e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70c06902-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70c08fcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70c0b6aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:70c0dfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.734']} DrugCentral uuid:70c10970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:70c1333c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.542']} DrugCentral uuid:70c15d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:70c184fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:70c1ac4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.616']} DrugCentral uuid:70c1d31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.211']} DrugCentral uuid:70c1f9ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:70c2212a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.365']} DrugCentral uuid:70c247f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70c26eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:70c29696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:70c2c0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:70c2e9ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y345 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Transporter (Sodium- and chloride-dependent glycine transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:70c3108a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:70c33754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:70c35ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:70c38592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70c3ac70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70c3d498-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:70c4027e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:70c4027e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:70c4027e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:70c43a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:70c46142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:70c48a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:70c4b2e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c4e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c54ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amperozide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:70c57262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amperozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:70c59940-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:70c5bc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.753']} DrugCentral uuid:70c5e36e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:70c60740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:70c62a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:70c65236-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:70c677d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:70c69eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:70c6c5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70c6ed2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c71400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:70c73ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c78d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:70c85c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:70c85c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:70c85c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:70c85c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:70c8aee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:70c8aee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:70c8aee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:70c8ef14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:70c915c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:70c9388e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.09']} DrugCentral uuid:70c9603e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c99b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:70c9fd6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70ca242e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:70ca46fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.172']} DrugCentral uuid:70ca6dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:70ca95d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:70cabcb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:70cae396-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:70cb0a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:70cb31ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:70cb588a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:70cb7f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:70cbb046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:70cbb046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:70cbb046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:70cbb046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:70cc01d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:70cc2ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:70cc54e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:70cc7c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:70cca2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:70ccc9ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:70ccf078-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:70cd1b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:70cd1b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:70cd4f14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagrelide is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:70cd75de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagrelide targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:70cd9f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anastrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:70cdc5fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androisoxazole targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:70cde8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:70ce0f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:70ce365e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:70ce5e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:70ce850a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.17']} DrugCentral uuid:70ceabe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenediol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:70ced2a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:70cefa9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:70cf2208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:70cf49f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:70cf71e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:70cf98f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54939 biolink:molecularly_interacts_with DrugCentral:215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:70cfbfba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anecortave targets Secreted (Plasminogen activator inhibitor 1) DrugCentral uuid:70cfe292-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:70d00560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:70d0293c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:70d04c0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:70d06ed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anhydrovinblastine targets Structural (Tubulin beta-4B chain) DrugCentral uuid:70d091b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anileridine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:70d0b4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P38435 biolink:molecularly_interacts_with DrugCentral:222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anisindione is inhibitor of Enzyme (Vitamin K-dependent gamma-carboxylase) DrugCentral uuid:70d0d7c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anisindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:70d0fede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:70d121ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:70d1454c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 antazoline is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:70d168a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 antazoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:70d18f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75342 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Arachidonate 12-lipoxygenase, 12R-type) DrugCentral uuid:70d1b220-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:70d1d8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:70d20108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:70d2282c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dithranol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:70d24ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:70d275de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:70d29d34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:70d2c426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:70d2eb22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:70d31214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:70d33a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70d36264-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70d38a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70d3b188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:70d3d99c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:70d40084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:70d42762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:70d44f44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:70d476a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:70d49d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:70d4c456-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:70d4eb3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:70d5138e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:70d53a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:70d56172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:70d58846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:70d5b028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:70d5d706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70d5fde4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:70d624d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:70d64bfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70d672e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d6a3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70d6a3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70d6a3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70d6a3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d71bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:70d7e6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70d7e6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70d7e6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70d829b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d829b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d86b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d86b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d86b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d86b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d86b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:70d8cd8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:70d8cd8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:70d8cd8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:70d90dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34949 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Enzyme (Mannose-6-phosphate isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:70d93518-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:70d95bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apomorphine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:70d982ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:70d9a994-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.938']} DrugCentral uuid:70d9d0fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:70d9f7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:70da2572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:70da2572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:70da2572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:70da6424-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:70da89ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:70dab29e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:70dad9d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5DUB1 biolink:molecularly_interacts_with DrugCentral:230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprepitant targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:70db0096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:70db23d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:70db46a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.757']} DrugCentral uuid:70db6d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:70db943e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32418 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Transporter (Sodium/calcium exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:70dbbb76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.359']} DrugCentral uuid:70dbe8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:70dbe8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:70dbe8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:70dc2b1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:70dc2b1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:70dc5b08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:70dc7dea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:70dca4be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:70dccba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:70dcf2ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:70dd199e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00735 biolink:molecularly_interacts_with DrugCentral:239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 argatroban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:70dd4072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.851']} DrugCentral uuid:70dd6746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:70dd9338-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:70ddbb56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:70dde234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.131']} DrugCentral uuid:70de0908-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:70de3324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:70de5d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:70de86f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:70deae4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:70ded590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:70defc50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:70df2310-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:70df49d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:70df716c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:70df984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.991']} DrugCentral uuid:70dfbf00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:70dfe5fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.681']} DrugCentral uuid:70e00e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:70e03552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.169']} DrugCentral uuid:70e05d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:70e083cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:70e0ab7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:70e0d246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.633']} DrugCentral uuid:70e0f8fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:70e11fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:70e14794-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.421']} DrugCentral uuid:70e16e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:70e19500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:70e1bbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.202']} DrugCentral uuid:70e1e64a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.463']} DrugCentral uuid:70e20f1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:70e235e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:70e25d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:70e283fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:70e2abac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:70e2d280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:70e2f9f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:70e320f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:70e347ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:70e36e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70e3962a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:70e3bcfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70e3e3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:70e40ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:70e43314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:70e45b1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arsenic trioxide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:70e48206-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arsenic trioxide is inhibitor of Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:70e4a4ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.312']} DrugCentral uuid:70e4cb9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.998']} DrugCentral uuid:70e4f2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:70e519d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:70e540a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:70e5677a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.741']} DrugCentral uuid:70e58f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:70e5b658-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:70e5dd22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:70e603c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:70e62ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:70e651b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:70e6787c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:70e69f50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:70e6c6ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.126']} DrugCentral uuid:70e6ed98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.027']} DrugCentral uuid:70e71480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:70e73b68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:70e762e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:70e789a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:70e7b070-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:70e7d73a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:70e7ff62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70e8264a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:70e84d78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:70e8744c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.297']} DrugCentral uuid:70e89bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:70e8c280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:70e8e954-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:70e9101e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:70e939d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:70e960aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:70e98774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:70e9aeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:70e9d580-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:70e9f826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:70ea258a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70ea258a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70ea258a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:70ea655e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:70ea8d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:70eab446-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:70eadafc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:70eb0478-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.701']} DrugCentral uuid:70eb2b38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.546']} DrugCentral uuid:70eb5202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.883']} DrugCentral uuid:70eb78ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:70eb9fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:70ebc7a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:70ebee88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:70ec1570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:70ec3d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.673']} DrugCentral uuid:70ec63fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.868']} DrugCentral uuid:70ec8ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:70ecb192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:70ecda1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:70ed0106-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:70ed2b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70ed2b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:70ed5e44-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:70ed850e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:70edabec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:70edd2ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 astemizole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.58']} DrugCentral uuid:70edfa0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asulacrine targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:70ee1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:70ee4368-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:70ee6aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:70ee921e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:70eebbc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.575']} DrugCentral uuid:70eee584-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:70ef0d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:70ef344e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:70ef5b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:70ef81d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.27']} DrugCentral uuid:70efa9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:254 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.12']} DrugCentral uuid:70efd110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70eff7c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:70f01e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:70f0456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:70f06e2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:70f097e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:70f0bf8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:70f0e654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:70f10ecc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.69']} DrugCentral uuid:70f135aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:70f15c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:70f18320-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.282']} DrugCentral uuid:70f1aa76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:70f1d136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:70f1f800-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:70f21ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:70f24aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:70f24aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:70f280b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:70f280b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:70f2b362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atomoxetine targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:70f2da86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:70f2fd2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:70f32400-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:70f34ba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:70f37306-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:70f399e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:70f3c0d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:70f3e782-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q1W675 biolink:molecularly_interacts_with DrugCentral:257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:70f40ece-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:70f435a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43264 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial) DrugCentral uuid:70f458fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02768 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone is inhibitor of Enzyme (Cytochrome b) DrugCentral uuid:70f47bb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:70f4a280-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:70f4c99a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:70f4ec68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:70f5131e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:70f540a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:70f540a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:70f540a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:70f58024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:70f5a702-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:70f5cdae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:70f5f572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:70f61c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:70f64306-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:70f669f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:70f69144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:70f6b822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:70f6dff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:70f707fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:70f72f8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:70f75660-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:70f77d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:70f7a3e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:70f7ccb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:70f7f67e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:70f81d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:70f8443a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:70f86b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:70f8926e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:70f8b94c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:70f8e02a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:70f914e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:70f914e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:70f914e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:70f914e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:70f914e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:70f96b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:70f99ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:70f99ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:70f99ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:70f9e6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:70f9e6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:70f9e6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:70fa2660-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapropazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:70fa4974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azapropazone targets Enzyme (Xanthine dehydrogenase/oxidase) DrugCentral uuid:70fa6c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:70fa930c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azatadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:70fab5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:70fadd58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:70fb0012-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:70fb22ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:70fb45cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63000 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Enzyme (Ras-related C3 botulinum toxin substrate 1) DrugCentral uuid:70fb69a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azathioprine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:70fb8d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelaic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) DrugCentral uuid:70fbafee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:70fbd6b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:70fbf986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:70fc20c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:70fc47b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70fc6e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.168']} DrugCentral uuid:70fc9576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:70fcbdee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70fce4d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:70fd0ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:70fd3670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:70fd3670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:70fd65b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:70fd8c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08703 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:70fdb352-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70344 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:70fdda9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azimilide is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:70fe0262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.39']} DrugCentral uuid:70fe2918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.7']} DrugCentral uuid:70fe4fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:70fe76fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70feae38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:70ff048c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:70ff2f0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:70ff55ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.317']} DrugCentral uuid:70ff7cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:70ffa3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:70ffcb4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:70fff28e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q83TT7 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Unclassified (AmpC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7100198a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7100405e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7100676e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:71008e24-59f3-11ec-9eaa-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7100c8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7101318a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:71015afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.716']} DrugCentral uuid:710184a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:7101ab88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60932 biolink:molecularly_interacts_with DrugCentral:281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bacitracin targets Unclassified (Undecaprenyl-diphosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7101d5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7101d5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71020d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:71020d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:71024048-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71029836-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7103834a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:7103a618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:7103c8dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:7103eba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 balsalazide is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:71040eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:71043178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:71045824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.25']} DrugCentral uuid:71047ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7104a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bambuterol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7104cd7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bamipine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7104f39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7104f39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:710520e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:71054874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:71056f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:71059612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7105bcdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7105e414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:71060b06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:71063270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7106593a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Y34 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate is agonist of GPCR (Probable G-protein coupled receptor 97) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:710682a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7106a96c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7106d16c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belotecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.561']} DrugCentral uuid:7106f822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:71071f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:71074642-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:71076dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7107948a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7107bbae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7107e25a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:71080906-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:71082fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendamustine targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:71085924-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:71087bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7108a262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:7108c4fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:7108e862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bendroflumethiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:71090b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benoxaprofen is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:71092dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benoxaprofen targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:710954b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.57']} DrugCentral uuid:71097c64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7109a31a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7109c9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7109f090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:710a1962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:710a436a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:710a6d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:710a975c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:710abfb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:710ae69e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:710b0d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:710b3414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:710b5c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:710b831a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:710ba9c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.486']} DrugCentral uuid:710bd068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:710bfea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:710bfea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:710bfea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:710c3d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:710c6078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:710c87ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:710cb208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:710cb208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:710ce606-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:710d0cc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03313 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Unclassified (Genome polyprotein [Cleaved into: P1; Capsid protein VP0) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:710d33e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52789 biolink:molecularly_interacts_with DrugCentral:314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benserazide targets Kinase (Hexokinase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:710d5aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzarone targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:710d8156-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:710da80c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:710dcf9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:710df668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:710e1d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:710e43ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:710e6b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:710e91cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:710eb878-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.908']} DrugCentral uuid:710ee01e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.711']} DrugCentral uuid:710f0738-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:710f2df8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:710f54c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.32']} DrugCentral uuid:710f7b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:710fa558-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:710fcd30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzbromarone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:710ff40e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15392 biolink:molecularly_interacts_with DrugCentral:321 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benziodarone targets Unclassified (Baculoviral IAP repeat-containing protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:71101ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:321 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benziodarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:71104242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:711064fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:711087c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:7110aa7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:7110cdb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:7110f05c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:711113a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:7111365c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:71115916-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01118 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 7 subunit alpha) DrugCentral uuid:71117f68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['3.495']} DrugCentral uuid:7111a8a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzonatate targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:7111cb44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:7111ee1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:7112116c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7112343a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzphetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:711256ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:71127dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7112a4f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.445']} DrugCentral uuid:7112cba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:7112f35c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:71131a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7113447e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzquinamide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:71136e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:71139118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7113b792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:7113dae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:7113fd9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzthiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:71142056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:7114472a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:71146e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:7114950e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7114bbc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.157']} DrugCentral uuid:7114e28e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:71150a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:711531bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:71155872-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:71157f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.654']} DrugCentral uuid:7115a6a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7115cd7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:7115f458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.636']} DrugCentral uuid:71161b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:711642b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:71166988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:71169052-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:7116b726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:7116dfc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.253']} DrugCentral uuid:71170708-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:71172ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:711754a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:71177c1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7117a2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7117c99a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:7117f064-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:711817a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71183e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzatropine is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:71186508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzyl benzoate targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:71188ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzyl benzoate targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7118b576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepotastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7118da24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:7118fcde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7119239e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:71194ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.149']} DrugCentral uuid:711971aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:71199996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7119c056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7119e766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:711a14d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:711a14d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:711a14d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:711a539a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is gating inhibitor of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:711a7b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:711aa106-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:711ac3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:711aea6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:711b1136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:711b38f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:711b5fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:711b867a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2Q167 biolink:molecularly_interacts_with DrugCentral:345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betacarotene targets Unclassified (Core protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:711bad1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betahistine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:711bd45e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betahistine is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:711bfb1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:711c21b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:711c4484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:711c69be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone benzoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:711c8f70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:711cb57c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:711cdc64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:711cff5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:711d2624-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:711d4cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:711d741c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:711d9b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:711dc1ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:711de898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.53']} DrugCentral uuid:711e0f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:711e37d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betazole is agonist of GPCR (Histamine H2 receptor) DrugCentral uuid:711e5c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:711e8410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:711eaaee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:711ed1ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:711ef8aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:711f1f60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH27 biolink:molecularly_interacts_with DrugCentral:358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bethanechol targets GPCR (Muscarinic receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:711f460c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betanidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:711f6916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bevantolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:711f8bc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:711fb36c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:711fdb80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71200380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:71202d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:71205772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71207e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7120a5a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7120cc66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7120f330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:712119d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:712140d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43174 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:712167a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR63 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:71218e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7121b5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7121de12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Enzyme (Lipoprotein lipase) DrugCentral uuid:712200d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7122276e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:71224f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:71227642-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:71229d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7122c412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezafibrate is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) DrugCentral uuid:7122e6ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:71230954-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:71232c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:71234f54-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:71237218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:712394f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7123bcc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7123e36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71240a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:712430d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:712457d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:71247ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifemelane targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7124a5d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7124cc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7124f3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:71251a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bifonazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:71254174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bimatoprost targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:71256834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bimatoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:712590ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biotin targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7125b78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.32']} DrugCentral uuid:7125deae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7126056e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:71262e72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7126553c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:71267c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biperiden targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:71269eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:7126c670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:7126ed44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisacodyl targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:712713d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisantrene targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:71273a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:71276206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:712788c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7127af90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7127d650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7127fd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bisulepine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:71282024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bitolterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:712842c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bivalirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7128698a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:71289162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7128b854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.854']} DrugCentral uuid:7128df28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blonanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:712905de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:71292dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:712957c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.014']} DrugCentral uuid:71297ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:7129a5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.262']} DrugCentral uuid:7129cc9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7129f35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:712a1b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bopindolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:712a41f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:712a6992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:712a905c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:712ab71c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:712adddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:712b0582-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:712b2c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:712b5320-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:712b79cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:712ba140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:712bc800-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99460 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Cytosolic other (26S proteasome non-ATPase regulatory subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:712beeca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.208']} DrugCentral uuid:712c1602-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:712c3d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:712c6468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:712c8b1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:712cb30a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:712cdb28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:712d0206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:712d28f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:712d4fcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:712d7722-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:712d9de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:712dc4c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:712deb94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:712e13bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:712e3a86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:712e613c-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5PKW4 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Unclassified (PH and SEC7 domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:712e8e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:712e8e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:712e8e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:712ed02c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:712ef6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IJT1 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:712f1db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28063 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.78']} DrugCentral uuid:712f4548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:712f6c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:712f92c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:712fb578-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:712fdc42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:71300398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:71302a58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:71305136-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q29010 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:713077e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:7130a262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21451 biolink:molecularly_interacts_with DrugCentral:392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosentan targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7130cbf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:7130eea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:71311170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bretylium is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:713134de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:71315b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:713182b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7131a996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7131d1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:7131f86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:71321f20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:713245e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:71326d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:71329432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:7132c196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7132c196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7132c196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71330908-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:71330908-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:71330908-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:713347d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:71336e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:713395d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7133bca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7133e36e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:71340a2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7134326a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71345916-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71347fd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7134a682-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7134cdd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7134f498-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:71351b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:71354218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:71356a4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7135910a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7135b7de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7135de9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7136070c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71363092-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7136575c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:71367e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7136a5ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7136cd90-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:7136f4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:71371bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:7137431a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:713769e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:713790a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:7137b764-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brinzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:7137dffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7138096c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:71383036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06479 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:713856e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:71387e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7138a4da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7138cb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7138f228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:71391a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:7139425a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7139691a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:71398fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:7139bfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7139bfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7139bfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7139f89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:713a1f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:713a4a38-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:713a4a38-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:713a7d00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:713aa3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:713aca76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:713af186-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromhexine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:713b186e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.858']} DrugCentral uuid:713b3f38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:713b6620-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:713b8dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:713bb486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:713bdb64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:713c021a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:713c2998-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:713c504e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:713c7704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:713c9dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:713cc506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:713cecb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:713d136c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:713d3a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:713d6236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:713d8900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:713dafca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:713dd69e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:713dfdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:713e24aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:713e4b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:713e722a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:713e99c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:713ec090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:713ee73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:713f0de8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:713f3822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:713f5ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:713f85d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:713fb36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:713fb36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:713fb36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:713ffffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:713ffffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:713ffffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:713ffffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:713ffffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:71405b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:71405b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:71408e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:7140b4d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7140db8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:714103b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:71412a88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:7141522e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:714178bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:71419fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7141c6aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:7141ed60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:714213f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.745']} DrugCentral uuid:71423b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:714261f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:714288b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.319']} DrugCentral uuid:7142af66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bromperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7142d72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7142fdf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.218']} DrugCentral uuid:71432b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71432b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71432b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71436a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brotizolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:71439142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7143b8f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buclizine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7143db98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7143fe5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:714425a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:71444c4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:714472f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71449a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7144c1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.701']} DrugCentral uuid:7144e98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:7145104e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:71453704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:71455e0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budesonide targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:714584ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7145bf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:71462e7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:71465120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:714678d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71469f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7146c22c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:7146e4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:71470782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:71472b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:71474e4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buflomedil targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7147750a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:71479bd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7147c3ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7147e65c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufuralol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.59']} DrugCentral uuid:71480d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7148340e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71485cd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:714883a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bumetanide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7148aa4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7148ccf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:7148f006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:714912ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bunazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:71493584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.399']} DrugCentral uuid:71495c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.263']} DrugCentral uuid:71498386-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:7149aa3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:7149d11a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:7149f7e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:714a1f6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:714a4668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:714a6d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:714a9532-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:714abcb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:714ae3e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.293']} DrugCentral uuid:714b0b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:714b3226-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:714b5954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:714b8000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.233']} DrugCentral uuid:714ba6ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:714bcd58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:714bf4fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:714c1baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z0V1 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:714c4260-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:714c68f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:714c908a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:714cb768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:714cde46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:714d051a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:714d2c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:714d5308-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:714d79e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:714da0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:714dc842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:714df24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:714e1c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buprenorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:714e4312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:714e6aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:714e9164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.796']} DrugCentral uuid:714eb84c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:714ee06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:714f043c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:714f2b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:714f51c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:714f7890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:714fa3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:714fa3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:714fd9b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:714fd9b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:71500c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.569']} DrugCentral uuid:7150332a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.52']} DrugCentral uuid:71505a76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01776 biolink:molecularly_interacts_with DrugCentral:436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7150810e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7150a7ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:7150ce84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7150f760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:71511e20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:715144b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:71516b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:715193be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7151ba6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.435']} DrugCentral uuid:7151e134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:715207ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:71522f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.277']} DrugCentral uuid:71525628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:71527dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.471']} DrugCentral uuid:7152a484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7152cb9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7152f254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:71531914-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:71533ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:71536a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:71539150-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7153b7fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7153deb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:71540608-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:71542caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71545356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:71547a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7154a130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7154c7d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:7154f874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7154f874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7154f874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7154f874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:71554dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71554dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71554dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:715599d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:715599d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:715599d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:715599d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:715599d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7155f92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:7155f92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:7155f92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:71563e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:71563e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:71563e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:71567f1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 busulfan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.283']} DrugCentral uuid:7156aca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7156aca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7156aca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7156eaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7156eaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7156eaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:715727f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:71574eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:7157763a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:71579d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:7157c432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7157ead4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.161']} DrugCentral uuid:71581180-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:71583494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.805']} DrugCentral uuid:71585b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7158820a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92206 biolink:molecularly_interacts_with DrugCentral:444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butenafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.347']} DrugCentral uuid:7158a9e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:7158cdc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:7158f4ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:71591b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:71594244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:71596990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:71599064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.405']} DrugCentral uuid:7159b706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7159d9b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:7159fc98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:715a1f70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:715a422a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:715a68fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:715a8fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:715ab8d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:715adf96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:715b0674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:715b2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:715b54bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:715b7b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:715ba250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:715bc924-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:715bf3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:715c1aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:715c42b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:715c697e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:715c92a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:715cb97e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:715ce020-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cadralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:715d02d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cadralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:715d2ac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:715d5186-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:715d7846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:715d9f1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:715dc756-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:715dee16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:715e14ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:715e3b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:715e6328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:715e89de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:715eb09e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:715ed74a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:715f02a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:715f02a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:715f3f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:715f3f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:715f3f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:715f3f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:715f8a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2T3 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets Enzyme (Guanine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:715fb106-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:715fd7c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:715ffea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcifediol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:71602348-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:465 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcipotriene is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:716049fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:71606cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:71609364-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:7160b6dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02774 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Secreted (Vitamin D-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7160dd92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:71610452-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42392 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.6']} DrugCentral uuid:71612b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28037 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7161525e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RGC1 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:71617914-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9PTN2 biolink:molecularly_interacts_with DrugCentral:466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:71619fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camphor targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7161c662-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camphor is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:7161edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7162164e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71623e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:716264f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01177 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:71628c5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:7162b306-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7162d9a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:71630054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7163275a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:71634e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:471 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:71637552-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:472 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 camylofin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:71639bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7163c39a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7163ed84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:71641822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:71643f0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBT6 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase kappa) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7164666a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNA4 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase iota) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:71648d34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y253 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase eta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:7164b3ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7164daaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:716501ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:7165288e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:71654f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:71657618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:71659e36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:7165c834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7165ef26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 candesartan cilexetil targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:716615f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canrenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:71663d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capecitabine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:71666028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:716686f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7166ae66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7166d5f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7166fcb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:71672378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:71674a24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:716771e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:71679966-59f3-11ec-9eaa-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7167c01c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7167e7cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q93T40 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase II) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:71680f4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:716836aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 captopril targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71685d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:71688448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7168ab58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7168d38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7168fa40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caramiphen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:71692100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.94']} DrugCentral uuid:7169491e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:716972b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:71699c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7169c600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7169ede2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:716a14a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:716a3b3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:716a61e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:716a88d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.577']} DrugCentral uuid:716aaf70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:716ad5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:716afcbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:716b2568-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:716b4c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:716b72fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:716b99b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:716bc1bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:716be886-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:716c0f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.74']} DrugCentral uuid:716c35f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:716c605e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:716c605e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:716c9696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:716c9696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:716cccce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:716cccce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:716d04aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:716d04aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:716d3af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:716d3af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:716d711a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:716d711a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:716db238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:716db238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:716db238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:716db238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:716db238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:716e08dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:716e2be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.495']} DrugCentral uuid:716e53d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.125']} DrugCentral uuid:716e7ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:716ea292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:716ecb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:716ef576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:716ef576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:716ef576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:716f305e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:716f305e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:716f6380-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H461 biolink:molecularly_interacts_with DrugCentral:489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamazepine is allosteric modulator of GPCR (Frizzled-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:716f8a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:716fb0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:716fd784-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71700e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71706fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone is inhibitor of Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:71709804-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7170c1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51661 biolink:molecularly_interacts_with DrugCentral:493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7170e926-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:71710fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:71713714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:71715dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:717184b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:7171ab86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7171d3b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7171fa6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7172212e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:7172480c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbetocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.149']} DrugCentral uuid:71727070-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa is inhibitor of Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:717295d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.168']} DrugCentral uuid:7172bcf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:7172e398-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbidopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71730ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbimazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:71733168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbimazole is inhibitor of Enzyme (Thyroid peroxidase) DrugCentral uuid:71735422-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbinoxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7173774a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carboprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:71739d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:71739d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7173e59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7174483c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:510 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carubicin targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:71746da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:717494b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:7174bb78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P7S1 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7174e54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13510 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:717510e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmofur targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7175379c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carmustine is inhibitor of Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:71755f2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:71758242-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:7175a8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocarnitine targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:7175cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:515 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7175f650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18910 biolink:molecularly_interacts_with DrugCentral:515 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:71761e82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:71764326-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfenazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:7176661c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carpipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:71768cc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carpipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7176b3e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7176da8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:7177011c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:717727b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:71774f82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7177762e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carprofen targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:71779ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carteolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7177c3ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carteolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7177ebd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carumonam targets Enzyme (Peptidoglycan synthase FtsI) DrugCentral uuid:71780e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is inhibitor of Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7178353c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:71785c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:71788366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:7178aa1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:7178d0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7178f80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:71791f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7179472e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:71796de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.273']} DrugCentral uuid:717995da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.476']} DrugCentral uuid:7179be02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:7179e792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:717a0e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:717a354e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:717a5c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:717a8328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:717aaa2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:717ad116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:717af88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:717b1f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:717b4614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.054']} DrugCentral uuid:717b6cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:717b94de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:717bbe50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:717be506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.706']} DrugCentral uuid:717c0bc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:717c32d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:717c5978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:717c8038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:717ca6f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:717cce3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:717cf4f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:717d1c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:522 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carvedilol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:717d431a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefacetrile targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:717d66a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:717d8992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717dc3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e25c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.14']} DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717e6042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717ec21c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.09']} DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717efe76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f642e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717f9a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:717ffd6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54286 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Enzyme (Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase) DrugCentral uuid:7180201c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:718042c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71807e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7180deee-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefdinir targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7181057c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:71812b06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q54906 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71816242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7181d7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71823a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:71825dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:71828082-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7182a6fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7182e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71834936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19174 biolink:molecularly_interacts_with DrugCentral:537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefixime targets Enzyme (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71838428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7183e530-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71841c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71847d56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7184a416-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7184cd42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7184f3ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:718517b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:71853e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71857954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7185da84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71861238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71867462-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7186adb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71870e90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:718735d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.512']} DrugCentral uuid:71875c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.659']} DrugCentral uuid:7187833e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7187a9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7187d172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.617']} DrugCentral uuid:7187f90e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:71881fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:7188424c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:718869de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71889076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:7188b704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7188f200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189534e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:718975fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:71899d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam targets GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7189d7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718a3b38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:718a5dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) DrugCentral uuid:718a8052-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:718aa708-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:718acdaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:718af4ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718b2f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ba5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718c06fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefprozil targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:718c2cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:718c53be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.522']} DrugCentral uuid:718c7a56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:718ca0f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:718cc812-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:718ceeb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:718d1556-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5A7N4 biolink:molecularly_interacts_with DrugCentral:558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefsulodin targets Unclassified (tRNA 2'-phosphotransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:718d3c02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.261']} DrugCentral uuid:718d63bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.534']} DrugCentral uuid:718d8aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:718db13c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q1J5W5 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein) DrugCentral uuid:718dd3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60FU1 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e0ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718e6eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:718e91a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime targets Enzyme (Beta-lactamase) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718ec824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:718f2af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.142']} DrugCentral uuid:718f51b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.513']} DrugCentral uuid:718f7878-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.744']} DrugCentral uuid:718f9f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.213']} DrugCentral uuid:718fc80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftriaxone targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:718feefc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:7190118e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:71903830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:71905f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719099ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71910f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719171c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:71919928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7191bfde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:7191e6a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.477']} DrugCentral uuid:71920d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7192348c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:71925b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.917']} DrugCentral uuid:719281f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7192a8b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7192d00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.856']} DrugCentral uuid:7192f6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:71931d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:71934412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:71936d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:719393cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7193ba82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7193e138-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:71940848-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:71942f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:7194564a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:71947cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:7194a53c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7194cbe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7194f2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:719519a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7195414a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:719567d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:71958e7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:7195b526-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.627']} DrugCentral uuid:7195dcc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.29']} DrugCentral uuid:719603e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:71962a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7196513e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7196789e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:71969f4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7196c5ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7196ec8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71971452-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HZR1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:71973afe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7197620e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:719788b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7197afb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7197d680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7197fd2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:719823d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:71984b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:719872fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:71989aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7198c14e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:7198e9d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O78750 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71991248-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:71993976-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:719960a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:719987aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:7199ae6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:7199d520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7199fd02-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:719a2444-59f3-11ec-9eaa-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:719a4adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:719a7192-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:719a9848-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:719ac0de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:719aea3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:719b111a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 celiprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:719b3820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:719b5bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16348 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin targets Transporter (Solute carrier family 15 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719b963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719c6e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:719c96d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:719cb98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:719ce03a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:719d06f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:719d2e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:719d5542-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35236 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719d8fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:719df1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:719e184c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:719e3ee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:719e6748-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:719e93e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:719ebac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:719ee164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:719f086a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:719f2f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:719f56c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:719f7958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:719fa0c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:719fc750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:719fee06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:71a0149e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:71a03cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:71a0643a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71a08ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:71a0b16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71a0d852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:71a0fef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a13c52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a1a084-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:71a1c320-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:71a1e9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a227b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71a292a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:71a2b686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:71a2dd1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerivastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:71a303ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:71a32a58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00488 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Coagulation factor XIII A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:71a351b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:578 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cerulenin targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71a37850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceruletide is agonist of GPCR (Cholecystokinin receptor type A) DrugCentral uuid:71a39b00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:71a3c31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:71a3eb8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetirizine targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:71a41242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrorelix targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:71a434fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrorelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:71a45c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:71a48330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.983']} DrugCentral uuid:71a4a9d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:71a4d056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.883']} DrugCentral uuid:71a4f6e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.201']} DrugCentral uuid:71a51e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:71a5450e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.93']} DrugCentral uuid:71a56ba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:71a5923e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:71a5b994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13443 biolink:molecularly_interacts_with DrugCentral:588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorambucil targets Enzyme (Disintegrin and metalloproteinase domain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:71a5e040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:71a606e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62580 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Chloramphenicol acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:71a62d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:71a6546c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q88N29 biolink:molecularly_interacts_with DrugCentral:589 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloramphenicol targets Unclassified (Probable HTH-type transcriptional regulator TtgR) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:71a67c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorcyclizine targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:71a6a2dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:71a6c99c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:71a6f0de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:71a717da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:71a73e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:71a76546-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:71a78d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:71a7bb2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:71a7bb2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:71a7bb2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:71a80118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:71a80118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:71a80118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:71a846fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:71a846fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:71a846fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:71a88c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:71a88c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:71a88c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:71a8d250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:71a8d250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:71a8d250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71a94352-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71aa9734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71aa9734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71aacd30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71aacd30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71ab00f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:71ab279e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:71ab5070-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:71ab771c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71ab9dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:71abc460-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:71abeb52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:71ac11fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71ac38b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:71ac5f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorhexidine targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71ac868e-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:71acad3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.764']} DrugCentral uuid:71acd3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:71acfa74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:71ad24d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlormadinone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.163']} DrugCentral uuid:71ad550a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:71ad550a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:71ad550a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:71ad8c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:71adb0ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloropyramine targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:71add7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:71adfe60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:71ae250c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71ae4cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:71ae73a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:71ae9b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:71aec1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:71aeeb4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:71af1534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:71af3e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:71af64da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:71af8c12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:71afb2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:71afd956-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05227 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Cytosolic other (Histidine-rich protein PFHRP-II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:71affff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:71b0274e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71b04e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:71b074a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:71b09b7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N6S8 biolink:molecularly_interacts_with DrugCentral:607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroquine targets Enzyme (Cysteine proteinase falcipain 2a) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:71b0c424-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorothiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:71b0e6de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['5.43']} DrugCentral uuid:71b10d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorotrianisene targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:71b13026-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorotrianisene is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:71b1533a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:71b179f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:71b1a0b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:71b1c766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:71b1eeb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:71b2154a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:71b23be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.818']} DrugCentral uuid:71b2627a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:71b28ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:71b2b1a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:71b2d868-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:71b2ff28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:71b32642-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:71b35432-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71b35432-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71b35432-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71b392bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:71b3ba1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96JM7 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:71b3e2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05BQ5 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Unclassified (MBT domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:71b4097c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:71b43014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.842']} DrugCentral uuid:71b45814-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphenamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:71b481d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphentermine is substrate of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.471']} DrugCentral uuid:71b4a9a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorphentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.404']} DrugCentral uuid:71b4d046-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:71b4f756-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.987']} DrugCentral uuid:71b51e0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorproethazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:71b544c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.233']} DrugCentral uuid:71b56b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:71b592ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:71b5b984-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:71b5e03a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:71b606d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:71b62f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71b6560a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:71b67cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:71b6a39e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:71b6cac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:71b6f18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:71b71838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:71b73eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:71b7664e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:71b78cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:71b7b3ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:71b7da7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:71b80270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71b82ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:71b853a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.759']} DrugCentral uuid:71b87a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:71b8a180-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:71b8c82c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.746']} DrugCentral uuid:71b8eece-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.251']} DrugCentral uuid:71b91570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:71b93cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:71b96372-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:71b98a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:71b9b0de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:71b9d834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:71b9fff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:71ba26ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:71ba4d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:71ba7640-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:71ba9cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:71bac3a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:71baea6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:71bb187a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:71bb187a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:71bb187a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:71bb5704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:71bb7db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:71bba4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:71bbce46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:71bbf4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:71bc1b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.061']} DrugCentral uuid:71bc4290-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.713']} DrugCentral uuid:71bc6928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.569']} DrugCentral uuid:71bc8fde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71bcb68a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:71bcddd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.043']} DrugCentral uuid:71bd04aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:71bd2b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.797']} DrugCentral uuid:71bd523e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:71bd798a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:71bda18a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.835']} DrugCentral uuid:71bdc854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:71bdef32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:71be1656-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.777']} DrugCentral uuid:71be3d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:71be63a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71be8a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:71beb1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:71bed88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:71beff58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:71bf260e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:71bf4ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:71bf749c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71bf9b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:71bfc21c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71bfe8be-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:71c00fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c04afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c0cf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71c1501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71c1501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71c1501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71c1501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71c1501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:71c1ada2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:71c1ada2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:71c1ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71c1ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71c1ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71c1ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71c1ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:71c24b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:71c24b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:71c24b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:71c29140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:71c29140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:71c29140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c2e708-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:71c36d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:71c39432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71c3baca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04925 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Unclassified (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71c3e194-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpromazine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71c4084a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:71c4334c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:71c4334c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:71c46786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:71c48e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:71c4b524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.367']} DrugCentral uuid:71c4de00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:71c50556-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:71c52c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:71c552f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:71c57a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:71c5a0b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:71c5c75c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:71c5ee08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:71c61644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:71c63cf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.194']} DrugCentral uuid:71c663c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:71c68a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:71c6b252-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral uuid:71c6d994-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorprothixene targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:71c70036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71c726e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Surface antigen (Major prion protein) DrugCentral uuid:71c749e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortetracycline targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71c77066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.56']} DrugCentral uuid:71c79726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:71c7b9cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:71c7e140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:71c807f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:71c82eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:71c85576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:71c87d58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:71c8a4f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:71c8cbbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71c8f27e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:71c9198e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:71c94044-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:625 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:71c96718-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71c98dc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:71c9b51a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:71c9dcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29474 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, endothelial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:71ca0376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29476 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.554']} DrugCentral uuid:71ca2a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:71ca5254-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorzoxazone is opener of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:71ca7c0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:71caa736-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:71cad03a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:71caf768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:71cb1e1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:71cb44de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:71cb6b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:71cb931c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.31']} DrugCentral uuid:71cbb9e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:71cbe0b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:71cc0766-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:71cc2f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:71cc5662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:71cc7da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:71cca45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:71cccb88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:71ccf220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.39']} DrugCentral uuid:71cd18f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:71cd3fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:71cd6728-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:71cd8e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:71cdb5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71cddc62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:71ce041c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4QEW7 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:71ce2ae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:71ce51b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:71ce7866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:71ce9f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:71cec60e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:71cee8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cibenzoline targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:71cf0f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:71cf36de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:71cf5da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:71cf8454-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:71cfab0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:71cfd314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:71cffc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:71d022ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:71d049c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicaprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:71d070c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d0a762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:71d10a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:71d13204-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:71d158c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox is inhibitor of Unclassified (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:71d17f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:636 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclopirox targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:71d1a752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicloprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:71d1d038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cicloprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:71d1f70c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cidofovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:71d219c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16444 biolink:molecularly_interacts_with DrugCentral:640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilastatin is inhibitor of Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:71d240ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22412 biolink:molecularly_interacts_with DrugCentral:640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilastatin targets Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:71d267aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilazapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:71d28e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71d2b930-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:71d2b930-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:71d2e72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71d30dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71d33482-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:71d35b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:71d3845a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:71d3ab1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:71d3d1c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:71d3f87c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is inhibitor of Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:71d41f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:645 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:71d446d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:71d46d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:71d4941c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:71d4bb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinacalcet is allosteric modulator of GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:71d4e23c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinalukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:71d509ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinalukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:71d52cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:71d5542e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:71d57aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:71d5a208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:71d5c8be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:71d5eff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.552']} DrugCentral uuid:71d616ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.208']} DrugCentral uuid:71d63d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.987']} DrugCentral uuid:71d66440-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:71d68ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:71d6b26a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:71d6da6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.064']} DrugCentral uuid:71d70120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:71d7297a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:71d75094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:71d7774a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:71d79dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:71d7c592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:71d7ec48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:71d812fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.242']} DrugCentral uuid:71d839c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.299']} DrugCentral uuid:71d8611e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.793']} DrugCentral uuid:71d887d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:71d8ae62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.97']} DrugCentral uuid:71d8dcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:71d8dcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:71d8dcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:71d91f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:71d94962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:71d94962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:71d976a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:71d99dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:71d9c464-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q45066 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:71d9ebf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:71da12a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:71da3a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:71da60c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dab8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:71dba752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71dba752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71dbdb50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciprofloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:71dc02c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:71dc298e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:71dc5030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:71dc76d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:71dc9e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:71dcc880-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:71dcef9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:71dd1650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:71dd3d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71dd6420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:71dd8ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:71ddb1d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:71ddd946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71ddfff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.281']} DrugCentral uuid:71de26b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:71de4dea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.947']} DrugCentral uuid:71de75ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:71de9fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:71dec914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.472']} DrugCentral uuid:71deefd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:71df16e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.063']} DrugCentral uuid:71df3da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:71df646e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71df8b24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:71dfb25c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:71dfd930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:71dfffdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:71e02692-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:71e04ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:71e07b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:71e07b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:71e0bb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:71e0bb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:71e0bb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:71e0bb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:71e0bb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:71e11bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e11bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e11bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e11bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e16e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e16e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e16e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:71e1b548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:71e1b548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:71e1b548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:71e1f3f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:71e22280-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:71e22280-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:71e22280-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:71e2610a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:71e287b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:71e2ae62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.935']} DrugCentral uuid:71e2d590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:71e2fc3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:71e32310-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.931']} DrugCentral uuid:71e349c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:71e37176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.456']} DrugCentral uuid:71e39818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:71e3bee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:71e3e598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:71e40f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:71e4387c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:71e45f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:71e485ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:71e4adb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:71e4d46c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:71e4fb40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:71e522c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:71e54a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:71e570d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q48255 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71e5978a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15474 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:71e5be4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPK8 biolink:molecularly_interacts_with DrugCentral:666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 citric acid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71e5e87a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:71e60dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.441']} DrugCentral uuid:71e636f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:71e65dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cladribine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:71e684ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:668 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clarithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:71e6ab5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'MPC', 'has_quantitative_value': ['8.719']} DrugCentral uuid:71e6d21c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.187']} DrugCentral uuid:71e6f8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:71e71ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71e74684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:71e76e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:71e79580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:71e7bfc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:71e7e95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:71e812ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:71e839e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:71e86096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:71e8874c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:71e8ae0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:71e8d544-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:71e8fbf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:71e92382-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:71e94a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:71e971e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:71e99b82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4TVR4 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:71e9c292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:71e9e934-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:71ea1026-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A3M1 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:71ea36dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:71ea5d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:71ea848e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:669 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:71eaabb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:71ead272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:71eaf91e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71eb1fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:71eb47ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:71eb6f84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:71eb963a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:71ebbcf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:71ebe40a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:71ec1164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71ec1164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71ec1164-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:71ec56a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:71ec56a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:71ec56a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:71ec95f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:71ecbdb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:71ece47c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:71ed0b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:71ed34cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:71ed5ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:71ed838c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.036']} DrugCentral uuid:71edaa56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:71edd170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:71edf830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:71ee1efa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:71ee45ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.604']} DrugCentral uuid:71ee6d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:71ee93f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:71eeba90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:71eee13c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:71ef08b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.084']} DrugCentral uuid:71ef2f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.558']} DrugCentral uuid:71ef5630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:71ef7ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:71efa414-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:71efcac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:71eff14e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:71f0180e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:71f03ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:71f066b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:71f08e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:71f0b534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:71f0ddca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:71f10480-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemastine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:71f12b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:71f151e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:71f178de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN4 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:71f19f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:71f1c62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:71f1ecd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:71f2141a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:71f23ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:71f261b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:71f2885a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:71f2b154-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:71f2d828-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:674 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:71f2faec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:674 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:71f31da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:71f340b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:71f36766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clindamycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:71f38a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:71f3b0b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:71f3d7f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:71f3fffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:681 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clioquinol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:71f42d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:71f42d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:71f42d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:71f465ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05141 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 2) DrugCentral uuid:71f48966-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12235 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Transporter (ADP/ATP translocase 1) DrugCentral uuid:71f4ac02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12236 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 3) DrugCentral uuid:71f4ce9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:71f4f158-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT1 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid is inhibitor of Transporter (Solute carrier family 17 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:71f5185e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clodronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:71f53f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:71f561c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:71f588ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:71f5b002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:71f5d294-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HA47 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 1) DrugCentral uuid:71f5f59e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZX2 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 2) DrugCentral uuid:71f6183a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:691 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofarabine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:71f63fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L2G3 biolink:molecularly_interacts_with DrugCentral:692 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofazimine targets Enzyme (Uncharacterized oxidoreductase CzcO-like) DrugCentral uuid:71f6627c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:692 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofazimine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:71f6891e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:71f6afd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:71f6d662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Enzyme (Lipoprotein lipase) DrugCentral uuid:71f6f962-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:71f72004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofibric acid targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:71f7469c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clometacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:71f76d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.461']} DrugCentral uuid:71f794a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:71f7bb68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:71f7e200-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.745']} DrugCentral uuid:71f808b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:71f833c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:71f85a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:71f88142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:71f8a82a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.062']} DrugCentral uuid:71f8cf6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:71f8f636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:71f91cf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:71f943a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:71f96b0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:71f991b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:71f9b85a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.889']} DrugCentral uuid:71f9df10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.358']} DrugCentral uuid:71fa0a44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:71fa310e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:71fa57b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.371']} DrugCentral uuid:71fa7e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.668']} DrugCentral uuid:71faa594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:71facc40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:71faf2c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:71fb1998-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:71fb4184-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.979']} DrugCentral uuid:71fb681c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:71fb8ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.778']} DrugCentral uuid:71fbb5a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:71fbdd42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:71fc04fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:71fc2bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:71fc5272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:71fc7978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:71fca02e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:71fcc6ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:71fcedb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:71fd1522-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.703']} DrugCentral uuid:71fd3bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:71fd628e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:71fd8944-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:71fdb266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:71fdd91c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:71fdffc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:71fe2674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:71fe4d8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.412']} DrugCentral uuid:71fe744e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.007']} DrugCentral uuid:71fe9afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.696']} DrugCentral uuid:71fec1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:71fee924-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:71ff0fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:71ff36ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:71ff5d78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:71ff84d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.319']} DrugCentral uuid:71ffab70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:71ffd334-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:71fff9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:72002154-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:7200481e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Glutathione S-transferase P) DrugCentral uuid:72006ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:720092ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7200ba42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:7200e116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.937']} DrugCentral uuid:7201084e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:72012edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:72015808-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:72017eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7201a54c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7201f740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7202c4c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7202c4c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7202c4c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7202c4c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7203176a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7203176a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7203176a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:72035cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:72035cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:72035cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:72039b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39051 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7203c2a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clomipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7203f00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:7203f00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:7203f00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:720460d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:72055192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7205e5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7206c48c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7206ebba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:72071284-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:72073962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:72076086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:72078746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7207adfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7207d4bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7207fbc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:72082264-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:72084a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7208712e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:72089974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7208c368-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7208ea46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:7209117e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:720938de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:72095f9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:72098654-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:7209ad0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7209d41a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7209fbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:720a2262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:720a4fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:720a4fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:720a4fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:720a930a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70507 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:720ab9de-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:720ae080-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clonixin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:720b07cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloperastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:720b2e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.524']} DrugCentral uuid:720b554c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:720b7c0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopidogrel targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:720ba9f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:720ba9f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:720ba9f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:720bef2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:720bef2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:720bef2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:720c2d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:720c2d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:720c2d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:720c710c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:720c710c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:720c710c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:720ca88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:720ccf44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:720cf76c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:720d1e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:720d44d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:720d7930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:720d7930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:720d7930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:720d7930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:720d7930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:720dd7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:720dd7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:720dd7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:720e1840-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:720e3f1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.379']} DrugCentral uuid:720e65d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:720e8c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.136']} DrugCentral uuid:720eb3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:720eda78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:720f0138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:720f2870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.351']} DrugCentral uuid:720f4f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:720f7622-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:720f9cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:720fc398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:720fec06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.104']} DrugCentral uuid:7210147e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.995']} DrugCentral uuid:72103c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:721062ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:72108a44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7210b118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.235']} DrugCentral uuid:7210d7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.429']} DrugCentral uuid:7210fea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:72112738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.466']} DrugCentral uuid:72114ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:72117562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:72119c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:7211c3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:7211ea7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:72121152-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:72123812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.267']} DrugCentral uuid:72125f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:721285e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.106']} DrugCentral uuid:7212acac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:7212d362-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7212fab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:72131d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:7213441e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.521']} DrugCentral uuid:72136aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:721392ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.598']} DrugCentral uuid:7213bcf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:7213dfbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:7214067e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:72142e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.712']} DrugCentral uuid:72145520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:72147bd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.645']} DrugCentral uuid:7214a30e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7214ca64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:7214f124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.159']} DrugCentral uuid:721517c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:72153e72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.058']} DrugCentral uuid:721565c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.089']} DrugCentral uuid:72158c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7215b334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7215d9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.497']} DrugCentral uuid:721600dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:72162774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:72164e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:721674f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:72169c68-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7216c30a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.471']} DrugCentral uuid:7216e9ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:721710a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.906']} DrugCentral uuid:72173844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:72175efa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:7217859c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.942']} DrugCentral uuid:7217ac52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7217d358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7217faea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:721821b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72184860-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:72186fe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.99']} DrugCentral uuid:721896b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7218bd5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7218e41e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72190bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:72193298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPN5 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Putative cytochrome P450 130) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:72195944-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7219800e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:7219a7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7219cea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clotrimazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7219f548-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:721a191a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:721a4098-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:721a6762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:721a8e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:721ab4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:721ae9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:721ae9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:721ae9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:721ae9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:721ae9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:721b367e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxazolam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:721b5d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:721b8444-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.783']} DrugCentral uuid:721babfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:721bd2c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:721bf988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.154']} DrugCentral uuid:721c20d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:721c4776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:721c6e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:721c94ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:721cbce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:721ce3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:721d0a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:721d3136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:721d5832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:721d7efc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:721da5bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:721dcca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:721df3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:721e1aba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.594']} DrugCentral uuid:721e417a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:721e6830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:721e9062-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:721eb77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.181']} DrugCentral uuid:721ede28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:721f04d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.591']} DrugCentral uuid:721f2bda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:721f5272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.792']} DrugCentral uuid:721f7a4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:721fa0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:721fc84c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:721fef16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72201658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:72203e3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:72206694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72208dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7220b46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:7220db10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22310 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (UDP-glucuronosyltransferase 1-4) {'has_attribute_type': 'IAO:0000004', 'name': 'app Km', 'has_quantitative_value': ['4.208']} DrugCentral uuid:7221022a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:722128ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72214faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72217674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.445']} DrugCentral uuid:72219e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7221c4da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7221eba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:72221250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:72223aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:7222639a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:72228a46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7222b0fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7222d820-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7222fec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7223258c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:72234c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7223749c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:72239b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:7223c226-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7223e8e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:72241140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:72243a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:722460f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:722487a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7224aee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7224d59e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:7224fc7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:72252314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:72254a7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:72257120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:722597d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7225be8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7225e75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:72260e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:722634e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:72265ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:722682cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7226ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7226ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7226ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7226ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7226ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7226ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7226ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:722750bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:722750bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:722750bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:722750bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7227a206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7227a206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7227a206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7227e8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7227e8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:722828a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:722828a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:722828a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:722828a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:722828a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7228866c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7228866c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7228866c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7228dc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:72295ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:72295ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:72295ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7229a060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7229c77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7229ee1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:722a14e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clozapine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:722a3be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:722a5e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:722a8552-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:722aac12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:722ad4a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:722afb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:722b221e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:722b48d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:722b7296-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:722b9c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:722bc37c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:722bea28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:722c0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:722c33ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:722c56a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:722c7d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:722ca4f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:722ccbaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:722cf35a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:722d19f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:722d46e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:722d46e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:722d82ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:722d82ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:722d82ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:722dc118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27922 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:722de832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GJT6 biolink:molecularly_interacts_with DrugCentral:723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:722e0efc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:722e35c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:722e5c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:722e8de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:722e8de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:722e8de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:722e8de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:722ed80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:722efeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.801']} DrugCentral uuid:722f262a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:722f48c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.49']} DrugCentral uuid:722f6f68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:722f960a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:722fbd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:722fe3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:72300ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6B856 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin beta-2B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:72303182-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine is inhibitor of Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:723059f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27957 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Unclassified (Tubulin polymerization-promoting protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:72308092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin beta-4B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7230af40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7230af40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7230af40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7230f234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7230f234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:723124de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08828 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:72315256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:72315256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:72315256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:72319162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7231b818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19754 biolink:molecularly_interacts_with DrugCentral:729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7231deec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:723205ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:72322d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:723253f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:72327abe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conivaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:7232a192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7232cbb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:7232ee7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:72331550-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:72333c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:723363c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:72338ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:72338ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7233c1bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cortivazol is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7233e5b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cotinine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:72340866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:72342f1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:723455dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:72347c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7234a44c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7234caf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7234f1c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:72351882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:72353f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:72356648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72358d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7235b3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7235db46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:723601fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:72362894-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:72364f5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q33BM1 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G protein-coupled receptor GPR35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:723678d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES90 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7236a0a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7236c772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25815 biolink:molecularly_interacts_with DrugCentral:741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cromoglicic acid targets Cytosolic other (Protein S100-P) DrugCentral uuid:7236e9fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:72371114-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:723737c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72375e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:72378662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7237ade0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7237d482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.602']} DrugCentral uuid:7237fb4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:723821e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:72384994-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:7238704a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:7238970a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:7238bda2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyamemazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:7238e4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.235']} DrugCentral uuid:72390bb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:7239328c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:72395960-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:723980e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.993']} DrugCentral uuid:7239a82a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.353']} DrugCentral uuid:7239ceea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:7239f5be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.385']} DrugCentral uuid:723a1fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:723a4848-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.924']} DrugCentral uuid:723a6f12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:723a95b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:723abcec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.206']} DrugCentral uuid:723ae38e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:723b0a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:723b2cd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:723b5526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.728']} DrugCentral uuid:723b7bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:723ba274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:723bc948-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.541']} DrugCentral uuid:723bf224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.812']} DrugCentral uuid:723c18e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:723c3f90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:723c665a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:723c8d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.829']} DrugCentral uuid:723cb434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:723cdad6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:723d02b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:723d2a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:723d50ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclobenzaprine targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:723d77a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclofenil targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:723d9e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclofenil targets Nuclear other (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:723dc5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:723decb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:723e137e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:723e3a48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:723e614e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:723e880e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:723eaece-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:723ed58e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclopentolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:723ef8e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclophosphamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:723f2098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:723f4712-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:723f6dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:723f96c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:723fbd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:723fe47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:72400b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WQA8 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Enzyme (Alanine racemase) DrugCentral uuid:72402e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:724054c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60391 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:72407b96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WP31 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine is inhibitor of Enzyme (D-alanine--D-alanine ligase) DrugCentral uuid:72409e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WQA9 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine is inhibitor of Enzyme (Alanine racemase) DrugCentral uuid:7240c204-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7240e8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7241230c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:724198aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7241bf6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:7241e602-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:72420cfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:724233a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72425a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is modulator of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:7242821a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7242a984-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:7242d01c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7242f862-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72431f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:72434696-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02790 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:72436d38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:724393da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23284 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.01']} DrugCentral uuid:7243ba9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7243e1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7244086a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:72442f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08752 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:724455ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:72447d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7244a3f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7244cab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHG7 biolink:molecularly_interacts_with DrugCentral:760 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciclosporin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7244f176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:7245162e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72453cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:72456386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:72458a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:7245bb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7245bb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7245bb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7245bb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:72460728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:72462dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:724655b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05412 biolink:molecularly_interacts_with DrugCentral:762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclovalone targets Transcription factor (Transcription factor AP-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:72467c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cycrimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:72469f08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:7246c5be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:7246ed3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:724713f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.855']} DrugCentral uuid:72473aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:72475d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:724784ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7247ab6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:7247d22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.419']} DrugCentral uuid:7247f8e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.812']} DrugCentral uuid:7248203a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.652']} DrugCentral uuid:724846f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:72486d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72489452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7248bcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7248e3a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:72490bb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:7249325e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:72495978-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.185']} DrugCentral uuid:72498038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7249a6da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7249cd90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7249f5d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:724a1ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.559']} DrugCentral uuid:724a434c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:724a6a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:724a9392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:724aba70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:724ae7ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:724ae7ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:724ae7ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:724b1f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:724b4634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:724b6cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:724b9436-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:724bbbaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:724be256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:724c0902-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:724c2fcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:724c5812-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:724c7fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:724ca696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:724ccd56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:724cf448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:724d283c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:724d283c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:724d283c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:724d283c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:724d283c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:724d8dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:724d8dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:724d8dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:724d8dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:724d8dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:724deaf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:724deaf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:724deaf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:724e315a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:724e315a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:724e315a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:724e7160-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproheptadine targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:724e9802-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:724ebf44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:724ee604-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:724f0cba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:724f3352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:724f5aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.315']} DrugCentral uuid:724f8168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyproterone acetate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:724fa80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:769 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cysteine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:724fced4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15309 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (Prostatic acid phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'GI50', 'has_quantitative_value': ['7']} DrugCentral uuid:724ff648-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:72501fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Enzyme (DNA polymerase beta) DrugCentral uuid:72504c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:72504c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:72504c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:725089d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytarabine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7250b146-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacarbazine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.255']} DrugCentral uuid:7250d8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14181 biolink:molecularly_interacts_with DrugCentral:773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacarbazine targets Enzyme (DNA polymerase alpha subunit B) DrugCentral uuid:7250fb88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62993 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72512216-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7251498a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60631 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7251702c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96IV0 biolink:molecularly_interacts_with DrugCentral:774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dactinomycin targets Enzyme (Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:725197a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7251be56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7251e5fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:72520cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:72523386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:72525a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:7252816a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7252a80c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7252cec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7252fc12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7252fc12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7252fc12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:72533b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:72536206-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28731 biolink:molecularly_interacts_with DrugCentral:776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabigatran etexilate targets Unclassified (Thrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:725388bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:7253b134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:7253d808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.163']} DrugCentral uuid:7253ffc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.087']} DrugCentral uuid:72542678-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:72544ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:7254759c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.976']} DrugCentral uuid:72549c5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:7254c2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.425']} DrugCentral uuid:7254ea68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.708']} DrugCentral uuid:72551128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:725537e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:72555e9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.265']} DrugCentral uuid:725586a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7255ad5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:7255d428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:7255faf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:72561e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:725640c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7256673a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Enzyme (Steryl-sulfatase) DrugCentral uuid:725689ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7256b154-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.053']} DrugCentral uuid:7256d81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:7256ff6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 danazol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:7257263e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.757']} DrugCentral uuid:72574df8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15413 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 3) DrugCentral uuid:725770a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dantrolene targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7257977c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.929']} DrugCentral uuid:7257be46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.762']} DrugCentral uuid:7257e650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:72580d1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:725833f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:725856bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.279']} DrugCentral uuid:72587d9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.388']} DrugCentral uuid:7258a52c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:7258c7dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:7258ee88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:72591534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:72593dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:725964d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:72598b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone is inhibitor of Enzyme (Dihydropteroate synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7259b23c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7259d94c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7259ffe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:725a2294-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:725a4972-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:725a70c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:725a9760-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q57P83 biolink:molecularly_interacts_with DrugCentral:783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daptomycin targets Transporter (Outer membrane porin protein OmpD) DrugCentral uuid:725abb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:725ae1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:725b0a7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:725b3120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:725b57d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:725b7eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:725ba5ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:725bcd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:725bf448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:725c1afe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:725c4222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:725c68ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:725c8fac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:725cb66c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:725ce07e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:725d0748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:725d2de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Breakpoint cluster region protein) DrugCentral uuid:725d50a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:725d77c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:725d9e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:725dc566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:725dec3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.07']} DrugCentral uuid:725e139a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:725e3a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:725e60fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:725e87b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:725eb07a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:725ed73a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:725efddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:725f24a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.33']} DrugCentral uuid:725f4bca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:725f7280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:725f9a44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.46']} DrugCentral uuid:725fc104-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:725fe8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:72600f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7260363e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:72605cea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:726085da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7260ad44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7260d404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7260faba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:72612314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:726149b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:72617058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:72619704-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7261be50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.77']} DrugCentral uuid:7261e506-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:72620b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:72623236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:72625a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72628150-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7262a806-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7262ceb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7262f5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:72631cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7263439c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:72636b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.03']} DrugCentral uuid:726392b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7263b98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:7263e040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:72640700-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:72643004-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:726459c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:72648112-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.35']} DrugCentral uuid:7264a7be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7264ceba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.25']} DrugCentral uuid:7264f570-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:72651c12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.16']} DrugCentral uuid:726542b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.47']} DrugCentral uuid:72656a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:726590b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7265b776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7265de22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:72660726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:72662de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72665488-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:72667b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7266a230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06240 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase LCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.19']} DrugCentral uuid:7266c8f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:7266ef9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7267163e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:72673e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:72676544-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:72678bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7267b3dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7267dd26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:726806b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7268305a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:726859d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:726880e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7268a792-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7268ce20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7268f4f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:72691c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27037 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:726942f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:726969a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:726990bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7269ba7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7269e1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:726a0862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:726a2f18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:726a5632-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:726a7cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:726aa376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:726aca18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:726af182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36894 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:726b1914-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:726b3fd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:726b6680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:726b8e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:726bb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:726bdc00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:726c02a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:726c29e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:726c5090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:726c7746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:726c9dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:726cc566-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:726cec08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:726d12be-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.41']} DrugCentral uuid:726d3960-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:726d635e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:726d8a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:726db0c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:726dd762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:726dfe7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:726e2672-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:726e4d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:726e73d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:726e9b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:726ec1c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:726ee990-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:726f1046-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:726f3a8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:726f644c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:726f8d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:726fb47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:726fdb2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7270024e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:727032fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:727032fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:727032fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:727032fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:72708188-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:72708188-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7270b7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7270b7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7270ead8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01538 biolink:molecularly_interacts_with DrugCentral:785 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasatinib targets Transcription factor (Myelin transcription factor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7271145e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:72713718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:727159b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:72717c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:72719f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:7271c20a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7271e8ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:72720f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deanol targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:72723690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deanol targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:72725e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:788 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:72728186-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:788 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:7272a486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:7272ccd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7272f616-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:72731cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:727346d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:727346d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:72738770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:72738770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:72738770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:72738770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:72738770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:7273d518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7273fc6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:72741f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferoxamine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:727445ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferoxamine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72746c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:72749322-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.84']} DrugCentral uuid:7274bad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7274e192-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GRG7 biolink:molecularly_interacts_with DrugCentral:795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:72750834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:72752eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.97']} DrugCentral uuid:7275560e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:72757cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7275a366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7275ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7275f28a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:72761936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delavirdine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72764730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:72764730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:72764730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7276b940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:72779450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demecarium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:7277b7a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:7277da50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:7277fd14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demeclocycline targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:727824c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denopamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:72784d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:72787564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deptropine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72789c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deptropine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7278c9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7278c9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7278c9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:72790894-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deserpidine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:72792b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:72794e12-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:727970cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:72799408-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:7279b6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:7279dcce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:7279dcce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727a3c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:727afc58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:727b22fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.631']} DrugCentral uuid:727b49a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:727b70e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:727b97b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.755']} DrugCentral uuid:727bbe68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.081']} DrugCentral uuid:727be528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.194']} DrugCentral uuid:727c0e72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:727c3532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:727c5bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:727c826c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:727ca968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:727ccc0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:727cf2ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:727d1aba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:727d4292-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:727d6934-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:727d8fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:727db678-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:727de0e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:727e07e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:727e2a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:727e513c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:727e7842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:727e9fe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:727ec6c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:727eed7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:727f1536-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:727f3bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:727f6270-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:727fb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:72807f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:72807f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:72807f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7280bdf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7280e578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:72810d3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:72814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:7281bc3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:7281e310-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:72820a20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:728230e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.025']} DrugCentral uuid:728257a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:72827e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7282a5b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:7282cc8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:7282f340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.189']} DrugCentral uuid:72831a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:72834214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:72836c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7283955c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7283bd02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7283e41c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:72840ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72843174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7284582a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:72848084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desloratadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:7284a74e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.027']} DrugCentral uuid:7284cdf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28476 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-2) DrugCentral uuid:7284f730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:7284f730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:7284f730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:728567ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:72863690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:72865e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:72868618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7286acce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:7286d46a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7286fdd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:728726a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:72874d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desmopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72877438-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:72879774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7287be3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.932']} DrugCentral uuid:7287e4f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone targets Cytosolic other (Annexin A1) DrugCentral uuid:7288079a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoximetasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72882edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:72885588-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.498']} DrugCentral uuid:72887c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7288a312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7288cb4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:7288f1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:728918a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycortone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:72893f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycorticosterone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) DrugCentral uuid:72896270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desoxycorticosterone pivalate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:72898908-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:7289afd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.88']} DrugCentral uuid:7289d66a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:7289f9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:728a203e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:728a46ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05112 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Cytokine (Interleukin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:728a6e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:728a95be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:728abdc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.786']} DrugCentral uuid:728ae492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:728b0b3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.517']} DrugCentral uuid:728b324e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:728b5904-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:728b7fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:728ba256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:728bc9b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:728bf058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:728c170e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:728c3dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:728c656a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:728c8c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:728cb31c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone palmitate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:728cdafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:728d0222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:728d28c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:728d4f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:728d7626-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:728d9d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:728dc41e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:728deade-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone valerate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:728e11a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexbrompheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:728e3462-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:728e5ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:728e92fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:728e92fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:728e92fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:728e92fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:728e92fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:728ee998-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:728f1062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:728f3722-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:728f5dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:728f8538-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:728fac02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.607']} DrugCentral uuid:728fd2c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.384']} DrugCentral uuid:728ff978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:729020ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:729047b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.257']} DrugCentral uuid:72906e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:72909518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7290bc32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:7290e2de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:72910980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:72913018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:72915764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:72917e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.898']} DrugCentral uuid:7291a55c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:7291cd0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:7291f5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:72921f78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:729248ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:72926f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexloxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:729296ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7292bd5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7292e430-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:72930c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:72933390-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:72935a46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:729380fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:7293a7c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7293d84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:7293d84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:7293d84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:72942278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72942278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72942278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:729461ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:72948876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:7294ab26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7294d1f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:7294f95a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:72952d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:72952d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:72952d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:72952d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:72952d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:729584e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7295af30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7295d5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:7295fc9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:72962352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:72964a76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:72967136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:72969a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7296c122-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.824']} DrugCentral uuid:7296e88c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:72970f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:72973602-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:72975cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:729787a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7297ae5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:7297dbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7297dbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7297dbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:72981e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:72981e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:72984b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:72986f5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:729897e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7298bf68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7298e628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:729908f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:72992fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:729954e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:72997bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:72999e6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7299c502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7299ecf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:729a139a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:729a3a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:729a6110-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:729a882a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ad9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:729ba598-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is agonist of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'D2', 'has_quantitative_value': ['6.458']} DrugCentral uuid:729bcc44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:729bf304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.48']} DrugCentral uuid:729c19ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:729c40f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan is blocker of Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:729c67d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:729c8e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:729cb578-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729cf146-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:729d67b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:729d67b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:729d67b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:729da744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:729dced6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:729df56e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:729e18d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:729e3baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:844 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextropropoxyphene targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:729e6350-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:729e8d80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:729e8d80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729ecf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:729f3db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dezocine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:729f64e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dezocine is antagonist of GPCR (Kappa-type opioid receptor) DrugCentral uuid:729f87a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42574 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (Caspase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:729fae68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55210 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (Caspase-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:729fd50a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q17339 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Unclassified (Female germline-specific tumor suppressor gld-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:729ffc06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02083 biolink:molecularly_interacts_with DrugCentral:849 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diacerein targets Enzyme (N-acylethanolamine-hydrolyzing acid amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:72a02988-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a02988-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a02988-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a0683a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:72a09080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:72a0b754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is allosteric modulator of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:72a0de46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:72a10574-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:72a12d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:72a1552e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:72a17c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:72a1a33a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:72a1ca40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.67']} DrugCentral uuid:72a1f10a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:72a217ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:72a23e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:72a2672a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:72a28f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:72a2bcc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:72a2bcc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:72a2bcc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:72a30266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:72a30266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:72a30266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:72a347b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:72a347b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:72a347b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:72a38d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72a38d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72a38d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72a3d9c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:72a3d9c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:72a3d9c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:72a42100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:72a42100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:72a42100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a4920c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a57e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72a5e8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:72a5e8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:72a5e8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:72a632d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:72a632d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:72a632d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:72a67824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:72a67824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:72a67824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a6e5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72a7bd1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72a7bd1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72a7bd1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72a8045a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:72a8045a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:72a8045a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:72a84adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:72a84adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:72a84adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:72a891ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:72a891ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:72a891ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:72a8d72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a8d72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a8d72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:72a91dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:72a91dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:72a91dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:72a95c74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.64']} DrugCentral uuid:72a986b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:72a986b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:72a9bc64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diazoxide is activator of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:72a9e658-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibekacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.921']} DrugCentral uuid:72aa10c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:72aa3392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:72aa5d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72aa5d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72aa5d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72aa9bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:72aac2e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.081']} DrugCentral uuid:72aaea30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15118 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3']} DrugCentral uuid:72ab110e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15119 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.699']} DrugCentral uuid:72ab37c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15120 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.097']} DrugCentral uuid:72ab5e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16654 biolink:molecularly_interacts_with DrugCentral:862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.301']} DrugCentral uuid:72ab8634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:72abacea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:72abd3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorophen targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:72abfa60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:72ac21a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:72ac4876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:72ac6f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:72ac95ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:72acbd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:72ace402-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:72ad0aae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:72ad316e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.577']} DrugCentral uuid:72ad591e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:72ad8312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:72ada9d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:72add092-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:72adf7c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:72ae1e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:72ae4554-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:72ae6c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:72ae9428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:72aebb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:72aee1e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:72af089a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:72af3054-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:72af570a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:72af7dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:72afa49e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:72afcbd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:72aff3fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72b01aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:72b0416a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:72b068d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dichlorphenamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:72b08f9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72b0b654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:72b0dcf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:72b10492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:72b12bb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:72b15370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:72b17a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72b1a12c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:72b1c7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:72b1eea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:72b2153a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:72b23c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:72b26346-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:72b289fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:72b2b0c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:72b2d88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:72b30260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:72b32c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:72b355ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60656 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:72b37e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAW8 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:72b3a53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:72b3cbf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:72b3f274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:72b419a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:72b4403a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:72b466d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:72b48d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:72b4b15a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:72b4daea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:72b50498-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:72b52f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:72b5638e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:72b5638e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:72b5638e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:72b5638e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:72b5638e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:72b5afec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:72b5d68e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72b5ff42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.388']} DrugCentral uuid:72b625ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.354']} DrugCentral uuid:72b64cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:72b67364-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:72b69d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:72b6c3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:72b6ea92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WMN1 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (ATP phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:72b71148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05982 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol targets Enzyme (NULLD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:72b73876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:72b75f22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:72b785ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.773']} DrugCentral uuid:72b7ac98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:72b7d420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.082']} DrugCentral uuid:72b7fad6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:72b82196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:72b8484c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:72b87204-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:72b89b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.079']} DrugCentral uuid:72b8c3a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:72b8ea86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.033']} DrugCentral uuid:72b911aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.386']} DrugCentral uuid:72b93874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.767']} DrugCentral uuid:72b95fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.327']} DrugCentral uuid:72b98644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70676 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Unclassified (SMR1-alpha2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:72b9adae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:72b9d46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.61']} DrugCentral uuid:72ba01e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:72ba01e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:72ba01e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:72ba42dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 didanosine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:72ba69ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dienestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:72ba908e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dienogest is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:72bab35c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:72bada6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:72bafd1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:72bb2346-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:72bb2346-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:72bb5078-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:72bb73dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:72bb96aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:72bbbd60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:72bbe42a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.252']} DrugCentral uuid:72bc0bee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:72bc33ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:72bc5b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:72bc8268-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:72bca996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:72bcd060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:72bcf720-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.439']} DrugCentral uuid:72bd1dcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:72bd45a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:72bd6c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:72bd9356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.223']} DrugCentral uuid:72bdba16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.272']} DrugCentral uuid:72bde28e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:72be094e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.437']} DrugCentral uuid:72be300e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:72be5746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.317']} DrugCentral uuid:72be7e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.657']} DrugCentral uuid:72bea552-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:72becc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:72bef2e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:72bf1a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:72bf4124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:72bf680c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.739']} DrugCentral uuid:72bf8ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:72bfb78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:72bfde54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.593']} DrugCentral uuid:72c00500-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:72c02ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72c05406-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:72c07ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.983']} DrugCentral uuid:72c0a190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.847']} DrugCentral uuid:72c0c832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.361']} DrugCentral uuid:72c0efd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72c11698-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.483']} DrugCentral uuid:72c13d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:72c16404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:72c18c7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:72c1b58a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:72c1dc40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:72c2030a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:72c22a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:72c250c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08580 biolink:molecularly_interacts_with DrugCentral:875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72c2779a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 difenoxin is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:72c29b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:72c2c2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:72c2e9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:72c31056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd1', 'has_quantitative_value': ['7.125']} DrugCentral uuid:72c336f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:72c35f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:72c38e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:72c3b524-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.648']} DrugCentral uuid:72c3dbe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:72c40484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:72c42752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c44e12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c506ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.783']} DrugCentral uuid:72c52ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.136']} DrugCentral uuid:72c555fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72c57c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72c5a35c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c5e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72c65cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51450 biolink:molecularly_interacts_with DrugCentral:882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:72c68416-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.007']} DrugCentral uuid:72c6aafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:72c6d1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.187']} DrugCentral uuid:72c6f892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.526']} DrugCentral uuid:72c7204c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:72c7470c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:72c76df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:72c794be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.085']} DrugCentral uuid:72c7bbe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:72c7e3f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.121']} DrugCentral uuid:72c80ac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:72c83194-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:72c858b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:72c87f6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.261']} DrugCentral uuid:72c8a62e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.369']} DrugCentral uuid:72c8ccee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:72c8f73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:72c92108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.299']} DrugCentral uuid:72c9485e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:72c96faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:72c9966a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydrocodeine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:72c9b910-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:72c9dfd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.462']} DrugCentral uuid:72ca06ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:72ca2ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.309']} DrugCentral uuid:72ca556e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.127']} DrugCentral uuid:72ca7c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:72caa384-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.385']} DrugCentral uuid:72caca8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.373']} DrugCentral uuid:72caf154-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:72cb1828-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:72cb3f60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:72cb6634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:72cb88da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.442']} DrugCentral uuid:72cbaf90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:72cbd65a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.605']} DrugCentral uuid:72cbfdc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:72cc207e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:72cc473e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.183']} DrugCentral uuid:72cc6df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:72cc922a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:72ccb8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:72ccdfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.896']} DrugCentral uuid:72cd0674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72cd2db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.79']} DrugCentral uuid:72cd546c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:72cd7b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocristine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:72cda214-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:72cdc99c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.922']} DrugCentral uuid:72cdf066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.529']} DrugCentral uuid:72ce1834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:72ce4052-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:72ce6938-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.424']} DrugCentral uuid:72ce900c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.644']} DrugCentral uuid:72ceb6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.364']} DrugCentral uuid:72cede4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:72cf0582-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.83']} DrugCentral uuid:72cf2c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:72cf5316-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:72cf75d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.752']} DrugCentral uuid:72cf9d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:72cfc404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:72cfead8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:72d011ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.821']} DrugCentral uuid:72d03a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:72d060f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:72d0839e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 5A) DrugCentral uuid:72d0a662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:72d0cd90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:72d0f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.349']} DrugCentral uuid:72d11b38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.416']} DrugCentral uuid:72d141ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72d16944-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:72d18ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:72d1b6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:72d1dd5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72d205fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:72d22c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:72d25340-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:72d28086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:72d28086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:72d28086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:72d2bf92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:72d2e22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:72d304d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:72d3277a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:72d34ac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:72d36d70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:72d39020-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:72d3bdc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72d3bdc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72d3bdc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72d4014a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54699 biolink:molecularly_interacts_with DrugCentral:893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:72d427e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:72d44bc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:72d46edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:72d4916e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:72d4b414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dilevalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:72d4daf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:72d501a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:72d528ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:72d5500e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:72d576b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:72d59e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:72d5c62e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:72d5ecda-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.017']} DrugCentral uuid:72d613a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:72d63a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:72d6616a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:72d6882a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:72d6aee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:72d6d596-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:72d703cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72d703cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72d703cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72d748fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:72d748fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:72d748fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:72d789fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:72d7b128-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:72d7d7e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:72d7feb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimemorfan is inhibitor of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:72d82612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.791']} DrugCentral uuid:72d84cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.312']} DrugCentral uuid:72d8737e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:72d89a48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:72d8c176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:72d8e93a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.479']} DrugCentral uuid:72d90ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:72d936ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:72d95faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:72d98660-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.785']} DrugCentral uuid:72d9ad34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:72d9d3f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:72d9fb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:72da2246-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:72da4a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:72da70fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimenhydrinate targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:72da982a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KQK5 biolink:molecularly_interacts_with DrugCentral:902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetacrine targets Unclassified (Apical membrane antigen 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:72dabec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:72dae5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:72db0c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:72db35dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:72db5fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:72db8988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:72dbb700-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:72dbb700-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:72dbb700-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:72dbf9b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:72dbf9b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:72dc26cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:72dc4d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:72dc7618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:72dc9cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72dcc398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:72dcea30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:72dd1294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:72dd3940-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:72dd5ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:72dd86a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:72ddae84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:72ddd53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:72ddfc18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:72de22ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:72de49fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:72de70bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:72de9786-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:72debe50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:72dee826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72df0f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:72df3632-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72df5d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:72df847a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:72dfab30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:72dfd20e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:72dff8d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:72e02010-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:72e047de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72e06eb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:72e096bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:72e0c100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:72e0eab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:72e113a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:72e13b3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:72e16272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:72e18928-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:72e1afc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:72e1d6c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72e1fd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72e22428-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72e24ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:72e27220-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:72e29962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:72e2bfe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:913 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:72e2e6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:72e3097e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:72e32ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:72e35384-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.018']} DrugCentral uuid:72e37ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:72e3a17c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:72e3c8b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:72e3ef88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:72e41756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:72e43e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:72e465b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:72e48c68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:72e4b31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:72e4d9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:72e50120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.932']} DrugCentral uuid:72e52880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:72e54f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:72e57c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:72e57c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:72e57c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:72e5bb9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:72e5e23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenhydramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.658']} DrugCentral uuid:72e6091c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:918 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenoxylate is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:72e63252-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:918 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenoxylate targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72e65c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.076']} DrugCentral uuid:72e6852c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:72e6abe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:72e6d478-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:72e6f732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:72e71de8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:72e740b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:72e76460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipivefrine is agonist of GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:72e786fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:72e7a9a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:72e7cd56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:72e7f0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:72e819e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:72e8409c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72e86766-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:72e88eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.802']} DrugCentral uuid:72e8b5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:72e8dc96-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:72e90374-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:72e92a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:72e95176-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:72e978ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.158']} DrugCentral uuid:72e99faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:72e9c73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:72e9f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:72e9f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:72ea2ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72ea2ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ea6f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:72ead938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72ead938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72ead938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:72eb1844-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:72eb3f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TP1 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Enzyme (Protein prune homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:72eb65ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:72eb8c70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dipyridamole is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:72ebb60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:72ebdb4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:72ec025e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:72ec291e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:72ec4c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:72ec702c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:72ec92c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48544 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:72ecb97e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:72ece08e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:926 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disopyramide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.604']} DrugCentral uuid:72ed07bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 distigmine is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:72ed2a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:72ed5118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:72ed792c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Translocator protein) DrugCentral uuid:72ed9e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:72edc6fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:72ededb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.735']} DrugCentral uuid:72ee1508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.156']} DrugCentral uuid:72ee3bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.658']} DrugCentral uuid:72ee6288-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.129']} DrugCentral uuid:72ee8a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:72eeb1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.434']} DrugCentral uuid:72eed876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:72eeff22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:72ef25e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.957']} DrugCentral uuid:72ef4df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:72ef74ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:72ef9b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.862']} DrugCentral uuid:72efc222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05091 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram is inhibitor of Enzyme (Aldehyde dehydrogenase, mitochondrial) DrugCentral uuid:72efe57c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.319']} DrugCentral uuid:72f00c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.738']} DrugCentral uuid:72f032fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:72f059bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:72f08112-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:72f0a7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.794']} DrugCentral uuid:72f0ce60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.669']} DrugCentral uuid:72f0f520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:72f11d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.333']} DrugCentral uuid:72f145a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:72f16c44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:72f192f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:72f1ba5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:72f1e0fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:72f207da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:72f22e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:72f25672-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:72f27e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:72f2a4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:72f2ccd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disulfiram targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72f2f4a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:72f31b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:72f34244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:72f368fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:72f3905a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:72f3b710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:72f3ddd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:72f40508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:72f42c04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:72f452d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:72f47998-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:72f4a058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ditiocarb targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:72f4c81c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:72f4eec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:72f5156a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:72f53c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:72f563d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z2W7 biolink:molecularly_interacts_with DrugCentral:934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:72f58a72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:72f5b128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:72f5d7ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.976']} DrugCentral uuid:72f5ff0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:72f625d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:72f64d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:72f674b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:72f69cbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:72f6c3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:72f6ea7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:72f71144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:72f738b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:72f75f78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:72f7862e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:72f7ace4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.256']} DrugCentral uuid:72f7d3fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:72f7fabe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:72f82160-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:72f84820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:72f87016-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.401']} DrugCentral uuid:72f899ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.301']} DrugCentral uuid:72f8c11a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:72f8e7ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:72f90f44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:72f9360e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:72f95df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.223']} DrugCentral uuid:72f984a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:72f9abd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:72f9d280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:72f9f92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:72fa20d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:72fa48d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:72fa6f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:72fa9242-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:72fab4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.086']} DrugCentral uuid:72fadc66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:72fb031c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets GPCR (Growth hormone-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fb4476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:72fbcb8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docetaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fc17fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:72fcad98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:72fcd52a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide targets Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:72fcf7da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:72fd1e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:72fd4578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:72fd6cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.988']} DrugCentral uuid:72fd937a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:72fdba26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:72fdde2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:72fe07e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:72fe2f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:72fe55ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:72fe7cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:72fea418-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:72fecae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.013']} DrugCentral uuid:72fef1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:72ff1876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:72ff3f9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:72ff663c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:72ff8cfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:72ffb3b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:72ffdd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:73000696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:730033fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:730033fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:730033fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:73006d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:73009430-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7300baf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7300e1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:730108e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:73012fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:73015654-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:73017cf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:7301a578-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:7301cc38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7301f2d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:73021972-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.046']} DrugCentral uuid:73024140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:73026814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:73028eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7302b558-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7302dc5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:730302f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:730329a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:73035058-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:730377e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:73039e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7303c52e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7303ebd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7304133a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:73043bf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:73046290-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7304895a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:7304b074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7304d716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7304fde0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.19']} DrugCentral uuid:730524a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73054d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73057716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.18']} DrugCentral uuid:73059e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:7305c4f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7305ec50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7306131a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:730639d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73066090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.375']} DrugCentral uuid:730687aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7306ae88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7306d570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7306fc3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73072516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:73074cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7307737c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:73079a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7307c19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7307e870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:73080f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:730836a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73085e2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09172 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3']} DrugCentral uuid:73088ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73088ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73088ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73088ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7308e004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7308e004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7308e004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:73092302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:73092302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:730962fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:730962fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:730962fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:730962fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:730962fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7309c24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7309c24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7309c24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a1848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:730a93f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:730abbae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:730ae46c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopamine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:730b0bea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopexamine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:730b2e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dopexamine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:730b515e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:730b78e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:730b9fce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:730bc6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:730bed6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:730c1490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:730c3b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:730c61fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:730c88bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:730cb0c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:730cd786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:730cfe5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:730d252e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:730d4c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:730d7344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:730d99f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:730dc0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:730de806-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:730e0ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:730e35ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:730e5d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:730e87e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:730eb24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:730edbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:730f0344-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:730f2a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:730f50e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:730f7900-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:730fa060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:730fc72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:730fedf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:731014be-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dorzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73103c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.066']} DrugCentral uuid:7310668a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.337']} DrugCentral uuid:7310906a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.588']} DrugCentral uuid:7310ba68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.378']} DrugCentral uuid:7310e3e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:73110aae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7311315a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.744']} DrugCentral uuid:73115810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:73117f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7311a61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:7311ccc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:7311f37e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dosulepin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.275']} DrugCentral uuid:73121bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:731244fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:731267c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:73128a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:7312b1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:7312d8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7312ff8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:73132636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:73134d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:73137410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.631']} DrugCentral uuid:73139ae4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:7313c1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7313e9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7314130c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:731439d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:731460aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:731488a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7314af60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.381']} DrugCentral uuid:7314d648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:7314fd58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxazosin targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:73152468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:73154b00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:731571ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:73159862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:7315bfe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:7315e7fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.53']} DrugCentral uuid:73160f9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:73163650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:73165d88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:73168434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7316aad6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:7316d196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 7) DrugCentral uuid:7316f4aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.629']} DrugCentral uuid:73171b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:73174270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.325']} DrugCentral uuid:7317691c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:73179112-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:7317ba66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7317e3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:73180a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:731831ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:7318589a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:73187f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7318a624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:7318cdd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:7318f476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:73191b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:731941f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73199516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:731a5906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxepin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:731a7fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:957 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxercalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:731aa366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxifluridine targets Enzyme (Thymidylate synthase) DrugCentral uuid:731ac60c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:731aeccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:731b136e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.433']} DrugCentral uuid:731b3c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:731b5f9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:731b86b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:731ba950-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:731bcbe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:731bef1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.914']} DrugCentral uuid:731c15e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.496']} DrugCentral uuid:731c3c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.288']} DrugCentral uuid:731c632c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:731c8a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:731cb0d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:731cd88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:731cff12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:731d2672-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:731d4d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61823 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Ribonuclease pancreatic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:731d73b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.867']} DrugCentral uuid:731d9a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.805']} DrugCentral uuid:731dc1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:731de882-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:731e0f38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43870 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme HindIII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:731e35d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O52691 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme ScaI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:731e5cea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:731e836e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:731eaa06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxorubicin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:731ed0a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:731ef5c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:731f1c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:731f4330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:731f69d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:731f913c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:731fb7b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:731fde58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09237 biolink:molecularly_interacts_with DrugCentral:961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxycycline is inhibitor of Enzyme (Matrilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.14']} DrugCentral uuid:73200518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxylamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7320282c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drostanolone propionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:73204ac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:73207188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:73209848-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.602']} DrugCentral uuid:7320c1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:7320eb36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7321121e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:7321397e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.132']} DrugCentral uuid:732160de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:732188de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:7321af94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.996']} DrugCentral uuid:7321d64a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.027']} DrugCentral uuid:7321fd5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:732223fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:73224ac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:7322719a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:73229936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.076']} DrugCentral uuid:7322c000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.175']} DrugCentral uuid:7322e6ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:73230d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:732334b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:73235b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:732388b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:732388b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:732388b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7323c7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:7323ee3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:732414fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drospirenone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:73243ba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drotaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:73246036-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 drotaverine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:732485c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:7324c774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:73253e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:732564cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:73258baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7325b2ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7325d98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7326003a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:732626fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:73265026-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:732676d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:73269d88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:7326c416-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.402']} DrugCentral uuid:7326eb6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:73271376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:73273a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.352']} DrugCentral uuid:732760c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:73278860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.09']} DrugCentral uuid:7327af0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7327d6a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7327fd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duloxetine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7328272a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:732850ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:73287a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:7328a0f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dyclonine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7328c82e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dyclonine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:7328eae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dydrogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:732911a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dydrogesterone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.561']} DrugCentral uuid:73293868-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:73295b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diprophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:73297e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:7329a500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7329cbac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.506']} DrugCentral uuid:7329f532-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:732a1bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:732a429e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:732a6954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:732a90d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:732ab788-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:732ade48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:732b0508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.905']} DrugCentral uuid:732b2c36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:732b5300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.472']} DrugCentral uuid:732b79c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.384']} DrugCentral uuid:732ba062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.543']} DrugCentral uuid:732bcaba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:732bf152-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.554']} DrugCentral uuid:732c181c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:732c3ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.937']} DrugCentral uuid:732c6646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.615']} DrugCentral uuid:732c8cfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:732cb3d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.397']} DrugCentral uuid:732d24f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.106']} DrugCentral uuid:732d4f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:732d7658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:732da010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:732dc90a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.126']} DrugCentral uuid:732defac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.253']} DrugCentral uuid:732e164e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:732e3dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:732e6450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.191']} DrugCentral uuid:732e8ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.633']} DrugCentral uuid:732eb1b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:732ed8d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:732eff78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:732f262e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:732f4cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:732f7674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:979 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ebrotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:732f992e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 echothiophate is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:732fbbde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.131']} DrugCentral uuid:732fe29e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.543']} DrugCentral uuid:73300ae4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:733031ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:7330586e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:73307f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.086']} DrugCentral uuid:7330a63e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7330ccfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:7330f3aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:73311a42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:73314328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:73316ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:733191a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:7331b876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:7331dfea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.202']} DrugCentral uuid:733206b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:73322d7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.572']} DrugCentral uuid:73325452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:73327b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:7332a2c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:7332c964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:7332f02e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.421']} DrugCentral uuid:733318d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.529']} DrugCentral uuid:73333fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:7333666c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.178']} DrugCentral uuid:73338d2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:7333b478-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.006']} DrugCentral uuid:7333dc28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:733402de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.485']} DrugCentral uuid:733429a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.359']} DrugCentral uuid:733451ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.463']} DrugCentral uuid:733478b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:73349b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:7334c21e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7334eaa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.864']} DrugCentral uuid:733511f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7335388e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:73355f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.489']} DrugCentral uuid:73358668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:7335ad1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7335d3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:7335fa62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.916']} DrugCentral uuid:73362186-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:7336481e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:73366eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:73369580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:7336bdbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7336e472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:73370b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:733731fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.999']} DrugCentral uuid:73375970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.431']} DrugCentral uuid:73378030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.503']} DrugCentral uuid:7337a6e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49146 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Neuropeptide Y receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.959']} DrugCentral uuid:7337ce8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.498']} DrugCentral uuid:7337f5a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:73381c5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:73384376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:73386a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:733891b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:7338b856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7338df16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:733905c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:73392d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:733953ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:73397aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7339a162-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 econazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7339c8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:7339ef82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:733a1228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:733a38de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:733a6034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:733a86ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Ceramide glucosyltransferase) DrugCentral uuid:733aaad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:733ad168-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XAY4 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Unclassified (Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:733af8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:J3SE37 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:733b1f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:733b4620-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:733b6ce0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:733b9508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edrophonium is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.79']} DrugCentral uuid:733bbbbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edrophonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:733be27e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:733c0920-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:733c2cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:733c56b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:733c7d7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:733ca434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:733ccc16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efavirenz targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:733cf2d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11926 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:733d198c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09057 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine targets Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:733d4056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9TZZ6 biolink:molecularly_interacts_with DrugCentral:990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) DrugCentral uuid:733d6356-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:733d8a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.621']} DrugCentral uuid:733db446-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:733db446-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:733de16e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:733e0928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:733e2ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:733e56b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:733e7d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:733ea4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:733ecb60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:733ef202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elliptinium targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:733f1f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:733f1f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:733f1f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:733f9130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:73407366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emedastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:73409a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:7340c0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:7340e792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:73410eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:73413558-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:73415c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75884 biolink:molecularly_interacts_with DrugCentral:1001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emetine targets Enzyme (Putative hydrolase RBBP9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:734182c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emtricitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:7341a664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7341d134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7341f7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:73421e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:734245b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:73426c70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:73429326-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5EGZ1 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7342b9d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09470 biolink:molecularly_interacts_with DrugCentral:1006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.94']} DrugCentral uuid:7342e07e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:73430338-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:734325de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:73434870-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:73436b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:73438ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 endralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:7343b1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:7343d448-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:7343f702-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:73441a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:73443d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:73445fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:73448276-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q53I07 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide targets Viral envelope protein (Envelope glycoprotein) DrugCentral uuid:7344a530-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40239 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide is inhibitor of Membrane other (Transmembrane glycoprotein gp41) DrugCentral uuid:7344c83a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76270 biolink:molecularly_interacts_with DrugCentral:1010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfuvirtide targets Unclassified (GP41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7344eec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin targets Enzyme (DNA gyrase subunit A) DrugCentral uuid:73451178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21281 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin targets Enzyme (V-type proton ATPase subunit B, brain isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:73453b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:73453b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:73456df8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:73456df8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:73459c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.345']} DrugCentral uuid:7345cdde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7345cdde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7345cdde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7345cdde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:73461910-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:73463fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:734666fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:73468e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.03']} DrugCentral uuid:7346b4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:7346d742-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7346fdf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:73472486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:73474d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:734773be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:1015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprofylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:73479a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7347c0e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7347e812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil targets GPCR (Prostacyclin receptor) DrugCentral uuid:73480acc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7348318c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7348584c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:73487f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7348a612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7348cca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7348f338-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73491d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7349448c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entacapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:73496c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17394 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir targets Polyprotein (Protein P) DrugCentral uuid:73498eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir is inhibitor of Polyprotein (Protein P) DrugCentral uuid:7349b21e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:1019 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entecavir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7349d8ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7349ff3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:734a25dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:734a4cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:734a7384-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:734a9a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:734ac0c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:734ae986-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02928 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat is inhibitor of Enzyme (Cytochrome P450 4A11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:734b1046-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epalrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.678']} DrugCentral uuid:734b36d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:734b5d8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.859']} DrugCentral uuid:734b84f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:734bacea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eperisone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:734bd382-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1024 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ephedrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:734bfa2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:734c1d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:734c43da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:734c6676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:734c8912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:734cacf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:734cd6ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Histamine H2 receptor) DrugCentral uuid:734cfabe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:734d2156-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:734d48a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:734d7034-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:734d96b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.401']} DrugCentral uuid:734dbd8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:734de4a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.26']} DrugCentral uuid:734e0b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:734e3230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:734e58d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:734e806e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:734ea74c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:734ecea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.449']} DrugCentral uuid:734ef576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:734f1cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:734f43b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.484']} DrugCentral uuid:734f6a4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:734f90f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:734fb81c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:734fded2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:73500592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:73502c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7350543e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:73507e00-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7350adda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7350adda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7350adda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7350f3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7350f3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7350f3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:73513390-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:1028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epinephrine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73515a28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.878']} DrugCentral uuid:735180e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:7351a938-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:1030 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epirubicin targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7351cfe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7351f6a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:73521d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7352453c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:73526bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:735292bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear other (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7352b986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eplerenone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7352e096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7353072e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol targets GPCR (P2Y purinoceptor 12) DrugCentral uuid:735329d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:73535094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:735377cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73539e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7353c52e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7353ef36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7353ef36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:735429b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:735429b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:735429b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:73546d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:73546d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:7354a034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7354c6f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7354ed8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:73551442-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.333']} DrugCentral uuid:73553b34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:735561d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.58']} DrugCentral uuid:735588a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7355af56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:7355d774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:7355ff10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.714']} DrugCentral uuid:735625d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:73564c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.367']} DrugCentral uuid:735673a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:73569a42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.889']} DrugCentral uuid:7356c0e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:7356e786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:73570ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:73573560-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:73575c20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.722']} DrugCentral uuid:735782ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:7357aae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:7357d52e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.099']} DrugCentral uuid:7357fc02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73582380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.354']} DrugCentral uuid:73584ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:735871b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7358986a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7358bf20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7358e6da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:73590980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.754']} DrugCentral uuid:73593036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.836']} DrugCentral uuid:735956d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:73597eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.064']} DrugCentral uuid:7359a82c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7359cef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:7359f5d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:735a1d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:735a43ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.487']} DrugCentral uuid:735a6aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:735a9174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:735ab910-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:735adfe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:735b0686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:735b2d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:735b54a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:735b7b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.041']} DrugCentral uuid:735ba208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:735bc8a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.11']} DrugCentral uuid:735befe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:735c17ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:735c3e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:735c6526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:735c8c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:735cb2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08786 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets GPCR (Cholecystokinin A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:735cd98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32393 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine targets Unclassified (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:735d0030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:735d2826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:735d4ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:735d759c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:1044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eritoran targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:735d9c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:735dc38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:735dea22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:735e10d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:735e38ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:735e5fde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:735e868a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:735ead40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:735ed3f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:735efbc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:735f2536-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:735f4dcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:735f746e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:735f9bb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:735fc25c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:735fe9f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:736010a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:736037b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:73605e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:73608624-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7360acd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7360d426-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7360fb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:73612228-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:736148de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7361700c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:736196b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7361bd50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7361e3fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:73620af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7362319a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7362583c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:73627ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7362a6c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7362ce0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7362f4ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:73631b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:736342a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:73636948-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:73638fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7363b77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7363de78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7364052e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:73642bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:73645272-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:73647a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7364a0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7364c892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7364ef3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:736516f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:73653db8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:73656464-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:73658b1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7365b22a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7365d8d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7365ff78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7366262e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:73664d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7366744e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:73669af0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7366c1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7366e910-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:73670fd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:73673672-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73675d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:736785be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7367ac7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7367d320-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7367f9cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:73682136-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:736847d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:73686e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:73689526-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7368bc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7368e332-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:736909de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:73693080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7369579a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:73697e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7369a4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7369cb8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7369f2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:736a19aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:736a4060-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:736a670c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:736a8e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:736ab504-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:736adbba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:736b0270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:736b2aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:736b525c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:736b791c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:736b9fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:736bc73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:736bee1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:736c14d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:736c3b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:736c62c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:736c8960-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:736cb020-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:736cd6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:736cfdb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94956 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib is inhibitor of Transporter (Solute carrier organic anion transporter family member 2B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:736d24a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:1045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:736d4b34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:736d6dc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:736d9076-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:736db5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:736dd87e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:736dfb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:736e1dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:736e4110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1B) DrugCentral uuid:736e63b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:736e8a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:736eb0be-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:736ed7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:736efe84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:736f2620-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:736f4cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:736f7486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:736f9d8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:736fc440-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:736fead8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.412']} DrugCentral uuid:73701238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.706']} DrugCentral uuid:737038f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:73705fae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7370865a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7370adba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 escitalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:7370d47a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7370fb3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:737121e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esmolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:73714d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:73714d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:737186cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:737186cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:737186cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7371c93e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:7371c93e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:7371c93e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:7372084a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:7372084a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:7372084a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:73724698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:73724698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:73724698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:73727fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:7372a66a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.538']} DrugCentral uuid:7372cd02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.725']} DrugCentral uuid:7372f3c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.926']} DrugCentral uuid:73731b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:737344ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:73736be0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol is activator of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73739282-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7373b9c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7373e05c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7374078a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:73742e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.83']} DrugCentral uuid:73745532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:73747bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:7374a294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7374c940-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.947']} DrugCentral uuid:7374f0f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:73751a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:737540dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:73756788-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08537 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:73758ef2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19785 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:7375b5a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7375e032-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:7375e032-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:737613c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:73763afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.767']} DrugCentral uuid:737661c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:7376887a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.637']} DrugCentral uuid:7376af30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.446']} DrugCentral uuid:7376d816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:73770016-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:737726d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:73774da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:73777500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.156']} DrugCentral uuid:73779bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1058 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol benzoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.902']} DrugCentral uuid:7377c280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol cypionate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:7377e530-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol mustard targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73780cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol valerate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:73782f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:73785222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:737878d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7378a0c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:1066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estramustine phosphate targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:7378c7de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7378ee80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:73791540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:73793d2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:737963c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:73798a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:7379b130-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7379d930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:7379ffe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol succinate targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:737a2688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:737a4d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:737a7570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:737a9ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:737aca2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:737aca2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:737aca2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:737b0aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:737b0aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:737b0aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:737b4dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:737b4dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:737b4dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:737b8c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:737b8c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:737b8c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:737bcac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:737bcac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:737bcac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:737c08ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:737c08ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:737c08ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:737c4260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid is inhibitor of Transporter (Solute carrier family 12 member 1) DrugCentral uuid:737c66dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:737c8d7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08263 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:737cb510-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.939']} DrugCentral uuid:737cdc48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:737d02f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacrynic acid targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:737d29a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:737d5024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:737d76c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:737d9dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:737dc504-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNL8 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:737de7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNL6 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase B) DrugCentral uuid:737e0a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNL5 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase C) DrugCentral uuid:737e2ec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:737e5578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNL9 biolink:molecularly_interacts_with DrugCentral:1073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethambutol is inhibitor of Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:737e780a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:737e9aa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:737ebde2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-2) DrugCentral uuid:737ee740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:737ee740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:737ee740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:737f25f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:737f25f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:737f25f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:737f5dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:737f8498-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:737fab30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.964']} DrugCentral uuid:737fd1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:737ff996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7380204c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:73804702-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:73806e9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:738095ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.353']} DrugCentral uuid:7380bc8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:7380e32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.985']} DrugCentral uuid:73810a02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.83']} DrugCentral uuid:7381316c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:738157fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:73817eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:7381a566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7381cdb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.246']} DrugCentral uuid:7381f566-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:73821db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:73824458-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:73826b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:738291f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide targets Enzyme (Catalase-peroxidase) DrugCentral uuid:7382b4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) DrugCentral uuid:7382d742-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7382fea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:7383256c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.78']} DrugCentral uuid:73834c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:738372e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.111']} DrugCentral uuid:73839ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1084 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethisterone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7383c24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7383e4fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:738407ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:73842e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:73845676-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:73847da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:7384a46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:7384cbb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7384f27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1086 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:73851912-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethosuximide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:738559a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7385e54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:73860c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:73863356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:73865a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:73868108-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7386a872-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7386cf32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7386f610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:73871cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:738744d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73876b9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7387926e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7387bb36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7387e246-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:73880906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73882fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:738856c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:73887e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7388a4c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7388cb7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7388f23a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:73891a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:73894136-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:73896800-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:73898f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7389b652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:7389dd12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:738a03dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:738a2e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:738a2e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:738a612e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:738a87e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:738aaeb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:738ad56e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethoxzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:738afec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:1091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl biscoumacetate targets Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:738b244c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:738b4b3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:738b71f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.983']} DrugCentral uuid:738b9a4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:738bc118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:738be3be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:738c0a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.889']} DrugCentral uuid:738c3184-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:738c5844-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethylestrenol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:738c7f04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:738ca1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:738cc5cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.368']} DrugCentral uuid:738cec64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:738d1324-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etynodiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:738d39ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:738d5d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:738d8048-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:738da2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:738dc990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:738df172-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:738e188c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:1098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etidronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:738e3f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1100 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:738e6620-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilefrine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:738e9136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:738e9136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:738e9136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:738ed6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:738ed6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:738ed6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:738f14da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:738f14da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:738f14da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:738f5468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:738f5468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:738f5468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:738f8bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etodolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:738fb2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1103 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etodolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.577']} DrugCentral uuid:738fd9ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:739000ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:73902744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:73904de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7390769a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7390a7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:7390a7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:7390a7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:7390ed82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7390ed82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7390ed82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:73912c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:73914f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:739171f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etonogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:739198a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:7391c018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.051']} DrugCentral uuid:7391e6d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:73920d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:7392343a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.282']} DrugCentral uuid:73925fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.21']} DrugCentral uuid:739286c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:7392a96a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7392d00c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:7392f2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:73931594-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:73933966-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:73935c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:73938376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:7393aa54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7393d114-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7393f7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:73941f8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7394463a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:73946cf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7394940a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7394bb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7394e1da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:73950886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:73952f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7395569c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:73957d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:73959fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7395c672-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7395ee2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etravirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:739614ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1116 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:73963882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:1116 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) DrugCentral uuid:73965b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.63']} DrugCentral uuid:73968210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:7396a894-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etryptamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7396cf18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7396f1dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:73971874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:1118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 everolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73974042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exemestane targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:739762f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exemestane is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:7397899e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:1123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:7397b040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:1123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exenatide targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:7397da3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHC9 biolink:molecularly_interacts_with DrugCentral:1125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ezetimibe is antagonist of Membrane other (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:73980342-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6T3U3 biolink:molecularly_interacts_with DrugCentral:1125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ezetimibe targets Unclassified (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73982a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:739850d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:739877e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:73989e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fadrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7398c53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:7398e7ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:1128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famciclovir targets Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:73990b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.93']} DrugCentral uuid:73993208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:739958d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:739980dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7399aa1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7399d154-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7399f814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:739a1fc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:739a46e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:739a6d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:739a945e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:739abb1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:739ae27e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:739b0952-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:739b2fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:739b568c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:739b8030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.304']} DrugCentral uuid:739ba72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:739bcdc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:1130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 famprofazone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:739bf484-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:739c1b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:739c4240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:739c68ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:739c8f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:739cb6f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13500 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Cytokine (C-C motif chemokine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:739cdd90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:739d0446-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:739d2aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62868 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:739d536a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:739d7a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:1132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:739da0e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:739dc7a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:739defb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:739e164c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:1137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:739e3ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:739e5f9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:739e86f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:739ea9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.049']} DrugCentral uuid:739ed064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:739ef788-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:739f1fc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:739f4288-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:739f6538-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.339']} DrugCentral uuid:739f8be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.168']} DrugCentral uuid:739fb2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:739fd9a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine is activator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:73a00862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:73a00862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:73a00862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:73a04778-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:73a06e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:73a094d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:73a0b780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:73a0da30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:73a101d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73a12878-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:73a14f1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:73a175c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35384 biolink:molecularly_interacts_with DrugCentral:1148 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendiline is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:73a19db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.004']} DrugCentral uuid:73a1c472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:73a1eb14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.428']} DrugCentral uuid:73a211c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:73a23916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.172']} DrugCentral uuid:73a25fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:73a28678-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:73a2ad2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:73a2d754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:73a2fec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:73a3257e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:73a34c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:73a3736c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:73a39a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.726']} DrugCentral uuid:73a3c178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.489']} DrugCentral uuid:73a3e81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:73a40f84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:73a43630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:73a45ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.735']} DrugCentral uuid:73a483a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:73a4adfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:73a4d4fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:73a4fbba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:73a52266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:73a54980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.331']} DrugCentral uuid:73a571b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.032']} DrugCentral uuid:73a5987c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.164']} DrugCentral uuid:73a5bf1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:73a5e67e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.808']} DrugCentral uuid:73a60d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73a63548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:73a65bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:73a68656-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenofibrate targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:73a6af14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:73a6d5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:73a6fcd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:73a7239a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:73a74a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:73a770f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73a79852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:73a7bef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:73a7ec58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73a7ec58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73a7ec58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73a82ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:73a85472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoldopam targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:73a87b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:73a8a1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:73a8c88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:73a8f300-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:73a8f300-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:73a926cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:73a94d96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:73a974d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:73a99b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.001']} DrugCentral uuid:73a9c23a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:73a9e8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:73aa1028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:73aa36fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:73aa5dc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:73aa8468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73aaab50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:73aad206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:73aaf8bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:73ab1ffe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:73ab477c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:73ab6e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:73ab94e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73abc594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:73abc594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:73abc594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:73abc594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:73ac197c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:73ac197c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:73ac4e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:73ac74a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73ac9c94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:73acc336-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fentiazac targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:73ace9e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:73ad1070-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:73ad37ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:73ad5eae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:1170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fexofenadine targets Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:73ad8578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:73adac24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73add38e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14060 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:73adfa44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24008 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:73ae20f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:73ae4af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:73ae4af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:73ae7e24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:73aea4d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:1171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:73aecb7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.704']} DrugCentral uuid:73aefcfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:73aefcfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:73aefcfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:73aefcfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:73af4232-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:73af4232-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:73af72ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:73af72ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:73afa182-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:73afc82e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:73afeeda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:73b01676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:73b03d90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.77']} DrugCentral uuid:73b06450-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:73b08b06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:73b0b1b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:1176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:73b0d98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fleroxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:73b10040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:73b126e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:73b14da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flopropione is inhibitor of Enzyme (Catechol O-methyltransferase) DrugCentral uuid:73b171ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:73b19474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:73b1bb20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:1183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxacillin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:73b1e30c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxuridine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:73b2062a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 floxuridine targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:73b22cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:73b25382-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:73b27a2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:73b2a17a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:73b2c81c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:73b2eed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:73b31588-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:73b33df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:73b3651a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:73b38bd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:1187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:73b3b25e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:73b3da68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0CS13 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:73b3fd22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12461 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:73b41fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02829 biolink:molecularly_interacts_with DrugCentral:1188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flucytosine targets Cytosolic other (ATP-dependent molecular chaperone HSP82) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:73b4469c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73b46e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73b494c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:73b4bb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:73b4e246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:73b50a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:73b53142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:73b55802-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:1189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludarabine phosphate is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:73b57abc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:73b5a1ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:73b5c468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludrocortisone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:73b5eb28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:73b61274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:73b6390c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:73b660da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:73b68790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:73b6ae28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:73b6d4ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73b6fe00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:73b724ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:73b74b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:73b771fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:73b799fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:73b7c092-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:73b7e734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:73b80dea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:73b83540-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:73b85d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZQ8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:73b883ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73b8aac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:73b8d23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:73b8f8fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:73b91f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:73b94660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flufenamic acid is agonist of GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.863']} DrugCentral uuid:73b96d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:73b993fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73b9bad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:73b9e1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:73ba08fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:73ba2fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73ba5d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:73ba5d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:73ba5d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:73baa5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:73baa5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:73baa5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:73baf26c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:73baf26c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:73baf26c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:73bb3be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:73bb3be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:73bb3be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bbaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bc9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:73bd091c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:73bd091c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:73bd091c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:73bd4e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73bd4e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73bd4e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73bd947c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:73bd947c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:73bd947c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:73bdd9e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:73bdd9e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:73bdd9e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73be4c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:73bf2922-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1198 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flumetasone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:73bf4bc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:73bf733c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:73bf99f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:73bfc0b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:73bfe790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:73c0104e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:73c0392a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.304']} DrugCentral uuid:73c05fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:73c086aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:73c0aefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:73c0d5d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:73c0fcac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:73c1236c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:73c14aae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:73c17182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:73c19932-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:73c1bff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.151']} DrugCentral uuid:73c1e8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:73c212a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.103']} DrugCentral uuid:73c239be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:73c26074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:73c28784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:73c2ae9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:73c2d568-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:73c2fc32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.357']} DrugCentral uuid:73c32392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:73c34a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:73c3711c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:73c397d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:73c3c130-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:73c3ea0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:73c410b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:73c4376e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:73c45e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:73c48bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:73c48bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:73c48bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:73c4cab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:73c4f1f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:73c51896-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73c54064-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:73c5672e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:73c58f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:73c5b666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunisolide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:73c5dd08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunisolide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:73c603fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:73c62b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:73c65242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:73c6792a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:73c6a6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c6a6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c6a6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c6ee00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c6ee00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c6ee00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:73c7334c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:73c7334c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:73c7334c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:73c77afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:73c77afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:73c77afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:73c7c046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:73c7c046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:73c7c046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:73c806dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:73c806dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:73c806dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c87770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73c95da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:73c95da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:73c95da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:73c9a2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:73c9a2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:73c9a2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:73c9e9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73c9e9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73c9e9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73ca2fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73ca2fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73ca2fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:73ca7732-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73ca7732-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73ca7732-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:73cab5d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1204 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:73cadc9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1204 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.475']} DrugCentral uuid:73cb04a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1205 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.622']} DrugCentral uuid:73cb2b78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1205 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluocinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.538']} DrugCentral uuid:73cb5238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.042']} DrugCentral uuid:73cb78ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:73cb9fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:73cbc6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:73cbed60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.801']} DrugCentral uuid:73cc1434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.067']} DrugCentral uuid:73cc3b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:73cc6268-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:73cc891e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:73ccafd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:73ccd8b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:73cd02a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.091']} DrugCentral uuid:73cd2c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:73cd533a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:73cd7ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73cda196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:73cdc856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:73cdef16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:73ce161c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:73ce3ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:73ce6392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:73ce8a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.047']} DrugCentral uuid:73ceb266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:73cedc46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:73cf061c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:73cf301a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:73cf57a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.444']} DrugCentral uuid:73cf7e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:73cfa4f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:73cfcc28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:73cff342-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:73d019ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73d040ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:73d0676e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:73d091a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:73d0bbb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:73d0e27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:73d1093a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:73d130b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:73d15782-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:73d18838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73d18838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73d18838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73d18838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:73d1d9be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:73d1d9be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:73d1d9be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:73d21f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:73d21f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:73d21f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:73d25f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:73d2899a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25122 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:73d2b05a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxetine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:73d2d724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoxymesterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:73d2feb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:73d32594-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73d34c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:73d37300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:73d39a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.058']} DrugCentral uuid:73d3c0b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:73d3e448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:73d40b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73d43358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.066']} DrugCentral uuid:73d45a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:73d4811e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:73d4a7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:73d4cf20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:73d4f5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:73d529c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73d529c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73d529c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73d529c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73d529c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:73d58136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.075']} DrugCentral uuid:73d5a7e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.649']} DrugCentral uuid:73d5ceac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.269']} DrugCentral uuid:73d5f5e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:73d61f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.067']} DrugCentral uuid:73d64620-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:73d66cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:73d693aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:73d6bb00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.838']} DrugCentral uuid:73d6e1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.044']} DrugCentral uuid:73d70862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:73d72f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:73d75f9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.464']} DrugCentral uuid:73d78652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:73d7acf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.191']} DrugCentral uuid:73d7d4e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:73d7fe84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:73d8281e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:73d850dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.793']} DrugCentral uuid:73d87828-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:73d89ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:73d8c58a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.575']} DrugCentral uuid:73d8ec4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:73d91364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.315']} DrugCentral uuid:73d93a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:73d960c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.655']} DrugCentral uuid:73d98772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:73d9af40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:73d9d5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:73d9fcac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.788']} DrugCentral uuid:73da2358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:73da4a7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.535']} DrugCentral uuid:73da7128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.019']} DrugCentral uuid:73da97de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:73dabe94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.005']} DrugCentral uuid:73dae5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:73db0ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:73db3450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:73db5b06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.397']} DrugCentral uuid:73db82b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:73dba958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:73dbd004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.708']} DrugCentral uuid:73dbf69c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.125']} DrugCentral uuid:73dc1dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:73dc4462-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.67']} DrugCentral uuid:73dc6b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:73dc939a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.061']} DrugCentral uuid:73dcbae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:73dce1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:73dd0852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:73dd2eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:73dd56ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73dd7daa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:73dda46a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:73ddd1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:73ddd1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:73ddd1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73de27dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:73dea3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine decanoate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:73dec6a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:73deed8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:73df1458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:73df3e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:73df6746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:73df8de8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:73dfb48a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.048']} DrugCentral uuid:73dfdb9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:73e00246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:73e028f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:73e04fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:73e07708-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:73e09db4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:73e0c460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:73e0eb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:73e11294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.961']} DrugCentral uuid:73e13936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.145']} DrugCentral uuid:73e15fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.841']} DrugCentral uuid:73e18698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:73e1adbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:73e1d468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:73e1fc2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:73e222ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:73e24b82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:73e27242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:73e298f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:73e2bfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:73e2e736-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:73e30de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 3) DrugCentral uuid:73e3309c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:1215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flupirtine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:73e35752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1216 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:73e37ade-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludroxycortide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.695']} DrugCentral uuid:73e3a19e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fludroxycortide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:73e3c868-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.222']} DrugCentral uuid:73e3f5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73e3f5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73e3f5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:73e43500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:73e45bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:73e48262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:73e4aa76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:73e4d1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:73e4f882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:73e51f2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:73e5462a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:73e56ce0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:73e5947c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:73e5bb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:73e5e288-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.436']} DrugCentral uuid:73e6093e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:73e62ffe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:73e656aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:73e67eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:73e6a812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:73e6cefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:73e6f5a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:73e71ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:73e74376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:73e76a2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:73e790e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:73e7b824-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:73e7dee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:73e8059a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:73e82c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73e8546e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:1222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluspirilene targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:73e87cc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:73e8a388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.082']} DrugCentral uuid:73e8ca5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:73e8f158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:73e91804-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:73e93ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:73e96660-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.74']} DrugCentral uuid:73e98d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:73e9b4b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.77']} DrugCentral uuid:73e9db4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate targets Enzyme (Cytosolic phospholipase A2) DrugCentral uuid:73e9fdf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.12']} DrugCentral uuid:73ea2578-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:73ea4c1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flutrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:73ea72bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:73ea9558-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:73eabc72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:73eae33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:73eb09fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:73eb30bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:73eb5830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:73eb7ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:73eba59c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:73ebcc48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:73ebf3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:73ec1acc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:73ec41a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:73ec684c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1230 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:73ec8f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 folic acid targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:73ecb61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 folic acid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:73ecdcbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucovorin targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.071']} DrugCentral uuid:73ed0374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucovorin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:73ed32b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:73ed32b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:73ed32b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:73ed6d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:73ed6d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:73eda040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fondaparinux is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:73edc796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formestane targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:73edeec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:73ee15a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:73ee3c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:73ee6340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:73ee8a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:73eeb21e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:73eed8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 formoterol targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:73ef0084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosamprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:73ef2348-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosamprenavir is inhibitor of Enzyme (Pol polyprotein) DrugCentral uuid:73ef460c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet is inhibitor of Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:73ef6cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08546 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73ef935a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:73efbd26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 foscarnet targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73efe5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfluconazole targets Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:73f00862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q836E5 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1) DrugCentral uuid:73f02b08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q831A8 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2) DrugCentral uuid:73f04e3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A749 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin is inhibitor of Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:73f074e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HVW7 biolink:molecularly_interacts_with DrugCentral:1243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:73f09ba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:73f0c252-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:73f0eade-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosphenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:73f10d8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:73f13462-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:73f15b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:73f183ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fructose targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:73f1aaf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ftivazide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:73f1d192-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:73f1f834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:73f21f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:73f245e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:73f26c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:73f2932a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:73f2ba58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:73f2e0fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:73f3079c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:73f32e48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:73f35706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:73f38096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furaltadone targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:73f3a92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:73f3cfba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:73f3f332-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:73f419fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:73f440c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:73f46790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:73f48f68-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:73f4b70e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:73f4ddba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:73f505ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:73f52eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:73f5579a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:73f57e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:73f5a4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:73f5cc0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:73f5f2cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:73f61964-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:73f64074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96618 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Enzyme (Holo-[acyl-carrieir-protein] synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:73f667d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furosemide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:73f68e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:73f6b522-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:73f6dbd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73f70464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:73f72afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:73f7519e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:73f77836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:73f79f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:73f7c5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48066 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:73f7ec9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48065 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:73f81340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31650 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:73f83a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31646 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:73f86228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31649 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:73f888d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23574 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:73f8af6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid is agonist of GPCR (Gamma-aminobutyric acid type B receptor subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:73f8d6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSD5 biolink:molecularly_interacts_with DrugCentral:1262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:73f8fd78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:73f92000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:73f942b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Adenosine receptor A1) DrugCentral uuid:73f965ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) DrugCentral uuid:73f98856-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:73f9aae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:73f9d220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:73f9f8e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:73fa2040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:73fa46e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:73fa6db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:73fa9476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:1264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.928']} DrugCentral uuid:73fabe92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:73fae5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:73fb0c4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:73fb330e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73fb5a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:73fb81e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:73fba88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:73fbcf44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:73fbf622-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:73fc1dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:73fc4492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:73fc6b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:73fc9406-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:73fcbac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:73fce168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:73fd0814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:73fd2f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallamine is negative allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:73fd5cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:73fd5cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:73fd5cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:73fd9b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:73fdc2d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:73fde98c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:73fe102e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:73fe36e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:73fe6074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:1276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gamolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:73fe8770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:73feaa0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Kinase (Thymidine kinase) DrugCentral uuid:73fecc94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:73fef412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:73ff1ab4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10210 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Enzyme (Capsid scaffolding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:73ff4156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganciclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:73ff6898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ganirelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:73ff8ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:73ffb352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:73ffdd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:73ffdd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:74000e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74000e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:7400401a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7400401a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:740072b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:74009952-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7400c0b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7400e772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:74010e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:740134e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:74015d42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:740183ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7401aaa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7401d132-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7401f9aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:740222ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7402495a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:74026ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:74029770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7402be26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7402e4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:74030b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:74033298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:74035a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:740380ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7403a796-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7403d022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7403fa0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:740422fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7404498a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:740470f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:740497a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7404be60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7404e50c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:74050c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:740532be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7405596a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:74058106-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7405a9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7405d0d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7405f834-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74061ed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:74064640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:74066d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:740693a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7406ba62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7406e1fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:740708a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:74073050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74075706-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:74077fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7407a95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7407d208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7407f9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:74082168-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:74084828-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:74086eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7408958a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7408bc90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7408e33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:740909e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7409309e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74095a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:74098120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7409a7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7409ce82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7409f5d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:740a1ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:740a4344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:740a69e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:740a9182-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:740ab824-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:740adeda-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:740b0676-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:740b3010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:740b59a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:740b804c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:740ba6d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:740bce26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:740bf4dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:740c1b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:740c422a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:740c694e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:740c8fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:740cb692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Enzyme (Thymidylate synthase) DrugCentral uuid:740cd92e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:740cfe54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:740d2334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:740d45d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30085 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine targets Kinase (UMP-CMP kinase) DrugCentral uuid:740d6f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:740d6f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:740d6f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:740da714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Lipoprotein lipase) DrugCentral uuid:740dc99c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:740df03e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:740e1834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:740e3f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:740e660e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:740e8cba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemfibrozil targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:740eb37a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:740edea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:740f0410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:1286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemifloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:740f2878-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestodene targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:740f4b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestodene targets Enzyme (Cytochrome P450 3A5) DrugCentral uuid:740f6e1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1292 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gestrinone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:740f94fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12882 biolink:molecularly_interacts_with DrugCentral:1293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gimeracil is inhibitor of Enzyme (Dihydropyrimidine dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:740fbb94-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:740fe240-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:74100cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:74100cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:74104302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:74104302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:74107912-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:74107912-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7410b382-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:7410b382-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:7410ed2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7410ed2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:74112358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:74112358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:741159e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:741159e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:7411900e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7411900e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7411c63c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7411c63c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7411fa3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:741220dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:741247a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:7412701e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:741298fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7412bfb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7412e65c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00367 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 1, mitochondrial) DrugCentral uuid:74130966-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49448 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 2, mitochondrial) DrugCentral uuid:74132c02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:741352ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7413795a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7413a09c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7413c8ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7413ef98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7414166c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:74143df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:741465b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14416 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:74148c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:7414b2fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:7414d9f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:741500c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:74152764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.595']} DrugCentral uuid:74154e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.738']} DrugCentral uuid:7415755c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:74159c08-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7415c390-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7415ea14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7416119c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:74163b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:741662e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:74168988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:7416b084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7416d79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7416fe2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.31']} DrugCentral uuid:741724ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03469 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:74174c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70579 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:741772f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47743 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:74179986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7417c00a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23385 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7417e792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31421 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:74180e20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31422 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:741834ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56068 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:74185b78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7418827e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:1311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutamine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:7418a916-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2Q3 biolink:molecularly_interacts_with DrugCentral:1312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutathione targets Enzyme (Glutathione S-transferase kappa 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7418d670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7418d670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7418d670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:74190df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:7419353e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:74195d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.795']} DrugCentral uuid:741983ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7419aa82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7419d782-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7419d782-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:741a0b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:741a3240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:741a595a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96P20 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Unclassified (NACHT, LRR and PYD domains-containing protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:741a801a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:741aa784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide targets Nuclear other (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:741ad1aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:741ad1aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:741b0850-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:741b0850-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:741b3b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:741b61b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48067 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Transporter (Sodium- and chloride-dependent glycine transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741b9e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741c1678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycine targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:741c3e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:741c6524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:741c8bd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:741cb312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycyrrhizic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:741cda5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:1327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 goserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:741cfd04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 goserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:741d1fb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:741d466a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:741d6e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:741d953e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:741dbbfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:741de2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:741e09c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00346 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:741e3048-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0PJ46 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Lactate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:741e56b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6VVP7 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:741e7d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11708 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:741ea46a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:741ecb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:741ef1f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52732 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (Kinesin-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:741f188c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:741f406e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:741f6774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07195 biolink:molecularly_interacts_with DrugCentral:1328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:741f8e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:741fb616-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:741fdd26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:742004c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:74202eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:74202eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:742064f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:742064f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:74209888-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7420bf34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:7420e5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:742110ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:742110ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:7421413e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:7421413e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74216e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10875 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Structural (Tubulin beta chain) DrugCentral uuid:742190d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7421b7ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7421e54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:7421e54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:7421e54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:74221ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7422448a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:74226b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanadrel is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:74228ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanadrel targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7422b064-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:7422d31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:7422f826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:74231af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:74233d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:7423600e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:74238318-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanethidine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:7423a6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.065']} DrugCentral uuid:7423cd78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:7423f42e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:74241b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.926']} DrugCentral uuid:74244226-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:742468b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:74248f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7424b6fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:7424e096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanfacine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.164']} DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:742589f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74277c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:74283e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ulobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7428623e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halofantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:74288944-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7428b00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:7428d6ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7428fe06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:742924d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.947']} DrugCentral uuid:74294b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:74297228-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:74299960-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7429c02a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7429e6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:742a0d96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:742a3528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:742a5cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:742a8398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:742aaa58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:742ad14a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:742af80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:742b1eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:742b456c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:742b6cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:742b936e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:742bbb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:742be1de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:742c092a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:742c2fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:742c5696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:742c7d42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.569']} DrugCentral uuid:742ca43e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:742ccb08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:742cf2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:742d19b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:742d47cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:742d47cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:742d47cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:742d8642-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.648']} DrugCentral uuid:742dacf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:742dd3b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:742dfda2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:742e244e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:742e4b04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:742e71c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:742e98e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:742ebfa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.76']} DrugCentral uuid:742ee65e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:742f0d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:742f3474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:742f5c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:742f8302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:742fa9cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:742fd38e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:742ffa30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:743020e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7430479c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:74306ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:74309580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7430bc2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7430e2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:74310b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:743131b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:74315880-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:74317f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7431a880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7431cf40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:7431f5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:74321c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50129 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:743243c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:74326a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:74329150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62744 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (AP-2 complex subunit sigma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7432c666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7432c666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7432c666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7432c666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7432c666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:74332994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74332994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74332994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74332994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:743381c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:743381c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:743381c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:743381c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7433d4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7433d4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7433d4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:74341c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:74341c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:74346750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74346750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74346750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74346750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74346750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7434c60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7434c60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7434c60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74350c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:74350c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:74350c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74356628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7435edbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:7435edbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:7435edbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:74362c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:74365326-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:74367a68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7436a13c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7436c810-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60493 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol targets Unclassified (Zinc finger protein 664) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:7436ef02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol is inverse agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:743718c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halopredone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:74373b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:74376248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.339']} DrugCentral uuid:74378912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.366']} DrugCentral uuid:7437b036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.561']} DrugCentral uuid:7437d782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7437fe4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:7438250c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:74384c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:743873fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:74389adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:7438c19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:7438ea82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7439112e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.338']} DrugCentral uuid:743937ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:74395f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloprogin targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:743986b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:7439a972-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:7439cc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:7439eef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:743a11f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:743a3806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:743a3806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743a96b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:743b5a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:743b817a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:743ba84e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 heparin targets Unclassified (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:743bcef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:743bf75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:743c1f04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:743c4b78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:743c722e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:743c998e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:743cc03a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:743ce6e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:743d0d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d456e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:743d9cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.212']} DrugCentral uuid:743dc480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.191']} DrugCentral uuid:743deb36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.043']} DrugCentral uuid:743e11ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.686']} DrugCentral uuid:743e38c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:743e60b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:743e87e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:743eaea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:743ed654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:743efeb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:743f2564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.521']} DrugCentral uuid:743f4c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:743f72da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.882']} DrugCentral uuid:743f99d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.126']} DrugCentral uuid:743fc06e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.911']} DrugCentral uuid:743fe71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06149 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (D-lactate dehydrogenase) DrugCentral uuid:744009ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.614']} DrugCentral uuid:7440318e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.459']} DrugCentral uuid:74405ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.479']} DrugCentral uuid:74408562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7440ac18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:7440d350-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.057']} DrugCentral uuid:7440fa10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:744120da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.479']} DrugCentral uuid:744147ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:74416eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) DrugCentral uuid:74419164-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:7441b928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7441e11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:744208ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:744232a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7442596e-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:74428010-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7442a84c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7442cf84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7442f64e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:1364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexachlorophene targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:74431dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:74434126-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:744367f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexafluronium targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7443927a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7443927a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7443c89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7443c89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:744402dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:744402dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:744443e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:744443e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:744443e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:744443e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:744494e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7444bb82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7444e22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexestrol is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:74450fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74450fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74450fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74454dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74454dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74454dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74458c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:74458c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:74458c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:7445cee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7445cee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7445cee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:74460e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:74460e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:74460e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:74464db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:74467076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7446974a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7446be1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7446e6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:74470d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:74473c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74473c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74473c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74477aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7447a2b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7447c958-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexylresorcinol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7447f022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:744816ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:74483e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:744864ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.508']} DrugCentral uuid:74488b9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7448b80e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7448e040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:744906c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:74492d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:744954a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:74497e6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7449a7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7449cee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:7449f64c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91ZY3 biolink:molecularly_interacts_with DrugCentral:1375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:744a1ed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histidine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:744a4570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:744a6c30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:744a935e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:744aba14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:744ae0de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:744b0780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hycanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:744b2f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:744b5848-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:744b7bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:744b9e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:744bc134-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:744be484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:744c0b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.438']} DrugCentral uuid:744c31e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:744c58a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:744c7fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:744ca676-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0LPN4 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine targets Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.152']} DrugCentral uuid:744cd38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:1384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydralazine is blocker of Ion channel (Ryanodine receptor 2) DrugCentral uuid:744cf63a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:744d21d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.01']} DrugCentral uuid:744d486a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:744d6f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:744d91d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:744db548-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:744ddc12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:744e02be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:744e2aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:744e51ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochlorothiazide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:744e792e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:744ea00c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocodone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:744ec6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortamate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:744eec06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:744f1532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Cytosolic other (Annexin A1) DrugCentral uuid:744f37f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.95']} DrugCentral uuid:744f5ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:744f86e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.881']} DrugCentral uuid:744fadc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:744fd4a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:1388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.37']} DrugCentral uuid:744ffb6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone cypionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:74501e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.37']} DrugCentral uuid:7450454c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:74506c20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:745092ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7450c788-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7450c788-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7450c788-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7450c788-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7451183c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.1']} DrugCentral uuid:74513f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74516670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.529']} DrugCentral uuid:74518d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7451b404-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7451daba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:7451fe46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:7452251a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.81']} DrugCentral uuid:74524bee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:745273c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:74529dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7452c4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7452eba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7453125e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:745335ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:74535dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:745384aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7453abe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxychloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7453d41e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1398 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxystilbamidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7453faac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:74542162-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74544930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:74546eec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:74549476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:7454bdd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7454e49e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74550cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:74553836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.409']} DrugCentral uuid:74555ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyzine targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:745585ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:7455acbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7455d372-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7455fa3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:745620fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:74564b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:74567214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:745699f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7456c0c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7456e80c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:74570ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7457356e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:74575c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7457833e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7457aa58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:1404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7457d0fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7457f896-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:7458212c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:745847ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:1406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:74586e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7458953a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7458bc7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7458e328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:745909d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:74593076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:7459592a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:74597fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7459a722-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7459cfb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7459f6fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:745a1d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:745a4452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:745a6b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:745a9236-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:745ab9fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:745ae09c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:745b0b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:745b0b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:745b3dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:745b6490-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VD48 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:745b8b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuprofen is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.53']} DrugCentral uuid:745bb2e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:745bdde4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:745bdde4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:745c119c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibutilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:745c3870-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75907 biolink:molecularly_interacts_with DrugCentral:1413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icosapent ethyl is inhibitor of Enzyme (Diacylglycerol O-acyltransferase 1) DrugCentral uuid:745c5b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:745c7e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:745ca102-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idarubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:745cc3b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:745ceb08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:745d11c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:745d384c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:745d5fc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:1417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idoxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:745d886a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:1417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idoxuridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:745db24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:745dde96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:745e0538-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:745e2c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:745e52e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:745e79aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:745ea06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:745ec7e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:745eee8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:745f15cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:745f3d5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:745f66bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:745f8db8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.99']} DrugCentral uuid:745fb8ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:745fb8ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:745ff2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:745ff2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:745ff2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:746032b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00960 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate [NMDA] receptor subunit epsilon 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7460596e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60490 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Unclassified (3-beta-hydroxysteroid-delta(8),delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:7460804c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7460a7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7460cf34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7460f5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ifenprodil targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:74611caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:746146d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:746170a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:74619c20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7461c358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7461ea04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:746210ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:74623784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:74625ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:746285b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7462ad18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7462d3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7462fcbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7463254a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:74634d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:7463739c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:74639a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7463c144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7463e7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:74640eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:746436ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:74645d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7464843a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:7464aa32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7464d1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7464f884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:746520b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:74654762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:74656f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7465960e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7465bd32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7465e41a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:74660b7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:74663230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:74665f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7466864a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7466aea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:7466d578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7466fc24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:746723de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:74674ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:746771a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7467985a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:7467bf06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7467e652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:74680d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746833d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:74685a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:746882ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7468aca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7468d3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7468fa92-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746921b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7469486c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:74696f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:746995d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7469bd2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7469e3e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746a0a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:746a313c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:746a59be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746a807e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:746aa734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:746acdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:746af5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:746b1c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:746b434c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:746b6b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746b92d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:746bb98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:746be040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:746c06d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:746c2e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:746c5534-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:746c7bea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:746ca28c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:746cc9b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:746cf1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:746d1866-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:746d4002-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:746d6776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:746d8e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:746db4ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:746ddb7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:746e041a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:746e2de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:746e54d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:746e7b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:746eaca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:746ed44e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:746efb04-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:746f250c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:746f250c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:746f5b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:746f5b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:746f919a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:746f919a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:746fc46c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05030 biolink:molecularly_interacts_with DrugCentral:1423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:746fee88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74701534-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74703bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:747062a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:747089ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7470c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74712618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:74714de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:74717488-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:74719bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.854']} DrugCentral uuid:7471c37a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7471ea30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:747211d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:74723918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:74725fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:747287ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7472ae98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:7472d5b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.614']} DrugCentral uuid:7473019a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:74732850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:74734efc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7473771a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:74739dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.081']} DrugCentral uuid:7473c5b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:7473ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:747413b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74743a56-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:747460f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:747487cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7474af54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7474d600-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7474fcb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:74752466-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:74754c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:74757394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:74759a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7475c114-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:7475e964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:74761024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:747636da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74767140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7476f296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7476f296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7476f296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7476f296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7476f296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747778ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:747845ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:747845ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:747845ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:74789236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:74789236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:74789236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:74789236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:74789236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7478f032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7478f032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7478f032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:74793614-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74793614-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74793614-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74797bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:74797bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:74797bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7479baf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7479e1a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:747a0864-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:1427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imipramine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:747a2f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:747a5710-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:747a7dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:747aa53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imiquimod is agonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:747ad1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:747af88c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8MTZ4 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid targets Unclassified (Vacuolar-type proton translocating pyrophosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:747b1f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 incadronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:747b45ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indalpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:747b6d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:747b93f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.54']} DrugCentral uuid:747bba74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:747be134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:747c08e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:747c2fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:747c5790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) DrugCentral uuid:747c7a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:747ca196-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:747cc86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:747cef34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:747d15ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:747d3d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.535']} DrugCentral uuid:747d63f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:747d8aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:747db20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:747dd520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indenolol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:747df7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indenolol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:747e1a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:747e421c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:747e68c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.733']} DrugCentral uuid:747e92f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:747ebb16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:747ee6b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:747f0e36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:747f34ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:747f5b7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:747f8230-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:747fa95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:747fd014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:747ff6ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:74801970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:74803cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7480648e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:74808b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7480b1c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7480d874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:7480ffc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:74812676-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:74814d18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:748173b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:74819b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7481c1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7481e89a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.691']} DrugCentral uuid:74820f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:74823a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74826176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7482880e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7482aece-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7482d750-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:7482fdf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74832516-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:74834bb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:748372dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7483997e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7483c00c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7483e6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:748410f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:748442ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:748442ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:74847916-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:74847916-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7484b05c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7484b05c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7484e306-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:74850a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:74853162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17516 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7485580e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:74857ed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indomethacin targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7485aa2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7485d31a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:1442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoprofen targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7485f9bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:7486207c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:74864750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:74866e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:74869552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:7486bbfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7486e2be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:74870a28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:748730e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:74875e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:74875e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:74875e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7487a44c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:7487a44c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:7487a44c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:7487e2ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:748809aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:74883038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:74885734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.278']} DrugCentral uuid:74887df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.724']} DrugCentral uuid:7488a5d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.609']} DrugCentral uuid:7488cc8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.804']} DrugCentral uuid:7488f3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.067']} DrugCentral uuid:74891a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.279']} DrugCentral uuid:74894220-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.439']} DrugCentral uuid:748968b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.043']} DrugCentral uuid:74899040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.532']} DrugCentral uuid:7489b6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diiodohydroxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7489dd8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:748a043a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:748a2b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.292']} DrugCentral uuid:748a5278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.181']} DrugCentral uuid:748a792e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:748a9fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:748ac74e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:748aee90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.74']} DrugCentral uuid:748b1546-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipratropium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:748b3bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipriflavone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:748b65f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipriflavone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:748b8c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:748bb348-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:748bd9ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:748c00d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iprindole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.185']} DrugCentral uuid:748c281e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:748c4eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:748c756c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:748c9cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:748cc378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:748cea2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:748d11ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:748d3fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:748d3fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:748d79da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:748d79da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:748d79da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:748db8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irbesartan is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:748de492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:748e074c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:748e2e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:748e515c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:748e7812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:748e9b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:748ebdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:748ee1b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:748f0c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:748f2f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:748f55ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:748f7c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:748fa354-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:748fca64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:748ff124-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:749017bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:74903f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 irofulven targets Kinase (Serine/threonine-protein kinase Chk2) DrugCentral uuid:7490626c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isepamicin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.87']} DrugCentral uuid:74908940-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1490 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:7490abf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1490 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:7490d1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoetarine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7490f8e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:74911fae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:74914272-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:7491657c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:749188a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:7491ab72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:7491d188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:7491d188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:749230ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7492ff7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:74932646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:74934d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:74937420-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:74939ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7493c394-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q29550 biolink:molecularly_interacts_with DrugCentral:1494 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluostigmine targets Enzyme (Liver carboxylesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7493eaea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:74941178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Catalase-peroxidase) DrugCentral uuid:74943450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:74945af2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:749482ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7494a96c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoniazid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7494d040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7494f6ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:74951df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:749544bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:74956b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7495921e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7495b9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.752']} DrugCentral uuid:7495e052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:749606d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:74962da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7496567c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:74967dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7496a488-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7496cb20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7496f24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7497190e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:74973fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:74976698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74978f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59534 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7497b5b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59535 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 40) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7497dc5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59536 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74980314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59537 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 43) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74982cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59538 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 31) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74985684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59539 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 45) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7498803c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7498a6fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59541 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 30) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7498ce16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59542 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 19) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7498f4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59543 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74991b82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59544 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 50) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74994238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59551 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 60) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749969ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTR8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 42) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7499906c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYV7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 16) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7499b718-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7499ddd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYV9 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749a0790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749a2fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW1 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749a58d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW2 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749a7f90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW3 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749aa72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749acde2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW5 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749af498-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW6 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749b1b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:749b42ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:749b6662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:749b8912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:749bb5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749bb5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749bb5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749bb5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749bfdde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:749c2da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749c2da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749c2da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749c2da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:749c7336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:749c9a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:749cc0ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:749ce79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:749d0efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08319 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (Alcohol dehydrogenase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:749d35be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:749d5c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:749d8320-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14756 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Enzyme (17-beta-hydroxysteroid dehydrogenase type 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:749dad00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin is inhibitor of Nuclear hormone receptor (Retinoic acid receptor beta) DrugCentral uuid:749dd28a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.597']} DrugCentral uuid:749dfc74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.335']} DrugCentral uuid:749e2668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:749e4dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isotretinoin targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:749e7474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1509 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:749e9b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1509 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:749ec1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:749ee526-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:749f08ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:749f2fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:749f5696-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:749f8058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:749fa72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:749fcdec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:749ff600-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:74a01da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:74a0447a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:74a06b3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.246']} DrugCentral uuid:74a09218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:74a0b98c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:74a0e04c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74a10716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:74a12de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:74a15798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:74a17e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:74a1a55e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:74a1cc32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1513 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 itraconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a20dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:74a28564-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:74a2ac2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:74a2d2d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29033 biolink:molecularly_interacts_with DrugCentral:1519 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kanamycin targets Unclassified (Gap junction beta-2 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:74a2f986-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:1520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bekanamycin targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:74a3223a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bekanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:74a348fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a383b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a40678-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:74a47f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:74a47f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:74a47f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:74a47f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:74a4c388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:74a4eb9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:74a51572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki'} DrugCentral uuid:74a53cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:74a563a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:74a58aa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:74a5b16c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:74a5d822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:74a5fed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:74a6262e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:74a64d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:74a673c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:74a69a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:74a6c228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74a6e8f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.747']} DrugCentral uuid:74a70fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:74a7367c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:74a75d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:74a7841a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:74a7aae4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:74a7d1a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:74a7f904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:74a81fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.903']} DrugCentral uuid:74a84684-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:74a86d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:74a8960c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:74a8bccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:74a8e38c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.33']} DrugCentral uuid:74a90a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:74a9318e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:74a95844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74a97f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:74a9ac68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:74a9ac68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:74a9ac68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:74a9f29a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:74a9f29a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:74a9f29a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:74aa314c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:74aa5960-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:1524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:74aa8340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:74aaabf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:74aad2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.585']} DrugCentral uuid:74aaf956-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:74ab2a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74ab2a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74ab2a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74ab2a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74ab7ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74ab7ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74ab7ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74ab7ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74abcb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.821']} DrugCentral uuid:74abf1da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:74ac193a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:74ac416c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:74ac6b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:74ac92ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:74acb98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:74ace0c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:74ad0782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.667']} DrugCentral uuid:74ad2e42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:74ad54ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:74ad7c4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.729']} DrugCentral uuid:74ada30e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:74adc5b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:74adec7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:74ae1492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:74ae3b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:74ae629e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:74ae895e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:74aeb06e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:74aed72e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:74aeff24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:74af25c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.665']} DrugCentral uuid:74af4e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'app Ki', 'has_quantitative_value': ['7.197']} DrugCentral uuid:74af74ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74af9bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:74afc24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:74afeaf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:74b011ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.266']} DrugCentral uuid:74b038c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.897']} DrugCentral uuid:74b060da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.211']} DrugCentral uuid:74b08808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:74b0aebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:74b0d574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:74b0fc16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07973 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.506']} DrugCentral uuid:74b12362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08686 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 21) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:74b149f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:74b1709c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14137 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:74b19748-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09128 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 24A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:74b1bf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18125 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 7A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:74b1e8e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64654 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 51) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:74b21254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:74b23914-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:74b2601a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35084 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:74b286da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:74b2ad90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:74b2d46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.896']} DrugCentral uuid:74b2fbec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:74b323b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:74b34b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:74b371f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:74b39d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:74b39d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:74b3cfa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:74b3f664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:74b41d1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:74b4443e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.214']} DrugCentral uuid:74b46aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:74b491aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:1529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketorolac targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:74b4b84c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.361']} DrugCentral uuid:74b4dfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:74b5064e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:74b52912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.839']} DrugCentral uuid:74b55068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.047']} DrugCentral uuid:74b57a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:74b5a36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:74b5ca48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:74b5f0fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.489']} DrugCentral uuid:74b61836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:74b63ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.509']} DrugCentral uuid:74b665c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:74b68c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:74b6b520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:74b6dbcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:74b70372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:74b72a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.075']} DrugCentral uuid:74b751e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:74b778a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:74b79f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:74b7c60e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1530 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74b7ed32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.234']} DrugCentral uuid:74b8141a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:74b83af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.117']} DrugCentral uuid:74b861cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.478']} DrugCentral uuid:74b88922-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:74b8aff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:74b8d6b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:74b8fd76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:74b92724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:74b94e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:74b9751c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:74b99bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:74b9c6d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:74b9ed6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:74ba1404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:74ba3aa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.245']} DrugCentral uuid:74ba6210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:74ba88d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:74baaf86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:74bad72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:74baff40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.771']} DrugCentral uuid:74bb268c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:74bb50bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:74bb50bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:74bb7e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00214 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:74bba4ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00182 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74bbcbaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17931 biolink:molecularly_interacts_with DrugCentral:1535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lactose targets Unclassified (Galectin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.03']} DrugCentral uuid:74bbf256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:74bc1772-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine is inhibitor of Polyprotein (Protein P) DrugCentral uuid:74bc3a4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1539 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamivudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:74bc611e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:74bc87b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.839']} DrugCentral uuid:74bcae76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:74bcd284-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74bcf962-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74bd2158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74bd4840-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:74bd6b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74bd9214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.744']} DrugCentral uuid:74bdb8fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:74bddfa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:74be0708-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:74be3480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:74be3480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:74be3480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:74be7436-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74be9d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1545 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 landiolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:74bec09e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:74bee768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:74bf0e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:74bf3588-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:74bf5c5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:74bf82fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:74bfa9c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:74bfd150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:74bff806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:74c01ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:74c04590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.275']} DrugCentral uuid:74c06e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.473']} DrugCentral uuid:74c09504-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:74c0bc50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCT1 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Phosphoethanolamine/phosphocholine phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:74c0e2f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:74c10a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:74c13432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:74c13432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:74c16150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:74c18806-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:74c1af84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1547 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:74c1d612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:74c1f8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:74c21b68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:74c24480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74c26b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:74c2921e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:74c2b8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:74c2dbde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:74c3029e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74c32a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:74c35140-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:74c378a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74c39f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:74c3c5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:74c3ec9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:74c41512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:74c43bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:74c46288-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:74c4893e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:74c4b044-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:74c4d6e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1549 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine hydrochloride targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74c4fda6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:1549 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine hydrochloride is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:74c52448-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75746 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar1) DrugCentral uuid:74c5477a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17174 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, cytoplasmic) DrugCentral uuid:74c56a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45381 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartoacylase) DrugCentral uuid:74c58cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08243 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Asparagine synthetase [glutamine-hydrolyzing]) DrugCentral uuid:74c5af62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00966 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Argininosuccinate synthase) DrugCentral uuid:74c5d21c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03154 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aminoacylase-1) DrugCentral uuid:74c5f5bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00505 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, mitochondrial) DrugCentral uuid:74c6195c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14868 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartate--tRNA ligase, cytoplasmic) DrugCentral uuid:74c63bf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12797 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Enzyme (Aspartyl/asparaginyl beta-hydroxylase) DrugCentral uuid:74c65ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:74c6864e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:74c6ad18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:74c6d3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UJS0 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar2) DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c70a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:74c778e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:74c79fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O59010 biolink:molecularly_interacts_with DrugCentral:1550 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aspartic acid targets Transporter (Glutamate transporter homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:74c7c95a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.757']} DrugCentral uuid:74c7f344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:74c81a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:74c84132-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:1551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:74c86860-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:74c88f20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:74c8b5e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:74c8dcaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74c90540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:74c92c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.684']} DrugCentral uuid:74c95392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:74c97a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:1552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:74c9a4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:74c9cb92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:74c9f252-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:74ca1908-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leucine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:74ca4022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leuprorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:74ca66e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1559 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 leuprorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:74ca8db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:74cab480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:74cadbe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:74cb0ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:74cb0ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:74cb0ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:74cb0ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:74cb57d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N587 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Ion channel (Acetylcholine receptor subunit alpha-type unc-63) DrugCentral uuid:74cb7c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:74cba336-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96760 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole is agonist of Ion channel (Nicotinic acetylcholine receptor alpha subunit) DrugCentral uuid:74cbc5e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.568']} DrugCentral uuid:74cbed3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09487 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:74cc1460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:1561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamisole targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:74cc3b0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:74cc61e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:74cc8882-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:74ccafe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:74ccd774-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cd28f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:74cdf032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:74ce12ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:74ce3592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:74ce584c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:74ce801a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:1563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levetiracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:74cea6d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:74cec980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.279']} DrugCentral uuid:74cef040-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95665 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:74cf19b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63384 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine targets GPCR (Neurotensin receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:74cf4090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70310 biolink:molecularly_interacts_with DrugCentral:1564 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:74cf675a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levocetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:74cf8f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:74cfb642-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.541']} DrugCentral uuid:74cfdcee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:74d00390-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:74d02a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:74d05192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa is agonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:74d07456-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1567 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levodopa is agonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:74d09710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.04']} DrugCentral uuid:74d0bdc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:74d0e58a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:74d10f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:74d10f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:74d14020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74d14020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74d16d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levofloxacin targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:74d19462-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadyl acetate is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:74d1b71c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadyl acetate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:74d1de54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:74d2050a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:74d22cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:74d24fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['12.796']} DrugCentral uuid:74d27652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.91']} DrugCentral uuid:74d29d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:74d2c706-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levonorgestrel targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.339']} DrugCentral uuid:74d2ee34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:74d314e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:74d33ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:74d363d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:74d38a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:74d3b12a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:74d3d7e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:74d3ff40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74d42722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:74d44dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55242 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d4899c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d50cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:74d584f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:74d584f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:74d584f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:74d584f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:74d5d7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74d5d7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74d5d7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:74d61668-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:74d63d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1575 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosalbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:74d665dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:74d68918-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:74d6abb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15842 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 8) DrugCentral uuid:74d6ce8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63316 biolink:molecularly_interacts_with DrugCentral:1576 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosimendan is opener of Cytosolic other (Troponin C, slow skeletal and cardiac muscles) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.155']} DrugCentral uuid:74d6f592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:74d71c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:74d74326-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:74d76a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:74d791be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:74d7b892-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:74d7ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:74d7ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:74d7ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:74d7ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:74d7ec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:74d84cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:74d84cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:74d84cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:74d899a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:74d899a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:74d899a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:74d8dd3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:74d903f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:74d926b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:74d94d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:74d974fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:74d99b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.296']} DrugCentral uuid:74d9c25e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:74d9e4fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.559']} DrugCentral uuid:74da14e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:74da14e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:74da14e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:74da5a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:74da5a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:74da5a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:74da9954-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:74dac00a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:1579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:74dae6ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:74db0d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:74db3b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:74db3b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:74db3b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:74db7a4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 limaprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:74db9cf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:1582 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lincomycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:74dbbf96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:74dbe818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:74dc0fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75NA5 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:74dc366a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:74dc63c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:74dc63c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:74dc63c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:74dca942-59f3-11ec-9eaa-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dca942-59f3-11ec-9eaa-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dca942-59f3-11ec-9eaa-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dce768-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dce768-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dce768-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:74dd2656-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74dd2656-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74dd2656-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74dd6d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:74dd6d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:74dd6d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:74ddaca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:74ddd362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:74ddfa18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74de20ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31040 biolink:molecularly_interacts_with DrugCentral:1584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linezolid targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:74de47de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:74de6ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:74de959a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:74debc46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:74dee3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:74df0b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:74df31e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74df8b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e0984a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:74e17936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1587 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:74e19ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1587 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:74e1c6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:74e1edc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:74e2149a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:74e23b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:74e261f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.936']} DrugCentral uuid:74e28952-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:74e2b0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.061']} DrugCentral uuid:74e2d79a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:74e2fe82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.259']} DrugCentral uuid:74e32646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:74e3503a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.625']} DrugCentral uuid:74e3775e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:74e39e1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:74e3c57e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:74e3ed2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:74e413ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:74e43aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:74e4622c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.203']} DrugCentral uuid:74e488e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:74e4affc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:74e4d6bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.037']} DrugCentral uuid:74e4fe6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:74e52540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:74e54c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.338']} DrugCentral uuid:74e572ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:74e599da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:74e5c086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.33']} DrugCentral uuid:74e5e732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:74e60e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:74e635ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisuride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.489']} DrugCentral uuid:74e65c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:74e6832c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:74e6aa0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:74e6d1ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:74e6fab4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:74e72174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:74e74816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.444']} DrugCentral uuid:74e7705c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:74e796f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:74e7bea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:74e7e546-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.468']} DrugCentral uuid:74e80ca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:74e8335c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:74e85a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:74e880e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:74e8a8aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:74e8d618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:74e8d618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:74e8d618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:74e91b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:74e91b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:74e91b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:74e95a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lofexidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:74e9811c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:74e9ab38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74e9ab38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:74e9d856-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomerizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:74e9ffb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonazolac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:74ea266c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:74ea4d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:74ea73e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:74ea9de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:74eac0a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:74eae7f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:74eb0eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:74eb36e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.343']} DrugCentral uuid:74eb5d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:74eb843a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:74ebaaf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74ebd23c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:74ebf4f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:74ec1bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:74ec4276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:74ec714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:74ec714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:74ec714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:74eca8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:74eccf7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.345']} DrugCentral uuid:74ecf694-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) DrugCentral uuid:74ed1a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) DrugCentral uuid:74ed3d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) DrugCentral uuid:74ed5fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:74ed8794-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:74edae40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:74edd50a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:74edfbb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:74ee2348-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:74ee4a12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74ee70e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:74ee9e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:74ee9e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:74ee9e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:74eede5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:74ef04f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loperamide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:74ef2bb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:74ef5272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:74ef79c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:74ef9c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:74efc342-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:74efe9f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:74f011c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.59']} DrugCentral uuid:74f0389a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:74f06680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74f06680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74f06680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:74f0a500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74f0a500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74f0a500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:74f0e394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:74f0e394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:74f0e394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:74f121ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:74f121ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:74f121ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:74f159c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f19028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:74f1f7b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:74f21e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:74f24540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:74f26c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:74f2931a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:74f2b9a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:74f2e040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:74f3078c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:74f32e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:74f354da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:74f37b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2J7 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Transporter (Sodium-dependent neutral amino acid transporter B(0)AT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:74f3a336-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:74f3ccf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:74f3fd86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:74f3fd86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:74f3fd86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:74f43c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:74f45f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:74f48198-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:74f4a434-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:74f4c6da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:74f4ea2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.498']} DrugCentral uuid:74f510f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:74f53796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:74f55e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:74f586ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:74f5ae92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:74f5d53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:74f5fbea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:74f622f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:74f649b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:74f6705c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WV26 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:74f69a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:74f69a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:74f6d7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:74f6d7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:74f6d7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:74f6d7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:74f725ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:74f725ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:74f76156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:74f76156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:74f76156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:74f7a4ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:74f7a4ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:74f7d78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCN6 biolink:molecularly_interacts_with DrugCentral:1610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 losartan targets Unclassified (Platelet glycoprotein VI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:74f7feae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loteprednol etabonate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:74f82168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:74f84814-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:74f86ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:74f89648-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:74f8bcfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.67']} DrugCentral uuid:74f8e4ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:74f90b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:74f933fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:74f95ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:74f98152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:74f9a808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:74f9cf2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.697']} DrugCentral uuid:74f9f5f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:74fa1cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:74fa4362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01237 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:74fa6ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:74fa9178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:74fab842-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95214 biolink:molecularly_interacts_with DrugCentral:1612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lovastatin targets Enzyme (Acyl-CoA:cholesterol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:74fadeda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:74fb077a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:74fb2f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:74fb55cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.244']} DrugCentral uuid:74fb7c78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:74fba3ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:74fbca7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:74fbf13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:74fc17f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:74fc3fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:74fc66ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:74fc8d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:74fcb52a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:74fcdd20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:74fd03cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:74fd2aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:74fd5124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.376']} DrugCentral uuid:74fd78ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:74fd9f76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:74fdc62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.829']} DrugCentral uuid:74fdee04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:74fe156e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:74fe3c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:74fe6302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:74fe89b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:74feb2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.276']} DrugCentral uuid:74fed968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:74ff0028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:74ff26f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:74ff4dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:74ff749a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:74ff9b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:74ffc2b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:74ffeaa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7500115c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:750037fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:75006576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:75006576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:75006576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7500a8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:1614 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7500cf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:1614 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxiglumide is antagonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7500f630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:75011d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:750143ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lucanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75016a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumefantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:75019144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7501b8b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7501df8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumiracoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7502064c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:75022d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:750255b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.979']} DrugCentral uuid:75027d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.856']} DrugCentral uuid:7502a3e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.12']} DrugCentral uuid:7502caa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7502f1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7503187a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:75033f30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:750365f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:75038d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7503b424-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:7503dada-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:7504021c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:75042b7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:75045244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:75047904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75049fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:7504c6d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7504eda8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:75051468-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:75053b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7505694a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7505694a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7505694a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7505a81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lysine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:7505cebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7505f748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:75062498-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:75064b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:75067218-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:75069950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:7506bc0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:7506e2c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:75070976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:750730c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:75075782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:75077e4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7507a502-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7507cd02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7507f4bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:75081b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:75084246-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:75086960-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7508900c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7508b6d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7508dda0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:750904d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:75092ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:75095258-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:750979a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7509a15e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7509c832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7509eefc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:750a159e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:750a3cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:750a6378-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mafenide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:750a8b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 malathion targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.538']} DrugCentral uuid:750ab238-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2PZ98 biolink:molecularly_interacts_with DrugCentral:1626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 malathion is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:750ad6a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:750b00da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:750b00da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:750b2e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.308']} DrugCentral uuid:750b54c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:750b7d80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.165']} DrugCentral uuid:750ba72e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.364']} DrugCentral uuid:750bd1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:750bfb7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.27']} DrugCentral uuid:750c22a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:750c4968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:750c7032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:750c96e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:750cbeca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.854']} DrugCentral uuid:750ce576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.876']} DrugCentral uuid:750d0c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:750d3300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:750d5cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.777']} DrugCentral uuid:750d8698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.406']} DrugCentral uuid:750dad58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:750dd404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:750dfb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:750e21f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:750e48bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.939']} DrugCentral uuid:750e6f5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:750e96b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.355']} DrugCentral uuid:750ebd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:750ee42a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:750f0aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:750f3056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:750f5806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:750f7f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:750fa702-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:1634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maprotiline is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:750fce30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc is antagonist of GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:750ff4f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:75101b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:75104248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61813 biolink:molecularly_interacts_with DrugCentral:1635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:751069a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:75109054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:7510b70a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7510deec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:751108b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:75113180-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:75115822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:75117ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7511a5e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7511cc8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7511f318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:751219d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:75124124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:751267e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:75128e86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7512b532-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7512def4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7513088e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:751331ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:75135c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:75135c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:75138ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7513b6a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:7513dd4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:751404a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:75142b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:751451f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:1638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maxacalcitol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:751478b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:1638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maxacalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7514a0ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:7514c7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7514eec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:75151570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:75153c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:75156354-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:75158a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:7515b0ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7515d816-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1640 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7515feb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:75162578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75164c1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BJF5 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole targets Kinase (Calmodulin-domain protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:75167a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:75167a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:75167a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7516c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:751729aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:75175056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (Histamine H4 receptor) DrugCentral uuid:751772e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:7517998a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebhydrolin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:7517c0e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.161']} DrugCentral uuid:7517e778-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75181176-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:75181176-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:751848e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:751848e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:75187f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:75187f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:7518b572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7518b572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7518ebe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7518ebe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:75192872-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75192872-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75192872-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75192872-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75197304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:75199b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7519c200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7519e8a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:751a0f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:1648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecillinam is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.035']} DrugCentral uuid:751a39b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:751a62f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:751a85aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine is agonist of Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:751aac7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclozine targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:751ad410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:751afac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:751b2172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:751b4814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:751b6f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:751b9634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:751bbcf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:751be3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:751c0b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:751c3364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:751c5a24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.503']} DrugCentral uuid:751c80c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:751ca7c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:751cce6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:751cf876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:751cf876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751d5d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:751e4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:751e4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:751e4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:751e926c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:751e926c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:751e926c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:751ed7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:751ed7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:751ed7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:751f1d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:751f1d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:751f1d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:751f5d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxalol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['7.82']} DrugCentral uuid:751f83e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['6.08']} DrugCentral uuid:751fadaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.561']} DrugCentral uuid:751fd6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:751ffda0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:75202442-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75204b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.59']} DrugCentral uuid:75207208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:752099ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7520c0a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7520e846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:75210ef2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7521359e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:75215c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.032']} DrugCentral uuid:75218648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7521b082-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7521b082-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7521e336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1662 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 medrysone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:75220640-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:75222cf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:752253ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:75227a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7522a17c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7522c922-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7522efec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:752316ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:75233e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7523659e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:75238c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7523b2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7523d9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:75240080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:75242740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:75244dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:75247074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:75249798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:7524ba34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7524e0b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P90584 biolink:molecularly_interacts_with DrugCentral:1665 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefloquine targets Unclassified (Protein kinase Pfmrk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:75250750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:75252d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.057']} DrugCentral uuid:75255728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:752579f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7525a098-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:7525c7d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 megestrol acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:7525ee72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1670 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meglutol targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:7526151e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:75263bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:7526635c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:75268a8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7526b208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7526d9ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:752701d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7527288c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:75274f4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:75277c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:75277c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:75277c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:7527bb80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7527e218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:752808f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7528306a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75285716-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75287dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7528a482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7528cd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:7528f4be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75291b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:75293e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:75296534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:75298bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:7529b2aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7529d974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.063']} DrugCentral uuid:752a00ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:752a2776-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:752a4e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:752a75c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.469']} DrugCentral uuid:752a9e90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:752ac12c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:752ae7f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:1678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 melphalan targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:752b0e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:752b31b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:752b5484-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:752b7b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:752ba1dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:752bcd42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:752bcd42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:752c0370-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:752c0370-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:752c3688-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:752c5d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:752c8750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:752cae10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:752cd4d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:752cfcbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30305 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:752d23cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:752d4a78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30307 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:752d7106-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15374 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Ubiquitin carboxyl-terminal hydrolase isozyme L3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:752d97a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:752dbed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64346 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:752de578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28563 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:752e0d14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:752e33c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:752e5b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menadione sodium bisulfite targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:752e81c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1685 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 menatetrenone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:752ea850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:752ecf10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:752ef6f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:752f1dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:752f4486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:752f6b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:752f92ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:752fb970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:752fe03a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:753006e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.504']} DrugCentral uuid:75302fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:75305696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:75307d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:7530a420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7530cb4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:7530f204-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:753118c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:75314006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:75316766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:75318e1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7531b4b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UDY8 biolink:molecularly_interacts_with DrugCentral:1688 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pecazine targets Enzyme (Mucosa-associated lymphoid tissue lymphoma translocation protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7531dc5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7531ffc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:753226b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:75324d70-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepenzolate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:75327430-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:75329b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7532c20a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:7532e4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:75330b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:75332eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:75335698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:75337d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7533a42c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7533d6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7533d6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7533d6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7533d6e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:75342b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75342b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75342b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75342b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7534762c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:75349cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephentermine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7534dd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7535660e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7535660e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7535660e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:75359e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:7535c13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:7535e3f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:753606c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:753629ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:75364cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:75366f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1700 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:75369236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7536b4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.821']} DrugCentral uuid:7536e380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:7536e380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:7536e380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:753721b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:753721b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:753721b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:753760f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:753760f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:753760f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:7537a5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7537a5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7537a5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7537dd80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meproscillarin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:75380198-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:75382830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:75384edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:75387574-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:75389ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meptazinol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:7538c362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:7538ea18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:753910b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:7539389c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.276']} DrugCentral uuid:753961a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.955']} DrugCentral uuid:75398856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7539af0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7539d612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7539fcdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q389T8 biolink:molecularly_interacts_with DrugCentral:1707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:753a2388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:753a4a20-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:753a6d66-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:753a9002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) DrugCentral uuid:753ab2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06203 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine is inhibitor of Enzyme (Amidophosphoribosyltransferase) DrugCentral uuid:753ad56c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:753af83a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:753b21ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:753b447a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:753b6734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:753b89da-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:753bace4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:753bcfb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:753bf33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:753c19c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:753c4140-59f3-11ec-9eaa-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:753c6800-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XEC0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meropenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:753c8ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:753cb5a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:753cd876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:753cfeb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:753d218c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:753d4842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:753d7038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:753d975c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WU19 biolink:molecularly_interacts_with DrugCentral:1710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesalazine targets Enzyme (Hydroxyacid oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:753dbe12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:753de540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.724']} DrugCentral uuid:753e0c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:753e3374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:753e5a48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:753e8108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:753ea7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:753ed1bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:753ef9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.744']} DrugCentral uuid:753f2054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:753f46ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:753f6e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:753f94bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:753fbb7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:753fe336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesoridazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.041']} DrugCentral uuid:75400abe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.647']} DrugCentral uuid:75403174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:75405848-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:75407f1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.282']} DrugCentral uuid:7540a92e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:7540d002-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestranol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.958']} DrugCentral uuid:7540f6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orciprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75411d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orciprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:754144ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metaraminol is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7541677e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:75418e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7541b512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:7541dc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:7542033c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:754229f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:754250b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:75427844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:75429f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7542c65a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7542ed1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7543143e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75433aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.124']} DrugCentral uuid:754361aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.583']} DrugCentral uuid:7543886a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:7543b0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:7543d7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7543ffb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:75442676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:75445042-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:7544770c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:75449db8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7544c482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.872']} DrugCentral uuid:7544eb92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7545125c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7545391c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:75455fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:7545876e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:7545ae24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7545d4d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7545fb7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75462480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75464b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:75467228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7546a356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7546a356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7546a356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7546a356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7546f4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7546f4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7546f4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:75473488-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:754757e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:75477f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.697']} DrugCentral uuid:7547a5d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.401']} DrugCentral uuid:7547cc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.499']} DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:75489940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:754aca94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:754af2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:754b19a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:754b3c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:754b630a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:754b8be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:754bb3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:754bdb28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:1726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:754c01e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:1727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metacycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:754c28da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:754c4fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:754c7650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:754c9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:754cc010-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:754ce2c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:754d1362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:754d1362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:754d1362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:754d1362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:754d5eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylmethadol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:754d85cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetylmethadol is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:754da868-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.383']} DrugCentral uuid:754dcf32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:754df66a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:754e1d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:754e43ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:754e6aa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:754e9264-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:754eb924-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.611']} DrugCentral uuid:754edff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:754f078a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:754f2f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:754f58f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:754f7fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:754fb3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:754fb3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:754fb3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:754fb3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:754fb3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:7550005e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7550271e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:75504dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:75507552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:75509c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7550c3d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.409']} DrugCentral uuid:7550ea8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:755112b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7551397e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:75516188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:7551882a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:7551af3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7551d5e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7551fca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methapyrilene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:75522a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:75522a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:75522a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:755270dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:755270dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:755270dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7552b614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7552b614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7552b614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7552ff48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:7552ff48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:7552ff48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:755344da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:755344da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:755344da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:75538a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:75538a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:75538a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:7553cfe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:7553cfe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:7553cfe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:7554127a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:7554127a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:75544bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:75544bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:75544bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:75549240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75549240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75549240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75550798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7555c89a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7555f00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:755616f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:75563dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7556648a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:75568c08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7556b2aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7556da0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:755701b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:755728d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:75574f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7557765e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:75579d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7557c46a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7557eb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:755811fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:755838be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:75586096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:75588760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7558ae20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7558d4ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7558fc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:75592300-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:755949c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:75597094-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:755997e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7559bea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7559e560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:755a0c20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755a581a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:755b0878-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:755b0878-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:755b3b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:755b62be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:755b8974-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:755bb048-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methdilazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:755bd2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07944 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin targets Enzyme (Beta-lactam-inducible penicillin-binding protein) DrugCentral uuid:755bf580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18843 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin targets Enzyme (NH(3)-dependent NAD(+) synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:755c2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:755c2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:755c2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:755c2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:755c2d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:755c7a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:755ca12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:755cc7da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:755cee7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15101 biolink:molecularly_interacts_with DrugCentral:1745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamazole targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:755d155a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1747 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methocarbamol is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:755d3cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:755d662c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:755d662c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:755d662c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:755da236-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:755da236-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:755dcf22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:755df524-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:755e17de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:755e3a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:755e5d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:755e841c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:755ea6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:755ecd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:755ef01e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:755f174c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:755f3dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:755f6472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:755f8b00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:755fb42c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:755fdae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.14']} DrugCentral uuid:756001a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:75602830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:75604f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:756075e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:75609c70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7560c2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:7560ea4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:756110ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:75613874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75615f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:75618734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:7561ae12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7561d4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00380 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:7561fb2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:75622234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:756248d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:75627018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methotrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:756296ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomepromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.237']} DrugCentral uuid:7562be42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomepromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7562e50c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:75630bae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7563325a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:756359e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75638746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75638746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75638746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7563c5d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is agonist of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:75641a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7564dca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:75650346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:75652b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:756554e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.01']} DrugCentral uuid:75657e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:7565a51c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7565d2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:7565d2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:7565d2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:75660a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:75662cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metildigoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:75664f76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:756672c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:75669562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.282']} DrugCentral uuid:7566bc0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:7566e2ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.672']} DrugCentral uuid:75670b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:75673206-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:75675894-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:75677f22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7567a77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7567ce1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15770 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7567f4c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:75681b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:75684272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylthioninium chloride targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:756869b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:7568907e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:7568b73e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:7568ded0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.633']} DrugCentral uuid:7569057c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:75692c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is partial agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:756952fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75697a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.928']} DrugCentral uuid:7569a11c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.678']} DrugCentral uuid:7569c7c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:7569ee88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:756a15fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:756a3cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:756a637c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.033']} DrugCentral uuid:756a8a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:756ab3e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:756add98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1764 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:756b0570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:756b2c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:756b5386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:756b7bae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:756ba278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:756bc910-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:756bf034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.58']} DrugCentral uuid:756c16e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:756c3da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:756c6460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:756c8d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:756cb460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:756cdb02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:756d019a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:756d32f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:756d32f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:756d32f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:756d32f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:756d814c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:756d814c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:756db482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:756ddb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:756e01e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:756e2890-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:756e50cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:756e7a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1766 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:756ea0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:756ec796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:756eef00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:756f16b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.615']} DrugCentral uuid:756f3d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:756f641c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:756f8b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:756fb1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:756fd88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:756ffb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:757022d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:1768 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:75704968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:75706c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1771 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylprednisolone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:75709576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:75709576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:75709576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:7570ced8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:7570f584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:75711c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:757142c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:757169ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:757190a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7571b758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7571ddfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.663']} DrugCentral uuid:7572069a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:75722d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:757253fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:75727a8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.213']} DrugCentral uuid:7572a1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.334']} DrugCentral uuid:7572c990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7572f050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:75731706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:75733e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:757364f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75738baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7573b27e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:7573dbb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:75740440-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:75742aec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:7574518e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:757478da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:75749f90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7574c650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7574ed06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:75751ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:75751ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:75751ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7575593a-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:75757fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7575a7be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7575d1a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7575f99e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:75762068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:757647c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:75766f82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metiazinic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:7576961a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metipranolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:7576b8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1779 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metipranolol is antagonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:7576dd28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene is antagonist of GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:7576ffd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:75772288-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metixene targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7577492a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metochalcone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:75776fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:75779a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:7577c1e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:7577e8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:75780f5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:757836be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:75785d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:75788420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7578a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.509']} DrugCentral uuid:7578cdc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:7578f464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:75791b38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:757941f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:75796ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:7579939c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:7579ba48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7579e108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:757a0890-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:757a2f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:757a5a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:757a5a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:757a9aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:757a9aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:757a9aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:757a9aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:757a9aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:757afb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757afb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757afb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757afb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757b4e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757b4e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757b4e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:757b939a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:757b939a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:757b939a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:757bd990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:757bd990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:757bd990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:757c1cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:757c1cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:757c4fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:757c76d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone targets Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.45']} DrugCentral uuid:757c9d8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:757cc116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1783 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metolazone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:757ce7fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:757d0fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:757d36a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metopimazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:757d5d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:757d8420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:757dab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:757dd240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:757df8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.83']} DrugCentral uuid:757e2650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:757e2650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:757e2650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:757e655c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:757e8c12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:757eb2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4LW95 biolink:molecularly_interacts_with DrugCentral:1790 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metronidazole targets Enzyme (Thioredoxin reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:757edafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:757f0192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:757f283e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:757f4ef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:757f7640-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1791 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metyrapone is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.84']} DrugCentral uuid:757f9d00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07101 biolink:molecularly_interacts_with DrugCentral:1792 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metirosine is inhibitor of Enzyme (Tyrosine 3-monooxygenase) DrugCentral uuid:757fbfc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:757fe652-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:75800948-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:75802be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:75804e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:75807126-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:758098d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7580c252-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7580e8f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:75810faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7581366a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:75815dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7581848a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:7581ab2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.51']} DrugCentral uuid:7581d1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:7581f8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:7582208e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62205 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75824726-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2APX8 biolink:molecularly_interacts_with DrugCentral:1794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:75826dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75829582-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7582bc1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7582e2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7583095e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:75832cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:7583535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:758379f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7583a094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7583c772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7583ee0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:758414b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:75843b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:758464ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:75848b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7584b218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:7584d8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7585009c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:75852748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:75854dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:758574a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:75859bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:7585c27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7585e912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02768 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:75860faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:75863980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14778 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Membrane receptor (Interleukin-1 receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:75866036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41222 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:75869a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7586fc58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75872304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:758749b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:758770b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:75879758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.149']} DrugCentral uuid:7587be0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7587e6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7588100c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:758836d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:75885d96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.175']} DrugCentral uuid:7588844c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7588abb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7588d258-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:7588f90e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:75892028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.245']} DrugCentral uuid:7589479c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:75896e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:758994cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:7589bb6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:7589e580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:758a0f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.541']} DrugCentral uuid:758a367a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:758a5d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:758a8490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:758aab50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:758ad206-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:758af8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:758b1fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:758b4664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:758b6d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:758b93e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:758bbf22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:758be5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:758c0c98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:758c333a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:758c5af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:758c81aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:758ca842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:758ccee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:758cf5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:758d1caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:758d4356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:758d6a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:758d94a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:758dbbd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:758de27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:758e09d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:758e3068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:758e5a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:758e5a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:758e988c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:758e988c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:758e988c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:758e988c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:758ee9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:758ee9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:758ee9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:758f303a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:758f303a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:758f303a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:758f7752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:758f7752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:758fb0aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:758fb0aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:758fb0aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:758ff362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:758ff362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7590260c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NG02 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin targets GPCR (G-protein coupled receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:75904cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7590735a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75909a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7590c116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7590e7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:75910e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75913600-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:75915cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75918376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7591aa22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7591d164-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:7591f81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75921ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:759246ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75926dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:759294b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7592bb56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07652 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent R-type calcium channel subunit alpha-1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7592e20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:75930b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:75933202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15390 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7593589a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:75937f50-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:7593a69c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AIC4 biolink:molecularly_interacts_with DrugCentral:1798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 micafungin targets Unclassified (Beta-1,3-glucan synthase) DrugCentral uuid:7593cb68-59f3-11ec-9eaa-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:1798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 micafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) DrugCentral uuid:7593ee18-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.715']} DrugCentral uuid:759414ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.137']} DrugCentral uuid:75943bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.588']} DrugCentral uuid:7594629e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:75948968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:7594b01e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.505']} DrugCentral uuid:7594d918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7594ffc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:7595267a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:75954d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:7595706c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75959704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:7595bdc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.535']} DrugCentral uuid:7595e47a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.183']} DrugCentral uuid:75960c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:75963344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.452']} DrugCentral uuid:759659fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.555']} DrugCentral uuid:759680c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:7596a996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:7596d330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.964']} DrugCentral uuid:7596fca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:7597260a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:75974e14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:759774ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.175']} DrugCentral uuid:75979be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:7597c286-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.386']} DrugCentral uuid:7597e9aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.869']} DrugCentral uuid:75981060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:759836ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.136']} DrugCentral uuid:75985da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.799']} DrugCentral uuid:75988716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.271']} DrugCentral uuid:7598ae26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:7598d4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:7598fba6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:75991eec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.923']} DrugCentral uuid:759945ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:75996c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.729']} DrugCentral uuid:759992f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7599b9ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7599e0a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.534']} DrugCentral uuid:759a0834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:759a2ed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:759a5758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:759a7e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:759aa4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.381']} DrugCentral uuid:759acb52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.562']} DrugCentral uuid:759af280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:759b192c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:759b3fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:759b6666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:759b8d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:759bb44a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:759bdb00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.029']} DrugCentral uuid:759c01ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.922']} DrugCentral uuid:759c2a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.674']} DrugCentral uuid:759c5120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.792']} DrugCentral uuid:759c77e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.692']} DrugCentral uuid:759c9ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:759cc60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:759cecc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:759d13ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:759d3a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:759d6196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:759d8856-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:759daef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:759dd6a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:759dfe12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:759e24dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:759e4b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:759e722a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:759e9976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6']} DrugCentral uuid:759ec022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.353']} DrugCentral uuid:759ee6d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:759f0da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:759f3b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:759f3b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:759f3b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:759f80ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:759f80ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:759f80ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:759fc710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:759fc710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:759fc710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a036f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75a11be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:75a11be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:75a11be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:75a16142-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:75a16142-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:75a16142-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:75a1a8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a1a8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a1a8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a1ee6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:75a1ee6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:75a1ee6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:75a235a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a235a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a235a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75a2792e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midodrine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:75a29bd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midodrine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:75a2c28a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.001']} DrugCentral uuid:75a2e9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.957']} DrugCentral uuid:75a3106e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:75a33738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.918']} DrugCentral uuid:75a35e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:75a386ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:75a3ad6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:75a3d422-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:75a3face-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75a42210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:75a448da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:75a470d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:75a497a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:75a4beb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.081']} DrugCentral uuid:75a4e56a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.255']} DrugCentral uuid:75a50c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.256']} DrugCentral uuid:75a532d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.374']} DrugCentral uuid:75a55a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:75a580d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:75a5a784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:75a5ce4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1Q298 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:75a5f5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1U3 biolink:molecularly_interacts_with DrugCentral:1805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:75a61d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75a64432-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:75a666ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:75a68de8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:75a6b49e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:75a6db54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:75a70214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:75a72b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75a752a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:75a77938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q58D55 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:75a7a002-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0HJB3 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Alpha-mannosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:75a7c780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56526 biolink:molecularly_interacts_with DrugCentral:1806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglitol targets Enzyme (Alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:75a7ee18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:75a814ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:75a83b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75a862f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:75a889a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q69ZF3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:75a8b046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:75a8d6de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:75a900dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75a927d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:75a94e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70699 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:75a97526-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5THE3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75a99c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9LGC6 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Putative alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:75a9c31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70282 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Trehalase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:75a9e9b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:I3LIR5 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:75aa1152-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88693 biolink:molecularly_interacts_with DrugCentral:1807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miglustat targets Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:75aa3858-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:75aa5f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:75aa85e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:75aaac98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:75aad75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:75ab001c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:75ab26c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milnacipran targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:75ab4d7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:75ab74de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:75ab9b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:75abc222-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:75abe8b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:75ac0fac-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:75ac3658-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75ac5cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O89085 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:75ac870c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75ac870c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75acc640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:75acc640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:75acc640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:75acc640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:75ad10f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miltefosine targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:75ad3850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 miltefosine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:75ad5ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:75ad827e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:75ada902-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08543 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:75add012-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:75adf6b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:1811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mimosine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75ae1d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:75ae440c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:75ae6bee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:75ae931c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:75aeb9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.638']} DrugCentral uuid:75aee04c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z7H2 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Unclassified (30S ribosomal protein S4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['6']} DrugCentral uuid:75af0806-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z8T8 biolink:molecularly_interacts_with DrugCentral:1813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minocycline targets Unclassified (30S ribosomal protein S9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['5.756']} DrugCentral uuid:75af2ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:75af58e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:75af58e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:75af85ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:75afad06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:75afd3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:75affa86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:75b0213c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75b04a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:75b0733a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:75b099f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:75b0c0a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:75b0e950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:75b11010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:75b136c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:75b15e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:75b18144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:75b1a3fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:75b1cac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:75b1f188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:75b219ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75b24098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:75b2673a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:75b28e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75b2bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75b2bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75b2bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:75b2fad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:75b3218e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:75b348c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:75b36f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 misoprostol targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:75b399ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75b399ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75b3cc4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitomycin targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:75b3f514-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:75b41e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:75b44500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:75b46bc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.512']} DrugCentral uuid:75b49334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.186']} DrugCentral uuid:75b4b9f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:75b4e096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:75b508b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) DrugCentral uuid:75b52baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10109 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane targets Unclassified (Adrenodoxin, mitochondrial) DrugCentral uuid:75b54e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:1820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitotane is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:75b57128-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:75b597de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.841']} DrugCentral uuid:75b5bfd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.306']} DrugCentral uuid:75b5e856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.729']} DrugCentral uuid:75b60f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.744']} DrugCentral uuid:75b635c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:75b65d18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.047']} DrugCentral uuid:75b683ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:75b6a674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC90', 'has_quantitative_value': ['5.959']} DrugCentral uuid:75b6cd16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.287']} DrugCentral uuid:75b6f57a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kact', 'has_quantitative_value': ['5.155']} DrugCentral uuid:75b71c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:75b742d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:75b76974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:75b7916a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:75b7b870-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:75b7df12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:75b805be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:75b82d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:75b853ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:75b87a62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:75b8a0f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:75b8c922-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:75b8efb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:75b91684-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:75b93d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:75b964ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:1821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoxantrone targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:75b98bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:75b9b53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:75b9b53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:75b9b53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:75b9ecb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:75ba1408-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:75ba36b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mizolastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:75ba5d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:75ba841a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:75baabc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:75bad29e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75baf95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:75bb2028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75bb490e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:1825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:75bb72c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:75bb99c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:75bbc078-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:75bbe3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.396']} DrugCentral uuid:75bc0a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:75bc2d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:75bc53a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 modafinil targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:75bc7bd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moexipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:75bca27c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:75bcc914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:75bcefac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:75bd1810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:75bd422c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.157']} DrugCentral uuid:75bd68d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:75bd8f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:75bdb6d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.421']} DrugCentral uuid:75bddda4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:75be0450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:75be2afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:75be5216-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:75be78cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:75be9f82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.254']} DrugCentral uuid:75bec638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:75beeece-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:75bf18ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:75bf4054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.763']} DrugCentral uuid:75bf6714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:75bf8e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:75bfb50c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75bfdbae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molindone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:75c00278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 molsidomine targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:75c02992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:75c05142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:75c077f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mometasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:75c09ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.429']} DrugCentral uuid:75c0c76c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.992']} DrugCentral uuid:75c0ee0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.414']} DrugCentral uuid:75c114ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:75c13800-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 monobenzone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.311']} DrugCentral uuid:75c15f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:75c18620-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:75c1acea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.574']} DrugCentral uuid:75c1d38c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:75c1fac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:75c22184-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:75c2481c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.853']} DrugCentral uuid:75c26edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.495']} DrugCentral uuid:75c29664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:75c2bd24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:75c2e3da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:75c30a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.958']} DrugCentral uuid:75c331dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:75c358a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:75c37f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.328']} DrugCentral uuid:75c3a748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.495']} DrugCentral uuid:75c3ce9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:75c3f540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.817']} DrugCentral uuid:75c41cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:75c4439c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:75c46b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.895']} DrugCentral uuid:75c491ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:75c4b8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:75c4df82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:1836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 montelukast is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:75c50692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75c52d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:75c553d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1837 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.134']} DrugCentral uuid:75c57a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1842 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moracizine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:75c59de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.86']} DrugCentral uuid:75c5c474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:75c5eb20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:75c611f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:75c639f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:75c66302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:75c689e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:75c6b08c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:75c6d79c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:75c6fee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:75c725b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:75c74c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:75c7740e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:75c79bdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47748 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:75c7cc74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75c7cc74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75c7cc74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75c7cc74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75c8267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:75c8267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:75c8267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:75c8267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:75c8267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:75c88682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:75c88682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:75c88682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:75c88682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:75c8d150-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q98UH1 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Mu opioid receptor-like OR2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:75c8f81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B3DH72 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor, delta 1b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75c91ee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O57585 biolink:molecularly_interacts_with DrugCentral:1845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 morphine targets GPCR (Opioid receptor homologue) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:75c9477a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:75c96e44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:75c9950e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:75c9bbce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:75c9e3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.891']} DrugCentral uuid:75ca0d5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:75ca3446-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:75ca5ade-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.694']} DrugCentral uuid:75ca8216-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.725']} DrugCentral uuid:75caa8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.683']} DrugCentral uuid:75cacfb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:75caf66a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:75cb1eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:75cb455c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:75cb6c08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:75cb95f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:75cb95f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:75cbcbc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mosapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:75cbf2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.938']} DrugCentral uuid:75cc19d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.716']} DrugCentral uuid:75cc4088-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.637']} DrugCentral uuid:75cc67ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:75cc8a48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:75ccb0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:75ccdb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:75ccdb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:75cd0ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:75cd0ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:75cd3f9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75cd665c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:75cd8e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:75cdb5a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75cddc5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:75ce02f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:75ce2a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxonidine is agonist of Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:75ce50c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00956 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:75ce7790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41252 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:75ce9e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41972 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:75cec1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99YW3 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:75cee54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56690 biolink:molecularly_interacts_with DrugCentral:1857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:75cf0c1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:75cf32f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:75cf5c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:75cf85c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:75cfb04c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:75cfb04c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:75cfe2f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5KP44 biolink:molecularly_interacts_with DrugCentral:1860 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mycophenolic acid targets Unclassified (Inosine-5'-monophosphate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:75d00a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:75d030e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75d05790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:75d07e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:1862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:75d0a5b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:75d0c86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.34']} DrugCentral uuid:75d0ef20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.732']} DrugCentral uuid:75d115cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:75d13e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nabumetone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.001']} DrugCentral uuid:75d165cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:75d18c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:75d1b374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nadolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75d1da8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:75d2014e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:75d22818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:75d24eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:75d27610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:75d29da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:75d2c4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00736 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Complement C1r subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:75d2eb86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09871 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Complement C1s subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:75d313ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:75d33a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:75d36124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:75d387bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:75d3aee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:75d3d578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:75d3fc2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:75d422ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:1867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafamostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75d44a76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafarelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.699']} DrugCentral uuid:75d47122-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:75d4a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:75d4a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:75d4a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:75d4a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:75d4a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:75d4efda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftidrofuryl targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75d516b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:75d53d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:75d56564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (Squalene monooxygenase) DrugCentral uuid:75d5888c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:75d5ab3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:75d5d1e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O07855 biolink:molecularly_interacts_with DrugCentral:1872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftifine targets Enzyme (Dehydrosqualene desaturase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:75d5f89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75d626b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:75d626b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:75d626b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:75d66d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:75d66d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:75d66d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:75d6acda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:75d6d700-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:75d70112-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naftopidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:75d72822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:75d74f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:75d77610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75d79cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:75d7c386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:75d7ee6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:75d7ee6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:75d81b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.53']} DrugCentral uuid:75d8425c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:75d8699e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:75d89248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:75d8b976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:75d8e036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalmefene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75d906f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:75d92e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:75d954b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:75d97b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:75d9a228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:75d9ca78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:75d9fb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:75d9fb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:75d9fb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:75d9fb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:75da4f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:75da4f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:75da4f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:75da4f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:75daa06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:75dac874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:75daef20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:75db1612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:75db3cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:75db6392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:75db8a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75dbb1a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:75dbd84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:75dbff0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:75dc25ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:75dc4dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:75dc7476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75dc9b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75dcc1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.98']} DrugCentral uuid:75dcf32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:75dcf32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:75dcf32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:75dcf32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:75dd3ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:75dd63fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:75dd8b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75ddb1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:75ddd884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.678']} DrugCentral uuid:75ddfff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:75de26b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:75de4968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:75de7032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75de97d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:75debee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:75dee59e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone decanoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:75df0c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone phenpropionate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75df331e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nandrolone phenpropionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:75df5a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:75df8166-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:75dfa830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:75dfced2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:75dff66e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:75e01da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:75e04466-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:75e06b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75e0922c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:75e0bd2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:75e0bd2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:75e0f104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:75e1188c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:75e13f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.796']} DrugCentral uuid:75e1660c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:75e18ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1884 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:75e1b544-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:75e1e2d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:75e1e2d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:75e2191c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:75e2191c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:75e24c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:75e2733a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:75e299e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:75e2c0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:75e2e82e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:75e30ee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nedocromil targets GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:75e331b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nedocromil is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:75e35854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:75e38036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75e3a84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.699']} DrugCentral uuid:75e3cf14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:75e3f5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:75e41cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:75e444a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.143']} DrugCentral uuid:75e46c30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.789']} DrugCentral uuid:75e492e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.635']} DrugCentral uuid:75e4bad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:75e4e16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:75e50820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:75e52ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:75e55654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:75e57f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:75e5a5e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:75e5cc92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:75e5f3b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:75e61a62-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:75e64104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:75e6679c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:75e68f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:75e6b210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:75e6d8bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:75e6ff54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:75e7284e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:75e74f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:75e775ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nefopam targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:75e79c70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:75e7c394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:75e7ea54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:75e811f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:75e8389c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.057']} DrugCentral uuid:75e85ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.209']} DrugCentral uuid:75e886a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.592']} DrugCentral uuid:75e8ad68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.909']} DrugCentral uuid:75e8d414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.078']} DrugCentral uuid:75e8fb6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.842']} DrugCentral uuid:75e92554-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.632']} DrugCentral uuid:75e94c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.255']} DrugCentral uuid:75e972ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:75e9955c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.101']} DrugCentral uuid:75e9bc62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.098']} DrugCentral uuid:75e9e318-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.676']} DrugCentral uuid:75ea09c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.648']} DrugCentral uuid:75ea307a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.739']} DrugCentral uuid:75ea57d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:75ea7e68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.615']} DrugCentral uuid:75eaa514-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:75eacbc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.236']} DrugCentral uuid:75eaf672-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:75eb1d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:75eb43de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:75eb6aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:75eb91ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:75ebb882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:75ebdf38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:75ec06de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:75ec2e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:75ec54e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nemonapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:75ec7b96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:75eca242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:75ecc826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08312 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase alpha subunit) DrugCentral uuid:75eced60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07395 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase beta subunit) DrugCentral uuid:75ed1042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75ed36f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:75ed5e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:75ed84be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:1896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 framycetin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:75edacb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:75edd36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:75edfa7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:75ee2112-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:75ee47b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:75ee6e6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:75ee9606-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:75eebcb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:75eee6ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75eee6ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75ef1de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75ef1de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75ef50aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nepinalone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:75ef7774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nesiritide is agonist of Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:75ef9a24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:75efc2a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:75efe952-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:75f01030-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:75f036e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nevirapine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:75f05f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 2) DrugCentral uuid:75f08240-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 3) DrugCentral uuid:75f0a4dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:75f0c76e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:75f0ea8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:75f11174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:75f1382a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:75f15eb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53686 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase HST2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:75f18596-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NTG7 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase sirtuin 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:75f1ac38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:75f1d2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8I6E4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Unclassified (Putative silent information regulator 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:75f1f97c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:1906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinamide targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:75f22032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:75f24800-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:75f26eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:75f29558-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:75f2b7fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:75f2df0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:75f3059c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.553']} DrugCentral uuid:75f32c5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:75f3531c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:75f37a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:75f3a1fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:75f3c9f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54698 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:75f3f1c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:75f42238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75f42238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75f42238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:75f46784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75f46784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75f46784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:75f4ad34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:75f4ad34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:75f4ad34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:75f4ef2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:75f4ef2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:75f51c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:75f543e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15385 biolink:molecularly_interacts_with DrugCentral:1909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicardipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:75f56a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:75f59122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:75f5b7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:75f5e000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:75f60698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:75f62d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:75f653f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:75f67b00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:75f6a22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:75f6c9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:75f6f062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:75f717c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:75f73e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:75f764fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:75f78bb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:75f7b434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niclosamide targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:75f7db1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:75f801c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:75f82860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1919 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicorandil targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:75f84f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:75f875fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:75f89c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:75f8c32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:75f8eaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:75f91158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75f937fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:75f95ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:75f98764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:75f9b220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43144 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:75f9d8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit beta-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:75f9ffb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04757 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:75fa26ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12389 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:75fa4d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:75fa7570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:75fa9c08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21687 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Enzyme (Lycopene cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:75fac354-59f3-11ec-9eaa-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:75faea1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25162 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit beta-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:75fb10d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09482 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:75fb37b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70174 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:75fb6426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fb6426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fb9dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75fb9dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:75fbd3f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75fbd3f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:75fc0b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:75fc0b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:75fc4116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fc4116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fc774e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:75fc774e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fcd248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:75fd95ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fd95ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:75fdcc70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:75fdcc70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:75fe0280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:75fe0280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:75fe39c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:75fe39c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:75fe709e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:75fe709e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:75feb090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:75feb090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:75feb090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:75feb090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:75feb090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:75ff13d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:75ff13d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:75ff13d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:75ff13d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:75ff6f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:75ff6f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:75ff6f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:75ff6f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:75ffbddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:75ffbddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:75fffa90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:75fffa90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:75fffa90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:75fffa90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7600530a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7600530a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7600530a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7600530a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7600530a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7600a95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:7600d15e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7600fb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:76012262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:76014922-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:76017028-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.089']} DrugCentral uuid:760196d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:7601be84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7601e530-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:76020c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:7602330a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.019']} DrugCentral uuid:760259d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.348']} DrugCentral uuid:76028076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7602a92a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:7602d24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:7602fa38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:760320f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76034812-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:76036ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.672']} DrugCentral uuid:76039588-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7603bc16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:7603e362-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:76040a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:760430ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.355']} DrugCentral uuid:7604575c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76047f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16389 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7604a61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:7604ccbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.731']} DrugCentral uuid:7604f374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:76051a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76054144-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:760568e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.821']} DrugCentral uuid:76058f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7605b75a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7605de2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:76060520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:76062c44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:760654c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:76067ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7606a5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7606cc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35505 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7606fa48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:7606fa48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:7606fa48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:76073f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:76073f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:76073f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:76077dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:7607a51a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:7607cbc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7607f272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7608191e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:76084420-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:76086db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1922 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifedipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7608945c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7608bca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:7608e34e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:76090b3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:760931d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.037']} DrugCentral uuid:76095946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.973']} DrugCentral uuid:76097ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7609a680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7609cd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51800 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Ka) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7609f4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:760a1be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:760a4298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51801 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Kb) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:760a6944-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niflumic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.55']} DrugCentral uuid:760a9068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifuroxazide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:760ab70a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:760addac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:760b0458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:760b2bc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:760b5278-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:760b792e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:760b9ff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:760bc7a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:760befa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:760c1668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:760c3d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.83']} DrugCentral uuid:760c6442-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:760c8be8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:760cb294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.33']} DrugCentral uuid:760cd936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:760d0096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:760d272e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:760d4dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:760d74a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:760d9c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:760dc3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:760deae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:760e117a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:760e388a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.387']} DrugCentral uuid:760e5f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:760e85e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:760eac7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:760ed3e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:760efa86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:760f2114-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:760f47ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:760f6f20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:760f9784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:760fbe30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:760fe4dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:76100bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:761032ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.096']} DrugCentral uuid:76105a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:761080fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7610a84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7610cef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7610f598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:76111c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.141']} DrugCentral uuid:7611437c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:76116a46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:761190de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7611b78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7611de36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:76120532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76122be8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7612529e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:76127954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7612a0b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7612c76a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7612ee16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:761314cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:76133c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:76136346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:761389e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7613b080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7613d858-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7613fefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:761426d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:76144d88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:761474f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:76149b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7614c2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7614e950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:76151178-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7615381a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:76155ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76158572-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7615ac96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7615d342-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7615fe80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:7615fe80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:761631d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:76165876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:76167b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:76169dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:7616c4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7616c4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7616f1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:7617186a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:76173f0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.927']} DrugCentral uuid:761765fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:76178c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7617b32e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7617daca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.632']} DrugCentral uuid:76180202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7618289a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76184f50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2A865 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:7618761a-59f3-11ec-9eaa-0242ac110003 UniProtKB:L8I2E6 biolink:molecularly_interacts_with DrugCentral:1935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimesulide targets Enzyme (Dipeptidyl peptidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:76189e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:7618c534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:7618ebf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76191296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:761939ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7619602a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:761982ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7619a99a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:7619cc40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:7619ef90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:761a161e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:761a3ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:761a639e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:761a8d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:761ab75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:761ade00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:761b0498-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:761b2bb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:761b525e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:761b791e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:761ba0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:761bc824-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:761bead4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.395']} DrugCentral uuid:761c1194-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:761c3994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:761c5eba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:761c8584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:761cb2fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:761cb2fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:761cb2fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:761cf208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:761d18b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99246 biolink:molecularly_interacts_with DrugCentral:1942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:761d3f4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:761d65f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q968X7 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate dehydrogenase [NADP(+)]) DrugCentral uuid:761d8966-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q24982 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate:ferredoxin oxidoreductase) DrugCentral uuid:761dabf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0P8E1 biolink:molecularly_interacts_with DrugCentral:1943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitazoxanide targets Enzyme (Pyruvate-flavodoxin oxidoreductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:761dd2c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32754 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone is inhibitor of Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:761df946-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02110 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone targets Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:761e209c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32755 biolink:molecularly_interacts_with DrugCentral:1944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitisinone targets Unclassified (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:761e4df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:761e4df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:761e4df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761e9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:761f00c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:761f274e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:761f4eae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:761f755a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:761f980a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.921']} DrugCentral uuid:761fbeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:761fe56c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:76200fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.056']} DrugCentral uuid:762039d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:762062b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:762089c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7620b0fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:7620d7c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7620fe7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:762125e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21556 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:76215348-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76215348-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76215348-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76219344-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1947 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:7621c4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7621c4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7621c4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7621c4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7622084c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurantoin targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:76222b06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurantoin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:762251bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurazone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:762274c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:1950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitrofurazone targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:76229b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:7622c818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7622c818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7622c818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7622c818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:76230abc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76233172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7623581e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:76237ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7623a7f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7623d1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7623fa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nizatidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76242154-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nizatidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.251']} DrugCentral uuid:7624485a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76246f1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:762495c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:7624bc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7624e44a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:76250b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.947']} DrugCentral uuid:762531b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.963']} DrugCentral uuid:7625584e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:762581ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7625a95c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7625d008-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7625fa24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:7625fa24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:76262d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norelgestromin is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:762650be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7626779c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:76269e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7626c5b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7626ec7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7627135a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:76273a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:762762f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.367']} DrugCentral uuid:762789b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7627b062-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:7627d722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7627fe5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:76282524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:76284be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:762872a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:762899f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7628c0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7628e75c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:76290e12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:76293892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:76296222-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76299080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:76299080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:76299080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:7629d658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7629d658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7629d658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a2590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:762a8f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:762a8f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:762a8f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:762acde2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01337 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:762af5b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:1960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norepinephrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:762b1c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:762b4330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:762b69fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.636']} DrugCentral uuid:762b911e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:762bb7de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:762bde94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:762c055e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:762c2d2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.914']} DrugCentral uuid:762c5838-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:762c5838-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:762c8bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:762cb3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.533']} DrugCentral uuid:762cddd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:762d072e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:762d2dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:762d549a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:762d7bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:762da274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:762dc93e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1963 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethindrone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:762df012-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethynodrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:762e1376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norethynodrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:762e3a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762e60ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762e8770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762eb182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762ed842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:762eff0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:762f25c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:762f4cf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:762f73b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762f9a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:762fc108-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:762fea3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76304268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76312bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:1967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norfloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.01']} DrugCentral uuid:76315298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:7631755c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:76319ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:1968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7631c37c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7631eb7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7632123c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:763239ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7632650c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.36']} DrugCentral uuid:76328bcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:7632b282-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:7632d992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:76330048-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:763326f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:76334daa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:763374f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:76339bb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:7633c24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.033']} DrugCentral uuid:7633e904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.639']} DrugCentral uuid:763410a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:76343a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:7634646a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:76348b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:7634b212-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:7634d8c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:7634ff4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:76352602-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.921']} DrugCentral uuid:76354d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6.225']} DrugCentral uuid:763573e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:76359a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:7635c13e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7635e902-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:76361008-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:763637a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:76365e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:76368556-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7636ac16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78508 biolink:molecularly_interacts_with DrugCentral:1971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nortriptyline is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:7636d2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.087']} DrugCentral uuid:7636f950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:763720c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7637475c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 noscapine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:76376df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:76379482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:7637bc32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A4L9 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7637e4dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7X1P7 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (ParE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:76380b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SLN2 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7638355e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7638355e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:76386d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:76386d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:76389ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C559 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7638c15e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0K8 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7638e814-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0QNE0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:76390f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SLN3 biolink:molecularly_interacts_with DrugCentral:1974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:76393ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:76393ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:76393ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:76397b30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:7639a948-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.699']} DrugCentral uuid:7639d148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7639f81c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:763a1ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:763a45d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:763a6c98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:763a9362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.98']} DrugCentral uuid:763aba22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:763ae18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:763b084c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:763b2ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08858 biolink:molecularly_interacts_with DrugCentral:1980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:763b55a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:763b7f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:763ba66c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:763bcd18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:763bf3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:763c16a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:763c3d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763c954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:763d7546-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:763d9bd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofloxacin targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:763dc262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:763de972-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:763e101e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:763e36de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:763e5d8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.492']} DrugCentral uuid:763e84e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:763eab96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:763ed238-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:763ef916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:763f226a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:763f498e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:763f703a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:763f96fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:763fbed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:763fe59c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:76400d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:7640340c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:76405b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:76408218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:7640a8d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.506']} DrugCentral uuid:7640cf98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:7640f8f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.136']} DrugCentral uuid:76411f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.682']} DrugCentral uuid:76414644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:76416ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:764193ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.233']} DrugCentral uuid:7641ba8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:7641e13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:764207fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:76422f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:76425624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:76427ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:7642a3ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.916']} DrugCentral uuid:7642ccf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:7642f412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:76431adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.558']} DrugCentral uuid:76434188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:764368ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:764390c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7643b762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7643defe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:764406f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:76442dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7644547e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:76447b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7644a500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7644cc24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7644f2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7645199a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:764540c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7645677e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:76458e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7645bb98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7645bb98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7645bb98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:764601ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:764601ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:764601ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:76464072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7646687c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olanzapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:764690a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmesartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7646b750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmesartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:7646ddfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olopatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.284']} DrugCentral uuid:76470516-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olopatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:76472f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:76472f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:76475d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:7647800e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:7647a6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7647a6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7647d3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7647fa8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7648213a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7648494e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76486fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7648967e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7648bd0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.31']} DrugCentral uuid:7648e41c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.051']} DrugCentral uuid:76490abe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:76493160-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:764957f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7649807a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7649aaa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7649aaa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7649e0b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7649e0b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:764a14f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:764a3e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:764a651c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:764a8f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:764a8f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:764ac21e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:764ae9ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:764b1070-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.678']} DrugCentral uuid:764b3712-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:764b5e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:764b8532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:764babe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:764bd2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:764bfca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:764c23ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:764c4ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:764c719a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:764c98dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:764cbf9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:764ce65c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:764d0d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:764d347c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:764d5b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:764d81ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:764dabdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:764dabdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:764de2f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:764de2f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:764e1c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:764e1c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:764e1c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:764e5fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:764e5fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:764e92b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1992 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:764eb96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:764ee038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:764f0798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opipramol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:764f2f8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:764f5658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:764f7cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:764fa54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4D2 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:764fcbf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:764ff298-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NCG7 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76501944-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95870 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Abhydrolase domain-containing protein 16A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7650405e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N2K0 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7650670a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13093 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Platelet-activating factor acetylhydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:76508da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00591 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7650b444-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BV23 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7650dba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6WQJ1 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76510246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7651296a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11150 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Hepatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:76515020-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5X9 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat targets Enzyme (Endothelial lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7651794c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7651a00c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07098 biolink:molecularly_interacts_with DrugCentral:1996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orlistat is inhibitor of Enzyme (Gastric triacylglycerol lipase) DrugCentral uuid:7651c2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:7651e97c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:76521190-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:76523846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.614']} DrugCentral uuid:76525f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:765285e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:7652ad44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:7652d404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:7652fac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:76532184-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:76534916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:76536fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.165']} DrugCentral uuid:765396aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7653bd56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.873']} DrugCentral uuid:7653e48e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:76540b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:765431fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:765458ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.889']} DrugCentral uuid:76548024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:7654a6ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.764']} DrugCentral uuid:7654cd90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:7654f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:76551cbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7655436a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76557e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7655ef18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06818 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.83']} DrugCentral uuid:765615a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76563db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:76566470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:76568b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:7656b1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7656d95a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:765702fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:765729aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76575056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7657775c-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:76579df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7657c48c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7657eb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:76581270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:76583908-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:76585fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.96']} DrugCentral uuid:7658864c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7658add4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11172 biolink:molecularly_interacts_with DrugCentral:2002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oteracil is inhibitor of Enzyme (Uridine 5'-monophosphate synthase) DrugCentral uuid:7658d0c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.169']} DrugCentral uuid:7658f762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.009']} DrugCentral uuid:76591e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:765941c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:2004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ouabain targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:765968c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76598f60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7659b5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:7659d88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:765a0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:765a0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:765a0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:765a0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:765a0d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:765a5968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:765a801e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:765aab16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:765aab16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:765addac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:765b0192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:765b2898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:765b4f3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:765b71d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:765b9904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:765bc05a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:765be724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxaprozin targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:765c0da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:765c344a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.148']} DrugCentral uuid:765c5bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:765c8274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:765ca920-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:765cd0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxatomide is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:765cfec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:765cfec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:765cfec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:765d3d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxcarbazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:765d6018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:765d82d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:765da636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:765dcd0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:765df3d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:765e1a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:765e43a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.991']} DrugCentral uuid:765e6a4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.589']} DrugCentral uuid:765e910e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:765eb7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:765edef2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:765f05a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:765f2c68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:765f5328-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.168']} DrugCentral uuid:765f7a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:765fa148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:765fc7fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:765feea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7660184e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:76603f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:766066f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2028 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:76608dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7660b57e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7660dc20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:766102ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7661296e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:766151fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:766178b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:76619f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7661c5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7661ef84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:76621626-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:76623cf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:766263a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.493']} DrugCentral uuid:76628aa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7662b158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:7662d7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7662feb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.111']} DrugCentral uuid:76632674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:76634d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:766373cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:76639a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7663c3fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7663edde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7664149e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76643c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:76646372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:76648a28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7664b0de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.162']} DrugCentral uuid:7664d79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.041']} DrugCentral uuid:7664fefe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:766525a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:76654c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:766572e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:76659cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7665c62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7665ecce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:76661aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:76661aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:76661aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:76665fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:76665fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:76665fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:76669e6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7666c680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7666ed0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:76670fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:7667326e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2033 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymetholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:76675ba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:7667853e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:7667aef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7667d98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:76680108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:766827c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:76684e7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7668752a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:76689c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7668c34a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7668f400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:7668f400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:7668f400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:7668f400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:766944a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:766944a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:766979de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:76699c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:7669c2e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7669c2e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7669f012-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2036 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:766a16c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:766a398c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:766a5c28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:766a83b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2041 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:766aa656-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2041 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:766ac8e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:766aef76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:766b1906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:766b3fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:766b6654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01178 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets Secreted (Oxytocin-neurophysin 1) DrugCentral uuid:766b89ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:766bb0f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:766bd7b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxytocin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:766bfe5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:766c24fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49430 biolink:molecularly_interacts_with DrugCentral:2043 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:766c4c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:766c72f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:766c9998-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:766cc04e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Bile salt export pump) DrugCentral uuid:766ce4d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:766d0770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766d2e9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.621']} DrugCentral uuid:766d5694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.954']} DrugCentral uuid:766d7d9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.643']} DrugCentral uuid:766da450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:766dcb06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.794']} DrugCentral uuid:766df1c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:766e1926-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:766e3fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13509 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Structural (Tubulin beta-3 chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:766e667e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766ea8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:766f304a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:766f576e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:766f7e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:766fa4c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:2045 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palmidrol is agonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:766fcb72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:766ff638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:766ff638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:767028ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamabrom targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:76704fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:76707658-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:76709df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07010 biolink:molecularly_interacts_with DrugCentral:2048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pamidronic acid targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7670c4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7670eb4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:767111f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:7671391c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:76715fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q81VW8 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:76718688-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7671ad2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WNC6 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) DrugCentral uuid:7671d066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.92']} DrugCentral uuid:7671fa78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7671fa78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:76722e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:76722e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:76722e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:767275a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:767275a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:7672b3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7672b3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7672b3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7672b3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7672feb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:7673215a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:76734810-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76736ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:767395fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7673bcaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:7673e6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7673e6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:767413da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:767440d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:767440d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76747726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:76749ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7674c4ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:7674e788-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:76750e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:767534c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:76755baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.118']} DrugCentral uuid:7675835a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:7675a9e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7675d08a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7675f72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:76762170-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7676488a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:76766f18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:76769646-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7676bce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYJ6 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7676ea42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7676ea42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7676ea42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:76772c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:76772c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:767765a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:767765a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:767765a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7677a450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7677cb60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7677f9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:7677f9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:7677f9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:7678326c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.854']} DrugCentral uuid:76785922-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:76788096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7678a864-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7678cfc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7678f67a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:76791d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:2065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pargyline targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7679442c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paricalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:76796aa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7679915c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:7679ba74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.068']} DrugCentral uuid:7679e18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:767a0844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.398']} DrugCentral uuid:767a2ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.52']} DrugCentral uuid:767a5628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:767a7cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:767aa394-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:767aca5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:767af15a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:767b181a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:767b3eb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:767b6572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:767b8e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:767bb54a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:767bdbd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:767c0266-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:767c29a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:767c5054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:767c77e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:767c9ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.36']} DrugCentral uuid:767cc5b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:767cec6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:767d13c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:767d3b04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:767d6b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:767d6b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:767d6b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:767db3cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:767db3cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:767db3cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:767df47c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:767e1b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:767e41e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21146 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:767e6880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:767e8f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:767eb60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.097']} DrugCentral uuid:767edc98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:767f0344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.468']} DrugCentral uuid:767f2b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:767f5416-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:767f76b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:767f9d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Serine hydroxymethyltransferase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:767fc482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:767feb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:768012ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:76803976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7680607c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:76808732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7680ade8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7680d480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7680fc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7681264c-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:76814cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:E2QDN0 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:76817386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.86']} DrugCentral uuid:76819ac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7681c174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64737 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7681e834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22102 biolink:molecularly_interacts_with DrugCentral:2073 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:76820efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:76823672-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:76825d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:768283d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7682aa76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02763 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets Secreted (Alpha-1-acid glycoprotein 1) DrugCentral uuid:7682ce16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7682f562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:76831876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:76833f0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2079 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:76836632-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:76838cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:7683b3c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7683da7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:7684027c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:76842946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:76844fde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:768477d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76849fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7684c694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7684ed4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:76851400-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76853b56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76856216-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:768588e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7685afb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7685d6b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7685fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:76862426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76864ae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:768671a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7686a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7686a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7686a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7686a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7686a6b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7686fcde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:2081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 penicillamine targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:76872420-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:768746c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:76876d86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7687a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76880a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:76883108-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76886a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7688cc08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:7688f35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:76891a00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:768941d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:2088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:76896884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.287']} DrugCentral uuid:76898fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7689b690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:7689dd32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:768a03f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:768a2c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:768a5302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.295']} DrugCentral uuid:768a79b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:768aa168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.683']} DrugCentral uuid:768ac882-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:768aef42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:768b15ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.101']} DrugCentral uuid:768b3c7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:768b6364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:768b8a24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:768bb0c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:768bd772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04271 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Cytosolic other (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:768c0026-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:768c26f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:768c4d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19801 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:768c7448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:768c9b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:768cc218-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:768ce8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:768d0f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:768d3658-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768d70dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:768de62a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:768de62a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:768e1942-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21673 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Spermidine/spermine N(1)-acetyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:768e3fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75365 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein-tyrosine phosphatase 4A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:768e6712-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:768e8db4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04631 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Unclassified (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.36']} DrugCentral uuid:768eb46a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:768edb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:768f0208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12974 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:768f29fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q93096 biolink:molecularly_interacts_with DrugCentral:2090 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:768f50be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:768f7760-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.553']} DrugCentral uuid:768fa6a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:768fa6a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:768fa6a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:769018aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7690fc20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7690fc20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7690fc20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:76913a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:769160ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:769160ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:7691918a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:2098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentostatin is inhibitor of Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.8']} DrugCentral uuid:7691ba66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56658 biolink:molecularly_interacts_with DrugCentral:2098 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentostatin targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:7691e13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7692080e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:76922b18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:769251c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentoxifylline is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) DrugCentral uuid:76927456-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:76929b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7692c21c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7692e8dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76930f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:76933616-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:76935fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:76938760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7693af4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7693d60c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7693fd1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:769423be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76944a4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:769470ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:76949812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7694bea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7694e5d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:76950c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:769535ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.838']} DrugCentral uuid:76955c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:76958330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:7695a9d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7695d0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7695f770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:76961e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:769644d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:76966bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:76969964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:76969964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:76969964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7696db54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7696db54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:76971dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:76971dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:76971dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:76971dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:76971dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:769778ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:769778ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7697abce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7697d27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pergolide is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7697f930-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:76981ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7698470a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.486']} DrugCentral uuid:76986dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:7698948a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7698bb36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7698e34a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:76990a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.027']} DrugCentral uuid:769930ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:7699535c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:76997bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) DrugCentral uuid:76999e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:7699c0da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23786 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:7699e786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.828']} DrugCentral uuid:769a0e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:769a3560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:769a62a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:769a62a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:769a62a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:769aa39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:769acab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32198 biolink:molecularly_interacts_with DrugCentral:2106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:769af158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:769b180e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:769b3f1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:769b65d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2107 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 periciazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:769b8c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2108 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perindopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:769bb322-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:769bda1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.704']} DrugCentral uuid:769c00e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:769c279e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:769c4e36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:769c7686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:769c9d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:769cc42e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:769ceaee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:769d1208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:769d38dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perospirone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:769d5f92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:769d8634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:769dad4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:769dd3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:769dfaa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:769e2256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:769e4a2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:769e70e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:769e9790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:769ebefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:769ee60a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.521']} DrugCentral uuid:769f0cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.088']} DrugCentral uuid:769f3380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:769f5a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.481']} DrugCentral uuid:769f810a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:769fa900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:769fcfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:769ff658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:76a01ea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76a045b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacemide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:76a06840-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacetin targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:76a08ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:76a0b1d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:76a0d8a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:76a0ff62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76a125f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a16b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76a1ed3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:2120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenazopyridine targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:76a21776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:76a24160-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:76a2688e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:76a28fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:76a2b654-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76a2dd0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:76a303c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a33f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a3c1fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:76a4361e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76a4361e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76a46c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76a46c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76a4ac3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:76a4ac3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:76a4ac3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:76a4ac3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:76a4ac3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:76a50346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:76a525f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76a54cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:76a56f84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:76a5972a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.076']} DrugCentral uuid:76a5bee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76a5e572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:76a60c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:76a63360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:76a65a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:76a680f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:76a6a7a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16853 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76a6cef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76a6f58e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:76a71c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:76a742be-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:76a76b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenelzine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:76a79368-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:2126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:76a7b67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2129 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:76a7dd32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:76a7ffc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione targets Enzyme (Prothrombin) DrugCentral uuid:76a822b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2130 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76a84970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2131 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:76a86c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2131 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:76a88ee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:76a8b22a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:76a8dfc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:76a8dfc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:76a8dfc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:76a91e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.298']} DrugCentral uuid:76a94654-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.883']} DrugCentral uuid:76a96fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenmetrazine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:76a99244-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:76a9b616-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:76a9dfec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76a9dfec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76a9dfec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76aa1e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76aa1e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76aa1e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76aa5cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:76aa842e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:76aaaaee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:76aad2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q834R3 biolink:molecularly_interacts_with DrugCentral:2135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76aaf990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:76ab2212-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:76ab4b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:76ab72d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76aba6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76aba6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76aba6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76aba6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76aba6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76ac043e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:76ac043e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:76ac043e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:76ac49a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:76ac49a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:76ac49a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:76ac89a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:76acb064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:76acd724-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:76ad0096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenprocoumon is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.745']} DrugCentral uuid:76ad3098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:76ad3098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:76ad3098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:76ad6892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentermine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:76ad8b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.801']} DrugCentral uuid:76adb360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:76adda16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:76ae00ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:76ae27fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.667']} DrugCentral uuid:76ae4e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:76ae755c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.616']} DrugCentral uuid:76ae9c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.684']} DrugCentral uuid:76aec43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:76aeef8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:76af167e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:76af3d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:76af6476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:76af8b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:76afb21e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:76afd8e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:76b00034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:76b026ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:76b04d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:76b0744c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:76b09be8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:76b0c2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76b0e954-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:76b11014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:76b13dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:76b13dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:76b13dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:76b184cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:76b184cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:76b184cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:76b1c37e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:76b1eac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:76b21180-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:76b23836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:76b25ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:76b2866a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:76b2ada2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P98170 biolink:molecularly_interacts_with DrugCentral:2144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylalanine targets Unclassified (E3 ubiquitin-protein ligase XIAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:76b2d444-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:76b2fae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:76b321ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:76b3449c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:76b36b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:76b39564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76b39564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76b3c890-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2145 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:76b3ef64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:76b4162e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76b43dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:76b466ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:76b48d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:76b4b430-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76b4e414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:76b4e414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:76b4e414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:76b5297e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:76b5297e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:76b5297e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:76b56ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:76b56ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:76b56ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:76b5ae30-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:76b5d4be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:76b5fb60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:76b61ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:76b646d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:76b66da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:76b6903e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:76b6b744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:76b6ddf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:76b7049c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.166']} DrugCentral uuid:76b72b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:76b752b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:76b77986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:76b7a046-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylpropanolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:76b7c706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:76b7ef24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:76b818f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:76b83fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:76b86698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenyltoloxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:76b889a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:76b8ac70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:76b8cfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:76b8f270-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76b91926-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:76b93c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:76b96368-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:76b9862c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:76b9a8f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:76b9d8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76b9d8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76b9d8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76ba175e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phloroglucinol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76ba4170-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76ba4170-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:76ba7c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:76ba7c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:76ba7c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:76babb96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:76bae256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.37']} DrugCentral uuid:76bb09ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:76bb3062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:76bb5704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:76bb7eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:76bba7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:76bbce5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:76bbf51a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:76bc1bc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:76bc42b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:76bc695a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:76bc9010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:76bcb6c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36196 biolink:molecularly_interacts_with DrugCentral:2159 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76bcde3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:76bd04f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76bd2b9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:76bd5270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76bdab76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:76be879e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:76beaef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76bed5b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:76befcd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:2163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:76bf2366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:76bf4922-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:76bf6bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:76bf9274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:76bfb920-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:76bfe008-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:76c013e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:76c013e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:76c013e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:76c013e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:76c013e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:76c06a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:76c091ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:76c0b852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:76c0deea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:76c10578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:76c12f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilsicainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:76c15a50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pilsicainide is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.377']} DrugCentral uuid:76c183b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interleukin-5) DrugCentral uuid:76c1a780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interferon gamma) DrugCentral uuid:76c1ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:76c1f0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Cytokine (Interleukin-2) DrugCentral uuid:76c2135a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) DrugCentral uuid:76c23600-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62658 biolink:molecularly_interacts_with DrugCentral:2168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:76c25d38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:76c283f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:76c2aa90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:2169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimethixene targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:76c2d132-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:76c2fdd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:76c2fdd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:76c33050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:76c356d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.862']} DrugCentral uuid:76c37dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.798']} DrugCentral uuid:76c3a490-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:76c3cb28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:76c3f1b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:76c418d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.63']} DrugCentral uuid:76c43f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.559']} DrugCentral uuid:76c46628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:76c48cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:76c4b362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.301']} DrugCentral uuid:76c4db1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:76c502b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:76c52a7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:76c552d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:76c57964-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:76c5a006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.709']} DrugCentral uuid:76c5c680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:76c5ed9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.424']} DrugCentral uuid:76c6145a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:76c63b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76c6619e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76c6882c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76c6af78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:76c6dcb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:76c6dcb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:76c6dcb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:76c71b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:76c7421c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:76c768b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:76c78f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:76c7b60c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:76c7dd8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:76c80422-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:76c82ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:76c8517a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:76c88870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76c88870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76c88870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76c88870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76c88870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76c8dfbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94782 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide targets Enzyme (Ubiquitin carboxyl-terminal hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:76c906c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EQ60 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:76c92d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:76c9541c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:2172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:76c97ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60706 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil targets Ion channel (ATP-binding cassette sub-family C member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:76c9a1ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:76c9c802-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:76c9c802-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:76c9faca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is partial agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:76ca219e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is partial agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:76ca49ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:76ca709a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:76ca9750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:76cabe1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:76cae548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.78']} DrugCentral uuid:76cb0d34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:76cb33d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.209']} DrugCentral uuid:76cb5a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:76cb81f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:76cbb324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:76cbb324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:76cbb324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:76cbb324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:76cc054a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:76cc054a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:76cc054a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:76cc44ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.943']} DrugCentral uuid:76cc6b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:76cc921c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:76ccb940-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.455']} DrugCentral uuid:76ccdff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:76cd0698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:76cd2d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.879']} DrugCentral uuid:76cd54a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76cd7b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:76cda1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:76cdc89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88275 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:76cdf198-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:76ce184e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:76ce3ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:76ce65a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:76ce8cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:76ceb358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:76ced9f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:76cf00b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.87']} DrugCentral uuid:76cf2806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:76cf4fb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:76cf766c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.461']} DrugCentral uuid:76cf9d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:76cfc61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.992']} DrugCentral uuid:76cfefd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.256']} DrugCentral uuid:76d0198c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:76d04254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:76d06978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:76d0902e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.105']} DrugCentral uuid:76d0b6e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.799']} DrugCentral uuid:76d0dd9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.939']} DrugCentral uuid:76d10978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:76d13182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.189']} DrugCentral uuid:76d1582e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:76d17ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:76d1a82e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:76d1ceda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:76d1f57c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.429']} DrugCentral uuid:76d21c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:76d2431a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:76d269a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:76d29054-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:76d2b6f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:76d2de56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:76d30502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76d32c94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:76d35340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.324']} DrugCentral uuid:76d37d66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:76d3a426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:76d3cad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:76d3f19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76d418c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:76d43f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:76d46636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:76d48cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:76d4b42e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:76d4de2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:76d4de2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:76d511ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:76d511ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:76d511ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:76d54f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:76d54f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:76d57fd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:76d57fd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:76d5acd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:76d5d08e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:76d5fa32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d636e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:76d69a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O18276 biolink:molecularly_interacts_with DrugCentral:2188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperazine targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) DrugCentral uuid:76d6bd3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipotiazine palmitate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:76d6e3f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2193 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pipotiazine palmitate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:76d70c06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2199 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirbuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:76d7310e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:76d757ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:76d77e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:76d7a58a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:76d7cc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:76d7f2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:76d819a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:76d8417a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:76d8683a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:76d88ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:76d8b5ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:76d8dd42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:76d90420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:76d93832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76d93832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76d93832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76d93832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76d93832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:76d99c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76d99c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76d99c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76d99c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76d99c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:76d9f3bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:76da1b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:2201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:76da41be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:76da6888-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:76da8f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76dab752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:76dae0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:76db0a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76db31c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:76db58ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:76db7fac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:76dba658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:76dbcd22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piribedil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:76dbf482-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76dc1b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28347 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:76dc4324-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:76dc69e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15562 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:76dc9248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99594 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:76dcbb2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2206 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirlindole is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:76dce1d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirmenol targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:76dd0480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:76dd2b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:76dd521e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:76dd7d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:76dd7d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:76ddb2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:76ddb2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:76dde60c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:76de08b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:76de2b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.168']} DrugCentral uuid:76de529a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:76de7a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitavastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:76dea0e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:76dec7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:76deee6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:76df159a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:76df3c5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:76df631a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:76df89da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pizotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:76dfb1bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polythiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['9.09']} DrugCentral uuid:76dfd868-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralidoxime is activator of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.59']} DrugCentral uuid:76dfff28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08725 biolink:molecularly_interacts_with DrugCentral:2232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:76e025de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:2232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) DrugCentral uuid:76e0494c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:76e07020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76e096ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.121']} DrugCentral uuid:76e0bd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:76e0e47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:76e10b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:76e132b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:76e15968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.668']} DrugCentral uuid:76e180aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:76e1a760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:76e1ce16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:76e1f4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.282']} DrugCentral uuid:76e21eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:76e248aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:76e270fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:76e297a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:76e2c23a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:76e2c23a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:76e2f836-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:76e2f836-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:76e32e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:76e32e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:76e361d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76e38878-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:76e3af1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:76e3d6b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:76e4008c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:76e427e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast targets Nuclear other (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:76e44eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:76e4759e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:76e49c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2238 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:76e4c418-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:76e4ead8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:76e51238-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pravastatin targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:76e53fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76e53fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76e53fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76e576e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:76e59d66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08515 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel targets Enzyme (Glutathione S-transferase class-mu 26 kDa isozyme) DrugCentral uuid:76e5c28c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95US7 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB1) DrugCentral uuid:76e5e7a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q962H3 biolink:molecularly_interacts_with DrugCentral:2241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB2) DrugCentral uuid:76e60a4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2243 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednicarbate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:76e62cea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:76e653e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:76e6768c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:76e69d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76e6c40c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76e6eb44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:76e711f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:76e73888-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76e75f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:76e7868a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:76e7ad2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:76e7d3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:76e7fa66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:76e82176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76e84840-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:76e86d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.28']} DrugCentral uuid:76e893e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:76e8bb40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:76e8e20a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76e90938-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:76e93016-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:76e95780-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76e97e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:76e9a4ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:76e9cb8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:76e9f294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:76ea1968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:76ea4014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:76ea66ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:76ea8e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:76eab4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisone targets Cytosolic other (Annexin A1) DrugCentral uuid:76ead768-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.801']} DrugCentral uuid:76eafe1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:76eb24de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:76eb4c8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:2255 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:76eb7312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:76eb99c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:76ebc092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pregnenolone succinate targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:76ebe784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenalterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:76ec0f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenalterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:76ec3c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:76ec3c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:76ec3c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:76ec827a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:76ec827a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:76ec827a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:76ecc118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prenylamine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:76ece7c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:76ed0fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:76ed36a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.194']} DrugCentral uuid:76ed5d4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:76ed83fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.799']} DrugCentral uuid:76edb1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:76edb1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:76edb1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:76edf0f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.668']} DrugCentral uuid:76ee1798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.075']} DrugCentral uuid:76ee3ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:76ee62b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:76ee894e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:76eeafe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.739']} DrugCentral uuid:76eed7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:76eefeba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:76ef2156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:76ef4910-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:76ef700c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35869 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transcription factor (Aryl hydrocarbon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:76ef96b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:76efbd5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:76efe406-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primaquine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:76f01228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76f01228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76f01228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:76f0498c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:2267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 primidone is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:76f0702e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:76f096ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:76f0c042-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:76f0e720-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:76f10dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 8) DrugCentral uuid:76f130d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 11) DrugCentral uuid:76f153d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:76f17a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:76f1a11a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:76f1c7da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.02']} DrugCentral uuid:76f1ef58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:2268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probenecid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:76f215f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.686']} DrugCentral uuid:76f23c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76f26334-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95477 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol is inhibitor of Transporter (ATP-binding cassette sub-family A member 1) DrugCentral uuid:76f2879c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:76f2b1f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:2269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 probucol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:76f2daf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.86']} DrugCentral uuid:76f3029e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.812']} DrugCentral uuid:76f329cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76f35078-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:76f37300-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:76f39588-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:76f3b8d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f3fd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:76f483da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.569']} DrugCentral uuid:76f4aaa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.529']} DrugCentral uuid:76f4d150-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:76f4f450-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.222']} DrugCentral uuid:76f521a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:76f521a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:76f521a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:76f5600c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:76f586ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2273 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:76f5adfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:76f5d4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:76f5fb84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.764']} DrugCentral uuid:76f6232a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:76f64d96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:76f67762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:76f6a12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.207']} DrugCentral uuid:76f6c8ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.402']} DrugCentral uuid:76f6ef58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:76f7160e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:76f73cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:76f7642e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:76f78aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:76f7b190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.622']} DrugCentral uuid:76f7d850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.324']} DrugCentral uuid:76f8005a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.611']} DrugCentral uuid:76f82792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.723']} DrugCentral uuid:76f84e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.613']} DrugCentral uuid:76f87512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:76f89c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.493']} DrugCentral uuid:76f8c35a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:76f8ea1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:76f9115c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:76f938e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:76f95f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:76f98628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:76f9ace8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:76f9d614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:76fa006c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.245']} DrugCentral uuid:76fa2718-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:76fa4da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:76fa74b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:76fa9b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.381']} DrugCentral uuid:76fac222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:76fae8b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:76fb1006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prochlorperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fb36bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.337']} DrugCentral uuid:76fb5d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:76fb8414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.907']} DrugCentral uuid:76fbac0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:76fbd374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:76fbfa16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fc34c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:76fca9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:76fca9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:76fca9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fd1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76fe2d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:76ff0bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.174']} DrugCentral uuid:76ff3262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:76ff5abc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:76ff81cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:76ffa896-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:76ffcf4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:76fff256-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:770019a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['9.876']} DrugCentral uuid:77004058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7700670e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.94']} DrugCentral uuid:77008e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35610 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Sterol O-acyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7700b4fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7700dbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:77010272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:77012a68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:7701518c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77017842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:77019eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:7701c608-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7701edb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:770217ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:770217ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77024de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:77024de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:77028160-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7702a816-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7702cec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7702f5fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:77031df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:770344a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 progesterone targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77036b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proglumide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.6']} DrugCentral uuid:77039230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proglumide is antagonist of GPCR (Gastrin/cholecystokinin type B receptor) DrugCentral uuid:7703b4ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0IJY2 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:7703d786-59f3-11ec-9eaa-0242ac110003 UniProtKB:O02604 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:7703fa40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:77041ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proguanil targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:77044428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:77046afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:770491d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7704b890-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:7704e19e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:77050b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:77053342-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.529']} DrugCentral uuid:77055a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:770582b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.656']} DrugCentral uuid:7705a980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:7705d040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:7705f6f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.226']} DrugCentral uuid:77061e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:77064516-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:77066bcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:77069278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.551']} DrugCentral uuid:7706ba3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:7706e0f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:770707bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.056']} DrugCentral uuid:77072e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:77075596-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:77077c2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.796']} DrugCentral uuid:7707a2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7707c968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7707f0aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:77081760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:77083e0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:770864a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:77088dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.344']} DrugCentral uuid:7708b7d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.806']} DrugCentral uuid:7708de8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:77090526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:77092c4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:770953dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:77097de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77097de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7709bfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7709bfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7709bfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7709bfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7709bfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:770a1ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:770a1ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:770a1ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:770a5cbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:770a8342-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promegestone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:770aa9ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promegestone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:770ad09a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:770af796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:770b1e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:770b4598-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:770b6c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:770b93b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:770bba6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:770be124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:770c07e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:770c3084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.188']} DrugCentral uuid:770c574e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.948']} DrugCentral uuid:770c7efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:770ca1b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:770cc8dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:770cefb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:770d167a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.941']} DrugCentral uuid:770d3d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.823']} DrugCentral uuid:770d647c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.479']} DrugCentral uuid:770d8b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:770db1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.382']} DrugCentral uuid:770dd8a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.975']} DrugCentral uuid:770e001c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:770e26b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:770e4d42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.452']} DrugCentral uuid:770e73f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:770e9b08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:770ec1d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:770ee874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:770f0f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:770f3630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:770f5e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:770f84d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:770fab7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:770fda4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:770fda4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:770fda4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:771019c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:77104084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:77106758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77108e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:2286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 promethazine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:7710b532-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pronetalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7710dc06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:77110384-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:77112a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7711517c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:77117418-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:771196be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:7711bc3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:7711e0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:77120770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:77122e12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:77125522-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:77127bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.029']} DrugCentral uuid:7712a284-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.728']} DrugCentral uuid:7712c94e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:7712f0c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:77131782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:77133e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:771364c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.498']} DrugCentral uuid:77138e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:7713b598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.337']} DrugCentral uuid:7713dc44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:771403fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.483']} DrugCentral uuid:77142b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:771451a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:77147852-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:77149eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:7714c62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:7714ecec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:771513a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:77153a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7715626c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.602']} DrugCentral uuid:77158c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:77158c88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7715c0e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7715e80e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:77160ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:77163584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:77165cc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:77168426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7716aabe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:7716d43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7716d43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7716d43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:771712ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propentofylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:77173d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:771761d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(2) dopamine receptor) DrugCentral uuid:7717856a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:7717a7fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:7717cb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7717edca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7718105c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:771832f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:77185648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:771878ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:77189b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (D(4) dopamine receptor) DrugCentral uuid:7718be12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiomazine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:7718e0d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propiram is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:771905de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:77192fb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.417']} DrugCentral uuid:771956ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.031']} DrugCentral uuid:77197d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:7719a49e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.218']} DrugCentral uuid:7719cb4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.005']} DrugCentral uuid:7719f1ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:771a1866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:771a3fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.119']} DrugCentral uuid:771a6654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:771a8d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:771aba8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:771aba8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:771aba8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:771b04e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:771b04e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:771b04e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771b77ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:771c59be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:771c59be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:771c59be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:771c98ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:771cc142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:771ce884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:771d0f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.913']} DrugCentral uuid:771d3726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:771d5ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:771d84a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:771dab70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:771dd2d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.699']} DrugCentral uuid:771df9b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:771e205a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:771e4706-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:771e6e70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:771e951c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.319']} DrugCentral uuid:771ebbbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:771ee26a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:771f0934-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.297']} DrugCentral uuid:771f2fd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:771f568c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:771f7d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:771fa40c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:771fcb62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.01']} DrugCentral uuid:771ff20e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:772018ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:772040d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:77206ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:77209826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:77209826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:77209826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7720d7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7720fece-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7721258e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:77214c44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:77217304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:77219a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7721c110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7721e7c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49895 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil is inhibitor of Enzyme (Type I iodothyronine deiodinase) DrugCentral uuid:77220a62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:2308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propylthiouracil targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:77223406-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:2309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propyphenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.481']} DrugCentral uuid:77225aee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:77227d80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:7722a404-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7722a404-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7722d708-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proscillaridin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:7722fd96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proscillaridin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:7723203c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:772346de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:77236e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:772394f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R297 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7723bbaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7723e238-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERT1 biolink:molecularly_interacts_with DrugCentral:2316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:772409a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protokylol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:77242c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.928']} DrugCentral uuid:772452fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:772479aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:7724a1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7724c860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7724ef0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:772515ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:77253ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:77256374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:77258a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7725b0c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7725d9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:77260356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:77262a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protriptyline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7726523e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:7726753e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:772697f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:7726ba80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pseudoephedrine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7726dd12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77270440-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:77272ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPB6 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cyclopropane mycolic acid synthase 1) DrugCentral uuid:77274d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50575 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA) DrugCentral uuid:77276ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7727978e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P95029 biolink:molecularly_interacts_with DrugCentral:2328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrazinamide is inhibitor of Enzyme (3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase)) DrugCentral uuid:7727bd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7727e40a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:77280ac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:772831b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:77285872-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:77288022-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:7728a750-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7728ce9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:7728f552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:77291c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.751']} DrugCentral uuid:772942c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:77296a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:77299138-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:7729b7e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7729de86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:772a0528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:772a2c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:772a52b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:772a7954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:772aa000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.288']} DrugCentral uuid:772ac756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.409']} DrugCentral uuid:772aee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:772b14c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:772b3b78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:772b65da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:772b8cea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:772bb3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:772bda7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:772c0152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:772c27f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.009']} DrugCentral uuid:772c4fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:772c76c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:772c9d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08966 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:772cc592-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K0H1 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Unclassified (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:772cec34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:772d1358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06865 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:772d3a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07686 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:772d610a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3V050 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine is inhibitor of Unclassified (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:772d87c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:772dae76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8I1R6 biolink:molecularly_interacts_with DrugCentral:2332 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:772dd5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1KRD8 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Unclassified (Fumarate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:772dfcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:772e237e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43426 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Synaptojanin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:772e4a20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrvinium targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:772e7810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:772e7810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:772e7810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:772ebd66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:772ebd66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:772ebd66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:772f05b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:772f05b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:772f05b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:772f49e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:772f7198-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:772f989e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:772fbf54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.483']} DrugCentral uuid:772fe5f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77300ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:773033e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:77305a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7730811e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:7730a7b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:7730d038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7730f72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:77311dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:77314464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.512']} DrugCentral uuid:77316b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.027']} DrugCentral uuid:773191f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.127']} DrugCentral uuid:7731b8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7731df64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:773206c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:77322d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:773253f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:77327a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.795']} DrugCentral uuid:7732a340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.266']} DrugCentral uuid:7732c9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:7732f070-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:773316f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:77333efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:773365a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.241']} DrugCentral uuid:77338c6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7733b320-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:7733da8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:7734012c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.506']} DrugCentral uuid:773427e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77344e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:77347760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.866']} DrugCentral uuid:77349e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:7734c530-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7734eca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:773513b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:77353a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7735613e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:773587e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7735af22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7735d5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quetiapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7735fc8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:77362344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.542']} DrugCentral uuid:77364be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:773673da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.079']} DrugCentral uuid:77369a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:7736c13c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.459']} DrugCentral uuid:7736e856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:77370fe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:773736ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.575']} DrugCentral uuid:77375dcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.558']} DrugCentral uuid:7737852c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:7737abce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:7737d25c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:7737f91c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:773821f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.574']} DrugCentral uuid:7738489a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:77386f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:773895f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:7738bd16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7738e3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:77390dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:77390dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:773948ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:773948ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:773948ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:77399182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77399182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77399182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77399182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7739dbc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00592 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:773a04c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04055 biolink:molecularly_interacts_with DrugCentral:2338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773a5680-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:773b21c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:773b21c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:773b21c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:773b63ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:773b63ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:773b9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:773b9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:773b9ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:773bdf1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:773c0890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.397']} DrugCentral uuid:773c2f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:773c525a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinethazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:773c756e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quingestanol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:773c992c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:773cbfba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:773ce24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:773d05d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:773d2874-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:773d4c64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:773d7310-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:773d9b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:773dc518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:773ded5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:773e1428-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:773e3b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.106']} DrugCentral uuid:773e61ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:773e889a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:773eaf1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:773ed66a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:773f03c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:773f03c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:773f03c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:773f4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:773f6a44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:773f9398-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:773fba4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:773fe122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinidine is inhibitor of Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:77400828-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:77402fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.102']} DrugCentral uuid:77405698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:77407d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:7740a0bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7740c768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7740f198-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7740f198-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:77411f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:774146f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:77416db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:77419454-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:7741bb64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7741e27e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:2350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:77420920-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:77422fcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:77425678-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.408']} DrugCentral uuid:77427dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:7742a47a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.205']} DrugCentral uuid:7742cb30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7742f1be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:77431a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:774343bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:77436d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:77439862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:7743c0b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7743e75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:77440f18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:774435ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:77445d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:774483bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7744aa86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:7744d132-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:7744fa22-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:7745218c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:7745484c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.193']} DrugCentral uuid:77456f20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:77459626-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7745bce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:7745e388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:77460a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:77463176-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:774657fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:77467f14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:7746a5c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:7746cd16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.876']} DrugCentral uuid:7746f3c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13393 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Phospholipase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:77471a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14939 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Phospholipase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:77474106-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:7747682a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:77478eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.625']} DrugCentral uuid:7747b596-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7747dd28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:77480488-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:77482b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:774851e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:77487bca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:77487bca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:7748afe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7748d692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7748fd52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raloxifene targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:77492408-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:77494b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:774971c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7749987a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7749bf1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7749e7d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:774a0e72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:774a3514-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:774a5ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:774a8334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.244']} DrugCentral uuid:774aa9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:774ad0a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:774af742-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:774b1e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:774b44f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:774b6b96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:774b93d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raltitrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:774bbb50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:774be21a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is inverse agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:774c08da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:774c2f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XKD3 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:774c5772-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:2354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:774c7e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:2355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.9']} DrugCentral uuid:774ca510-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:2355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.39']} DrugCentral uuid:774ccbe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:774cf308-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramipril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:774d19be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:774d4074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:774d672a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:774d8e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:774db52c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:774ddbce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:774e02a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:774e2cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:774e569e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:774e7c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5YLN7 biolink:molecularly_interacts_with DrugCentral:2359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranolazine targets Unclassified (Voltage-gated sodium channel Nav1.5 cardiac isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:774ea5f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rebamipide is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:774eccaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:774ef360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:774f1a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:774f4144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:774f6908-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:774f8fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:774fb64c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:774fdd98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:77500782-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:7750339c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:7750339c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:77506ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:77506ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:77509dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:7750c460-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.398']} DrugCentral uuid:7750eaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7751119a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:77513904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regadenoson targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:77515fce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:77518274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7751a92a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7751d274-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7751f998-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7752203a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:775246dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:77526df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:775294a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7752bb62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7752e204-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:77530964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:77533e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77533e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77533e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77533e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77533e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:775396cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09428 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Ion channel (ATP-binding cassette sub-family C member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7753bfda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:7753e280-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:77540c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:77540c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:775442f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:775442f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:775475c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reproterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:7754987e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rescinnamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:7754bb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:7754e28e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.415']} DrugCentral uuid:7755093a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.232']} DrugCentral uuid:77552fdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:77555688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:77557fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:7755a692-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7755cd48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7755f3ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:77561c4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:775642f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:77567068-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77567068-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77567068-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7756b0fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:7756d792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2370 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reserpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.836']} DrugCentral uuid:7756fe48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol acetate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:775724fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol acetate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:77574ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:77577346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Kinase (Adenosine kinase) DrugCentral uuid:775795d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22413 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 1) DrugCentral uuid:7757b874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49902 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (Cytosolic purine 5'-nucleotidase) DrugCentral uuid:7757db88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:775802c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:77582976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:77585004-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin is inhibitor of Enzyme (NS5B protein) DrugCentral uuid:7758734a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:775899f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WGY9 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin targets Enzyme (DNA-directed RNA polymerase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7758caa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:7758caa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:7758caa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:7758caa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:77590d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:775936f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:77596052-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:77598988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7759b098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7759d758-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7759fe04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:775a2190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:775a48dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:775a6fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:775a9648-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:775abcf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:2377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifampicin targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:775aef8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775aef8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775aef8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775aef8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775b3332-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:775b63c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775b63c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775b63c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775b63c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:775ba772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:775bce14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:775bf4d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:775c1cac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:775c4376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:775c6a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:2381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilmenidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:775c90ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:775cb45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:775cdb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:775d01da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:775d287c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:775d4b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:775d720a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:775d9a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:775dc1ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:775de91a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:775e0fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21430 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Ion channel (Matrix protein 2) DrugCentral uuid:775e3276-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:775e5922-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:775e7fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine is inhibitor of Ion channel (Matrix protein 2) DrugCentral uuid:775ea42c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:775ecaec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:775ef18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:775f1858-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:775f3f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimexolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:775f93b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:77607388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:77609a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7760c130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q197X6 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:7760e7dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WS26 biolink:molecularly_interacts_with DrugCentral:2387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:77610f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:776135e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:77615c94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:77618336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7761aa96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7761d156-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7761f7f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:77621eae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7762467c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:77626d3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:776293e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7762baa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7762e1c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.788']} DrugCentral uuid:7763086e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:77632f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.443']} DrugCentral uuid:77635652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.364']} DrugCentral uuid:77637da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7763a468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7763cc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:7763f2e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:77641c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:776442d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:776469ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:77649058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.023']} DrugCentral uuid:7764b772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:7764de1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:776504d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:77652b8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:776552e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:77657982-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:7765a056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7765c72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7765ef70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:77661630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.278']} DrugCentral uuid:77663ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:77666392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:77668a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7766b144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7766d7d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.687']} DrugCentral uuid:7766ffdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:77672750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:77674e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.967']} DrugCentral uuid:776774c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:77679c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7767c5d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7767eeec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:776815a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:77683c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:77686962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:77689004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7768b6b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7768dd52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:776904d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:77692b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:77695232-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:776978d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:7769a2fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7769cb36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7769f2aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:776a1974-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:776a4ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:776a4ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:776a4ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:776a4ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:776a9bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:776a9bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:776a9bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:776ae1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:776ae1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:776ae1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:776b2170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risperidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:776b4844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritodrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:776b70ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritodrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:776b9790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:776bbe32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:776be4c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:776c0c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:776c32cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:776c557c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:776c7c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:776ca342-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.303']} DrugCentral uuid:776ccb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:776cf1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.119']} DrugCentral uuid:776d1890-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:776d4108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:776d67be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:776d8e92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:776db566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir is inhibitor of Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:776ddcc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:776e0368-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:776e2a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:776e50c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ritonavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.47']} DrugCentral uuid:776e77ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:776e9eb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:776ec6cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:776eed6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:776f1672-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:776f3e86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:776f6528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:776f8c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:776fb384-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:776fda30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7770014a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:77702800-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:77704f1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:777075d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:77709ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7770c350-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:7770ec9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77711698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77713ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7771656c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7771901e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7771901e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7771c99e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7771c99e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7771c99e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:77721318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:77721318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:77721318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:77721318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:77725f6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7772860e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7772add2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.466']} DrugCentral uuid:7772d8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7772ffda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7773267c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:77734dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:77737474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:77739b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:7773c1ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7773e8d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:77740f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:77743634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:77745cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:2399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolitetracycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:777484a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7774ac22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:7774d2e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:7774fa1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:77752170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:77754808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:77756ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:77759574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7775bc98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7775e452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:77760afe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7776322c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:77765a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7776811e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7776a7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7776ce6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropinirole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7776f5d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:77771c78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:77773faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:77776250-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:7777850a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:7777a81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:7777cad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:7777ed88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:77781042-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:7778381a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:77785ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7778857c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:7778ac28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7778d37e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7778fa34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:77792248-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:777948fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7779700e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:777996ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7779be6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:7779e516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:777a0ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:777a3386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:777a5a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:777a80ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:777aa7e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:777ace72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:777af53c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:777b1bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:777b4398-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:777b6ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:777b9172-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:777bb83c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:777bdfc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:777c068e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:777c2d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:777c53e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:777c7b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:777ca18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43924 biolink:molecularly_interacts_with DrugCentral:2406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rosuvastatin targets Enzyme (Phosphodiesterase 6D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:777cc84e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:777cef2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:777d16a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:777d3d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:777d651a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:777d8bd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:777db344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rotigotine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:777dda0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxatidine acetate is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:777e00a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:777e2360-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:777e4a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxithromycin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.261']} DrugCentral uuid:777e713a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rupatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:777e97e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rupatadine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:777ebe88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:777ee5de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:777f0c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3SIU2 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Unclassified (Met repressor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:777f3340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11086 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Phenylethanolamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:777f59ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22061 biolink:molecularly_interacts_with DrugCentral:2414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ademetionine targets Enzyme (Protein-beta-aspartate methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:777f81d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:777fa9f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:777fd0ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.95']} DrugCentral uuid:777ff762-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6RYA0 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Salicylic acid-binding protein 2) DrugCentral uuid:77801a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:77804136-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:778067ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:77808e98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7780b5f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7780dcc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:778103f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:77812a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:77815328-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.36']} DrugCentral uuid:77817ca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7781a3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7781ca92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7781f1ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:7782186c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:77823f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:778265d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.004']} DrugCentral uuid:77828d24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7782b3c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7782da72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:77830128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:77832928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:778352fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:77837cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:7783a4a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:7783cbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.282']} DrugCentral uuid:7783f268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.699']} DrugCentral uuid:7784191e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.555']} DrugCentral uuid:77843fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.556']} DrugCentral uuid:7784670c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:778489a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.003']} DrugCentral uuid:7784b068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.153']} DrugCentral uuid:7784d728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.187']} DrugCentral uuid:7784ff14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.661']} DrugCentral uuid:778528ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:77855108-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:778577d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:77859ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7785c55c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:7785ec26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:778613fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:77863b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:2422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7786620a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:778688c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7786af8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7786df5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7786df5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7786df5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:77871e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:778744fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:77876c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:778792b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:7787b97a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7787e01c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7788077c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:77882e28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:778854de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:77887b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7788b104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7788b104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7788b104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7788b104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7788b104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:778908ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:2427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secnidazole targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:77892f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.578']} DrugCentral uuid:77895d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:77895d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:77895d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:77899470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.171']} DrugCentral uuid:7789bb30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.764']} DrugCentral uuid:7789e2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:778a0964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:778a301a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:778a56bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:778a7eb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:778aa72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:778ad150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:778ad150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:778b03f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 seratrodast targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:778b2b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:2433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sermorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:778b4db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:778b7074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertaconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:778b970c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:778bbf98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:778be658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:778c0d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.194']} DrugCentral uuid:778c34be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:778c5d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:778c84aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:778cab6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:778cd202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:778cf912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:778d1fc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:778d467e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:778d6d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:778d9480-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:778dbb40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:778de1ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:778e0898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:778e3174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:778e5834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:778e7f08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:778ea5d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:778eccce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:778ef398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:778f1a62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:778f4136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:778f68dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:778f8f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:778fb65c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:778fe3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:778fe3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:778fe3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:77902f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:77902f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:77902f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:7790733a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:77909a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7790c11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2435 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertindole is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7790e7ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.965']} DrugCentral uuid:77910e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:779135ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:77915d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.54']} DrugCentral uuid:77918414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7791aad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:7791d43c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:7791fe1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.246']} DrugCentral uuid:779227f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:77924ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.082']} DrugCentral uuid:77927662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:77929cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:7792c3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:7792ea48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:779311a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:7793385e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:77935f14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:779386b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7793af5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.475']} DrugCentral uuid:7793d912-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:7793ffd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:77942688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:77944dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:77947462-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77949b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sertraline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:7794c1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7794e528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:779507ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:77952a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:77954d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:77957006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:77959374-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7795e77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:7796ab1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:7796d34c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:7796f9e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:779720a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:77974354-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.026']} DrugCentral uuid:77976d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77979476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7797bb22-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.538']} DrugCentral uuid:7797e1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:2440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sibutramine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:779808d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77982f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:77985636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:77988192-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Transporter (Multidrug resistance-associated protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7798a88e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7798cf08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) DrugCentral uuid:7798f1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7799185a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:77993fc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7799665c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:77998d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7799b3be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7799dd58-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:779a03f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:779a2b96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.094']} DrugCentral uuid:779a524c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:779a79f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:779aa09e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:779ac722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16586 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:779aedce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:779b17ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:779b3e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:779b6858-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:779b6858-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:779ba53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:779ba53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:779ba53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:779ba53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:779bf980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:779bf980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:779bf980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:779bf980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:779c4b56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:779c4b56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:779c4b56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:779c8e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:779c8e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779cd292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:779d3c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:779d3c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:779d3c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:779d7b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:779da244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14099 biolink:molecularly_interacts_with DrugCentral:2441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:779dc8e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:779def92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:779e16d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:779e3d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:779e6440-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:779e8b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:779eb3dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.73']} DrugCentral uuid:779eda7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:779f01ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:779f2876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:779f4f7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:779f7632-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:779f9cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:779fc3b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:779feafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:77a011b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:77a038c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:77a06060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:77a087f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:77a0aea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14142 biolink:molecularly_interacts_with DrugCentral:2443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silymarin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:77a0d55e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:77a0f818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:77a11f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:77a145de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:77a16c94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:77a19340-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q10283 biolink:molecularly_interacts_with DrugCentral:2445 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:77a1ba8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.431']} DrugCentral uuid:77a1e138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:77a207c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:77a22fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:77a2588e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:77a27f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:77a2a5d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:77a2cc60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:77a2f35c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:77a31a12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:77a340c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q53EL6 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Nuclear other (Programmed cell death protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:77a3676a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06730 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Nuclear other (Eukaryotic translation initiation factor 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:77a38eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26883 biolink:molecularly_interacts_with DrugCentral:2446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:77a3b544-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2447 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sisomicin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:77a3d7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:77a3fe78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:77a42768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.774']} DrugCentral uuid:77a44e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:77a474b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:77a49b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:77a4c27c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77a4e93c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHL4 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:77a50ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:2448 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:77a53694-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:2449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitafloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:77a559da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:2449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitafloxacin targets Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:77a57c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:77a5a32c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:77a5c9e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:77a5f17e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:77a61b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77a64200-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:77a66898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:77a68f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (DNA polymerase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:77a6b640-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:77a6dcec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:77a70398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:77a72b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:77a751b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77a77850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24158 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Myeloblastin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:77a79ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3UP87 biolink:molecularly_interacts_with DrugCentral:2452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:77a7c634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:77a7ed08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:77a814cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:77a83b78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77a8627e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:77a88a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:77a8b120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:77a8d7e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:77a8ff36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:77a92664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:77a94d1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:77a973c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:77a99b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:77a9c574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:77a9ecc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:77aa1380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:77aa3aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:77aa6146-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77aa87fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:77aaaebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:77aad612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:77aafcbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:77ab236a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:77ab4a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:77ab7202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:77ab98cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:77abbf96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:77abe73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:77ac0e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:77ac3502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:77ac5bd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:77ac82aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:77acaa1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:77acd0c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:77acf762-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:77ad1e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:77ad45d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:77ad6ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:77ad9398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77adba3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:77ade14a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:77ae07f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77ae2f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:77ae55e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:77ae7d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77aea3c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77aecae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77aef18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:77af1a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:77af413e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:77af67fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:77af8e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:77afb6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:77afdd60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77b00416-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:77b02ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:77b05222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:77b078ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:77b09f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77b0c5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:77b0ed86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53778 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:77b11734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:77b13e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:77b164dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:77b18bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:77b1b298-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:77b1d958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:77b20004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:77b2275a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77b24dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:77b27494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:77b29b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:77b2c318-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:77b2ebcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77b3126e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77b33906-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:77b36020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:77b387bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:77b3ae86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:77b3d528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:77b3fc9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:77b42320-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:77b449c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77b4705a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:77b49814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:77b4c1ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:77b4eb70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:77b512bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15264 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:77b539b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77b5605a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:77b5883c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:77b5aed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:77b5d616-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:77b5fc9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:77b62332-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:77b649d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:77b671d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:77b69b82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:77b6c24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:77b6e8ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:77b70fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:77b7368c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:77b75e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77b784ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:77b7ac0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:77b7d2a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77b7f950-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:77b81ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:77b847d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00526 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:77b86e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:77b8952c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:77b8bbce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:77b8e2ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:77b90958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:77b93004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:77b956b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77b97e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVW4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:77b9a52a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77b9cbd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:77b9f26e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:77ba19d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:77ba407a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:77ba6726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:77ba8dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:77bab4ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:77badb7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:77bb021c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:77bb29c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:77bb5104-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:77bb77a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:77bb9e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:77bbc58a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5GIT4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:77bbed6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:77bc15bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:77bc3c68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:77bc62f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05622 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:77bc8a06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:77bcb0a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:77bcd74a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:77bcfdec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:77bd2538-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:77bd4bee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:77bd727c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77bd9914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:77bdc0e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XZT6 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Deoxynucleoside kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:77bdea36-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00142 biolink:molecularly_interacts_with DrugCentral:2463 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sorivudine targets Kinase (Thymidine kinase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:77be10d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:77be3798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:77be5ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:77be8572-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:77beac28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2464 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:77bed2e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.413']} DrugCentral uuid:77befeb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:77befeb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:77bf2f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:77bf2f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:77bf5c36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spectinomycin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:77bf7edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2469 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiclomazine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:77bfa7f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:77bfced2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:77bff588-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:77c01c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:77c04344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:77c06a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:77c090ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:77c0b77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77c0df48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:77c105fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:77c12caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:77c1534c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:77c17c78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.322']} DrugCentral uuid:77c1a36a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:77c1ca16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:77c1f0cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:77c217f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:77c23fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:77c26688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:77c28d34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:77c2b494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:77c2dc58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:77c302fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:77c329a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:77c35188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:77c37834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:77c39eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:77c3c596-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:77c3eca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:77c41352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:77c43a08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:77c460b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77c48832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:77c4bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77c4bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77c4bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77c4bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77c4bc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77c51ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77c51ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77c51ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77c51ea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:77c5777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77c5777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77c5777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77c5777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77c5777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77c5d5de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:77c5d5de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:77c5d5de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:77c61b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:77c61b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:77c61b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:77c667d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:77c667d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:77c667d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:77c667d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:77c667d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:77c6be18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:77c6e5be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:77c70f44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spiperone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77c73622-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spirapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:77c75cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spirapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:77c783d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.227']} DrugCentral uuid:77c7aaee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:77c7cd9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.884']} DrugCentral uuid:77c7f436-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:77c81b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.029']} DrugCentral uuid:77c841e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:77c86880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:77c88f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:77c8b5c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.663']} DrugCentral uuid:77c8e0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2475 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spironolactone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:77c9075e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:77c92e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.327']} DrugCentral uuid:77c9556a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:77c97c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:77c99ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.948']} DrugCentral uuid:77c9c59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:77c9ec46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:77ca13c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stanozolol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.316']} DrugCentral uuid:77ca3a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:77ca5d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:77ca83a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2478 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stavudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:77caad66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:77cad17e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:77caf816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:77cb1a9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stiripentol targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:77cb3d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WH62 biolink:molecularly_interacts_with DrugCentral:2481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 streptomycin targets Ribosomal protein (30S ribosomal protein S12) DrugCentral uuid:77cb6044-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:77cb86fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:77cbadb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:77cbd51a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:77cbfbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77cc290c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:77cc290c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:77cc290c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:77cc68b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07727 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:77cc90ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:77ccb796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:2484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 strychnine is agonist of GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.367']} DrugCentral uuid:77ccde2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:2487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinic acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77cd0534-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA5 biolink:molecularly_interacts_with DrugCentral:2487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinic acid is agonist of GPCR (Succinate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77cd2d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:77cd61a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:77cd61a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:77cd61a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:77cd61a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:77cd61a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:77cdaea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:77cdd554-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77cdfbd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:77ce228e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:77ce49da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:77ce70a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77cea11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:77cea11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:77cea11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:77cea11e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:77ceec14-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:77cf12d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sufentanil targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77cf3962-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:77cf6018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:77cf876e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:77cfae74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:77cfd6d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:77cffd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:77d026a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:77d04d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:77d073ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:77d09a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:77d0c17e-59f3-11ec-9eaa-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:77d0e834-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:77d10ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7X575 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:77d13564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0VTR6 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:77d15cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0VTR8 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:77d1833e-59f3-11ec-9eaa-0242ac110003 UniProtKB:D5HSX5 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:77d1a9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P83111 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Serine beta-lactamase-like protein LACTB, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:77d1d082-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:77d1f9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0VTS0 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (ADC-18 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:77d222b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00809 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:77d2494a-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77d26fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77d29756-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:77d2be16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:77d2e4b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:77d30cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:77d33436-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:77d35af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.716']} DrugCentral uuid:77d381b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:77d3a876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.786']} DrugCentral uuid:77d3d314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:77d3fa92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:77d4213e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:77d447f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.258']} DrugCentral uuid:77d46efa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:77d495b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.144']} DrugCentral uuid:77d4bc66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:77d4e312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:77d50a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:77d53128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:77d553ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:77d57a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:77d5a3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:77d5ccf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:77d5f3ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:77d61a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.431']} DrugCentral uuid:77d64162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.738']} DrugCentral uuid:77d66804-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:77d68e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:77d6b548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:77d6dca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:77d7034a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77d72a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2495 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:77d750a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:77d77a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77d79d14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:77d7c546-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2499 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfacytine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:77d7e7e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:77d80f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:77d8359e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:77d85844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77d87ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:77d8a268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZV3 biolink:molecularly_interacts_with DrugCentral:2500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:77d8c928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimethoxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:77d8eff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimidine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77d91284-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadimidine targets Enzyme (Lactoylglutathione lyase) DrugCentral uuid:77d93638-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2503 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadoxine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:77d95cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IAU3 biolink:molecularly_interacts_with DrugCentral:2503 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadoxine targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:77d9870a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:2504 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaethidole targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:77d9af96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:77d9dd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:77d9dd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:77d9dd36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:77da1bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2510 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamerazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77da3eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfameter is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77da6166-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethizole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77da84ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08192 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Bifunctional protein FolC) DrugCentral uuid:77daa770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:77dace26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:77daf4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:77db1e1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfamethoxazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:77db481a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2517 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfalene is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77db6d9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77db94be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:77dbbce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77dbe3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77dc0a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:77dc313a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77dc5494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:77dc7b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:77dca20a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:77dcc8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:77dcf138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:77dd1866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:77dd3f12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:77dd65d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:77dd8d14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:77ddb488-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:77dddb52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:77de0208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:77de2972-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:77de5032-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:77de76e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:77de9dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:77dec544-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:77deec04-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:77df12c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:77df397a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:77df6080-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:77df8736-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:77dfafea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:77dfd6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:77dffe28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:77e024c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:77e04b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:77e07218-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfanilamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:77e09aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaphenazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:77e0c1a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfaphenazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77e0e45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfapyridine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77e106f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q49184 biolink:molecularly_interacts_with DrugCentral:2524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfapyridine targets Enzyme (Dihydropteroate synthase type-1) DrugCentral uuid:77e129ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:77e150a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:77e17744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24752 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Acetyl-CoA acetyltransferase, mitochondrial) DrugCentral uuid:77e199f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:77e1bd30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:77e1e3f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:77e20b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.707']} DrugCentral uuid:77e231b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.628']} DrugCentral uuid:77e25862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:77e282f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:77e2aba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.768']} DrugCentral uuid:77e2d22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.198']} DrugCentral uuid:77e2fca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:77e2fca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:77e329cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:77e35096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:77e37756-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77e39fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.161']} DrugCentral uuid:77e3c648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:77e3ecf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25084 biolink:molecularly_interacts_with DrugCentral:2527 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfathiazole targets Unclassified (Transcriptional activator protein LasR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:77e41378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:77e43740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:77e46116-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:77e489e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2528 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfinpyrazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:77e4b09e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:77e4d77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:77e4fa0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:77e51ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:77e5434c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:77e56a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:77e59130-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfobromophthalein targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:77e5b7be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulforidazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:77e5dfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2532 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulforidazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:77e6071e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:2533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesulfone is inhibitor of Enzyme (Dihydropteroate synthase 1) DrugCentral uuid:77e629b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesulfone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:77e64c6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:77e67320-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:77e699c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:77e6c0b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:77e6e742-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:77e70dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (72 kDa type IV collagenase) DrugCentral uuid:77e7306c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:77e757d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.362']} DrugCentral uuid:77e77e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:77e7a5ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:77e7cd1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:77e7f628-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:77e81cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulindac targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:77e84362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:77e86a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.307']} DrugCentral uuid:77e8918c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:77e8b84c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.857']} DrugCentral uuid:77e8def8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.508']} DrugCentral uuid:77e905b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:77e92d22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.146']} DrugCentral uuid:77e953c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:77e97a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.053']} DrugCentral uuid:77e9a126-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:77e9caca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:77e9f1a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.196']} DrugCentral uuid:77ea1854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:77ea3f0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.426']} DrugCentral uuid:77ea6624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:77ea8ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:77eab386-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:77eada28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:77eb017e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.141']} DrugCentral uuid:77eb2816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.645']} DrugCentral uuid:77eb4ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:77eb765e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:77eb9f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:77ebc604-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:77ebec9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77ec13ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:77ec3a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:77ec629e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:77ec8940-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:77ecafe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:77ecd738-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:77ecfdee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:77ed2490-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:77ed4b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:77ed7328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:77ed99d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:77edc080-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GJU1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77ede718-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:77ee0e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:77ee34de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:77ee5ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:77ee8254-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:77eea9be-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:77eed06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:77eef72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:77ef1dea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:77ef4752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:77ef6f0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:77efa2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77efa2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77efa2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77efa2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77efa2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:77eff9f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:77f020aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:77f04760-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2537 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulpiride targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:77f06ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:77f0956c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:77f0bc22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:77f0e2ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:77f10b1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:77f13224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:77f158f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.38']} DrugCentral uuid:77f17f9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:2538 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:77f1a6aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:77f1cd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:77f1f434-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:77f21acc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:77f24218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:77f26a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:77f290c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:77f2b77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:77f2df2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:77f30766-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:77f32e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:77f354f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:77f37c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:77f3a284-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:77f3c930-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:77f3efd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2540 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultiame targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:77f416f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2541 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.571']} DrugCentral uuid:77f43d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2541 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sultopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:77f46458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:77f48afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:77f4b2fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:77f4d9ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:77f500c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:77f527b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:77f54eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:77f575a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:77f59c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:77f5c2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:77f5ea4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:77f61104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:77f63850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:77f65efc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:77f686a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:77f6ad3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:77f6d4e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:77f6fba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:77f722a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:77f74934-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N2B7 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:77f76fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8MI13 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan targets Unclassified (5-hydroxytryptamine 1D receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:77f79682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:2543 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:77f7be50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:77f7e506-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:77f80bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:77f83272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.12']} DrugCentral uuid:77f85a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:77f88100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:77f8a82e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:77f8ceda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:77f8f716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:77f91dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:77f9446e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:77f96b24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:77f99284-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:77f9b94e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:77f9e018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:77fa06ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:77fa2ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:77fa558e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:77fa7c26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:77faa44e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:77faccbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:77faf35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:77fb1a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:77fb40b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:77fb680c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:77fb8eae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:77fbb56e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:77fbdc2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:77fc041a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:77fc2ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:77fc5186-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:77fc7832-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:77fc9f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:77fcc5f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:77fcecae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:77fd1346-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:77fd3ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:77fd617a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:77fd8812-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:77fdaebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:77fdd664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:77fdfd60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:77fe240c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:77fe4acc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:77fe72f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:77fe99aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:77fec114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:77fee7c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:77ff0f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:77ff35cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:77ff5d90-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:77ff8428-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:77ffabc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:77ffd270-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:77fff91c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:78001fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:780046b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:78006d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:780093fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7800baa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7800e1d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:78010884-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:78012f1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:780155d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:78017d6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7801a6f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7801cda0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7801f442-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:78021b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78024302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:780269b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78029050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7802b7ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7802de52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:78030508-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:78032bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7803536e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:78037af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7803a18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7803c844-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7803ef4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:780415f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:78043c98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7804633a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:78048b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7804b646-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7804dce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7805039e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:78052b08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:78055236-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:780578d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:78059f84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7805c68a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7805ee94-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7806161c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:78063cbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:78066400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:78068ab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7806b14e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7806d804-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7806ffc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7807267e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:78074d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:780773e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:78079af0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7807c192-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7807e834-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:78080ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:78083622-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:78085cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7808837a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7808aa26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7808d1cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7808fa80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7809212c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:780947d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:78096ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:78099594-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7809bc40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7809e3e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:780a0b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:780a31de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:780a5894-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:780a7f4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:780aa70e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:780ace0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:780af4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:780b1b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:780b425e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:780b691e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:780b9038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:780bb6e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:780bde44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:780c04fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:780c2b92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:780c537e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:780c7b1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:780ca4d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:780ccb74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:780cf220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:780d193a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:780d3fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:780d6674-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:780d8d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:780db57a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:780ddc30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:780e02e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:780e2992-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:780e514c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:780e7b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:780ea4a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:780ecb40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:780ef250-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:780f18f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:780f3fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:780f6640-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:780f8d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:780fb41a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:780fdab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:78100140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7810292c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:78105046-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:781076f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78109da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7810c4ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7810eb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:78111210-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7811389e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:78116008-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:781187b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7811ae50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7811d4fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7811fd4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:78122416-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:78124ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7812716e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7812986a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7812bf20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7812e702-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:78130dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:78133504-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11799 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:78135bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:78138270-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7813a91c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7813d0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7813f7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:78141e42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCP0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:781444f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:78146bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:781492b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7814b94c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7814dfe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78150758-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:78152dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:781555be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:78157c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7815a424-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7815cbde-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7815f294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:78161936-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:78164050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:781666f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78168d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7816b436-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7816dbe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:781702b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:78172948-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:78174ff4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7817777c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:78179e1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7817c4c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7817eb76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7818129a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7818393c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80370 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Unclassified (Protein delta homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:78186074-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78188720-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7818ae80-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7818d536-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7818fbe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7819237e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:78194c64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78197360-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:78199a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7819c0b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7819e7c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:781a0e6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:781a3502-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:781a5ba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:781a82fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:781aa9a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:781ad052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:781af712-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:781b1e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:781b45aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:781b6c56-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:781b92f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:781bba1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:781be0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.23']} DrugCentral uuid:781c077e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:781c2e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:781c556c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:781c7c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:781ca2c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:781cca60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:781cf18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:781d1b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:781d421a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:781d68bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:781d8fd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:781db678-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:781ddd2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:781e03e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:781e2b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:781e51c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:781e7888-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:781e9f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:781ec676-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:781eedea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:781f14be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:781f3bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:781f62d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:781f8976-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:781fb022-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:781fd80e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:781fff32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:782025f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:78204ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H8M2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Unclassified (Bromodomain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7820735e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:78209b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.509']} DrugCentral uuid:7820c58e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7820ec8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:7821134a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2544 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.959']} DrugCentral uuid:78213a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:78216110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:782187b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2546 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:7821ae5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47872 biolink:molecularly_interacts_with DrugCentral:2548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secretin human is agonist of GPCR (Secretin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7821d5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7821fc4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:782222d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7822497c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:7822710e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:782297e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04844 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Acetylcholine receptor subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7822be8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7822e53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:78230c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:782332ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78235966-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:78238008-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7823a6c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7823cdf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7823f4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:78241b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:782441fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78246a68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:78249132-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7824b7d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7824deee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01984 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:782505e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:78252c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7825531a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.61']} DrugCentral uuid:78257dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:78257dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:7825b3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7825b3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7825f3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7825f3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7825f3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7825f3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7825f3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:78264d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:782673e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2551 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:78269a72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7826c178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7826e806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:78270e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:7827352c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.398']} DrugCentral uuid:78275c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Cytokine (Interleukin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:782782f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:7827aaa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:7827d144-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7827f976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:78282054-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7828471e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15393 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Nuclear other (Splicing factor 3B subunit 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:78286dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96AY3 biolink:molecularly_interacts_with DrugCentral:2552 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:782894c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7828bb86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7828e214-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:782908ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:78292fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:78295686-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:78297d14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7829b45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a2bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:782a8f4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782ae7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:782baa12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:782bd0b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:782bf756-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:782c19fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:782c40e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:782c67b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:782c8e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:782cb4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.915']} DrugCentral uuid:782cdc02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:782d0290-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:782d291e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:782d50ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:782d78d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:782d9fac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:782dc644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:782decdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:782e13ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:782e4128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:782e4128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:782e4128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:782e7fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2560 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 taltirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:782ea726-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.807']} DrugCentral uuid:782ecddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.001']} DrugCentral uuid:782ef492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:782f1b34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:782f42bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:782f6c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:782f955a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.335']} DrugCentral uuid:782fbc06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:782fe33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.139']} DrugCentral uuid:78300b3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:783031d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:78305878-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:78307fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7830a6ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:7830cd62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:7830f51c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:78311d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:783146d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:78317014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.618']} DrugCentral uuid:783196e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7831be70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.794']} DrugCentral uuid:7831e53a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:78320bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:783232a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:783259f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.557']} DrugCentral uuid:783280bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:7832a772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:7832ce50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.731']} DrugCentral uuid:7832f5c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:78331c70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.238']} DrugCentral uuid:78334330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.835']} DrugCentral uuid:783369dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.858']} DrugCentral uuid:783390ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:7833b784-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:7833de3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:783404dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.611']} DrugCentral uuid:78342c28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.204']} DrugCentral uuid:78345306-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:783479bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7834a072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.328']} DrugCentral uuid:7834c98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:7834f02c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:783516ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:78353d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:7835646c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:78358b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.095']} DrugCentral uuid:7835b1ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.923']} DrugCentral uuid:7835d870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:78360016-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.038']} DrugCentral uuid:783626cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78364d78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.913']} DrugCentral uuid:78367424-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.821']} DrugCentral uuid:78369d3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.919']} DrugCentral uuid:7836c442-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:7836eaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.604']} DrugCentral uuid:783711c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.761']} DrugCentral uuid:783738dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.419']} DrugCentral uuid:78376032-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.515']} DrugCentral uuid:783786de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.587']} DrugCentral uuid:7837ad8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7837d4b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7837fb64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:78382210-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:783848b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:78387396-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:78387396-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7838a76c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2561 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamoxifen targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7838ce9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7838f564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:78391c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78394366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:78396a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:783990e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:7839b864-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7839df2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:783a05f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:783a2cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:783a5526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:783a7bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:783aa2a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:783ac970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:783afa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:783afa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:783afa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:783afa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:783b4526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:783b6bfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:783b936e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2563 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tandospirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:783bba56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:783be12a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:783c08f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2571 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:783c32d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:783c59d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:783c810c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:783ca8ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:783ccff4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:783cf696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:783d1d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:783d43c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q46991 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (IMI-1; IMI-1 carbapenemase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:783d6b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:783d91be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6W9J1 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:783db874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:783ddf16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P94958 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:783e066c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05193 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:783e2d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:783e53b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:783e7a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:783ea162-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:783ec7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:783eeeba-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:783f1552-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:783f3cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:783f6390-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:783f8a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:783fb106-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:783fdaaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:78400246-59f3-11ec-9eaa-0242ac110003 UniProtKB:B8R6A5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:784028de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:78404f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78407686-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78409d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7840c3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7840ea62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1A) DrugCentral uuid:78410dc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:78413472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:78415722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:78417dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tegaserod is partial agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7841a70e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:2580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teicoplanin aglycone is inhibitor of Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:7841d0bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2581 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7841f7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:78421e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:78424600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.31']} DrugCentral uuid:78426cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7842943e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:7842baf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7842e254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:78430900-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2583 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telmisartan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:784330e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:78435a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:78435a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:78435a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:784395aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.444']} DrugCentral uuid:7843bd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:7843dff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:78440314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:784425b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:78444842-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:78446afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:2590 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teniposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:78448dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7844b516-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:2592 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7844dba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir disoproxil targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:7844fe68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2593 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenofovir disoproxil is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:78452104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:784544fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2595 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.943']} DrugCentral uuid:78456bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:7845929c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.628']} DrugCentral uuid:7845b952-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.388']} DrugCentral uuid:7845e044-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:784606e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:78462db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:78465060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.662']} DrugCentral uuid:784677de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52020 biolink:molecularly_interacts_with DrugCentral:2597 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:78469e9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2598 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbutaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7846c630-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2598 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terbutaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7846ecf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.373']} DrugCentral uuid:784714d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:78473e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.895']} DrugCentral uuid:784764f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.433']} DrugCentral uuid:78478bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:7847b446-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.216']} DrugCentral uuid:7847db06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.599']} DrugCentral uuid:784801bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.632']} DrugCentral uuid:78482886-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.438']} DrugCentral uuid:78484ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:784876b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:78489d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.862']} DrugCentral uuid:7848c43a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:7848ec44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:7849161a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:78493fe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:7849669c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:78498db6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:7849b46c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7849db36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:7849fdf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.666']} DrugCentral uuid:784a253c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.963']} DrugCentral uuid:784a4bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:784a72b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:784a994a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.612']} DrugCentral uuid:784ac136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.102']} DrugCentral uuid:784ae850-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.389']} DrugCentral uuid:784b0f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:784b35bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:784b5cc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:784b844a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.874']} DrugCentral uuid:784bab0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.687']} DrugCentral uuid:784bd1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:784bf934-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:784c1fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:784c46a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:784c6d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:784c9542-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:784cbcc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:784ce380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:784d0a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:784d31f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:784d589c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:784d7f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:784da5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.448']} DrugCentral uuid:784dcd9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:784df45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:784e1b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51589 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Enzyme (Cytochrome P450 2J2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:784e41bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:784e69b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:784e905e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.734']} DrugCentral uuid:784eb728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:784eddca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:784f0bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:784f0bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:784f0bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:784f4b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2600 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terfenadine targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:784f71fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:784f9a8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:784fc154-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:784fe814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78500eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:7850358a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:78505d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:785083f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7850aab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7850d184-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7850f894-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:78511f54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:78514614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:78516cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7851947a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7851bb3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:7851e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:785208b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:78523060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:78525720-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:78527dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7852a482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7852cc00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2603 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terodiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7852f3ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.087']} DrugCentral uuid:78531a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:78534162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:785368f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78538fbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7853b6f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testolactone is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:7853ddb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:78540840-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:78543248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:785459e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7854816c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7854a818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7854cece-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7854f570-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:78551ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.599']} DrugCentral uuid:785543a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:78556dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:78556dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7855a07e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:2607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone targets Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7855c8ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone undecanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:7855ec96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:7856134c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:78563a0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:78566144-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:785687f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7856afc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:7856d674-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:78570464-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:78570464-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:78570464-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:78574302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:785769b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:785791e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:7857bb66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:7857e28a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:78580936-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel protein type 8 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7858306e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78585724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.499']} DrugCentral uuid:78587de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00194 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7858ab66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7858ab66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7858ab66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7858f1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7858f1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7858f1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:78593040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:785952c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:78597780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:2612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sapropterin targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.95']} DrugCentral uuid:78599e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00439 biolink:molecularly_interacts_with DrugCentral:2612 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sapropterin is activator of Enzyme (Phenylalanine-4-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7859c5f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7859eca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:785a13de-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:785a3a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:785a6136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:785a87ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.432']} DrugCentral uuid:785aaed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:785ad580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:785afc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:785b22ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:785b4be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:2616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.393']} DrugCentral uuid:785b72ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:785b998e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:785bc058-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:785be8da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:785c0fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:785c368c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:785c5d38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:785c8448-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:785caae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:785cd1a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:785cf856-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:785d21f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:785d4b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:785d7254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:785d9d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:785d9d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:785dd08c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:785e0138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:785e0138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:785e0138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:785e0138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:785e52aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:785e52aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:785e52aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:785e9148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:785eb808-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:785ee04e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS9 biolink:molecularly_interacts_with DrugCentral:2620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 theophylline targets Unclassified (Transmembrane domain-containing protein TMIGD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:785f081c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:785f2ed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:785f5574-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09508 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) DrugCentral uuid:785f7856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:785f9f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:785fc5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AE18 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:785fec82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:78601a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78601a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78601a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:78606572-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:7860ca26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:7860ee0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:786114a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78616da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78622cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:78625378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78627a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:7862a422-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:7862cdf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7862f4a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78631b46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7863426a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78636a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:786390bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:7863b75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:7863da5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:7863fce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:78641f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:786441ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:78646604-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7864900c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiethylperazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7864b6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.221']} DrugCentral uuid:7864dd96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.912']} DrugCentral uuid:786504b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:78652760-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:786549fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) DrugCentral uuid:78656c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:786593bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) DrugCentral uuid:7865b66c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:7865daca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:78660176-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.792']} DrugCentral uuid:7866282c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26281 biolink:molecularly_interacts_with DrugCentral:2632 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioguanine targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.75']} DrugCentral uuid:786659be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:786659be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:786659be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7866c5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7867a26a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63734 biolink:molecularly_interacts_with DrugCentral:2633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiopental is gating inhibitor of Ion channel (Potassium voltage-gated channel subfamily C member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7867c90c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioproperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:7867efcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioproperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:7868179a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:78683a2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:786860e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7868889c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.872']} DrugCentral uuid:7868afca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:7868d676-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7868fd18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:786923ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.813']} DrugCentral uuid:78694b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:786971ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7869989a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:7869c040-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7869e8d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:786a12d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:786a39d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:786a6068-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.466']} DrugCentral uuid:786a8782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:786aaf64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:786ad624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:786afcd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.866']} DrugCentral uuid:786b2412-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:786b4aaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:786b714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:786b97f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.595']} DrugCentral uuid:786bc0ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:786be7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:786c0e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:786c34d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:786c5be8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:786c829e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.126']} DrugCentral uuid:786ca940-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.774']} DrugCentral uuid:786ccfec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.751']} DrugCentral uuid:786cf74c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:786d1e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:786d44ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:786d6b6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:786d95a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:786dbc72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:786de300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:786e09a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:786e3094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.195']} DrugCentral uuid:786e5736-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.297']} DrugCentral uuid:786e7de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:786ea466-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:786ecbd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:786ef286-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:786f1932-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:786f3fd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:786f6874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:786f91e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:786fbb62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:786fe4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:78701986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78701986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78701986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78701986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78701986-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7870799e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7870799e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7870799e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7870799e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7870cdf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7870cdf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7870cdf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:787119c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:787119c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:787119c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:787119c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:787119c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:78717b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:78717b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:78717b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7871c0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7871c0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7871c0ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7871ffb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioridazine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:78722654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2638 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiotepa is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:78724d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:787274a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:78729b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:7872c208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:7872e8b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:78731168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:78733832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:78735ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.681']} DrugCentral uuid:787385a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.817']} DrugCentral uuid:7873adb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:7873d472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7873fb14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:787421c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:7874498e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7874704e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:78749704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:7874bda6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:7874e5ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:78750d24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:787533d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:78755a72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:78758178-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.181']} DrugCentral uuid:7875a838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:7875cee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:7875f59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:78761e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:787645cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:78766c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) DrugCentral uuid:78768f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7876b78c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:7876e054-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:78770700-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:78772da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Unclassified (THAP domain-containing protein 1) DrugCentral uuid:7877508e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:78777820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40926 biolink:molecularly_interacts_with DrugCentral:2646 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levothyroxine targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:78779ed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine is inhibitor of Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7877c5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:7877ed00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:787813d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31651 biolink:molecularly_interacts_with DrugCentral:2648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78784138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:78784138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:78784138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:7878880a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7878880a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7878880a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7878c914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2650 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tianeptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:7878efd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.077']} DrugCentral uuid:7879166c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.108']} DrugCentral uuid:78793d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.756']} DrugCentral uuid:7879641e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:78798ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7879b180-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7879d908-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.317']} DrugCentral uuid:7879ffa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:787a2656-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:787a48f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:787a6e5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:787a94ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Enzyme (Steryl-sulfatase) DrugCentral uuid:787ab792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.123']} DrugCentral uuid:787ade52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tibolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.542']} DrugCentral uuid:787b0652-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b3d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:787b9ffe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:787bc6b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:787bed56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:787c1420-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.747']} DrugCentral uuid:787c3cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:787c6646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.767']} DrugCentral uuid:787c8fea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:787cb6dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:787cddf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:787d04fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:787d27ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.175']} DrugCentral uuid:787d4e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:787d75a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:787d9c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2657 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:787dc2e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tienilic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.494']} DrugCentral uuid:787dea70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tilidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:787e1360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiliquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:787e3d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:787e6234-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13488 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (V-type proton ATPase 116 kDa subunit a isoform 3) DrugCentral uuid:787e84ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:787ead0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:787ed3c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2666 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiludronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:787efa82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2672 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tinoridine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.987']} DrugCentral uuid:787f2110-59f3-11ec-9eaa-0242ac110003 UniProtKB:O69638 biolink:molecularly_interacts_with DrugCentral:2673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiocarlide targets Enzyme (Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:787f4866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2675 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:787f6b0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:2675 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:787f91cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiopronin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:787fb86e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:787fdfba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:78800684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11.1']} DrugCentral uuid:78802d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:788053d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:78807ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7880a170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7880c812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2677 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7880eec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1PT23 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78811650-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1PWR7 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.94']} DrugCentral uuid:78813d06-59f3-11ec-9eaa-0242ac110003 UniProtKB:F1PGZ2 biolink:molecularly_interacts_with DrugCentral:2678 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:788163bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2679 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiracizine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:78818dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:78818dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7881c1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7881e9c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:78820c90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:78823332-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:78825b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:78828206-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tizanidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7882a894-59f3-11ec-9eaa-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:2684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tobramycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.824']} DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7882edf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:78836dba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:78839740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7883c148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.292']} DrugCentral uuid:7883eede-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:7883eede-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:78841efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:788445dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:78846c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:78849370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7884bb02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7884e8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7884e8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7884e8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78852dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78852dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78852dee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78856f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:788595c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7885bfde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:7885bfde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:7885f2d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:78861966-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:78864008-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:788666aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78868e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:7886b538-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:2697 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolcapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.569']} DrugCentral uuid:7886dbda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:788703c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:78872b94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:78875420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:78877acc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:2698 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolfenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7887a182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:7887c89c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7887ef52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:788815ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:78883ca0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:788863e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2699 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.667']} DrugCentral uuid:78888a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:2701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolonium targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:7888b13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:2701 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolonium targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:7888d7dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:788900cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:788927c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:78894e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7889753e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toloxatone is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:78899c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:7889c322-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:7889e9f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70634 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Unclassified (SMR1-alpha3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:788a1098-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70635 biolink:molecularly_interacts_with DrugCentral:2703 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolperisone targets Unclassified (BetaB2-crystallin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.474']} DrugCentral uuid:788a3802-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:788a5ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:788a8550-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:788aabf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:788ad3a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:788afaa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:788b2140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:788b47ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:788b6f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.509']} DrugCentral uuid:788b95b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:788bbc68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:788be33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:788c0ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:788c3170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:788c58a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:788c7f5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:788ca72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:788ccf40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:788cf600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:788d1cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2705 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:788d440c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:788d67f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:788d8a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:788dad34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:788dd3f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:788dfb68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:788e223c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:788e48fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:788e6fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:788e9974-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:788ec2f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:788eeaaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:788f116a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:788f3898-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:788f5f44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:788f8604-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:788facce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:788fd410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27139 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:788ffac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:78902190-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.63']} DrugCentral uuid:78904850-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:78907014-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:789096f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7890be8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7890e558-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:78910c90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7891333c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:78915a7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7891812a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7891a84e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7891cf0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7891f5c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:78921c84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:78924bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:78924bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:78924bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:7892867e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7892867e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7892c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:7892c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:7892c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:7892c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:7892c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:78931d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:78931d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:78931d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:78931d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:7893618e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7893884e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiramate targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:7893af0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.818']} DrugCentral uuid:7893d5b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7893fa40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:78941d18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:78943fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:78946250-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:78948500-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan is inhibitor of Enzyme (DNA topoisomerase I, mitochondrial) DrugCentral uuid:7894a828-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.58']} DrugCentral uuid:7894ced4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7894f5a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:78951c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:789543d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78956a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04750 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (DNA topoisomerase I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:789590f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:7895b790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:2707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topotecan targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7895e076-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2708 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 torsemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:78960718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:78962de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene is modulator of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:7896509c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets Nuclear hormone receptor (Estrogen-related receptor gamma) DrugCentral uuid:7896739c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05320 biolink:molecularly_interacts_with DrugCentral:2709 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toremifene targets Unclassified (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:78969a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7896c1c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:7896e868-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:78970fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7897364c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:78975d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:789783a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2711 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramadol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7897abc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2712 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trandolapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:7897d55c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranexamic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7897fd8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2714 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranilast targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:78982412-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:78984b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:789871ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:78989884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:7898bf58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7898e69a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:78990dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78993622-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:78995cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:78998564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:7899ae54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7899d4ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7899fb8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:789a22bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:789a4972-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NB78 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:789a7028-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:2715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tranylcypromine targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:789a96e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 travoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:789abe66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 travoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:789ae512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:789b0c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:789b32ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:789b5bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.033']} DrugCentral uuid:789b8260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:789ba916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:789bd0bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:789bfb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:789c2666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:789c4d26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:789c73e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:789c9b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:789cc1ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.551']} DrugCentral uuid:789ce88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:789d0f40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:789d389e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:789d627e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.483']} DrugCentral uuid:789d8952-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:789db008-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:789dd768-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:789dfe0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:789e24b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:789e4b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:789e729a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.081']} DrugCentral uuid:789e9964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.083']} DrugCentral uuid:789ec006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:789ee69e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:789f106a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:789f3932-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:789f5ff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2717 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trazodone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:789f869e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:789faf16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:789fd720-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:789ffdb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:78a02464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a04c0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2720 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 treprostinil is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:78a072d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.642']} DrugCentral uuid:78a09980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:78a0c036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a0ea52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78a1111c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a137c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:78a15eec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:78a1861a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:78a1acd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a1d3fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a1faa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:78a221ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92753 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is antagonist of Nuclear hormone receptor (Nuclear receptor ROR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:78a24866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78a26f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:78a295d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:78a2be22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:78a2e4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:78a30b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62965 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:78a33244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22935 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78a35a94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:78a38172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:78a3a882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:78a3cf38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:78a3f652-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:78a41d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78a443a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:78a46a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13526 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin targets Unclassified (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:78a494a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78a4bb46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:78a4e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:78a508a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:78a52fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:78a55646-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.76']} DrugCentral uuid:78a5838c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:78a5838c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:78a5838c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:78a5cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a5cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a5cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a5cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a5cfae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a637dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:78a6a7b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78a6a7b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78a6a7b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78a6e6c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:78a70d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone targets Cytosolic other (Annexin A1) DrugCentral uuid:78a7302e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2725 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:78a752f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:78a7798a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide targets Cytosolic other (Annexin A1) DrugCentral uuid:78a79c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2726 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:78a7c372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:78a7e604-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Transporter (Solute carrier family 12 member 1) DrugCentral uuid:78a80936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:78a832da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:78a859d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:78a88064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:78a8add2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a8add2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a8add2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78a8ecca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:78a913da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.879']} DrugCentral uuid:78a93a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:78a96862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:78a96862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:78a96862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:78a9af16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:78a9af16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:78a9af16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:78a9f61a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:78a9f61a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:78a9f61a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:78aa3bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:78aa3bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:78aa3bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:78aa8166-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:78aa8166-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:78aa8166-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:78aac86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:78aac86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:78aac86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ab3958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78ac4262-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78acff86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:78acff86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:78acff86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:78ad4630-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:78ad4630-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:78ad4630-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:78ad8b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78ad8b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78ad8b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78add50a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:78add50a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:78add50a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:78ae1a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78ae1a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78ae1a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:78ae593a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:78ae8004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7']} DrugCentral uuid:78aea692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:78aecd3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:78aef458-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:78af1b18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:78af425a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:78af68f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:78af921e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:78afb8d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:78afdf80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:78b00730-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:78b02e68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclabendazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b086a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:78b1474e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:78b169fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2737 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:78b18cb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:78b1b350-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:78b1d9fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:78b2017a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:78b22830-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78b2501c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:78b276c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.31']} DrugCentral uuid:78b29e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:78b2c556-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:78b2ed92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:78b3142a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:78b33e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:78b365ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2738 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trientine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:78b38c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.841']} DrugCentral uuid:78b3b380-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:78b3da40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:78b400ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:78b427a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:78b44e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:78b475b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:78b49c78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:78b4c338-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:78b4e9ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:78b511e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:78b5389a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:78b55f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.786']} DrugCentral uuid:78b58688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.251']} DrugCentral uuid:78b5ada2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:78b5d44e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:78b5fae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:78b62192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:78b65018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:78b65018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:78b65018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:78b68f9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:78b6b63e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.27']} DrugCentral uuid:78b6ddd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:78b70490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:78b72b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:78b751a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06760 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Beta-glucuronidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:78b778a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00697 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Lysozyme C-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:78b79f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78b7c600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:78b7ecb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:78b81ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:78b81ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:78b81ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:78b861e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78b861e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78b861e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78b8a7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:78b8a7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:78b8a7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:78b8e670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2740 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:78b90d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:78b9344a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:78b95aec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:78b9818e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:78b9a83a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:78b9d0a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:78b9f74a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:78ba1e1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:78ba44d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:78ba6c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:78ba9646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:78babd74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:78bae40c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2742 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triflupromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:78bb0b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2743 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78bb31b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2743 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifluridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.01']} DrugCentral uuid:78bb58f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:78bb7fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:78bba72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.73']} DrugCentral uuid:78bbcdc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:78bbf4c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:78bc1b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:78bc42fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2745 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trihexyphenidyl targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.611']} DrugCentral uuid:78bc69a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26439 biolink:molecularly_interacts_with DrugCentral:2746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilostane is inhibitor of Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2) DrugCentral uuid:78bc8c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alimemazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:78bcaf12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alimemazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:78bcd596-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2750 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetazidine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:78bcfca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2751 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethadione is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:78bd1f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:78bd41d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) DrugCentral uuid:78bd64e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:78bd8c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:78bdb768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:78bdb768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:78bde468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:78be0b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:78be3512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:78be5d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:78be8404-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27713 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:78beaaa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:78bed224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78bef8e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:78bf1fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:78bf463c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:78bf6d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:78bf9434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:78bfbb08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:78bfe1fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:78c009fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:78c03132-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:78c057e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:78c07ea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:78c0a5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04174 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:78c0cc64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59487 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:78c0f324-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:78c119ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27552 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:78c141c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78c16958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:78c1900e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q54801 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:78c1b6ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UUP5 biolink:molecularly_interacts_with DrugCentral:2755 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:78c1de24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:78c20552-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:78c227e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:78c24f08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:78c27636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:78c29e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:78c2c4a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:78c2eb5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:78c312b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:78c33954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:78c36014-59f3-11ec-9eaa-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:78c386b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:78c3b050-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:78c3d760-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:78c3fe02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:78c424d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:78c44bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.423']} DrugCentral uuid:78c47292-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trimipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:78c49934-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:78c4c134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:78c4e894-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2759 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trioxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:78c50f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:78c536fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:78c55dba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2761 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triparanol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:78c58786-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2762 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tripelennamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:78c5ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triprolidine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:78c5d4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2763 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triprolidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.9']} DrugCentral uuid:78c5fb80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.208']} DrugCentral uuid:78c622ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.078']} DrugCentral uuid:78c6495a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:78c67010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:78c696a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:78c6bdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:78c6e496-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:78c70b42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:78c731ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Aldose reductase) DrugCentral uuid:78c7555c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:78c77bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:78c7a304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54840 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Glycogen [starch] synthase, liver) DrugCentral uuid:78c7c5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:78c7ecd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:78c81370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.907']} DrugCentral uuid:78c83a08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:78c860b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:78c8881e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78c8aec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:78c8d594-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:78c8fc2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:78c925f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:2767 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troglitazone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:78c94cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2769 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 troleandomycin is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:78c973aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:78c99a56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:78c9c18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:78c9e830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:78ca0edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:78ca3588-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:78ca5ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2774 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:78ca839e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:78caaa4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:78cad0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:78caf964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:78cb20b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:78cb48a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:78cb6f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:78cb966c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:78cbbd2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:78cbe3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:78cc0a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:78cc31c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:78cc587c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:78cc7f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70212 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:78cca96c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:78cca96c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:78cce210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:78cce210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:78cd1eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:78cd1eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:78cd1eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:78cd1eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:78cd6cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:78cd6cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:78cd9fc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:78cdc676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:78cded2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:2775 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tropisetron is antagonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:78ce14f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:78ce3796-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:78ce5a64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:78ce7cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2776 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:78cea190-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.306']} DrugCentral uuid:78cec85a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.395']} DrugCentral uuid:78cef276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:78cef276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:78cf22f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:78cf22f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:78cf50ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan is allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:78cf778c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:78cf9e24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:78cfc4bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:78cfebc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:78d0126e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:78d03a32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:78d060d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:78d088fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2S1 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78d0afa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:78d0d79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:78d0ff26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q401N2 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Zinc-activated ligand-gated ion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:78d125d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:78d14d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:78d173e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:78d19b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:78d1c26c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:78d1e922-59f3-11ec-9eaa-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:78d21334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:78d21334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:78d24dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:78d24dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:78d24dc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:78d28fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:78d28fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:78d2c5ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:78d2c5ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:78d2fc22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78d2fc22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:78d33228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:78d33228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:78d37094-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78d37094-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78d37094-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78d37094-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78d3be5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:78d3be5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:78d3f10e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d44d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78d52aba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2781 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:78d551f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tulobuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:78d578b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2782 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tulobuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:78d59b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:78d5c1f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.7']} DrugCentral uuid:78d5e9b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:78d61272-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:78d6390a-59f3-11ec-9eaa-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d68ae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:78d74d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2784 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:78d77432-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2786 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tyrosine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:78d79ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:78d7c2ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15144 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:78d7eab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28838 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:78d811f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78d8389a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15145 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:78d85fb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96935 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (M1 family aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:78d8867e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VCT3 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:78d8ad0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97629 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Leucyl-cystinyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:78d8d3cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09175 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:78d8fafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00727 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:78d9219c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97449 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:78d9483e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:78d96efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:78d99726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15684 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:78d9c098-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55786 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Puromycin-sensitive aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:78d9e870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:78da0f1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ08 biolink:molecularly_interacts_with DrugCentral:2787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubenimex targets Enzyme (Endoplasmic reticulum aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78da374e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:78da5e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:78da84ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:78daab98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urapidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:78dad2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Enzyme (Aldo-keto reductase family 1 member C2) DrugCentral uuid:78daf594-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol is agonist of Nuclear hormone receptor (Bile acid receptor) DrugCentral uuid:78db1830-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:78db3f54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:78db675e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ursodiol targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:78db8e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2798 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valaciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:78dbb10a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:78dbd8b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:78dc002e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.537']} DrugCentral uuid:78dc26c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:78dc4d68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:78dc740a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:78dc9b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:78dcc1e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:78dce890-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:78dd0f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:78dd36d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:78dd5fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:78dd8714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:78ddadd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:78ddd548-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:78ddfbf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:78de22a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:78de494c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:78de7066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:78de971c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:78debdd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:78dee47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:78df0c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:78df3320-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:78df5ac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:78df81a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:78dfaa08-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:78dfd0a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:78dff774-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:78e01e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:78e04562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:78e06c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:78e092ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:78e0bac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:78e0e256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:78e10998-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:78e1304e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valdecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:78e1570e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78e17e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:78e1a51a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:78e1cbc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:78e1f25e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:78e21996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:78e2402e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2800 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valethamate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:78e266e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:78e28a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51649 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid is inhibitor of Enzyme (Succinate-semialdehyde dehydrogenase, mitochondrial) DrugCentral uuid:78e2acb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:78e2d692-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:78e30004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78e326ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:78e34da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:78e374d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:78e39c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78e3c318-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35504 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (UDP-glucuronosyltransferase 1-5) DrugCentral uuid:78e3e5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5RJP0 biolink:molecularly_interacts_with DrugCentral:2803 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valproic acid targets Enzyme (Aldose reductase-related protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:78e40cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valrubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:78e42f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:78e45648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:78e47cea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:78e4aa3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:78e4aa3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:78e4dd48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:78e50412-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06241 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets Enzyme (D-alanyl-D-alanine dipeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:78e52b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17443 biolink:molecularly_interacts_with DrugCentral:2807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vancomycin targets Enzyme (UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:78e55200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:78e578ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:78e5a2be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:78e5a2be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:78e5d946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:78e5d946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:78e60f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:78e60f56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:78e6455c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:78e6455c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:78e67f04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:78e67f04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:78e6bb04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:78e6bb04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:78e6f4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:78e6f4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:78e72bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:78e72bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:78e76842-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:78e76842-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:78e76842-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:78e76842-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:78e7b680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:78e7b680-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:78e7f33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:78e7f33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:78e7f33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:78e7f33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:78e83f60-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:78e86666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.465']} DrugCentral uuid:78e88d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:78e8b396-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.041']} DrugCentral uuid:78e8db78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:78e9022e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:78e928bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:78e952c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78e952c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78e990d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78e990d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78e990d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78e990d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:78e9de7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78e9de7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78ea12c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:78ea39aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:78ea610a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:78ea87de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:78eaaf02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32307 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:78ead5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:78eafc6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:78eb231a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48044 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:78eb4a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:78eb7126-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:78eb9b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:78eb9b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:78ebcf5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:78ebf934-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:78ec2300-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:78ec5014-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:78ec5014-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:78ec8458-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:78ec8458-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:78ec8458-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:78ecc738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:78ecc738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:78ecf79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:78ecf79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:78ed2f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78ed2f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78ed2f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78ed2f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:78ed79e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.051']} DrugCentral uuid:78eda0ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:78edca16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.652']} DrugCentral uuid:78edf3b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:78ee1af2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.554']} DrugCentral uuid:78ee41bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:78ee68cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:78ee8f78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:78eeb624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:78eedd5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:78ef04bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:78ef2b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:78ef4de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:78ef7492-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:78ef9df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:78efc4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:78efeb70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:78f01212-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.763']} DrugCentral uuid:78f03a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:78f060e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:78f0879c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:78f0ae5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:78f0d602-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.594']} DrugCentral uuid:78f0fcae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:78f12346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:78f14b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:78f174ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:78f19e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:78f1c4a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:78f1e72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (G protein-activated inward rectifier potassium channel 2) DrugCentral uuid:78f20a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.485']} DrugCentral uuid:78f2310a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) DrugCentral uuid:78f253c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78f27a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:78f2a1c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96PR1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:78f2c872-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:78f2ef00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.348']} DrugCentral uuid:78f315a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:78f33e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:78f364d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:78f38b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:78f3b200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:78f3d91a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:78f400d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:78f4278a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:78f44e4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:78f475a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:78f49c24-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.071']} DrugCentral uuid:78f4ca0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:78f4ca0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:78f4ca0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:78f5110e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:78f5110e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:78f5110e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:78f552ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:78f5796e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:78f5a092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:78f5c72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULQ1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:78f5edd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NHX9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:78f61482-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:78f63bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:78f66270-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:78f68c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:78f68c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:78f6bf2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:2817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vesnarinone targets Enzyme (Transitional endoplasmic reticulum ATPase) DrugCentral uuid:78f6e362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:78f706ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:78f7298a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:78f74e24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:78f770c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:78f793ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16854 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Deoxyguanosine kinase, mitochondrial) DrugCentral uuid:78f7b648-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:78f7d8d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:78f7ff86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04400 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Adenylate cyclase type V) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:78f826c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50247 biolink:molecularly_interacts_with DrugCentral:2818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vidarabine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:78f84d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80404 biolink:molecularly_interacts_with DrugCentral:2819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vigabatrin is inhibitor of Enzyme (4-aminobutyrate aminotransferase, mitochondrial) DrugCentral uuid:78f87042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50554 biolink:molecularly_interacts_with DrugCentral:2819 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vigabatrin targets Enzyme (Gamma-amino-N-butyrate transaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:78f896e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.76']} DrugCentral uuid:78f8bfa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:78f8e89c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:78f90f3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:78f93608-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:78f95d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viloxazine is antagonist of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:78f983ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:78f9aaa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:78f9cd5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:78f9f084-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:78fa1334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.728']} DrugCentral uuid:78fa39e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.298']} DrugCentral uuid:78fa6096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78faa330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:78fb2af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:78fb51ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:78fb7882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:78fb9f38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:78fbc6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:78fbe93e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:78fc0be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:78fc2e8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:78fc58f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78fc58f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78fc58f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fcb756-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fd2d6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vindesine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.607']} DrugCentral uuid:78fd5418-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:78fd7ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fdbcd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:78fe3518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:78fe5e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:78fe8522-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine is inhibitor of Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:78feaf3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:78feaf3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:78fee260-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (11-cis retinol dehydrogenase) DrugCentral uuid:78ff0506-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NR8 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 12) DrugCentral uuid:78ff27a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NBN7 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 13) DrugCentral uuid:78ff4a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10745 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Surface antigen (Retinol-binding protein 3) DrugCentral uuid:78ff6d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P82980 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 5) DrugCentral uuid:78ff900c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96R05 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinoid-binding protein 7) DrugCentral uuid:78ffb2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:78ffd990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50120 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 2) DrugCentral uuid:78fffc2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94788 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 2) DrugCentral uuid:790020e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00352 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 1) DrugCentral uuid:7900438a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12271 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Transporter (Retinaldehyde-binding protein 1) DrugCentral uuid:7900663a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:79008d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09455 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 1) DrugCentral uuid:7900b022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2831 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retinol is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:7900d6b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60779 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Transporter (Thiamine transporter 1) DrugCentral uuid:7900f9ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29401 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Transketolase) DrugCentral uuid:79011d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3S4 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Kinase (Thiamin pyrophosphokinase 1) DrugCentral uuid:790141a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BU02 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Thiamine-triphosphatase) DrugCentral uuid:7901653a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51854 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Enzyme (Transketolase-like protein 1) DrugCentral uuid:790187f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7901aec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A2RI47 biolink:molecularly_interacts_with DrugCentral:2832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiamine targets Transporter (Thiamine transporter ThiT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.91']} DrugCentral uuid:7901d664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30043 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Enzyme (Flavin reductase (NADPH)) DrugCentral uuid:7901f91e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969G6 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Kinase (Riboflavin kinase) DrugCentral uuid:79021bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riboflavin targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7902428e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7902691c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:79028c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:7902aee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Enzyme (Nicotinamide phosphoribosyltransferase) DrugCentral uuid:7902d17c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80Z39 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7902f828-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EP66 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:79031f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:79034634-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:2835 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79036ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:79038f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NVS9 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Pyridoxine-5'-phosphate oxidase) DrugCentral uuid:7903b2fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD0 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Pyridoxal phosphate phosphatase) DrugCentral uuid:7903d5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00764 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Kinase (Pyridoxal kinase) DrugCentral uuid:7903f836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35520 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Cystathionine beta-synthase) DrugCentral uuid:79041adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y617 biolink:molecularly_interacts_with DrugCentral:2836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxine targets Enzyme (Phosphoserine aminotransferase) DrugCentral uuid:79043d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:790460b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:79048364-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2838 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ergocalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:7904a614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7904cc98-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:7904f010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:790516b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:79053962-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02318 biolink:molecularly_interacts_with DrugCentral:2840 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colecalciferol targets Enzyme (Sterol 26-hydroxylase, mitochondrial) DrugCentral uuid:79055c08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2841 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydrotachysterol targets Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:79057fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7905aa96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7905d160-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7905f816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:79061f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:2845 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voglibose is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:790645e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79066c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['8.73']} DrugCentral uuid:79069348-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7906bac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7906e168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['5.844']} DrugCentral uuid:79070832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:79072f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:790758aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:79077f74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7907a652-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6A2 biolink:molecularly_interacts_with DrugCentral:2846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voriconazole targets Enzyme (Cholesterol 24-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7907cd12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.98']} DrugCentral uuid:7907f42c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.867']} DrugCentral uuid:79081af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:790841a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:79086862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N0U8 biolink:molecularly_interacts_with DrugCentral:2847 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 warfarin targets Enzyme (Vitamin K epoxide reductase complex subunit 1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.284']} DrugCentral uuid:79088ffe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7908b6d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7908dda6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xamoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79090466-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:79092c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:790955ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:79097d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7909a452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08709 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor VII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7909cb58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7909f1fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:790a18a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03951 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Coagulation factor XI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:790a3f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:790a66a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2852 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ximelagatran is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:790a8d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.873']} DrugCentral uuid:790ab414-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.114']} DrugCentral uuid:790adb42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:790b0338-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:790b2c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Cytosolic phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:790b52de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:790b7976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:790ba05e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.419']} DrugCentral uuid:790bc71e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.359']} DrugCentral uuid:790bedc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:790c1476-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.452']} DrugCentral uuid:790c3b9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:790c625a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:790c8974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.269']} DrugCentral uuid:790cb02a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:790cd794-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:790cfe40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:790d24ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:790d4ca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:790d73b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:790d9a76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:790dc122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zalcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:790de526-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2856 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zalcitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:790e1370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:790e1370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:790e1370-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:790e58b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:790e58b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:790e58b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:790e9714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:790ec090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:790ee8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:790f0fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:790f3638-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:790f5d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:790f8408-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:790faad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:790fd192-59f3-11ec-9eaa-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:790ff974-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7910202a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:791046d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79106d96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ49 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:79109640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7910be0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7910e4ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3S340 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:79110bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWR8 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Sialidase-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:79113316-59f3-11ec-9eaa-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:791159cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:79118064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2859 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7911a71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:7911ce66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7911f508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:79121bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23919 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:79124256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:79126bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79129378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7912ba10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7912e0b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:791307c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:79132e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9PPP5 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:79135560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:2861 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zidovudine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:79137c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7913a38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7913ca36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:7913f20e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:791418ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:791442ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:791469b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7914904c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7914b7de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7914df16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zileuton targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:791505ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:79152c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:791552f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zimeldine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:79157a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7915a0b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7915c76e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:7915ee24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79161836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:79163f82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:79166606-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:79168cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:7916b4bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7916db7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:79170232-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.565']} DrugCentral uuid:79172906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:79175084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:79177744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:79179e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7917c4c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:7917ec60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:79181316-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:791839d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:79186096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:791888b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7918af56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:7918d616-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7918fcb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:79192404-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:79194ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:79197170-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79199826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:7919c134-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:7919e3c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:791a0a86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:791a3150-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:791a5874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:791a80b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:791aa77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:791ace3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:791af5ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:791b1c5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:791b4324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:791b69da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:791b995a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:791b995a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:791b995a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:791bd7ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziprasidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:791bfe9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:791c25aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:791c4d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zofenopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:791c741a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:791c9ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:791cc244-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:791ce92c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:791d0ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:791d36b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:791d5fa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:791d881e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:791daec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:791dd56c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:791dfc90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:791e233c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:791e49fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:791e70b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:791e981c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00481 biolink:molecularly_interacts_with DrugCentral:2868 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zoledronic acid targets Unclassified (Butyrophilin subfamily 3 member A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:791ebeb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:791ee574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:791f0c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:791f3542-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:791f5d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:791f842a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:791faaea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:791fd89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:791fd89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:791fd89e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:792018a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:79203f6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:792066ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:79208f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.703']} DrugCentral uuid:7920b5d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7920dc8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79210548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:79212c44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:792159c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:792159c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:792159c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:79219f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:79219f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:79219f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:7921e490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:7921e490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:7921e490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:792229e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:792229e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:792229e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79229ad4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79238502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:79238502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:79238502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7923ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7923ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7923ca3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7924109e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7924109e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7924109e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:792455cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:792455cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:792455cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:79249e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:79249e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:79249e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:7924dda8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:2870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zolpidem targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7925042c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:79252ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:7925554e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7925554e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:792587ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:7925aa94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:7925d154-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:7925f490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:79261b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:79264210-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:792668b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7926929c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7926b9a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7926e04e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7927070e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:79272e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:792754ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:79277c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7927a2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7927ca4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7927f0f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:792818b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79283f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:792866f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:79288db8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7928b46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7928db2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:79290234-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:792928f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:79294fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7929766a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:79299df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7929c89a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:7929c89a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:7929fb4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:792a2330-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6NSN2 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:792a4b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:792a71c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:792a987e-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2872 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zonisamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792af120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792bd3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:792bd3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:792bd3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:792c1dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792c1dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792c1dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792c696a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:792c696a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:792c696a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:792cb24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:792cb24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:792cb24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:792cf7cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:792cf7cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:792cf7cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:792d3ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792d3ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792d3ec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792d8426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792d8426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792d8426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:792dca9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792dca9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792dca9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:792e0c20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.394']} DrugCentral uuid:792e32d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:792e5982-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:792e8092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:792ea72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:792ecde0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:792ef48c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:792f1c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:792f42de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:792f69b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:792f9072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:792fba48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:792fe3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:79300aa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.273']} DrugCentral uuid:79303144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:79305840-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.606']} DrugCentral uuid:79307ff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:7930a692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:7930cd2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.704']} DrugCentral uuid:7930f48a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:79311ba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:7931425a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:79316906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:79319098-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:7931b73a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7931dddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:79320492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:79322bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:79325244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:793278dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:79329f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7932c6ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7932ed8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7933144a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:79333b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7933667a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:7933892a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7933afd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:7933d29a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:7933f5a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zuclopenthixol is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:79341854-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) DrugCentral uuid:79343afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:793463b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:2878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:79348b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotarolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7934b1d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zotarolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7934d87a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eledoisin is agonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7934ff26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:2955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eledoisin targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:7935276c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:79354e68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79357500-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16235 biolink:molecularly_interacts_with DrugCentral:2958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gonadorelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7935a278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:7935a278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:7935a278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:7935da9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mifamurtide is activator of Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) DrugCentral uuid:7935fd40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:793623ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['4']} DrugCentral uuid:79364a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:793671ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79369890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7936bf3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7936e5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:79370e1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:793734bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:79375b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:79378264-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7937a956-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.749']} DrugCentral uuid:7937d002-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15648 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (ATP-dependent 6-phosphofructokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938179c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7938bbd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:7938e622-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:79390fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80Z26 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Nucleoside triphosphate diphosphohydrolase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:793936c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35795 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Enzyme (Ectonucleoside triphosphate diphosphohydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:79395db4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49654 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7939846a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:7939ab16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47824 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7939d30c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7939fa62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42224 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 1-alpha/beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:793a2136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42229 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:793a47e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51692 biolink:molecularly_interacts_with DrugCentral:2966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:793a6e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.025']} DrugCentral uuid:793a951c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:793abe66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:793ae0ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:793b0b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:793b0b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:793b0b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:793b4304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 histrelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:793b65be-59f3-11ec-9eaa-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:793b8c6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WLT4 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin is inhibitor of Enzyme (1,3-beta-glucan synthase catalytic subunit FksP) DrugCentral uuid:793baf24-59f3-11ec-9eaa-0242ac110003 UniProtKB:O13383 biolink:molecularly_interacts_with DrugCentral:2977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caspofungin targets Unclassified (1,3-beta-D-glucan synthase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:793bd9d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:793bd9d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:793c1022-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:793c1022-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:793c46a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:793c46a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:793c7b34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:2989 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.086']} DrugCentral uuid:793ca1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['12.7']} DrugCentral uuid:793cc8a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:793cef74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:793d1698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30082 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793d54d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:793dd056-59f3-11ec-9eaa-0242ac110003 UniProtKB:F8V479 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:793df6f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35659 biolink:molecularly_interacts_with DrugCentral:2994 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.36']} DrugCentral uuid:793e1d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lepirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['13']} DrugCentral uuid:793e4540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:793e6c1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:793e92b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:793eb958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:793ee072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:793f159c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:793f159c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:793f159c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:793f159c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:793f159c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:793f7992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:793f7992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:793f7992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:793f7992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:793f7992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:793fcfd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.46']} DrugCentral uuid:793ff6a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:79401ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:79404606-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:79406cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:2997 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:79409390-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96529 biolink:molecularly_interacts_with DrugCentral:2999 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrantel targets Enzyme (Acetylcholinesterase) DrugCentral uuid:7940b67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7940dd46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:794104ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:79412b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:794152f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:3008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atosiban is antagonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:794179a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:7941a334-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7941a334-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7941a334-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7941e196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.934']} DrugCentral uuid:79420ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:794232ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:79425950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:79428010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:7942a734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:7942cdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.532']} DrugCentral uuid:7942f522-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.004']} DrugCentral uuid:79431bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:79434338-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.092']} DrugCentral uuid:794369ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:794390a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:7943b732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:7943e130-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:794407e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.649']} DrugCentral uuid:79442e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.115']} DrugCentral uuid:7944552a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.681']} DrugCentral uuid:79447c30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.192']} DrugCentral uuid:7944a4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:7944cb86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969F8 biolink:molecularly_interacts_with DrugCentral:3018 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzethonium targets GPCR (KiSS-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7944f214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:7945196a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:79454002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3021 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bergapten targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:794566a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:79458d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:7945b78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:7945de54-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.299']} DrugCentral uuid:794604f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.651']} DrugCentral uuid:79462ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:794652a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:7946795e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:7946a00a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.501']} DrugCentral uuid:7946c6ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:7946ee34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:794714f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:79473bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.844']} DrugCentral uuid:7947626a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:794789fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.761']} DrugCentral uuid:7947b094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7947d754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7947fe96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:794825b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.212']} DrugCentral uuid:79484c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.647']} DrugCentral uuid:794873f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:79489a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.735']} DrugCentral uuid:7948c1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.498']} DrugCentral uuid:7948e87e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:79490f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:794935cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.415']} DrugCentral uuid:79495fe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:79498702-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7949ad9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7949d446-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7949fb42-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:794a21da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:794a4854-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:794a6f0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:794a9642-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:3032 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bithionol is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:794abcee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:3042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:794ae3b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:3042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 broxuridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:794b0b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.97']} DrugCentral uuid:794b35ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.91']} DrugCentral uuid:794b5d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:794b8426-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufexamac targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:794bb1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:794bb1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:794bb1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:794bf744-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:794bf744-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:794bf744-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:794c36e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:794c5e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:794c8506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:794cab9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:794cd24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:794cfafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54577 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Tyrosine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:794d2218-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:794d48e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03887 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Unclassified (NADH-ubiquinone oxidoreductase chain 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:794d701a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:794d9734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q704Y3 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is activator of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:794dbde0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:794de496-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:794e0b38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:794e32f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:794e5994-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:794e8022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:794ea6ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NJH6 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Unclassified (Ace-orthologous acetylcholinesterase; Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:794ece2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7YWJ9 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:794ef4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:K4JQ36 biolink:molecularly_interacts_with DrugCentral:3066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:794f1b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:3067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbon tetrachloride targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:794f4246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31327 biolink:molecularly_interacts_with DrugCentral:3068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carglumic acid is positive allosteric modulator of Enzyme (Carbamoyl-phosphate synthase [ammonia], mitochondrial) DrugCentral uuid:794f6c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:794f6c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:794f6c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:794fabc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:3082 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrimonium targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:794fd274-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetylpyridinium targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:794ff9de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42575 biolink:molecularly_interacts_with DrugCentral:3083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetylpyridinium targets Enzyme (Caspase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:7950206c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxylenol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:79504722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chloroxylenol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.738']} DrugCentral uuid:79506dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:3095 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorquinaldol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:795095ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7950be8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:3096 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7950e524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:79510d1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79513772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:79513772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:79516d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:79516d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:7951a392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:7951a392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:7951da06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:7951da06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:7952100c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:7952100c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:795242b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:3097 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:79526a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3101 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.9']} DrugCentral uuid:79529252-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:3102 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cinromide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7952b980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7952e018-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:79530764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:79532dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79535b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79535b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79535b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:795399c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cynarine targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7953c0be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 demoxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7953f16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7953f16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7953f16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7953f16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79543c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:79545f2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:795485da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7954ac86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7954d350-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibrompropamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7954face-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 difluprednate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7955242c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7955242c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7955242c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:795562ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:795589bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:7955b16c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dioxadrol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7955d80e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7955fe9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:795627be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:3165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:79565022-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30987 biolink:molecularly_interacts_with DrugCentral:3165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:795676d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:79569d70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:7956c4d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7956eb7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7957121e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:3173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edoxudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:795738b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:79575fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79578690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7957ad46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7957d3f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7957fd32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7958242e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:79584ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79587208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7958995e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eicosapentaenoic acid targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7958c000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enilconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:7958e6c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:79590d76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:79593486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:79595c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:795982ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.91']} DrugCentral uuid:7959a970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:7959d2d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:7959f97a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:795a2012-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:795a46b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:795a6dec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16232 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:795a948e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50233 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:795abb26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:795ae1dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:795b0900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:795b3088-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:795b5734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9CPU0 biolink:molecularly_interacts_with DrugCentral:3178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxolone targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:795b7dea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:795ba662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:795bcd04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:3186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:795bf39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:795c1a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.748']} DrugCentral uuid:795c41c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:795c6886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:795c8f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:795cb5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:795cde42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.064']} DrugCentral uuid:795d04ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:795d2c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:3187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estriol targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:795d532c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:795d7d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.062']} DrugCentral uuid:795da548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:795dcbf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:795df282-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:795e19ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:795e4066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:795e66fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:795e8daa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:795eb4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:795edb66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:795f01f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:795f28aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacridine targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:795f50c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:3194 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethacridine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:795f777e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:795f9e3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:795fc4fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:795fec5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:79601314-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:796039c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:79606080-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:79608790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7960ae46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7960d4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7960fc84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:7961257e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:79614c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:796172cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7961998c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7961c100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7961e7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01812 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:79620e58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:79623504-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:79626600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:79626600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:79626600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:79626600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7962be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:7962be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:7962be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:7962be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:7962be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:796322a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:796322a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:796322a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:79637518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7963e4da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79640b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:796432a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:79645956-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13822 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:79648002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:3217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evans blue targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7964a69a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.217']} DrugCentral uuid:7964ce18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7964f4ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 exisulind targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.859']} DrugCentral uuid:79651b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:79654226-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:79656968-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:7965901e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.641']} DrugCentral uuid:7965b6ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.377']} DrugCentral uuid:7965dd62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:79660486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:79662b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:796651c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.328']} DrugCentral uuid:7966786c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:7966a18e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.688']} DrugCentral uuid:7966c880-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:7966ef40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:3220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:796715ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:3224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fendosal is inhibitor of Secreted (Plasminogen activator inhibitor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:79673e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenoxazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79676506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04303 biolink:molecularly_interacts_with DrugCentral:3227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenticlor targets Enzyme (Uracil-DNA glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:79678b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:3229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fumaric acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:7967b254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7967d982-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:79680024-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:3236 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:79682a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:79682a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:79688224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:796921e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3253 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fumagillin targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:79694880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:79696f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:79699650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7969bd24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7969e466-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:796a0b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:796a336c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:796a5a2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:796a80ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:796aa784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:796acea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:796af57c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:796b1c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:796b42c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:796b6962-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:796b9086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:3257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabexate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:796bb732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:796bddde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:796c048a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:796c2f14-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:796c5624-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:796c7cda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:796ca444-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:796ccafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:796cf1b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:796d1852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:796d3f44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:796d6690-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:3275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hexamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:796d8e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:796db532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:796ddc92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:796e035c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:796e2b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:796e51d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:796e792c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:796ea000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:796ec6c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:796eed80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:796f153a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:796f3c04-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:796f62b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:796f8966-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:796fb0a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.89']} DrugCentral uuid:796fdace-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7970049a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:79702b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:7970529c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:7970793e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:3290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxyquinoline targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:79709ff4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:3293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibufenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7970c68c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:7970edce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.969']} DrugCentral uuid:7971147a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:79713b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:797161c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:79718964-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.181']} DrugCentral uuid:7971b25e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.859']} DrugCentral uuid:7971d91e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.227']} DrugCentral uuid:797200c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:79722838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:79724eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7972759a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:79729c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7972c360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.496']} DrugCentral uuid:7972ea0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:797310b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:79733750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:79735ece-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7973857a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7973ac1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7973d368-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:7973fadc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:797422be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7974496a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7974700c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:79749726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7974bddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7974e4a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:79750b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:797532f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:79755ca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:797583c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7975b142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7975b142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7975b142-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7975f288-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:3309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:79761934-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:79763ff4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:797666fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:79768dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7976b4a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7976db6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:7976fe3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:3312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:797725ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 khellin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:79774c8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:79777342-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:797799f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7977c19e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:3317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:7977e82c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79780f96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:7978364c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79785da2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79788458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7978aafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7978d1c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7978fb0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:797921b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14721 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is activator of Ion channel (Potassium voltage-gated channel subfamily B member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7979496a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:79797002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7979974e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:7979bdfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:7979e4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:797a0b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lodoxamide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.793']} DrugCentral uuid:797a329e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:3328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubeluzole targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:797a5a8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:3328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubeluzole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:797a8140-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestanolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:797aa3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mestanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.81']} DrugCentral uuid:797ace34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesterolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.6']} DrugCentral uuid:797af8aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mesterolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:797b2294-59f3-11ec-9eaa-0242ac110003 UniProtKB:O34667 biolink:molecularly_interacts_with DrugCentral:3347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methionine targets Unclassified (S-ribosylhomocysteine lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:797b4cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.077']} DrugCentral uuid:797b73c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:797b9a58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:797bc118-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:797be832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyltestosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:797c0ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:3362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoguazone targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:797c3576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36633 biolink:molecularly_interacts_with DrugCentral:3362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mitoguazone targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:797c5f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:797c5f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:797c93b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:797cba8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:797ce16a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:797d0938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:797d3098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:797d5dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797d5dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797d5dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797da33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:797da33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:797da33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797df2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:797e54f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:3377 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neridronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:797e7cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nifenalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.88']} DrugCentral uuid:797ea388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:797eca3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:797ef0d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:797f1822-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:797f3ece-59f3-11ec-9eaa-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:3396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octopamine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:797f657a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01705 biolink:molecularly_interacts_with DrugCentral:3399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleandrin targets Unclassified (Neurogenic locus notch homolog protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:797f8bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:797fb336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:797fd9ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:79800278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7980292e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:79805098-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:79807730-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:79809df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01469 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, epidermal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7980c51e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7980ec74-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79811316-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07148 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:798139e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:79816096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:798187b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7981ae66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7981d508-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:3401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ornithine is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:79820370-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79820370-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79820370-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79824740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:7982709e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.815']} DrugCentral uuid:79829768-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:7982bedc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.372']} DrugCentral uuid:7982e588-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.723']} DrugCentral uuid:79830c5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:79833326-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:79835a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.533']} DrugCentral uuid:79838222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:7983a8ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.169']} DrugCentral uuid:7983cfac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.943']} DrugCentral uuid:7983f7fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:79841ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.449']} DrugCentral uuid:79844586-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:79846c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.676']} DrugCentral uuid:798493ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7984ba66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:7984e130-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:798503cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:79852b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.333']} DrugCentral uuid:798551c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:7985787a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:79859f26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.209']} DrugCentral uuid:7985c80c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7985eeb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.969']} DrugCentral uuid:79861578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:79863de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:3412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxybenzone targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7986653c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:3413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycinchophen targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:79868bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxycinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7986b2b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:7986d972-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine is modulator of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:7987006e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.658']} DrugCentral uuid:79872724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.307']} DrugCentral uuid:79874ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:79877580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:79879fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7987c71a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:7987f7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7987f7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7987f7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7987f7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7988499c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7988499c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7988499c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:79888830-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3467 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picloxydine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7988aefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:3467 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 picloxydine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7988d5ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:3474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adipic acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7988fca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:79892344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:798949f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:79897182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:79899838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04015 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7989bee4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7989e586-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03118 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.98']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798a3b58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:798b1302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:798b1302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:798b1302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:798b589e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:798b589e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:798b8b3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03120 biolink:molecularly_interacts_with DrugCentral:3481 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 podophyllotoxin targets Unclassified (Human papillomavirus regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:798bb1fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polyestradiol phosphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:798bd526-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:798bf7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.398']} DrugCentral uuid:798c1eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:798c4560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:798c6d60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:798c940c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:3483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 posaconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:798cbac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:798ce178-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:798d0aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.69']} DrugCentral uuid:798d31a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:798d5856-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:798d7f0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18762 biolink:molecularly_interacts_with DrugCentral:3486 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:798da662-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:798dcd22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:798dfa9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:798dfa9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:798dfa9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:798e3974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:798e6034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:798e8dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:798e8dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:798e8dc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:798ecc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:3500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protoporphyrin targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:798ef38c-59f3-11ec-9eaa-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:3500 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 protoporphyrin targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:798f1a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:798f40c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:798f6772-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:798f8edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:3502 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prucalopride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:798fb588-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:3505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 homonicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:798fdc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:3506 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxal phosphate targets Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:799002e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79902a0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:799050c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:79907874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:79909f20-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7990c91e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7990efe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:799116a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:79913d5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:79916586-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:79918c5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7991b2f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7991d9bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:799200e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7992278c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:79924e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:799274da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:79929c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3511 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrovalerone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7992c336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7992e9ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7993105c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:799337bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:79935e72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:79938532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7993abde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7993d302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7993f9a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:799420b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:79944fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79944fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79944fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79948eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7994b54c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7994dbda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:7995031c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:799529b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:7995507e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7995772a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:79959e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:7995c4aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7995eb60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:799611ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:79963a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:79966126-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:799687b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7996ae56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7996d598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7996fc3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:79972430-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:79974adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:79977200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7997988e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7997bf44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7997e5d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:79980fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:799836f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:79985d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:79988410-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7998ab48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7998d1ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7998f878-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:79991f1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79994634-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:79996ce0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:79999382-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:7999bae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7999e242-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:799a08ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:799a2f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:799a5628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:799a7d6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:799aa3ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:799acaa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:799af146-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:799b1842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:799b3ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:799b655e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:799b8bec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:799bb356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:799bdb06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:799c0234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:799c28cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:799c5004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:799c767e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:799c9d20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:799cc3b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39900 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Macrophage metalloelastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:799ceadc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:799d1174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:799d3820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:799d5ec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:799d8884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:799db1ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:799dd8ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:799dff44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06737 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Glycogen phosphorylase, liver form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:799e267c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:799e4d00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:799e738e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:799e9a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:799ec12c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:799ee7c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:799f0e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:799f3512-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:799f5da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:799f871a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:799fae34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:799fd5da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:799ffd3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:79a023fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:79a04aa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:79a07148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79a0984e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:79a0bef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79a0e588-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:79a10c34-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:79a134d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:79a15bf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:79a18286-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:79a1a928-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:79a1d074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:79a1f798-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:79a21e44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:79a244c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:79a26bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:79a2923e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:79a2b8f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:79a2df96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79a30764-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:79a32dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10584 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:79a3548a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21588 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (5'-nucleotidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:79a37b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q965D6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (3-oxoacyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:79a3a340-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q965D7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:79a3c9e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27986 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Phosphatidylinositol 3-kinase regulatory subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:79a3f08e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPH5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (NADPH oxidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:79a41852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:79a43f9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79a4660e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:79a48cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q1CTD3 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (D-alanine--D-alanine ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:79a4b35c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:79a4dc24-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:79a5065e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79a5065e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79a53c64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:79a53c64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:79a579ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:79a579ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:79a579ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:79a579ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:79a5d4c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:79a5d4c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:79a60bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:79a60bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:79a63e7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:79a66508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:79a68baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:79a6b472-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:79a6dc90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03114 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Cell division protein kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:79a7031e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:79a729b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07862 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (D-alanylalanine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79a750da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:79a77830-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01062 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:79a79eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:79a7c560-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41921 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:79a7ed38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:79a813f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:79a83a9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11168 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:79a86150-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14576 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (ELAV-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:79a889c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15717 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Unclassified (ELAV-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79a8b060-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:79a8d6f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:79a8fd9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19357 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:79a924d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79a94b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79a971f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:79a9989a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:79a9cd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:79a9cd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:79a9cd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:79a9cd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:79a9cd38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:79aa1ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:79aa4196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:79aa6a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:79aa90b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:79aab77a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:79aade1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:3521 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:79ab052c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:79ab2be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:79ab52a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:79ab794e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:79aba112-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:79abc7c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:79abee7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:79ac1534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:79ac3ece-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3524 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:79ac68fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:79ac68fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:79ac9612-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:3529 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rioprostil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) DrugCentral uuid:79acb980-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:79ace02c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.46']} DrugCentral uuid:79ad06c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:79ad377a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:79ad377a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:79ad377a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:79ad377a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:79ad82b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WQX9 biolink:molecularly_interacts_with DrugCentral:3531 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roflumilast targets Enzyme (Phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:79ada958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:79add004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:79adf8fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:79ae1ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:79ae46a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79ae6d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:79ae944e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:79aebafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79aee1b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:79af0866-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79af2fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:79af5654-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:79af7cec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79afa4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:79afccba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:79aff3c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:79b01a58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:79b0410e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:79b0680a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:79b08eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:79b0b562-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79b0dc2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:79b1038c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:79b12a2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:79b150da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:79b17790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:79b1a062-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:79b1ca56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79b1f10c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:79b217c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:79b23edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:79b265a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:79b28c48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:79b2b394-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:79b2daf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:79b301a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:79b32838-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:79b34f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:79b376f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79b3a06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b3c75c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b3edfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b414fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:79b43bb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79b46252-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79b48908-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:79b4b036-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79b4d6f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:79b4fdac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:79b5244e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:79b54bb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:79b5734a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:79b59a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:79b5c0a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:79b5e7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:79b60f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:79b63636-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79b65cd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:79b68442-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:79b6aada-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:79b6d190-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:79b6f81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:79b71fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:79b7468e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:79b76d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:79b793dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:79b7baf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:79b7e198-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:79b8083a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:79b82ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79b85628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b87cd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:79b8a38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79b8ca2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b8f22c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:79b918d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:79b94088-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:79b96716-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:79b98e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:79b9b4dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:79b9db9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:79ba0248-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:79ba29bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79ba5054-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79ba770a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:79ba9dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:79bac534-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:79baef00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:79bb1610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:79bb3cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79bb63cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79bb8a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:79bbb138-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:79bbd7ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:79bbff62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:79bc2618-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:79bc4cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:79bc737a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:79bc9c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:79bcc514-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:79bcecb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:79bd1366-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:79bd3a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:79bd612c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:79bd87c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:79bdae5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79bdd5bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:79bdfc68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:79be230a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:79be49ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:79be7166-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:79be9b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41743 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C iota type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79bec2ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79bee970-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:79bf1076-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79bf37c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:79bf5e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79bf852e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79bfc3a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:79c04ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79c04ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79c04ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79c04ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:79c0954a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c0d9d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:79c15c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:79c18310-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:79c1a9bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.454']} DrugCentral uuid:79c1d05e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:79c1f70a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:79c21ed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:79c248a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:79c26f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:79c295ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:79c2bd0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:79c2e3ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:79c30a46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:79c331ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:79c358c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:79c37f3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:79c3a5dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:79c3cc88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:79c3f47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:79c41bd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:79c44294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:79c46918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:79c49dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:79c49dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:79c49dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:79c49dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:79c49dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:79c4f3f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:79c51b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:79c54298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:79c569a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin is antagonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:79c5941e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:79c5941e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:79c5c86c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:79c5efae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:79c616be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:3548 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:79c63dc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:79c66574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:79c690f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:79c690f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:79c6c3f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbentine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:79c6eb0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:3557 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulbentine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:79c7128a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:79c73e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:79c73e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:79c77144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxedrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:79c7993a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3577 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxedrine targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:79c7c04a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3579 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:79c7e354-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:79c80a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:79c831ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3580 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:79c858b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:79c87fe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:79c8a6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:79c8ce7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:79c8f5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:79c91cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:79c943e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:79c96c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:79c992f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:79c9b5ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:79c9dcfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:79ca042c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:79ca2bdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:79ca5418-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:79ca7b32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:79caa314-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3584 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:79cad8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:79cad8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:79cad8c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:79cb1ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79cb1ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79cb1ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cb7000-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cbe562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:79cc3de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:79cc64ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:79cc8c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:79ccb384-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:79ccda8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:79cd01ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:79cd2bc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:79cd52bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:79cd79d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79cda0f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:79cdc896-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:79cdefb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.72']} DrugCentral uuid:79ce16ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3604 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyropropic acid targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:79ce3dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:79ce6558-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:79ce8bfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3607 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:79ceb2e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:79ced5ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:79ceff72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:79cf27ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:79cf4ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:79cf75ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:3609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipranavir targets Enzyme (Pepsin A-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79cf9eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:79cfc560-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:79cfebf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:79d012ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:79d039d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:79d06088-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:79d087ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:79d0ae6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:3613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Vitamin E targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:79d0d7de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49638 biolink:molecularly_interacts_with DrugCentral:3613 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Vitamin E targets Transporter (Alpha-tocopherol transfer protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:79d10240-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:79d128e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:79d14f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:79d176e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.75']} DrugCentral uuid:79d19d9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:79d1c464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:79d1eb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:3617 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolnaftate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:79d21216-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:79d238c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:79d25f78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:79d28cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:79d28cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:79d28cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:79d2d476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79d2d476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79d2d476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79d31300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:79d33a06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P95276 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase; Epoxide hydrolase EphB) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:79d3609e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07099 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:79d38736-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D379 biolink:molecularly_interacts_with DrugCentral:3630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:79d3ade2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:79d3d4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16152 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Carbonyl reductase [NADPH] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:79d3fba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6GI75 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:79d4224a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:79d448f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:79d47286-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54616 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:79d49c16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6UCJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:79d4c2d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BJJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-ACP reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:79d4e96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9RMI3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:79d510a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79d5375c-59f3-11ec-9eaa-0242ac110003 UniProtKB:M9TGV3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NULLDH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:79d55e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:3631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triclosan targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:79d584dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:79d5abd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:79d5d27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:79d5f99e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:79d62036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:79d64908-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:3639 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:79d671da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:79d69890-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:79d6bf46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:79d6e67e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:79d70d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BI31 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:79d733e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:79d75ab4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vildagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79d781ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:79d7a8e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:79d7cf94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79d7f636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3643 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d838da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:79d8b15c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3651 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:79d8d7f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:79d8fed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:79d9259c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:79d94cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:79d973a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:79d99a68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:79d9c128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:79d9e950-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79da101a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:79da36d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:79da5da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:79da84b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:79daab74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:79dad22a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79daf8ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:79db2004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:79db46ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:79db6d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:79db9520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:79dbbcd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79dbe39a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:79dc17f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:79dc17f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:79dc17f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:79dc17f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:79dc17f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:79dc6ed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:79dc959c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:79dcbc66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:79dce31c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:79dd0a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:79dd379a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:79dd379a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:79dd379a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:79dd7ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:79dd7ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:79dd7ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79ddce12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:79de330c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3658 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 xylometazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:79de59e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.163']} DrugCentral uuid:79de80aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:79dea774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79dece84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:79def54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:79df1c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:79df42ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79df6b5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79df9544-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:79dfbc5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:79dfe328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:79e00a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:79e0312a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:79e057d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:79e07e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:79e0a57e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:79e0cc5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:79e0f31c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:79e119e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:79e1422c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:79e16b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:79e19506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:79e1bcca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:79e1e3f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:79e20bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:79e2324a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:79e258ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:79e28010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79e2a766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:79e2ce26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:79e2f4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:79e31c78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:79e34324-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:79e37092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e37092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e37092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e3bdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79e3bdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79e3bdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79e3bdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79e3bdfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79e41af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:79e41af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:79e41af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:79e46114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e46114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e46114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:79e49fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:79e4c65e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:79e4efe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:79e51712-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:3659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:79e53ddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:79e56b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:79e56b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:79e56b54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:79e5aa60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:79e5d134-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:79e5f7f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:79e61f86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3686 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:79e64646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3689 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bropirimine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:79e66d06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:3707 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chlorthenoxazine targets Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:79e693c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ciramadol is modulator of GPCR (Mu-type opioid receptor) DrugCentral uuid:79e6b72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:3715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobenztropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:79e6e4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79e6e4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79e6e4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:79e729ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:79e729ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:79e729ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:79e7690e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3787 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 myrtecaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:79e7969a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:79e7969a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:79e7969a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:79e7d984-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:79e7d984-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:79e80d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:79e8344c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:79e85af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:79e881a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:79e8acf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:79e8d6b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:3848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velnacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:79e8ff8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:79e92690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:79e94d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:79e97406-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:79e99ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:79e9c15e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3851 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:79e9e8fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:79ea0fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:79ea3670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:79ea5d1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:79ea879c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:79eaae3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:79ead4f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:79eafbf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:79eb2292-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:79eb495c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:79eb7102-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:79eb9880-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:79ebbf40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:79ebe600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:79ec0cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:79ec351a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:79ec5f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:79ec8646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22736 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Nuclear receptor subfamily 4 group A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:79ecad10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:79ecd434-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:3862 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:79ecfae0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3871 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 artemisinin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:79ed2218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:79ed48ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:79ed7006-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:79ed96c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:79edbd54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:79ede414-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.843']} DrugCentral uuid:79ee0f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:79ee0f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:79ee4ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:79ee4ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:79ee4ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:79ee4ee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:79ee9904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:79eec168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:79eee90e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:79ef0fce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3883 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 biriperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:79ef3698-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3911 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:79ef59fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:79ef80c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:79efa77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.665']} DrugCentral uuid:79efce32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.372']} DrugCentral uuid:79eff5ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:79f01c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:79f04326-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:79f069d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:79f090ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:79f0b7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:79f0de6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:79f1052c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:79f12c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:79f15360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:79f17a34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:79f1ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79f1ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79f1ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79f1ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79f1ae3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:79f20bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:79f20bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:79f20bfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:79f252ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:79f252ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:79f252ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:79f29158-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:79f2b818-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:79f2ded8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:79f306d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79f32d98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:79f35458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.79']} DrugCentral uuid:79f37b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:79f3a4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:79f3ccd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3920 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexamethasone phosphate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:79f3f37c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:79f41a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:79f44124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:79f467e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:79f48fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:79f4b67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:79f4dddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:79f5049c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.57']} DrugCentral uuid:79f52b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:79f55212-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:79f57bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:79f5a492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:79f5cc4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:79f5f2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:79f619f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolasetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.226']} DrugCentral uuid:79f640aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.698']} DrugCentral uuid:79f66774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:3944 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etoposide phosphate is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:79f68a42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:79f6b1b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:79f6d876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:79f6ff40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:79f7261e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:79f74dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:79f774ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.793']} DrugCentral uuid:79f79b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:79f7c222-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:79f7e91e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:79f80fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:79f836f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:79f85da4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.122']} DrugCentral uuid:79f88518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:79f8abc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:79f8d914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:79f8d914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:79f8d914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:79f91884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:79f93ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:79f93ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:79f96cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:79f99390-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:79f9baaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:79f9e174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:79fa0820-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:79fa2ed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.924']} DrugCentral uuid:79fa5636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.891']} DrugCentral uuid:79fa7d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:79faa4f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:79facbc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.451']} DrugCentral uuid:79faf550-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.539']} DrugCentral uuid:79fb1e18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is allosteric modulator of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:79fb44ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:79fb75a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79fb75a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79fb75a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79fb75a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:79fbc020-59f3-11ec-9eaa-0242ac110003 UniProtKB:P91730 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:79fbe2da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:79fc0576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11507 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:79fc2ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06685 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:79fc536e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64578 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:79fc7a38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:3972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivermectin is allosteric modulator of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:79fca0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:3976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kinetin targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:79fcca6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:79fcf576-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:79fd1c90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:79fd433c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00371 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:79fd6a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:79fd9120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:79fdb7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2ZB02 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:79fddf68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:79fe0722-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00024 biolink:molecularly_interacts_with DrugCentral:3977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:79fe2dd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 meldonium targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:79fe54ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:79fe7b76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:79fea5b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niperotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:79feca04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:79fef0ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:79ff1798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:79ff3ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:79ff6586-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:79ff8fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:79ff8fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:79ffc300-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4004 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:79ffe9ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:7a001080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a00374a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7a005edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:7a008574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:7a00ac48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:4050 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spaglumic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7a00d506-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:7a00fc16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7a0122b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a017b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7a0259bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7a02805e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7a02a732-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a02ce60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:7a02f520-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7a031be0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a0343ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.78']} DrugCentral uuid:7a036b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 timolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.44']} DrugCentral uuid:7a0391d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:7a03b8a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:7a03dfe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.929']} DrugCentral uuid:7a0407e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.425']} DrugCentral uuid:7a042ef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.857']} DrugCentral uuid:7a0455a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7a047c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:7a04a366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.802']} DrugCentral uuid:7a04c9f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.952']} DrugCentral uuid:7a04f0a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:7a051738-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7a053e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7a056508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13674 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Prolyl 4-hydroxylase subunit alpha-1) DrugCentral uuid:7a058790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02809 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) DrugCentral uuid:7a05aa22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGH3 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 2) DrugCentral uuid:7a05cdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHI7 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 1) DrugCentral uuid:7a05f356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00689 biolink:molecularly_interacts_with DrugCentral:4072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ascorbic acid targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7a061a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7a0640f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a0667a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a068ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:4074 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a06b8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7a06b8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7a06e5d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:4106 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sucralfate is inhibitor of Enzyme (Pepsin A-5) DrugCentral uuid:7a07087c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7a0730e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:7a075764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a077df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7a07a494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7a07ce42-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a07f4da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7a081b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7a084214-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7a08691a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:7a088fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7a08b67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7a08e07a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7a08e07a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7a09177a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7a09177a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7a094a4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:4109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7a0970ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7a099966-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7a09c026-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7a09e75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7a0a117a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:7a0a117a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:7a0a4276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:7a0a4276-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:7a0a6f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:7a0a9636-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7a0abef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7a0ae5a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a0b0c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7a0b32e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:7a0b5ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) DrugCentral uuid:7a0b7fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:7a0ba29c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) DrugCentral uuid:7a0bc696-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:4112 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) DrugCentral uuid:7a0be93c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4113 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prasugrel is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:7a0c0c3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:7a0c2ed8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7a0c525a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7a0c7924-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a0ca098-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4114 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7a0cc744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7a0cede6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7a0d1492-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a0d3d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:7a0d63fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.187']} DrugCentral uuid:7a0d8ab2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:7a0db172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.61']} DrugCentral uuid:7a0dd882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7a0dff38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.93']} DrugCentral uuid:7a0e25da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7a0e4c90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:7a0e73dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7a0e9b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.73']} DrugCentral uuid:7a0ec242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:7a0ee8d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.644']} DrugCentral uuid:7a0f1062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7a0f3704-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7a0f5da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.107']} DrugCentral uuid:7a0f843e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.039']} DrugCentral uuid:7a0fab44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.491']} DrugCentral uuid:7a0fd1dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.565']} DrugCentral uuid:7a0ff892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7a101f48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7a1046a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:7a106d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:7a10946e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:7a10bb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:7a10e3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:7a110a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7a113126-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4115 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7a1157dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7a117f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7a11a5d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:7a11cc76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:4117 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralatrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a11f318-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7a121bb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7a124264-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a126a14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7a1290d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7a12b974-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a12e084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a130726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a132de6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a1354d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7a137b70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7a13a212-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7a13c8dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7a13f064-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7a141710-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7a143dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7a146490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7a148d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7a14b40e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a14dab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a15017a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a152876-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7a154f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a1575c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a159c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7a15c3d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a15ea86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a161114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7a1638ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a166128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7a168860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7a16aeee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7a16d59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a16fcb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:7a172356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a174a02-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a177090-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a1797e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a17be88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7a17e53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a180bea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a183426-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7a185d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a1883e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7a18abae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a18d2aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a18f956-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7a192002-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a1946a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a196e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7a1994ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7a19bb5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a19e1f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a1a0ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a1a32bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a1a595e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7a1a7fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a1aa706-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) DrugCentral uuid:7a1ac998-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a1af044-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7a1b16f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a1b3e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7a1b64e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7a1b8b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7a1bb240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7a1bda54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7a1c02fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7a1c29aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7a1c504c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7a1c7748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7a1c9dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a1cc482-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a1ceb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7a1d12f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a1d3976-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7a1d602c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7a1d86ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a1dae1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a1dd5c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a1dfc62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a1e22fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a1e4a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7a1e70b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7a1e974e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a1ebddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a1ee51e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a1f0d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7a1f33d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7a1f5a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a1f8262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7a1fa94a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a1fcfec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7a1ff684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7a201d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a204422-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a206ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a209166-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7a20b8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7a20df4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7a210614-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7a212cac-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a215498-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a217e8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a21a542-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7a21cbe4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7a21f2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pazopanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7a221996-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7a224042-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.328']} DrugCentral uuid:7a2266d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7a228e08-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.604']} DrugCentral uuid:7a22b4aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:7a22db74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7a230216-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7a232a02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:7a235108-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a2377b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7a23a23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7a23a23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7a23d8bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7a23d8bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:7a240b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z2V5 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a24f472-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7a251ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7a2545bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7a256c4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7a259346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a25b9ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:4120 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a25e062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7a260722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a262dce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:7a265510-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:7a267bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7a26a254-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.405']} DrugCentral uuid:7a26c900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:7a26ee26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:7a2710c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.922']} DrugCentral uuid:7a273782-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4122 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 auranofin is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7a275e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51788 biolink:molecularly_interacts_with DrugCentral:4123 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lubiprostone is opener of Ion channel (Chloride channel protein 2) DrugCentral uuid:7a278160-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7a27a820-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7a27cefe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7a27f5c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7a281ea4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7a284564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a286c1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:7a2892d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7a28ba4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7a28e12c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7a2907c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7a292e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q94F81 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7a29558a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O09106 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:7a297c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ZTP8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7a29a2a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:7a29c9ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q70I53 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase-like amidohydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7a29f120-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7a2a17d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7K6A1 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7a2a3e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7a2a64f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2a90ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a2a90ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a2ac85c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7a2ac85c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2b1ca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2bc626-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a2bc626-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a2bc626-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a2bc626-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a2c140a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2c140a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2c5c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:7a2ccabc-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7a2cf1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24527 biolink:molecularly_interacts_with DrugCentral:4124 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a2d1878-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:4125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7a2d3f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:4125 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 proline targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:7a2d65d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4126 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asparagine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7a2d8cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7a2db378-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7a2ddb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07314 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7a2e01fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63116 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Unclassified (Asc-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7a2e2966-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4127 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 serine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7a2e5030-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:4128 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:7a2e76dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:4134 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyridoxal targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7a2e9db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:7a2ec0d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:7a2ee392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:4135 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lisdexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:7a2f0638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7a2f2ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:7a2f54d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:7a2f7c9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.925']} DrugCentral uuid:7a2fa35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a2fca0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a2ff0b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:7a301852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.209']} DrugCentral uuid:7a303efe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:7a3065a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:7a308c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:7a30b352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:7a30d9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.635']} DrugCentral uuid:7a3100b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:7a31274c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7a314eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.251']} DrugCentral uuid:7a31754e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.916']} DrugCentral uuid:7a319bfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:7a31c3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:7a31eb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7a3211e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:7a32397a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.265']} DrugCentral uuid:7a32603a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:7a328754-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.556']} DrugCentral uuid:7a32ae00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:7a32d4ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7a32fb58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7a332290-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7a334946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7a337010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:7a3396c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.975']} DrugCentral uuid:7a33be8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:7a33e540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:7a340bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7a343298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.124']} DrugCentral uuid:7a345a16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:7a3480c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7a34a76e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.945']} DrugCentral uuid:7a34ce24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:7a34f53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:7a351bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:7a3542a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:7a356956-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.416']} DrugCentral uuid:7a359232-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:7a35ba50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7a35e0fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.084']} DrugCentral uuid:7a360794-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:7a362fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.012']} DrugCentral uuid:7a365690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a367d50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.233']} DrugCentral uuid:7a36a3e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.325']} DrugCentral uuid:7a36caf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:7a36f190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:7a371846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a373efc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4138 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentian violet targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:7a37667a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 udenafil targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7a378934-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 udenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.084']} DrugCentral uuid:7a37afe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine silver is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:7a37d27c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfadiazine silver targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:7a37f9e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7a382088-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.658']} DrugCentral uuid:7a38475c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.85']} DrugCentral uuid:7a386e12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.21']} DrugCentral uuid:7a389518-59f3-11ec-9eaa-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.96']} DrugCentral uuid:7a38bbce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7a38e28e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:4143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:7a390930-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7a3931c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7a395872-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:7a39804a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7a39a6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4146 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a39e1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a3a4296-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a3a69b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7a3a9066-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7a3ab726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a3adde6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:7a3b056e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7a3b2cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7a3b537a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a3b7a26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4150 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimonabant is antagonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:7a3ba2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7a3bc954-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7a3bec72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:7a3c13b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a3c3ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7a3c618e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 silodosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7a3c883a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2VKV7 biolink:molecularly_interacts_with DrugCentral:4152 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 permethrin is blocker of Ion channel (Sodium channel protein) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3cc660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7a3d4108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:4156 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edaravone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:7a3d6bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7a3d6bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:7a3d98d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7a3dbb88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) DrugCentral uuid:7a3dde2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7a3e052a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:4161 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 temsirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) DrugCentral uuid:7a3e2b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7a3e2b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7a3e5886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7a3e7f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4162 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexlansoprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a3f281a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a412a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7a415144-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:4163 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7a4177f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 liraglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.2']} DrugCentral uuid:7a419ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alcaftadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:7a41c1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4166 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ulipristal is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a41e92e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95470 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod targets Enzyme (Sphingosine-1-phosphate lyase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7a420fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7a42369a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7a425fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7a4286a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7a42ad5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923J1 biolink:molecularly_interacts_with DrugCentral:4167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fingolimod is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7a42d406-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7a42fb2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:7a432208-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.305']} DrugCentral uuid:7a4348d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.967']} DrugCentral uuid:7a436f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7a4396f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7a43bdbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:7a43e5bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.003']} DrugCentral uuid:7a440d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4168 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a444aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7a44abdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:4170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tesamorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a44e9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7a457076-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7a459736-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a45bdec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a45e484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7a460d2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7a4633e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7a465a90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7a468128-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a46a810-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBX1 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Enzyme (Cathepsin F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a46d330-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7a46d330-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7a4705da-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4172 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 boceprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7a472d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7a47540e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7a477ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNI1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Chymotrypsin-like elastase family member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7a47a15c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a47c8e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7a47ef86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7a48161e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7a483cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:7a4863c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7a488aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7a48b510-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:7a48b510-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:7a48e38c-59f3-11ec-9eaa-0242ac110003 UniProtKB:C1KIQ2 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a490ace-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7a4931a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q91RS4 biolink:molecularly_interacts_with DrugCentral:4173 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:7a49584e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7a497efa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:7a49a358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7a49cc34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7a49f2f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:4174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilpivirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7a4a19aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:7a4a40ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7a4a6770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7a4a8f0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7a4ab5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7a4add36-59f3-11ec-9eaa-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:4175 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a4b03d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a4b2aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7a4b5180-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7a4b79d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7a4ba220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:7a4bc8d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:4176 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7a4bef96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:4177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) DrugCentral uuid:7a4c12aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:4177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) DrugCentral uuid:7a4c3564-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a4c5bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7a4c82b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7a4caa12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:7a4cd0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:7a4cf79c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7a4d1e52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7a4d4652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a4d6fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a4d9936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a4dc2a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7a4dea6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7a4e112c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7a4e380a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a4e5fce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7a4e876a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a4eae02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7a4ed4cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7a4efb82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7a4f24ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a4f4b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a4f724c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7a4f98ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7a4fc01c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a4fe6c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a500d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7a503448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7a505b9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a508240-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a50a900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7a50cfa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a50f81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7a511eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a5145a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a516c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:7a51936a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a51ba34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a51e0fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a5207b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7a52302c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a5256d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a527d8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7a52a426-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a52cbd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a52f2a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7a531942-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7a53400c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a536712-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7a538dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.34']} DrugCentral uuid:7a53b488-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a53db52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7a54028a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7a5429cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a545082-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7a54774c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7a549f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a54c670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7a54ed1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a5513e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a553aec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7a5561a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a55884e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7a55b062-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7a55d7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7a55ff5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7a562614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a564d24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a567574-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7a569c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a56c312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a56e9c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a5710ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7a57377a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7a575e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a5784d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7a57ac14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7a57d2d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a57f980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7a582036-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7a584872-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a586fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7a589656-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7a58bdac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7a58e4a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7a590b5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a59320a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a5958ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a597ff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a59a6c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a59ce68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a59f528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7a5a1c6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7a5a432a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a5a69d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a5a9118-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7a5ab828-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a5adee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a5b05a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7a5b2c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7a5b535a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7a5b7a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a5ba116-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7a5bc7d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7a5beff4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a5c17f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7a5c3eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7a5c656a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7a5c8c7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a5cb33a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a5cd9dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4178 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7a5d0a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:7a5d0a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:7a5d0a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:7a5d0a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:7a5d4d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a5d750e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7a5d9bce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a5dc3d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7a5deaf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z351 biolink:molecularly_interacts_with DrugCentral:4181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 retigabine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a5e11a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7a5e3868-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a5e5f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rivaroxaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7a5e8638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7a5ead0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7a5ed3d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7a5efafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7a5f21ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 indacaterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7a5f488e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor is negative allosteric modulator of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7a5f6f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7a5f96ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EPX4 biolink:molecularly_interacts_with DrugCentral:4184 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ticagrelor targets GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a5fbd64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7a5fe42e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7a600abc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a603212-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7a6058b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7a607fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:7a60a67a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22830 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Enzyme (Ferrochelatase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a60cda8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:4185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7a60f45e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:7a611b1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25023 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.11']} DrugCentral uuid:7a6142ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70526 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.96']} DrugCentral uuid:7a616ac4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46663 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7a619242-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32299 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:7a61b916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97583 biolink:molecularly_interacts_with DrugCentral:4186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7a61dfe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7a620754-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7a622df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7a625600-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7a627ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a62a3bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7a62ca72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7a62f132-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7a6317f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a633f52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7a6365fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a638cb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a63b356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a63daca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a64016c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7a642836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7a644eec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a647624-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a649cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7a64c372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7a64ea3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7a65134a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a653a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a656110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a6587bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7a65af12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7a65d5d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a65fc92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7a662352-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7a664ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7a667190-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7a669832-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7a66bf74-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7a66e74c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7a671226-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7a6738c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7a675f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7a678684-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a67ad44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a67d3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7a67faa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7a6821c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7a6848b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.13']} DrugCentral uuid:7a686f7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7a689628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7a68bf36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7a68e6dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7a690da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7a693448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a695b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7a69820e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a69a8ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a69cf7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7a69f694-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a6a1d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7a6a43f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7a6a6aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7a6a92de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7a6ab98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7a6ae040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a6b06e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a6b2dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7a6b54bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7a6b7b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7a6ba232-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7a6bc960-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7a6bf00c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a6c16ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7a6c3d5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a6c6582-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a6c8c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7a6cb44c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a6cdaf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7a6d0226-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7a6d295e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a6d501e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a6d76ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7a6d9df8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7a6dc4a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7a6deb5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7a6e11f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a6e3a1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a6e612a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7a6e87f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7a6eaea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7a6ed5ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a6efc66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7a6f2326-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a6f4b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a6f724a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7a6f98f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7a6fbfa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7a6fe658-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7a700e76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7a703554-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7a705bf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a708392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:7a70aaa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a70d158-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7a70f7fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7a711ec4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7a7145ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7a716c80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7a719322-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a71b9ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7a71e1f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a720bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7a7234d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7a725b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7a728296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a72a960-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a72cff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7a72f6cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:7a731dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7a734474-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7a736b0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7a7391cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7a73ba94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7a73e2e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a740990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a743046-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7a745832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a747ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7a74a594-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7a74cc4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7a74f346-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7a751a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7a75409e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7a75675e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7a758fae-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a75b7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a75de64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7a76052e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a762c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a7652e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7a76798c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7a76a056-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7a76c75c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a76ee12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7a7714be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7a773b74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a776338-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7a778a02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62190 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7a77b0a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02858 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7a77d75a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a77ff64-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7a78262e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7a784cf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7a7873b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7a789e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7a789e38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7a78d10a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15357 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Enzyme (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7a78f7c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7a791e80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NB16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Mixed lineage kinase domain-like protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7a79478e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7a796e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:4188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deferiprone targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a799590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:7a79bc5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.261']} DrugCentral uuid:7a79e388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.573']} DrugCentral uuid:7a7a0a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7a7a3126-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7a7a57f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.501']} DrugCentral uuid:7a7a7f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:7a7aa5c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:7a7acc9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4189 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydroxyprogesterone caproate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.664']} DrugCentral uuid:7a7af34a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7a7b1bd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a7b42a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7a7b6956-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a7b9106-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7a7bb816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a7bdee0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a7c0596-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7a7c2daa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7a7c54b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a7c7b5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7a7ca208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7a7cc8dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7a7cf0be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7a7d177e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7a7d3e34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a7d64f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.44']} DrugCentral uuid:7a7d8c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7a7db2d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7a7dd98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7a7e003a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a7e274a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7a7e4de2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7a7e74c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7a7e9b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7a7ec3d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7a7eea7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7a7f1132-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7a7f38ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7a7f609c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7a7f8752-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7a7fae12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7a7fd4be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a7ffbe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a802284-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a804944-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a806ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7a8098f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7a80bfa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a80e656-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7a810d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7a813444-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a815afa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7a8181ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a81a870-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a81cf8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a81f636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a821d00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7a8243ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a826cb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7a8297c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7a82c174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7a82e884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7a8310b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7a833776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a835e2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7a8384e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a83abfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a83d2a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a83f95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7a84200a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7a8449e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7a8470be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7a849774-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a84be16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a84e530-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7a850bdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7a85329c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7a855952-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7a8580d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a85a790-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7a85cebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a85f574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7a861cfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:7a8643b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7a866a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a869100-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7a86b81a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7a86dfc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7a870694-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7a872d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a8754be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a877b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7a87a20c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7a87c8c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7a87f040-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7a8816e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7a883dac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7a88644e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7a888b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7a88b214-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7a88d8ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a88ff76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7a892834-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7a894eea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7a897596-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7a899c42-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a89c578-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a89ef08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7a8a188e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7a8a3f8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7a8a66a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a8a8e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7a8ab4ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7a8adb84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7a8b02da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7a8b2990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7a8b5050-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7a8b7710-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a8ba122-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a8bc800-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7a8beeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7a8c15e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a8c3cfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a8c647c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a8c8b8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7a8cb22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7a8cd98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7a8d003a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a8d26fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a8d4da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7a8d76d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7a8d9d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:7a8dc448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7a8dee46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7a8dee46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7a8e24b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7a8e24b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7a8e5c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7a8e5c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7a8e962a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:7a8e962a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:7a8e962a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:7a8ed842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7a8ed842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7a8f0c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7a8f3486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7a8f5baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:7a8f8256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7a8fa8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.393']} DrugCentral uuid:7a8fd008-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:7a8ff6f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:7a901d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:7a904448-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4191 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:7a906ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:7a90925e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:7a90b90a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.627']} DrugCentral uuid:7a90dfe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:4192 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafamidis is binding agent of Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.812']} DrugCentral uuid:7a9107c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99707 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase) DrugCentral uuid:7a912a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBK8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase reductase) DrugCentral uuid:7a914d0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXJ7 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Unclassified (Protein amnionless) DrugCentral uuid:7a916fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96EY8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial) DrugCentral uuid:7a919276-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH4 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Enzyme (Methylmalonic aciduria type A protein, mitochondrial) DrugCentral uuid:7a91b99a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20062 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-2) DrugCentral uuid:7a91dc54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20061 biolink:molecularly_interacts_with DrugCentral:4196 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-1) DrugCentral uuid:7a91ff18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:4197 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vitamin A palmitate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7a9225ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:4197 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vitamin A palmitate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7a924d42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4199 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium chloride targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7a927402-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:7a929ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:7a92c4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:7a92c4de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:7a92f54e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4207 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium carbonate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:7a931916-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7a933fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a936696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:7a9391ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.582']} DrugCentral uuid:7a93b894-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:7a93df5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7a940628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:7a942d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7a945452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7a947af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7a94a24a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a94ccac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:7a94f376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7a951a2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.157']} DrugCentral uuid:7a9540d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.394']} DrugCentral uuid:7a95695a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a9590f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:7a95b7b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7a95de80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a9605ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a962caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7a965360-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7a967a2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a96a1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:7a96c8a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:7a96ef6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7a9716a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7a973dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:7a976494-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:7a978b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7a97b1e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:7a97dff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7a97dff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7a97dff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7a98256e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:7a98256e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:7a98256e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:7a986c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a986c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a986c72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7a98b196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7a98b196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7a98b196-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7a98f886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7a98f886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7a98f886-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7a99371a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:4209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prazosin targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:7a995dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7a99847c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7a99abfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15552 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid is agonist of GPCR (Free fatty acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7a99d2b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14843 biolink:molecularly_interacts_with DrugCentral:4211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acetic acid targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7a99f970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7a9a1c0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4213 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7a9a4c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7a9a4c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7a9a4c40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7a9a83b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4219 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium phosphate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7a9aabc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:4220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telbivudine targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7a9ad2e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:4220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telbivudine is inhibitor of Polyprotein (Protein P) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:7a9af992-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4221 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mequinol is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:7a9b1c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7a9b4302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7a9b6a4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7a9b9104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7a9bb7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7a9bde84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7a9c05d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7a9c2c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7a9c542c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7a9c7ae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7a9ca1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7a9cc90c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7a9cefb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a9d1664-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:7a9d3da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a9d6452-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7a9d8b1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7a9db1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7a9dd900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7a9dffac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7a9e29be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7a9e29be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7a9e630c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7a9e630c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7a9e630c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7a9ea8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a9ea8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a9ea8b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7a9ee764-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7a9f0ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7a9f358e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7a9f5c4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7a9f8304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.31']} DrugCentral uuid:7a9fabf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7a9fd5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7a9fff50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7aa0266a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7aa04d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7aa07426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:7aa09ae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:7aa0c2f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7aa0ea3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7aa110fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.29']} DrugCentral uuid:7aa137a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7aa15e5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7aa18690-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7aa1b07a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7aa1d9ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7aa20070-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7aa22b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7aa25200-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7aa278a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aa29f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7aa2c640-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7aa2ed00-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aa313a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:7aa33a58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7aa36366-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7aa38b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7aa3b1e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7aa3d8aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7aa40000-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7aa426a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7aa44d3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7aa473e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7aa49b14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7aa4c1b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7aa4e862-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7aa50fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7aa538bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7aa55fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7aa58650-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7aa5acfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7aa5d470-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7aa5fb12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7aa621dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7aa6487e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7aa66fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7aa6964e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aa6bd04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7aa6e39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7aa70c50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7aa734a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7aa75c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7aa782f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7aa7aa66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7aa7d112-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aa7f7d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7aa81e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7aa84584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7aa86c30-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7aa892f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7aa8b992-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7aa8e2b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7aa909d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7aa9311a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7aa957c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aa97f3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7aa9a5dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7aa9cca6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7aa9f3e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7aaa1b20-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7aaa41b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7aaa6864-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7aaa8f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7aaab828-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7aaae212-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7aab092c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7aab30c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7aab5832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7aab7ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7aaba580-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7aabcc22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7aabf33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7aac19de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7aac408a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7aac6722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7aac9058-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7aacb6fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7aacdda6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7aad0466-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7aad2bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7aad5272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7aad791e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7aad9fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7aadc810-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7aadeec6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7aae1572-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4225 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 axitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7aae3c28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.79']} DrugCentral uuid:7aae65a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:7aae8c5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.197']} DrugCentral uuid:7aaeb306-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7aaed9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:7aaf0216-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.328']} DrugCentral uuid:7aaf28ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7aaf4f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15465 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7aaf762e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib is inhibitor of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:7aaf9d66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:4227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vismodegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7aafc494-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4228 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivacaftor is positive modulator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7aafeb4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafluprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:7ab00dfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginesatide is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.43']} DrugCentral uuid:7ab03744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:7ab05b8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7ab0824e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7ab0a90e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:7ab0d03c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:7ab0f6e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:4247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neomycin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:7ab11db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7ab1447c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ab16ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:7ab1927e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7ab1b952-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7ab1e008-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7ab20952-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7ab23346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7ab25a24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7ab280d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:7ab2a7f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7ab2cfb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ab2f696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7ab31d38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7ab347cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7ab347cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:7ab374f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7ab39baa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:7ab3c26a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4QYD9 biolink:molecularly_interacts_with DrugCentral:4258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thymol targets Unclassified (Heat sensitive channel TRPV3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7ab3ea4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7ab4122e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7ab43902-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:4264 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carbamide targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7ab45fa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7ab48718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7ab4add8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:4265 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gentamicin is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7ab4d47a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7ab4fba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7ab5233a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7ab549fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7ab570b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7ab59752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ab5bf3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:7ab5e5ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00720 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Endolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7ab60c96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:7ab63356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:7ab65a7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7ab6813a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:7ab6a8fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:7ab6cfc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenol targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:7ab6f750-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7ab71df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7ab7448a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:4267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7ab76b7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab803d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:7ab98c36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:7ab9b31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:7ab9d9fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7aba0170-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7aba2808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Florbetapir F-18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:7aba4edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7aba757e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7aba9cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7abac362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7abaea18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7abb10ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7abb39b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6RI86 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7abb60d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doconexent targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7abb8798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium iodide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7abbae58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7abbd5b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7abbfc82-59f3-11ec-9eaa-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4298 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apixaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:7abc2d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:7abc2d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:7abc2d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:7abc2d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:7abc79d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7abca088-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:7abcc748-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7abcede0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elvitegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:7abd17c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Flutemetamol (18F) targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7abd3e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.69']} DrugCentral uuid:7abd66a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:7abd8e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:7abdb50e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:7abddbe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abe2052-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:7abea0b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7abec85e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:7abef202-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7abf1b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7abf4626-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:4304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapagliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.87']} DrugCentral uuid:7abf6dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:7abf9478-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.201']} DrugCentral uuid:7abfbb10-59f3-11ec-9eaa-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:4305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avanafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7abfe50e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:7abfe50e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:7ac01830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7ac03ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7ac06646-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7ac08cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7ac0b68c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7ac0e080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7ac10a56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:7ac13350-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7ac15ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7ac18166-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7ac1a826-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7ac1cf04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7ac1f632-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7ac21cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7ac243c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7ac26a68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ac291dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7ac2b8b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7ac2df48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16555 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Enzyme (Dihydropyrimidinase-related protein 2) DrugCentral uuid:7ac30400-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:4310 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lacosamide targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7ac32b60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7ac35216-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7ac378ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7ac39f5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7ac3c656-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7ac3ecf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7ac420d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7ac420d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7ac420d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7ac420d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7ac420d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7ac4783a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7ac49ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7ac4c54c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7ac4ec8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7ac5134e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:7ac53a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7ac560ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7ac587d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7ac5ae94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7ac5d540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7ac5fbf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ac6240a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7ac64af2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7ac672a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ac699f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7ac6c126-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7ac6e7e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ac70e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7ac7353e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7ac75c30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7ac782f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7ac7a97e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7ac7d034-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ac7f820-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7ac821b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ac84b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7ac874a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7ac89d66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7ac8c408-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7ac8eaaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7ac912a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7ac939b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7ac96070-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ac98712-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7ac9adbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7ac9d672-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7ac9fda0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7aca2438-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7aca4bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7aca7334-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7aca99fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4318 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7acac0aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azilsartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7acae80a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:4322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 azilsartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7acb0f24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7acb35da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7acb5c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7acb8346-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7acbac4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:7acbd666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7acbff38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7acc262a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:4326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laropiprant is antagonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.52']} DrugCentral uuid:7acc4d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7acc744a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7acc9b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7accc1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7acce8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:4329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7acd1044-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7acd3704-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acde078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:7acfa28c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambrisentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:7acfc96a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ambrisentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:7acff0fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4340 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7ad017c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zucapsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:7ad03e5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:7ad06528-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:7ad08c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ad0b2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.726']} DrugCentral uuid:7ad0d9a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.363']} DrugCentral uuid:7ad10064-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.958']} DrugCentral uuid:7ad1290e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43194 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets GPCR (G-protein coupled receptor 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:7ad152a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6QR73 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets GPCR (G protein-coupled receptor 39-1b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7ad17968-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPD8 biolink:molecularly_interacts_with DrugCentral:4344 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zinc chloride targets Unclassified (Ubiquitin-conjugating enzyme E2 T) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7ad1a028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad1db7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:7ad23dda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:7ad264fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:7ad28bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:7ad2b36e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:7ad2da38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:4349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aurothioglucose targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7ad301ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bilastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:7ad3288a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:4357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anidulafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7ad34f22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:4358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arginine glutamate targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7ad375e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ad39d42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7ad3c470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7ad3eb30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.54']} DrugCentral uuid:7ad411f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7ad4391e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7ad45ffc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7ad486a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.23']} DrugCentral uuid:7ad4ad72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7ad4d4c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7ad4fb74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7ad52220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7ad548c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7ad57036-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7ad596e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7ad5bd70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7ad5e426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ad60b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7ad63214-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7ad658c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7ad6807a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7ad6a960-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7ad6d2dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7ad6fc4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7ad72566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7ad74cc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ad7737c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7ad79a28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7ad7c0d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7ad7e7f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7ad80e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7ad83686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7ad85d28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7ad88686-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ad8adbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ad8d488-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.38']} DrugCentral uuid:7ad8fb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7ad9228a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ad94936-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ad96fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7ad99698-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7ad9bdbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7ad9e47c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7ada0bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7ada326a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7ada5c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7ada82f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7adaa9a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7adad058-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7adaf7b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7adb1e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7adb451a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7adb6bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7adb92cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7adbb96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7adbe01a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7adc06b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:7adc3006-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7adc569e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:7adc7d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7adca3ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7adccb42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7adcf1f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7add18a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7add3f46-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7add6688-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7add8d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7addb3d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7addda78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7ade01e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7ade2988-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7ade5034-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.33']} DrugCentral uuid:7ade76e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ade9f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7adec640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7adeece2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:7adf138e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7adf3aa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7adf6154-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7adf880a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7adfaeb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7adfd62a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7adffcc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ae02364-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:7ae04a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ae07166-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7ae0988a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ae0bf36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7ae0e5e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:7ae10d06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ae133b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7ae15a7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ae18128-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7ae1aa86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7ae1d358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ae1fafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7ae221aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7ae2490a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ae26fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7ae29680-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7ae2bd2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7ae2e446-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7ae30ae8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7ae3318a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7ae35822-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7ae380e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ae3a796-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7ae3ce38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7ae3f4e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ae41c3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7ae442f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7ae469a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ae49048-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7ae4b776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7ae4de22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7ae504d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7ae52cba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7ae55668-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7ae58048-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7ae5a74e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7ae5cefe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7ae5f65e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7ae61d14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7ae643ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7ae66a62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7ae69172-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ae6b81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7ae6deb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7ae70580-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7ae72fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.29']} DrugCentral uuid:7ae7579c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7ae77e48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7ae7a508-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:7ae7cc54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7ae7f31e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7ae819ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7ae84080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ae8679a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ae88e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7ae8b4e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7ae8db9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7ae9040c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ae92aae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ae9515a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7ae977e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7ae9a06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7ae9c702-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ae9edb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7aea145a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7aea3b7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7aea622a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7aea88ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7aeaafa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:7aead8ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.49']} DrugCentral uuid:7aeaff50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7aeb2610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:7aeb4cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7aeb7408-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7aeb9bfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7aebc296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7aebe94c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7aec1070-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7aec3730-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7aec5dc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7aec846a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7aecabde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7aecd294-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:7aecf936-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7aed1fec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:7aed4738-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7aed6ee8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7aed9580-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7aedbcc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7aede3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7aee0a92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7aee3152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7aee581c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7aee80d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7aeea77c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7aeece14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7aeef4d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7aef1c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7aef42ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7aef6982-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7aef9038-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.11']} DrugCentral uuid:7aefb752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7aefde12-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7af004aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7af02b56-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7af052ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7af07980-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7af0a022-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7af0c6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7af0ee38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7af11502-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:7af13d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7af16430-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7af18b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7af1b200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7af1dc08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7af1dc08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7af214d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7af214d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7af24d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7af24d1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7af27fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:4360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetrimide targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7af2a6c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:7af2cdac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7af2f44e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chenodiol is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7af31adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:4362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chiniofon targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7af341d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:7af368d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7af38f76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZV8 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7af3b62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vernakalant is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.875']} DrugCentral uuid:7af3dd46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7af40514-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7af42bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7af45262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:7af47918-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4373 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7af4a0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7af4c882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:7af4ef4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:7af51616-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4374 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorcaserin is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:7af53d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7af563dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7af58a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7af5b292-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7af5da42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7af600ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29973 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7af6279a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16280 biolink:molecularly_interacts_with DrugCentral:4376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dequalinium is blocker of Ion channel (Cyclic nucleotide-gated olfactory channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7af64e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:4379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 degarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7af675ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.325']} DrugCentral uuid:7af69ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:7af6c358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 desvenlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7af6ea18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dapoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.95']} DrugCentral uuid:7af71146-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirabegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.65']} DrugCentral uuid:7af737fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7af75eda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7af785a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7af7b056-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7af7da4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:7af8015a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7af8289c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7af850a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7af87856-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7af89ef8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7af8c630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7af8ecf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7af9170c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:7af9170c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:7af94db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:7af94db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:7af98746-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7af98746-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7af98746-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7af98746-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7af9d1b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7afa032e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7afa032e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7afa032e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7afa032e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7afa5108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7afa5108-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7afa8a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7afa8a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7afa8a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7afac94e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline theophyllinate targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7afaf00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:7afb16ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:7afb3ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7afb66b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:7afb8956-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7afbb002-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:7afbd320-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:7afbf5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.582']} DrugCentral uuid:7afc1c68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.639']} DrugCentral uuid:7afc430a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.321']} DrugCentral uuid:7afc69b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.024']} DrugCentral uuid:7afc9102-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.029']} DrugCentral uuid:7afcb7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.154']} DrugCentral uuid:7afcde5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.335']} DrugCentral uuid:7afd04f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cisplatin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:7afd2cc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clofenotane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7afd5376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7afd7a2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltrombopag targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7afda0d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4399 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eltrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7afdc914-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casopitant targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7afdefde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casopitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:7afe168a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7DHH4 biolink:molecularly_interacts_with DrugCentral:4402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceftobiprole medocaril targets Enzyme (MecA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7afe3d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61073 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is partial agonist of GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7afe6cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:7afe934e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48061 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets Cytokine (Stromal cell-derived factor 1) DrugCentral uuid:7afeb608-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is antagonist of GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7afedd9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08565 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor targets GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7aff04b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25106 biolink:molecularly_interacts_with DrugCentral:4410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plerixafor is agonist of GPCR (Atypical chemokine receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7aff2ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.118']} DrugCentral uuid:7aff539c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.157']} DrugCentral uuid:7aff7aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:7affa18a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.308']} DrugCentral uuid:7affc836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:7affef00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.915']} DrugCentral uuid:7b00166a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:7b003d34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:7b0063f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.085']} DrugCentral uuid:7b008abe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.478']} DrugCentral uuid:7b00b228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:7b00d8fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.262']} DrugCentral uuid:7b00ffa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:7b012668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:7b014d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:7b01742e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.781']} DrugCentral uuid:7b019ae4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:7b01c1a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:4411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexchlorpheniramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.931']} DrugCentral uuid:7b01e8e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7b020fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7b023670-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diamorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7b025d44-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dibutylphthalate is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7b0283f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7b02abb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7b02d364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:4420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7b02fa38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:7b03212a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.018']} DrugCentral uuid:7b0347d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.652']} DrugCentral uuid:7b036e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:7b03951a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.604']} DrugCentral uuid:7b03bbc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 colistin targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.775']} DrugCentral uuid:7b03e330-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7b040a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7b0432a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7b045a18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7b0483b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:7b04ace8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7b04d376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7b04fa9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7b052146-59f3-11ec-9eaa-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7b0547f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7b056e9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7b0595fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7b05c006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:7b05c006-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:7b05f634-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:7b05f634-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:7b062d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7b062d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7b062d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7b062d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7b068090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:7b06b18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7b06b18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7b06b18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7b06b18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7b07001a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7b07001a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:7b073990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7b073990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7b073990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7b0778a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bufylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7b079f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:7b07c996-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7b07c996-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7b07ffb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:7b07ffb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:7b0837e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:7b0837e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:7b086aa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prednisolone sodium phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b088d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.179']} DrugCentral uuid:7b08b482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Cytosolic other (Annexin A1) DrugCentral uuid:7b08d73c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7b08fdf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:7b0924bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b094c1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.818']} DrugCentral uuid:7b0974da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7b099b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:7b09c2be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b09eb86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone cypionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:7b0a0f12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b0a31cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:4456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone succinate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7b0a5882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:7b0a7b96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7b0aa24c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:7b0ac8f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:4458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7b0aefae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:4466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eosin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7b0b16f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:4466 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eosin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0b5174-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:7b0bc1d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4470 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosaprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7b0beb7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7b0c1546-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4474 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7b0c3bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7b0c6320-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4477 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7b0c89d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:4480 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 potassium phosphate, monobasic targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b0cb08c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7b0cdef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:7b0cdef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:7b0cdef4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:7b0d24ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b0d24ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b0d24ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b0d6a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7b0d6a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7b0d6a36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:7b0da29e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7b0dc9ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b0df050-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7b0e171a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:7b0e3e2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:7b0e65e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b0e8c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:7b0eb47c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b0edbdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7b0f0274-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7b0f29c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:4483 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 carfilzomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:7b0f5062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7b0f79ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7b0fa094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7b0fc75e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7b0fedf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4484 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7b101524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4485 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflorasone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.536']} DrugCentral uuid:7b103cca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4485 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diflorasone diacetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7b10638a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4493 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b108644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:7b10ada4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:7b10d45a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:7b10fafc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:4496 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 haloperidol decanoate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7b1121a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4497 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estradiol acetate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:7b1146b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b116d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:7b11905c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4498 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paliperidone palmitate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:7b11b2f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:7b11d9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7b1200d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:7b12276a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:7b124a10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:7b126d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:7b128fc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4501 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 armodafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7b12b662-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4504 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b12d926-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:7b130086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7b1327f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7b134eb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:4505 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choline fenofibrate targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b137566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.135']} DrugCentral uuid:7b139cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:7b13c37c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4507 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 halcinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.917']} DrugCentral uuid:7b13ea1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7b1411e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:7b1438f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4508 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 racepinefrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7b1463ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:7b1463ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:7b1490d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4512 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lithium citrate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:7b14b39a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7b14db86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49190 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7b1504b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P70555 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7b152b86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25961 biolink:molecularly_interacts_with DrugCentral:4514 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b155228-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracosactide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.19']} DrugCentral uuid:7b157992-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4516 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tetracosactide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:7b15a034-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:7b15c2ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7b15e990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:7b160c4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92953 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine is blocker of Ion channel (Potassium voltage-gated channel subfamily B member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7b163346-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:7b1660aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7b1660aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7b1660aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7b169f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:4523 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quinine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:7b16c8e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbendazole targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.496']} DrugCentral uuid:7b16efa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:4536 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fenbendazole targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:7b171658-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.12']} DrugCentral uuid:7b173d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:7b176482-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b178c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:7b17b2e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7b17d98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b180090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7b182746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7b184e06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b1874d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7b18a96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b18a96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b18a96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b18a96e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b1900bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b1900bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b1900bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b19439c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:7b19439c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:7b1970b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6RY99 biolink:molecularly_interacts_with DrugCentral:4566 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium oxybate targets Unclassified (Gamma-hydroxybutyrate receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7b199752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4568 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrochloric acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7b19be8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4569 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 hydrocortisone probutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b19e1bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7b1a0890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7b1a2f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7b1a56ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:4573 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7b1a8784-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b1a8784-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b1a8784-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b1a8784-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b1ad478-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7b1afbc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7b1b2298-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7b1b494e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88944 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7b1b6ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:4588 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7b1b9700-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7b1bbd98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7b1be426-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7b1c0ac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:7b1c32c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7b1c59a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:4601 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diosmetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b1c805c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tonzonium targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7b1ca6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:4605 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tonzonium targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7b1cce36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4606 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clocortolone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7b1cf0e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:4608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7b1d1792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:4608 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7b1d3e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4609 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 testosterone enantate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:7b1d618e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7b1d884e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7b1daefa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7b1dd59c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7b1dfce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4611 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 stearic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b1e26fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27471 biolink:molecularly_interacts_with DrugCentral:4615 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 N-Acetylglucosamine targets Unclassified (Killer cell lectin-like receptor subfamily B member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b1e51fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7b1e78b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7b1e9ffe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:7b1ec6be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b1eed6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4616 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7b1f14c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7b1f3bda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7b1f6286-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:7b1f8946-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b1fb010-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.56']} DrugCentral uuid:7b1fd806-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7b2001dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7b2029c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7b205060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:7b207798-59f3-11ec-9eaa-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4618 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:7b209e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7b20c4f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:7b20ece6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7b2113ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:4621 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomefolic acid targets Enzyme (Thymidylate synthase) DrugCentral uuid:7b213688-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23897 biolink:molecularly_interacts_with DrugCentral:4622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:7b215d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:4622 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.907']} DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b219484-59f3-11ec-9eaa-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:7b21ef60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:4624 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenylacetic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:7b22160c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:7b223ccc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:7b226436-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7b228aec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7b22b1a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7b22d858-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:7b2302e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7b2302e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7b2335a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4628 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enzalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7b235c38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4628 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enzalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:7b2383a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4630 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium pyrophosphate targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7b23aa58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:7b23d6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7b23d6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7b23d6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7b23d6fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:7b241970-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trabectedin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7b244008-59f3-11ec-9eaa-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:4633 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trabectedin is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7b246740-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7b248df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7b24b4f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7b24db94-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:7b250308-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:4634 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7b2529b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:4635 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 Choline C-11 targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b255240-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7b2579f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7b25a06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7b25c6ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7b25ee3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O06446 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7b2614e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2FUW6 biolink:molecularly_interacts_with DrugCentral:4637 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b263b88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7b26636a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:7b268a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7b26b112-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:4641 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levmetamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7b26d7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7b26fe56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7b2725ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7b274c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7b27730e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:4642 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dodecanoic acid is agonist of GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7b2799ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4647 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluorometholone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:7b27c0fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b27e79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7b280e2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7b2834c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7b285b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b288262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7b28a8f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b28cf9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7b28f7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7b29223a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b294918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7b296fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2996fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b29bdbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b29e45e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2a0ae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2a31ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2a5862-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2a7f04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2aa57e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2acc02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2af650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2b1d56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7b2b43e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b2b6b26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:4655 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedisamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:7b2b91f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4659 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metamizole is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.041']} DrugCentral uuid:7b2bb87e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:7b2bdf34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7b2c0608-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7b2c2cbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:4660 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7b2c5374-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:4663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoin targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7b2c7a20-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:4663 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoin targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:7b2ca23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:7b2ccb56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b2cf356-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:4664 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benzoic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7b2d19f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:7b2d4130-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.776']} DrugCentral uuid:7b2d67dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:7b2d8e92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:7b2db53e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:7b2ddca8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4667 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.428']} DrugCentral uuid:7b2e035e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7b2e2a82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:7b2e5124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:7b2e7870-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:4671 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metizoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7b2ea156-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7b2ec7f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:7b2eee86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:7b2f1564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:7b2f3c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7b2f6294-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7b2f8918-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:7b2fb06e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7b2fd738-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7b2ffde4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:7b3024a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:7b304bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b30763e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:7b309d30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7b30c3aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7b30eaba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b311166-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4673 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nalfurafine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:7b313812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4676 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obidoxime targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.67']} DrugCentral uuid:7b315eb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7b3185ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7b31ac98-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7b31d358-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7b31fa22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:7b32218c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7b324b6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7b327290-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7b329964-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:7b32c092-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7b32e752-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:7b330e08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7b3334d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7b335dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4682 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:7b3384aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:7b33ab38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7b33d23e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7b33f9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7b3421f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:7b344980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7b347004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b349700-59f3-11ec-9eaa-0242ac110003 UniProtKB:O35678 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b34bd8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O08914 biolink:molecularly_interacts_with DrugCentral:4683 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 paraoxon targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7b34ee62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b34ee62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b34ee62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b34ee62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b35393a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7b355fc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7b358656-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7T664 biolink:molecularly_interacts_with DrugCentral:4690 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pleconaril targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7b35ad02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:4696 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remikiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:7b35d44e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b35fb04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7b3621ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:7b364870-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:7b366f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:7b369622-59f3-11ec-9eaa-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4702 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7b36bcd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4704 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 semustine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:7b36e3a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.074']} DrugCentral uuid:7b370af8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:7b372d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.624']} DrugCentral uuid:7b375454-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:7b377af6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4706 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium aurothiomalate targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7b37a2a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:4710 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatorelin is agonist of GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7b37cb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:7b37f1ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7b381894-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7b383f9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7b386646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7b388cde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b38b394-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7b38db94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:7b390254-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b392914-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7b394fc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7b397798-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7b399f98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7b39c644-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7b39ecfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7b3a140a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7b3a3ab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7b3a616c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7b3a8818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b3aaf78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7b3ad642-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7b3afcda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7b3b237c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7b3b4af0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7b3b7200-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:7b3b99b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b3bc070-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7b3be78a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b3c0e36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7b3c34ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7b3c5bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7b3c830c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62137 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7b3ca9b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7b3cd078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:7b3cf710-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b3d2262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7b3d2262-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7b3d60b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7b3d60b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7b3d60b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7b3da6b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7b3da6b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7b3dd9be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63272 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b3e03f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:7b3e03f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:7b3e3a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:7b3e3a6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:7b3e6dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.907']} DrugCentral uuid:7b3e946c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:7b3ebb0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7b3ee2aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b3f0be0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7b3f3584-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:7b3f5f32-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7b3f878c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7b3fae9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7b3fd548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:7b3ffc1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.947']} DrugCentral uuid:7b4022be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:7b404a1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.456']} DrugCentral uuid:7b4070b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.845']} DrugCentral uuid:7b409776-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4715 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabozantinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.886']} DrugCentral uuid:7b40be0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7b40e5aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:7b410c60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.903']} DrugCentral uuid:7b41330c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Breakpoint cluster region protein) DrugCentral uuid:7b41559e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7b417cae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7b41a364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7b41caa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:7b41f152-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7b4218c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:7b423f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.268']} DrugCentral uuid:7b426628-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7b428dc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:7b42b72c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7b42e0da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7b4307c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7b432e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b43557e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7b437c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b43a2ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7b43ccde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b43ccde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b440028-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4716 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7b442788-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95838 biolink:molecularly_interacts_with DrugCentral:4718 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teduglutide is agonist of GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7b444e02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z0W0 biolink:molecularly_interacts_with DrugCentral:4718 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teduglutide targets GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:7b44759e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:7b449844-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:7b44bad6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:7b44dd5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:7b44fffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4719 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:7b452304-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55157 biolink:molecularly_interacts_with DrugCentral:4721 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lomitapide is inhibitor of Cytosolic other (Microsomal triglyceride transfer protein large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:7b4549ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinimide targets Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:7b4570a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4723 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 succinimide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7b459758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:4727 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tacalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7b45becc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.573']} DrugCentral uuid:7b45e6ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7b460d64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:7b4633fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7b465dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7b46846a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O97554 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7b46ab16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O02768 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7b46d528-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7b46d528-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7b470822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48050 biolink:molecularly_interacts_with DrugCentral:4728 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenidap is activator of Ion channel (Inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b476038-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b484598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7b484598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7b484598-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7b488c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:7b488c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:7b488c10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:7b48d1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:7b48d1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:7b48d1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:7b49104a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7b493a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7b493a5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7b496dc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:4732 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thioctic acid targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7b499484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7b49bb44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:7b49e1e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:7b4a0bb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:7b4a3772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:7b4a603a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7b4a86f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.135']} DrugCentral uuid:7b4aae0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:7b4ad498-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:7b4afb62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7b4b2236-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7b4b4996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7b4b7042-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7b4b9702-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b4bbf0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b4be66c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b4c0d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7b4c33ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7b4c5aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:7b4c81c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7b4ca87c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:4733 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thiomersal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:7b4ccf14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d0dbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:7b4d78ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5TIX5 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7b4da09c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00845 biolink:molecularly_interacts_with DrugCentral:4741 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7b4dc770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crofelemer is inhibitor of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:7b4dee3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5XXA6 biolink:molecularly_interacts_with DrugCentral:4744 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crofelemer is inhibitor of Ion channel (Anoctamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:7b4e14fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b4e3c0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b4e62e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4746 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pomalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.577']} DrugCentral uuid:7b4e898a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4749 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ospemifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.082']} DrugCentral uuid:7b4eb04a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobetaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7b4ed7b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4752 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levobetaxolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7b4efe74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:4757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyl fumarate targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b4f262e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14145 biolink:molecularly_interacts_with DrugCentral:4757 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dimethyl fumarate is inhibitor of Cytosolic other (Kelch-like ECH-associated protein 1) DrugCentral uuid:7b4f48fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:7b4f714c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7b4f9ae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4758 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canagliflozin targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7b4fc1b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7b4fe884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:7b5010d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7b50379e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:7b505e40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7b508514-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7b50ac7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7b50d33e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4773 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7b50fa1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4778 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ridaforolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:7b5120b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.289']} DrugCentral uuid:7b5148b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:7b516fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.961']} DrugCentral uuid:7b5196a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.477']} DrugCentral uuid:7b51bd4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:7b51e454-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:7b520aec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:7b5231ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4794 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gramicidin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:7b525862-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium propionate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:7b527fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:B2GV46 biolink:molecularly_interacts_with DrugCentral:4796 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium propionate targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7b52a68c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.2']} DrugCentral uuid:7b52cd6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.08']} DrugCentral uuid:7b52f524-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4797 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.9']} DrugCentral uuid:7b531d06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7b5343bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7b536a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4799 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vilanterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b5390ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b53b810-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:7b53deb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7b540572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7b542c1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7b545388-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7b547a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7b54a14e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7b54c7f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b54efbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7b551674-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7b553d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7b5563f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b558b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b55b1ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:7b55d898-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.036']} DrugCentral uuid:7b55ff44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:7b5626ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4804 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palifermin is agonist of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:7b564972-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7b567172-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7b569922-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7b56c08c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:7b56e904-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7b570fe2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4805 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dolutegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.131']} DrugCentral uuid:7b57368e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7b575db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7b57845e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b57ab1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b57d1d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7b57f90c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b581fd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b58468c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7b586d56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7b58948e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b58be32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7b58e4fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7b590bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:7b5932ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:7b5959dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7b5980b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7b59a798-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:7b59cff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:7b59f6da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4806 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:7b5a1dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:4807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riociguat targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:7b5a4478-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4807 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 riociguat is positive allosteric modulator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'MEC', 'has_quantitative_value': ['7.523']} DrugCentral uuid:7b5a6d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7b5a96c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7b5abd86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7b5ae428-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.658']} DrugCentral uuid:7b5b0b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4808 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.569']} DrugCentral uuid:7b5b31f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macitentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:7b5b58d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4809 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macitentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.408']} DrugCentral uuid:7b5b7f78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7b5ba746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7b5bce10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:7b5bf4a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7b5c1b90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:7b5c435e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7b5c6cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7b5c9354-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7b5cba32-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7b5ce156-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRX8 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Unclassified (Redox-regulatory protein FAM213A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b5d0938-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:7b5d3016-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:7b5d56cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7b5d7e36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:7b5da4f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:7b5dcbb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7b5df26c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:7b5e1b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7b5e42f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:7b5e69c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:7b5e9078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7b5eb792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:7b5ede48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7b5f04f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7b5f2bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4810 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.143']} DrugCentral uuid:7b5f53aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofosbuvir is inhibitor of Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7b5f7a6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4811 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofosbuvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC90', 'has_quantitative_value': ['6.959']} DrugCentral uuid:7b5fa10c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b5fcb96-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b5fcb96-59f3-11ec-9eaa-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7b5ffff8-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:7b6026c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6GYR8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Polyprotein (Polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:7b604db4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4812 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 simeprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:7b607474-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:4813 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luliconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:7b609792-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:7b60be52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7b60e530-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4814 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olodaterol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:7b610bf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4815 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lixisenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.845']} DrugCentral uuid:7b613350-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7b6159fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:7b6180e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:7b61a7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.824']} DrugCentral uuid:7b61cf36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4816 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:7b61f6dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b621db0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b624484-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b626c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7b6292e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:4817 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rifamycin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:7b62b59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4818 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 florbetaben F18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:7b62dc6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:4820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:7b6303e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:4820 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7b632ab6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4821 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 seractide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.009']} DrugCentral uuid:7b6352b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7b637a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:4822 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7b63a1c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7b63c872-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:7b63ef1e-59f3-11ec-9eaa-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7b6415ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7b643cee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:7b6463c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7b648a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b64b12e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:7b64d8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7b64ff76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9IGQ6 biolink:molecularly_interacts_with DrugCentral:4823 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:7b65264a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4824 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etilefrine pivalate is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:7b654904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48357 biolink:molecularly_interacts_with DrugCentral:4826 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 metreleptin is agonist of Membrane receptor (Leptin receptor) DrugCentral uuid:7b656d08-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7b6593dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7b65baa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:7b65e256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4829 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:7b660970-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M3M2 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:7b66301c-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0PJK1 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:7b6656d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.081']} DrugCentral uuid:7b667d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:7b66a574-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4830 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 empagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.244']} DrugCentral uuid:7b66cc3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4832 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naloxegol is antagonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:7b66eeee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemigliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.328']} DrugCentral uuid:7b6715b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4833 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7b673d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:4834 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eliglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.827']} DrugCentral uuid:7b676748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7b678e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7b67b522-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7b67dc50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:7b68031a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33033 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7b6829c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41149 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7b68507c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56450 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:7b6877d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01727 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide targets GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:7b689e74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4836 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 afamelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7b68c548-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprotinin is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7b68ebf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4839 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aprotinin is inhibitor of Enzyme (Plasma kallikrein) DrugCentral uuid:7b690f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4846 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ecallantide is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.602']} DrugCentral uuid:7b6936b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:4848 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatropin is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:7b695972-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:4853 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cridanimod targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7b697ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3TBT3 biolink:molecularly_interacts_with DrugCentral:4853 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cridanimod targets Unclassified (Stimulator of interferon genes protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7b69a814-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:7b69cc54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4855 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:7b69ef0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:7b6a15d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7b6a3ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:7b6a6024-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4857 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:7b6a82de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q60748 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7b6aa98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47866 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7b6ad054-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13324 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7b6af94e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34998 biolink:molecularly_interacts_with DrugCentral:4858 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.481']} DrugCentral uuid:7b6b257c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:7b6b257c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:7b6b5286-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7b6b793c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6bb4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7b6c23c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.951']} DrugCentral uuid:7b6c4ae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4864 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.035']} DrugCentral uuid:7b6c71c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:7b6c9466-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4865 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:7b6cb720-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7b6ce114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7b6d08ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7b6d2f7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7b6d5676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b6d7cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b6da3a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7b6dca34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7b6df158-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7b6e1804-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7b6e3e9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7b6e6534-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7b6e8be0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7b6eb5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7b6ede9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7b6f0552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:7b6f2c58-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7b6f52e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7b6f7af0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7b6fa19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:7b6fc8de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7b6fef76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7b7016cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:7b703f58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:7b7066d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7b708d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7b70b42e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7b70dbc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7b71032a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7b7129c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7b715136-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41212 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transcription factor (Transcription factor ETV6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7b7177f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7b71a19a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:7b71c882-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:7b71efa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:7b721666-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4866 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ceritinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:7b72405a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b726724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b728dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7b72b49a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7b72dc36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b7302ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:7b7329a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7b73503a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:7b737830-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7b739ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7b73c97a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7b73c97a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:7b73f6a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25116 biolink:molecularly_interacts_with DrugCentral:4870 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vorapaxar is antagonist of GPCR (Proteinase-activated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.092']} DrugCentral uuid:7b741ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7b74454e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4873 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7b746c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:F2SHH3 biolink:molecularly_interacts_with DrugCentral:4874 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efinaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:7b748fc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:7b74b74a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:7b74de14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:7b7504ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:7b752b80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4875 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.301']} DrugCentral uuid:7b75536c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7b757a40-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7b75a114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7b75c914-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7b75f114-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7b76187e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7b763f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7b7665fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7b768db8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:7b76b48c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:7b76db2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7b7701ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7b7729da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4876 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.569']} DrugCentral uuid:7b775086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7b777746-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b779e10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7b77c6ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7b77edfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26637 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole targets Enzyme (Leucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:7b7814b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:F2SF18 biolink:molecularly_interacts_with DrugCentral:4877 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tavaborole is inhibitor of Enzyme (Leucine-tRNA ligase) DrugCentral uuid:7b783758-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7b785f80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NEB9 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 3-kinase catalytic subunit type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7b78864a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.086']} DrugCentral uuid:7b78acec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.248']} DrugCentral uuid:7b78d3ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.051']} DrugCentral uuid:7b78fb16-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4878 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 idelalisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:7b7921cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:4879 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enoxaparin sodium is activator of Secreted (Antithrombin-III) DrugCentral uuid:7b794472-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58308 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant targets GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:7b796b3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58307 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7b7992c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7b79b998-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:4881 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:7b79e062-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7b7a0722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7b7a2e3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7b7a54f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7b7a7c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b7aa2e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7b7aca2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7b7af0e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4882 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 istradefylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:7b7b17b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4885 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dulaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) DrugCentral uuid:7b7b3a66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:4886 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetilistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.225']} DrugCentral uuid:7b7b622a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:4888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiroxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:7b7b8c00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:4888 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 topiroxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.276']} DrugCentral uuid:7b7bb2fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:4889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asunaprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7b7bd9b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4889 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 asunaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:7b7c00e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7b7c28a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8C3K6 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7b7c50a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53790 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:7b7c775a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q923I7 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:7b7c9ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.727']} DrugCentral uuid:7b7cc566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4890 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.132']} DrugCentral uuid:7b7cec08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luseogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.399']} DrugCentral uuid:7b7d12aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4891 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luseogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.646']} DrugCentral uuid:7b7d3a96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4892 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.073']} DrugCentral uuid:7b7d6138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4892 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tofogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:7b7d87ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07650 biolink:molecularly_interacts_with DrugCentral:4893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipiracil targets Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7b7daeb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19971 biolink:molecularly_interacts_with DrugCentral:4893 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tipiracil is inhibitor of Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:7b7dd5c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:4894 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 iguratimod targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7b7dfc7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.54']} DrugCentral uuid:7b7e2316-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:7b7e49ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:7b7e7122-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4895 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teneligliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:7b7e97ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:7b7ebe70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:7b7ee508-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7b7f0cd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4896 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7b7f368e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4897 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 edoxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.252']} DrugCentral uuid:7b7f5d80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4898 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:7b7f8418-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:7b7fab28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:7b7fd1de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:7b7ff97a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4899 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.509']} DrugCentral uuid:7b80201c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:4900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7b804790-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:4900 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:7b806e32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4901 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin glargine is agonist of Kinase (Insulin receptor) DrugCentral uuid:7b8090e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidafenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['8.384']} DrugCentral uuid:7b80b7a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4902 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imidafenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['9.499']} DrugCentral uuid:7b80df48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:7b8108e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7b813268-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:7b81596e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7b818074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7b81a720-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:7b81cdc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7b81f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7b821bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7b82427a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7b82691c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7b828fd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.38']} DrugCentral uuid:7b82b8fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.02']} DrugCentral uuid:7b82dff0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7b83069c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7b832d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7b835458-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b837b0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7b83a1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7b83c942-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7b83f0a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7b841758-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7b843df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7b8464ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7b848c9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7b84b424-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7b84dad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:7b85017c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7b852896-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7b854f42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7b8575e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7b859c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7b85c3fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b85eab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7b861148-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b8637ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7b865f7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7b86863c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7b86acde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7b86d394-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7b86facc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7b872182-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b874824-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7b876ed0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7b879716-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7b87bdd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7b87e482-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7b880b24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7b8832c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b885c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7b8882fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7b88a9a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7b88d0ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7b88f75a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7b891dfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7b8945fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7b896d52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7b899408-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7b89babe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7b89e214-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.66']} DrugCentral uuid:7b8a0988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7b8a3034-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:7b8a56d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7b8a7da0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7b8aa4b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:7b8acb66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7b8af208-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7b8b18b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b8b4082-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7b8b683c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7b8b8ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7b8bb580-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.29']} DrugCentral uuid:7b8bdd30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7b8c0738-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7b8c2de4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7b8c5490-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7b8c7ba0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7b8ca256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b8cc8ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7b8cefa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7b8d16f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7b8d3d9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7b8d6498-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7b8d8b3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7b8db2ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7b8ddbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7b8e025e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7b8e290a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7b8e501a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7b8e76c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7b8e9d7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b8ec428-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7b8eeb6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7b8f1234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7b8f39c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7b8f6072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7b8f87e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b8fafe6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7b8fd67e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7b8ffd2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7b902430-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b904adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7b90717e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7b90982a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7b90bf76-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7b90e62c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7b910cce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7b913384-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7b915b2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7b9181e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7b91a904-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7b91cfba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7b91f6b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7b921d6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:7b924418-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b926ad8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7b929224-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7b92b8da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7b92df7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7b930718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7b932eaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7b9355c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7b937c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:7b93a312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7b93ca18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7b93f0e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7b94177a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b943e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7b94654a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7b948c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7b94b2b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7b94d958-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7b94fffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7b952750-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7b954dde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:7b957494-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7b959b40-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7b95c6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7b95ed84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b96143a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7b963cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b96635e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7b968a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7b96b1a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7b96d906-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7b96ffb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:7b972654-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b974cf6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b977442-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b979b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7b97c1a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.07']} DrugCentral uuid:7b97e850-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7b980fba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7b983670-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7b985cfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:7b9883aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7b98aace-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7b98d1f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7b98f894-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7b991f36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7b9945e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7b996cfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7b9993bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7b99ba54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b99e10a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7b9a084c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7b9a2f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7b9a559a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7b9a7d40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b9aa504-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7b9acbba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7b9af25c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7b9b1912-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7b9b4018-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7b9b66ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7b9b8d5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7b9bb408-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7b9bdb5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7b9c021e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b9c28b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7b9c4f6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7b9c78a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7b9ca084-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7b9cc730-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b9ceddc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7b9d1500-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7b9d3ba2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7b9d6244-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7b9d88dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7b9db0a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7b9dd742-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7b9dfe02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:7b9e2490-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:7b9e4f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7b9e7648-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b9e9cfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7b9ec3a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7b9eeaa6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:7b9f115c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7b9f381c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7b9f5ec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7b9f8632-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7b9facca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7b9fd376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7b9ffa22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7ba02344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7ba049e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7ba0709c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7ba0973e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:7ba0be58-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7ba0e4fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7ba10bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7ba1325c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7ba159c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7ba18072-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7ba1a714-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7ba1cdca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:7ba1f8f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7ba222de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:7ba24caa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.983']} DrugCentral uuid:7ba273ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7ba29aac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7ba2c162-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:7ba2e822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7ba30f82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4904 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 adalimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:7ba33372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4905 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegaptanib is antagonist of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:7ba35636-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4906 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fimasartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.377']} DrugCentral uuid:7ba37ce2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7ba3a384-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7ba3cc9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7ba3f348-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7ba419fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7ba440aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2NL67 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Unclassified (Poly [ADP-ribose] polymerase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7ba467c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5Y8 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Unclassified (Mono [ADP-ribose] polymerase PARP16) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7ba48e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:7ba4b512-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7ba4dbbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7ba50328-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:4907 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7ba529de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4908 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acotiamide is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:7ba55094-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31358 biolink:molecularly_interacts_with DrugCentral:4909 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alemtuzumab is antibody binding of Surface antigen (CAMPATH-1 antigen) DrugCentral uuid:7ba57358-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4910 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 felypressin is agonist of GPCR (Vasopressin V1a receptor) DrugCentral uuid:7ba598f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.85']} DrugCentral uuid:7ba5c2ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.92']} DrugCentral uuid:7ba5ee00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.301']} DrugCentral uuid:7ba614de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4912 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:7ba63be4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasabuvir targets Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7ba66268-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasabuvir targets Unclassified (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7ba68914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7ba6b740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7ba6b740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7ba6b740-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7ba6f5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:7ba71cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49763 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Placenta growth factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.409']} DrugCentral uuid:7ba743a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49765 biolink:molecularly_interacts_with DrugCentral:4916 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.717']} DrugCentral uuid:7ba76b2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4917 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ramucirumab is antibody binding of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7ba791ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7ba7b884-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7ba7df1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:7ba806fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7ba8344e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7ba8344e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7ba8344e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7ba8731e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4921 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 safinamide is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:7ba89ab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4923 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 nivolumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.14']} DrugCentral uuid:7ba8c184-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4924 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pembrolizumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:7ba8ebaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:7ba8ebaa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:7ba919fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:4927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7ba94302-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4927 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:7ba969ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:4928 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 follitropin is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:7ba98c86-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:4929 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lutropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.9']} DrugCentral uuid:7ba9b33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16473 biolink:molecularly_interacts_with DrugCentral:4930 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 thyrotropin alfa is agonist of GPCR (Thyrotropin receptor) DrugCentral uuid:7ba9d650-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7ba9fd24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7baa23ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7baa4ab8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:7baa6e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q64326 biolink:molecularly_interacts_with DrugCentral:4931 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7baa9860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:7baa9860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:7baac59c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:4934 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 secukinumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:7baae86a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03420 biolink:molecularly_interacts_with DrugCentral:4935 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palivizumab is antibody binding of Surface antigen (Fusion glycoprotein F0) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:7bab1196-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4936 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 parathyroid hormone is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) DrugCentral uuid:7bab363a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7bab5cc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7bab8392-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7babaac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7babd19e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:7babf87c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4937 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.319']} DrugCentral uuid:7bac1f50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7bac46c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:7bac6d84-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4938 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7bac9426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:7bacbb40-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7bace35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7bad0b36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.301']} DrugCentral uuid:7bad320a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:4939 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:7bad58e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01589 biolink:molecularly_interacts_with DrugCentral:4940 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 basiliximab is antibody binding of Membrane receptor (Interleukin-2 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:7bad7fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7bada69a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7badcd28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7badf730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7badf730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7bae2df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7bae2df4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7bae63e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7bae63e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7bae96a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:7baebf44-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:7baee604-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7baf0e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4941 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:7baf34c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:7baf5bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:7baf82b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:7bafa95e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:7bafd014-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7baff79c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7bb01e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.658']} DrugCentral uuid:7bb04512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:7bb06be6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:7bb0959e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:7bb0bc68-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4942 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenvatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:7bb0e30a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:7bb109b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:7bb13152-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.947']} DrugCentral uuid:7bb15812-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4943 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 arformoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.538']} DrugCentral uuid:7bb17edc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7bb1a592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin is agonist of GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7bb1ccde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7bb1f39e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7bb21a5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7bb24100-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4945 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:7bb26af4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7bb294e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7bb2bec8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.155']} DrugCentral uuid:7bb2e808-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7bb30f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:4946 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7bb335f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y275 biolink:molecularly_interacts_with DrugCentral:4949 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belimumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 13B) DrugCentral uuid:7bb35c0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:7bb35c0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:7bb389f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4951 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ofatumumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.92']} DrugCentral uuid:7bb3b0c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:4952 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 canakinumab is antibody binding of Cytokine (Interleukin-1 beta) DrugCentral uuid:7bb3da2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7bb3da2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7bb3da2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7bb418d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4954 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cetuximab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:7bb44338-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4955 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 panitumumab is agonist of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7bb46a02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4956 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bevacizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:7bb48cd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4957 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pertuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:7bb4af8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16410 biolink:molecularly_interacts_with DrugCentral:4958 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ipilimumab is antibody binding of Surface antigen (Cytotoxic T-lymphocyte protein 4) DrugCentral uuid:7bb4d2bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:4959 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 efalizumab is antibody binding of Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.4']} DrugCentral uuid:7bb4f990-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4960 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin degludec is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bb51c54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:4961 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 raxibacumab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.556']} DrugCentral uuid:7bb544d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28908 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is binding agent of Membrane receptor (Tumor necrosis factor receptor superfamily member 8) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb582de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bb5f98a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14788 biolink:molecularly_interacts_with DrugCentral:4965 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denosumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 11) DrugCentral uuid:7bb622a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:7bb622a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:7bb65402-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:7bb65402-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:7bb68120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4967 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 golimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:7bb6a45c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4968 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 certolizumab pegol is antibody binding of Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.046']} DrugCentral uuid:7bb6cb44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:4969 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eculizumab is antibody binding of Secreted (Complement C5) DrugCentral uuid:7bb6f16e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:7bb6f16e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:7bb721fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:7bb721fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:7bb74ff6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4971 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ranibizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:7bb772ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01854 biolink:molecularly_interacts_with DrugCentral:4972 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omalizumab is antibody binding of Antibody (Ig epsilon chain C region) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:7bb79a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7bb7c148-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide targets Cytokine (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7bb7eab0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.135']} DrugCentral uuid:7bb81152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.365']} DrugCentral uuid:7bb83808-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:7bb85ed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.022']} DrugCentral uuid:7bb885f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:7bb8acac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4973 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.108']} DrugCentral uuid:7bb8d362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4974 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infliximab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:7bb8f61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4975 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rituximab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:7bb91e26-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4976 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 triamcinolone hexacetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:7bb940e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:4977 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siltuximab is antibody binding of Cytokine (Interleukin-6) DrugCentral uuid:7bb963a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4978 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etanercept is inhibitor of Cytokine (Tumor necrosis factor) DrugCentral uuid:7bb98672-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4979 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:7bb9a9e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20138 biolink:molecularly_interacts_with DrugCentral:4980 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gemtuzumab ozogamicin is antibody binding of Surface antigen (Myeloid cell surface antigen CD33) DrugCentral uuid:7bb9cc9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4981 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin aspart is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bb9f2c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7bb9f2c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7bba26e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4983 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obinutuzumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) DrugCentral uuid:7bba4a12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4984 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibritumomab tiuxetan is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.854']} DrugCentral uuid:7bba70f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4985 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin detemir is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bba93be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4986 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:7bbab682-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4987 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:7bbad9d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:7bbb00a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:7bbb2752-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:7bbb4de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07445 biolink:molecularly_interacts_with DrugCentral:4988 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deoxycholic acid targets Unclassified (Steroid Delta-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7bbb766c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbbb49c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7bbc2ada-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4991 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lipegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:7bbc50e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7bbc50e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7bbc83cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4995 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.15']} DrugCentral uuid:7bbcaa82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4996 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romiplostim is agonist of Membrane receptor (Thrombopoietin receptor) DrugCentral uuid:7bbcce22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5000 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evolocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.72']} DrugCentral uuid:7bbcf4d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7bbd1b84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:7bbd42e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7bbd6c4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7bbd93a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7bbdba80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5001 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eluxadoline is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:7bbde168-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5002 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin lispro is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bbe0486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:7bbe2b28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15127 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.71']} DrugCentral uuid:7bbe51e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5003 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin human is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bbe74a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5005 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mirodenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.469']} DrugCentral uuid:7bbe9ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7bbec34e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7bbeea0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:5006 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.627']} DrugCentral uuid:7bbf10ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5007 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin theta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:7bbf3504-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:5008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sonidegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:7bbf5bba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5008 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sonidegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:7bbf827a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecasermin targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:7bbfaa66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5009 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mecasermin is agonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7bbfd1ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5010 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:7bbfff52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bbfff52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bbfff52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bc036b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:5012 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacubitril is inhibitor of Enzyme (Neprilysin) DrugCentral uuid:7bc059d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5013 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trelagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:7bc080ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7bc0a7ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7bc0cee6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:7bc0f718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7bc11e46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:7bc144f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:7bc16bbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:7bc1933a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7bc1ba0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:7bc1e0a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.857']} DrugCentral uuid:7bc20766-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:7bc22e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:7bc2554a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:7bc27cfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:7bc2a3c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7bc2cb6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7bc2f234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7bc318ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:7bc33fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:7bc36700-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:7bc38dca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.025']} DrugCentral uuid:7bc3b476-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:7bc3db40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:7bc4025a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:7bc42924-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:7bc44fee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:7bc476cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.921']} DrugCentral uuid:7bc49e5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5014 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:7bc4c6cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5015 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegvisomant is antagonist of GPCR (Growth hormone receptor) DrugCentral uuid:7bc4e990-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5016 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alirocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:7bc513b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7bc513b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7bc54728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:7bc56df2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.516']} DrugCentral uuid:7bc5949e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:7bc5bcb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:7bc5e3c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.049']} DrugCentral uuid:7bc60a8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:7bc6323c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.093']} DrugCentral uuid:7bc65910-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7bc6821e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5022 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7bc6af64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7bc6af64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7bc6e98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:7bc6e98e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:7bc717ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5027 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rolapitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:7bc73e70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:5031 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mogamulizumab is antibody binding of GPCR (C-C chemokine receptor type 4) DrugCentral uuid:7bc76116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7bc787d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:7bc7aef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7bc7d5b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7bc7fc70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7bc82312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7bc84ac2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7bc87182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7bc8984c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:7bc8bf02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.07']} DrugCentral uuid:7bc8e68a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:7bc90d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7bc9340a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:7bc95aca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7bc98220-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5037 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:7bc9a8cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7bc9cf96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7bc9f75a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7bca1ef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7bca47aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7bca6e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7bca94ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7bcabc9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7bcae340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7bcb09f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7bcb30b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7bcb57da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7bcb7e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7bcba578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7bcbcc2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:7bcbf384-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7bcc1b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6XA80 biolink:molecularly_interacts_with DrugCentral:5039 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tannic acid targets Unclassified (Leukotriene C4 synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7bcc421c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5042 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somatrem is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:7bcc64cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5044 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:7bcc8772-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:7bccaed2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib is allosteric modulator of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7bccd592-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5046 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cobimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:7bccfc48-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.187']} DrugCentral uuid:7bcd2312-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5047 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:7bcd4a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7bcd70ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:7bcd9770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7bcdbf0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7bcde748-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7bce0dfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7bce34aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7bce5b6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7bce82c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7bcea976-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7bced04a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:5048 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pitolisant is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:7bcef71e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7bcf1e4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7bcf450c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7bcf6bd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7bcf92a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7bcfbc8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7bcfe37c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7bd00a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7bd030e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:7bd05852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:7bd07f12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:7bd0a5be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:7bd0cc9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.469']} DrugCentral uuid:7bd0f3de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7bd11b48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5052 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 aripiprazole lauroxil is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.469']} DrugCentral uuid:7bd14212-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:7bd168aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:7bd193e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5054 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omarigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:7bd1bd46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5057 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 insulin glulisine is agonist of Kinase (Insulin receptor) DrugCentral uuid:7bd1e028-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5059 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lusutrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.076']} DrugCentral uuid:7bd206b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5060 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7bd22e16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:5060 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7bd254e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5061 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mepolizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:7bd27cd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:7bd2a364-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7bd2ca6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7bd2f116-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:7bd317ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53634 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Enzyme (Dipeptidyl peptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:7bd33e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7bd366c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5062 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osimertinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7bd38d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5063 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daratumumab is antibody binding of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7bd3b470-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5064 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 climbazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7bd3db08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trenbolone hexahydrobenzylcarbonate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:7bd40268-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5065 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trenbolone hexahydrobenzylcarbonate targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:7bd42932-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5066 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenecteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:7bd44be2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.509']} DrugCentral uuid:7bd4728e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:7bd499c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:5067 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:7bd4c09a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:5068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivaracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7bd4e764-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:5068 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brivaracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7bd50e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5071 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 necitumumab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.49']} DrugCentral uuid:7bd537e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQ25 biolink:molecularly_interacts_with DrugCentral:5072 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elotuzumab is antibody binding of Membrane receptor (SLAM family member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7bd55faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:5075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.432']} DrugCentral uuid:7bd586d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5075 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.137']} DrugCentral uuid:7bd5ad8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7bd5d502-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7bd5fbe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7bd62336-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7bd64a0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:7bd67138-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7bd69816-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:5077 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:7bd6bed6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:7bd6e58c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5078 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:7bd70f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:7bd738a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:7bd75f62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.523']} DrugCentral uuid:7bd78618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:7bd7ad78-59f3-11ec-9eaa-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5080 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:7bd7d424-59f3-11ec-9eaa-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:7bd7fac6-59f3-11ec-9eaa-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:7bd82190-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7bd848b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.301']} DrugCentral uuid:7bd86f7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.398']} DrugCentral uuid:7bd8962a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5081 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:7bd8bce0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:5083 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ixekizumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:7bd8e904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bd8e904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bd8e904-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:7bd92306-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06729 biolink:molecularly_interacts_with DrugCentral:5088 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alefacept is inhibitor of Surface antigen (T-cell surface antigen CD2) DrugCentral uuid:7bd945d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7bd96d7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5089 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7bd99444-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) DrugCentral uuid:7bd9b708-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5091 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) DrugCentral uuid:7bd9da58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5093 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 reslizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.092']} DrugCentral uuid:7bda0186-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:5094 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obiltoxaximab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.481']} DrugCentral uuid:7bda2846-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01583 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.854']} DrugCentral uuid:7bda4f10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18510 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Unclassified (Interleukin-1 receptor antagonist protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.215']} DrugCentral uuid:7bda7666-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:5105 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:7bda9e66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5109 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 urokinase is activator of Enzyme (Plasminogen) DrugCentral uuid:7bdac102-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7bdae7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7bdb0e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7bdb357e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7bdb5c2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7bdb82d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:7bdba982-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:7bdbd06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59750 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7bdbf716-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02401 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:7bdc1dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UUZ4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Alpha-galactosidase C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:7bdc445a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q42656 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Alpha-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7bdc6b92-59f3-11ec-9eaa-0242ac110003 UniProtKB:D3ZUM4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:7bdc9298-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8VNN2 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:7bdcb958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06280 biolink:molecularly_interacts_with DrugCentral:5110 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 migalastat is pharmacological chaperone of Enzyme (Alpha-galactosidase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7bdce0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chromic chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7bdd0836-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5118 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 chromic chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:7bdd2f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:7bdd55c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:7bdd7c94-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:5133 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:7bdda728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bdda728-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bddd7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bddd7ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bde083a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bde083a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7bde3562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5141 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:7bde590c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7bde7fe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5142 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7bdea696-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7bdecea0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O88587 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7bdef614-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:5143 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:7bdf1cb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:5144 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gluconolactone targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:7bdf4376-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:5149 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 choriogonadotropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:7bdf663a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5151 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atezolizumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7bdf8d72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:7bdfb4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:7bdfdb6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.796']} DrugCentral uuid:7be0020c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:7be02b2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.979']} DrugCentral uuid:7be0550e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:7be07f8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:7be0a63a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9DHD6 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:7be0cda4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O91936 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.426']} DrugCentral uuid:7be0f46e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5I2N3 biolink:molecularly_interacts_with DrugCentral:5154 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.097']} DrugCentral uuid:7be11b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:5155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obeticholic acid targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7be141bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:5155 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 obeticholic acid is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.004']} DrugCentral uuid:7be168ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5157 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darbepoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:7be18f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7be18f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7be1bc46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5160 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:7be1e270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7be1e270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7be212e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5165 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 methoxy polyethylene glycol-epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:7be23590-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:5167 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lenograstim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:7be25854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:5169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eldecalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:7be27b04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:5169 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eldecalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7be2a278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5170 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 epoetin zeta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:7be2c532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05362 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast targets Unclassified (Intercellular adhesion molecule 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:7be2ef58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:7be2ef58-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:7be3295a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:7be3295a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:7be3295a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:7be3642e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7be3642e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:7be396f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5181 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etelcalcetide is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:7be3be42-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5182 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eteplirsen is binding agent of RNA (exon 51 of dystrophin pre-mRNA) DrugCentral uuid:7be3e278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5183 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olaratumab is antibody binding of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:7be4094c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5185 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallium (68Ga) edotreotide is antagonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7be430ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18177 biolink:molecularly_interacts_with DrugCentral:5186 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bezlotoxumab is antibody binding of Enzyme (Toxin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7be45794-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5188 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 radotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.514']} DrugCentral uuid:7be47ecc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7be4a6a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7be4d778-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7be4d778-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7be4d778-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7be4d778-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7be52250-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7be54906-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7be56fc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7be59744-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.87']} DrugCentral uuid:7be5be22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.276']} DrugCentral uuid:7be5e4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:7be60bca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5202 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:7be63320-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7be659c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:7be68078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7be6a724-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7be6ce5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7be6f51c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7be71bdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:7be742a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7be76b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:7be79526-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5203 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7be7bc40-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7be7e2f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19438 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide targets Unclassified (Tumor necrosis factor receptor superfamily member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:7be80a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:5208 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 plecanatide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.721']} DrugCentral uuid:7be83120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5209 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 icotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:7be857d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7be87e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5210 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 olmutinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.036']} DrugCentral uuid:7be8a5d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7be8cca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.368']} DrugCentral uuid:7be8f362-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.276']} DrugCentral uuid:7be91a22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:7be94218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5211 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7be96a04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17752 biolink:molecularly_interacts_with DrugCentral:5214 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 telotristat ethyl is inhibitor of Enzyme (Tryptophan 5-hydroxylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7be990c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclabuvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:7be9b78e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O39930 biolink:molecularly_interacts_with DrugCentral:5215 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 beclabuvir targets Unclassified (RNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7be9df02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7bea05c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7bea2c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:7bea534c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:7bea7a8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7beaa13a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:5217 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cytisine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:7beac9c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:7beaf09a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:7beb19a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5218 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7beb4388-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naldemedine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:7beb6d5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5220 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 naldemedine is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:7beb9446-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5221 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avelumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:7bebb796-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7bebde4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7bec050c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7bec2bc2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7bec52d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7bec799c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7beca066-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:7becc726-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7becef30-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:7bed192e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5222 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:7bed421e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:5223 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ocrelizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:7bed6988-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24394 biolink:molecularly_interacts_with DrugCentral:5224 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dupilumab is antibody binding of Membrane receptor (Interleukin-4 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.06']} DrugCentral uuid:7bed90fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5226 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 deutetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:7bedb3c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:5227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:7bedda94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5227 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:7bee0168-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:7bee288c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55859 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.64']} DrugCentral uuid:7bee4f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:5229 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 forodesine is inhibitor of Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.143']} DrugCentral uuid:7bee762a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7bee9cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7beec4ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7beeed76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7bef1422-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:7bef3ae2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7bef6224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7bef88ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7befafa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7befd65a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7beffd6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7bf02434-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7bf04aea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7bf071b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7bf09900-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7bf0bfc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7bf0e66c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7bf10d36-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7bf13482-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7bf15c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7bf18324-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7bf1a9e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7bf1d0f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7bf1f7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7bf21e60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7bf2450c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7bf26d16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7bf29426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7bf2bbe0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7bf2e296-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7bf309f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7bf330a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7bf357da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7bf37e9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7bf3a5a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7bf3cc56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7bf3f302-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:7bf419c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7bf441ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7bf469c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7bf49078-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7bf4b724-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7bf4de66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7bf5051c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7bf52bbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7bf5527e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7bf5797a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7bf5a030-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7bf5c6f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7bf5ed9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7bf6157e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7bf63ca2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7bf6645c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7bf68b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7bf6b286-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7bf6d93c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7bf6fff2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7bf72694-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7bf74dae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7bf7745a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7bf79b1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:7bf7c310-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7bf7eaf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7bf812a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7bf83958-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7bf8600e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7bf88746-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7bf8ae10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7bf8d4a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7bf8fb5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7bf9226e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7bf9492e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7bf96fda-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7bf9969a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7bf9be86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7bf9e546-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7bfa0bf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7bfa33c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7bfa5b02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7bfa81cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7bfaa878-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7bfacf2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7bfaf63e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7bfb1cfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7bfb43a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7bfb6a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7bfb9224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:7bfbb8d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7bfbdf7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7bfc06be-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7bfc2e50-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7bfc54fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7bfc7ba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7bfca25e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7bfcc978-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7bfcf02e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7bfd16da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7bfd3d9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7bfd6540-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7bfd8eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7bfdb874-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:7bfde07e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7bfe07d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7bfe2e94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7bfe5694-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:7bfe7d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7bfea464-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7bfecb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7bfef1f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7bff18ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7bff40cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7bff6a84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7bff91bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7bffb85e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7bffdfd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7c000692-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c002dd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7c005480-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c007bb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7c00a25a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7c00c91a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c00efd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7c011744-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7c013e04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7c0164ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7c018c7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7c01b3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7c01da80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7c020140-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7c022800-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7c024f06-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7c0275b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7c029c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c02c30a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c02eb3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c0311f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c0338a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7c035f68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c038682-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7c03ad42-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:7c03d3ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7c03faa4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c0421f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7c04489c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7c046f5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c049612-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c04beda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7c04e586-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7c050c46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7c0532e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c055b10-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7c0581b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7c05a868-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7c05cf28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7c05f67e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7c061d3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c0643f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c066b22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c069354-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c06bc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c06e32c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c0709ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7c0730fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7c0757bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:7c077e7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7c07a532-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7c07cc88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7c07f348-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7c0819fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c0840c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7c0868fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:7c089280-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7c08b94a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c08e000-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c090724-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7c092ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7c095576-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7c097c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c09a38c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c09ca38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7c09f1b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7c0a1880-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7c0a4012-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c0a66d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7c0a8da6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c0ab470-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7c0adb8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7c0b024a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7c0b2900-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7c0b50f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7c0b786a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7c0b9f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c0bc5c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7c0bec6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c0c14d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7c0c3ea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7c0c6860-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7c0c9218-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c0cba54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:7c0ce1dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7c0d089c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c0d2fca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:7c0d573e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c0d7de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7c0da496-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7c0dcb38-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51817 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit PRKX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7c0df4a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7c0e1ea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5231 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 midostaurin is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c0e48ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:5232 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abaloparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c0e72ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:7c0e99e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:7c0ec088-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.137']} DrugCentral uuid:7c0ee73e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:7c0f0de0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:7c0f355e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5233 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brigatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:7c0f5c14-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5234 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 durvalumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:7c0f7ee2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5235 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenegermin is agonist of Kinase (High affinity nerve growth factor receptor) DrugCentral uuid:7c0fa192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08138 biolink:molecularly_interacts_with DrugCentral:5235 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenegermin is agonist of Membrane receptor (Tumor necrosis factor receptor superfamily member 16) DrugCentral uuid:7c0fca82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:7c0fca82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:7c10018c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evogliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:7c102892-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5239 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:7c104fc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c107676-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c109e30-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.081']} DrugCentral uuid:7c10c4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5240 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:7c10ec5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7c111338-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:7c1139f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5241 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 betrixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:7c1160c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.42']} DrugCentral uuid:7c118890-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5242 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:7c11b392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pibrentasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.19']} DrugCentral uuid:7c11da52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:5244 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pibrentasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c1200fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:5245 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 corifollitropin alfa is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:7c122818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:7c122818-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:7c125554-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5247 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inotuzumab ozogamicin is antibody binding of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c127c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:7c12a2ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.801']} DrugCentral uuid:7c12ca2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5248 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7c12f0c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:7c131778-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7c133e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5250 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imrecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:7c1365f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7c138cc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7c13b39a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48735 biolink:molecularly_interacts_with DrugCentral:5251 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enasidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP], mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7c13da3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c140142-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:7c142802-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7c144fbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c147668-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c149dbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7c14c47e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c14eb34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c1511e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c153a08-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7c1563f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7c158dd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7c15b7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c15e02a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7c1606e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c162d82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7c165442-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7c167bac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7c16a24e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7c16c8fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7c16efb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7c1718a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c17417c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c176828-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7c178eca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7c17b5d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7c17dc86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c1803aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7c182c5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c1853c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7c187a9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:7c18a148-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7c18c7f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7c18f152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:7c191876-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c193f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7c1965d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7c198ce8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7c19b3a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7c19da54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7c1a0114-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:7c1a286a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c1a4f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7c1a75d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7c1a9c82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7c1ac3e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7c1aeaac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c1b1162-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c1b3822-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c1b5f28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7c1b85de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7c1bac80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7c1bd340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7c1bfba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7c1c2246-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7c1c48de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:7c1c6f94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c1c98d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7c1cbf94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7c1ce65e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7c1d0d0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7c1d3424-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7c1d5ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7c1d817c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7c1da81e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7c1dcf88-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7c1df620-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7c1e1cd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7c1e4382-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7c1e6b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7c1e9364-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7c1eba2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c1ee0d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:7c1f07ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7c1f2e96-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7c1f554c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c1f7bf8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c1fa362-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c1fcaf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7c1ff1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:7c201860-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c20416e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7c2068b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c208f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7c20b5fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7c20dd18-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c2103ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:7c212a98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7c215144-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7c2178b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:7c219f64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7c21c61a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7c21ecbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:7c2215c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7c223cbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c226372-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c228adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7c22b200-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7c22d8b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c22ff6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY57 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 32B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c232640-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7c234eae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.036']} DrugCentral uuid:7c237578-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5252 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:7c239d32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7c23c3ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.432']} DrugCentral uuid:7c23ed3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:7c24150a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:7c243bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5256 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:7c246320-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:5257 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 butylphthalide is blocker of Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7c248a3a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:7c24b0e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:7c24d7b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.764']} DrugCentral uuid:7c24fe5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.788']} DrugCentral uuid:7c252710-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.375']} DrugCentral uuid:7c254dc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.866']} DrugCentral uuid:7c257490-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:7c259b50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:7c25c486-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.796']} DrugCentral uuid:7c25eb32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5258 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7c2611de-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:7c26389e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7c265fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7c268646-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c26ace8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c26d38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7c26fafe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7c2721be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5259 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:7c274996-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7c277042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7c2799e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7c27c1b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7c27e87e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:7c280f34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:7c28364e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.434']} DrugCentral uuid:7c285d04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5260 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.292']} DrugCentral uuid:7c2883ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:5261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprostene bunod targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7c28aa84-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:5261 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 latanoprostene bunod is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7c28d8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:7c28d8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:7c28d8c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:7c291776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01344 biolink:molecularly_interacts_with DrugCentral:5263 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 benralizumab is antibody binding of Membrane receptor (Interleukin-5 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.959']} DrugCentral uuid:7c293e4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:5267 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 semaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.42']} DrugCentral uuid:7c2966c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.73']} DrugCentral uuid:7c298d8c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00740 biolink:molecularly_interacts_with DrugCentral:5268 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor IX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c29b456-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7c29db0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5269 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:7c2a0230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.94']} DrugCentral uuid:7c2a28dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:7c2a4f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.708']} DrugCentral uuid:7c2a7652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5270 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.057']} DrugCentral uuid:7c2a9da8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:5271 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 macimorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:7c2ac562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II is agonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.2']} DrugCentral uuid:7c2aec22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:7c2b12ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:7c2b3c04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7c2b640e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:5272 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 angiotensin II is agonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7c2b8aba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:7c2bb152-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:7c2bd8bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5274 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bictegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.125']} DrugCentral uuid:7c2bff7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5275 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lutetium (177Lu) oxodotreotide is agonist of GPCR (Somatostatin receptor type 2) DrugCentral uuid:7c2c225e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5276 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tezacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7c2c4914-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12908 biolink:molecularly_interacts_with DrugCentral:5277 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elobixibat is inhibitor of Transporter (Ileal sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.276']} DrugCentral uuid:7c2c7042-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apalutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7c2c9734-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5278 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 apalutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:7c2cbde0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01730 biolink:molecularly_interacts_with DrugCentral:5279 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibalizumab is antibody binding of Membrane receptor (T-cell surface glycoprotein CD4) DrugCentral uuid:7c2ce0a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7c2d0cd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:7c2d35b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7c2d5c6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.092']} DrugCentral uuid:7c2d8324-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5280 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostamatinib is inhibitor of Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.387']} DrugCentral uuid:7c2dad9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:7c2dad9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:7c2de062-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZV9 biolink:molecularly_interacts_with DrugCentral:5282 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 burosumab is antibody binding of Secreted (Fibroblast growth factor 23) DrugCentral uuid:7c2e0344-59f3-11ec-9eaa-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5283 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosnetupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:7c2e2e0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:7c2e2e0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:7c2e6244-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5285 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avatrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:7c2e88e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:5286 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxidectin is inhibitor of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:7c2eab96-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c2ed3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7c2efcea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is agonist of GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:7c2f238c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:7c2f4a60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7c2f71ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7c2f986c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7c2fbf0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5S1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:7c2fe5c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:7c300cf2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is inhibitor of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:7c302fac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:5288 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cannabidiol is antagonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7c305662-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c307d22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:7c30a3e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5289 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 encorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.328']} DrugCentral uuid:7c30ce8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7c30f78e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5290 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:7c311e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33815 biolink:molecularly_interacts_with DrugCentral:5291 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tecovirimat is inhibitor of Viral envelope protein (Envelope protein F13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.382']} DrugCentral uuid:7c31457c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5292 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ivosidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.149']} DrugCentral uuid:7c316c28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c3192f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8SPZ1 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7c31bb1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5293 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elagolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:7c31e2f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7c320a3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7c323216-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:5295 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 doravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:7c3258d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c32811c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7c32a9da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.638']} DrugCentral uuid:7c32d0ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5296 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7c32f778-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:7c331e92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7c33452a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7c336bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:7c3392aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7c33b9ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5297 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.133']} DrugCentral uuid:7c33e08e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:7c340780-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5300 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:7c342e5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5301 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 baloxavir marboxil is inhibitor of Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.854']} DrugCentral uuid:7c3456a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7c347fb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.959']} DrugCentral uuid:7c34a686-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:7c34cd46-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7c34f456-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:7c351b16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:7c3541cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7c356896-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:7c358fb0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:7c35b67a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:7c35de34-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.569']} DrugCentral uuid:7c360508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5302 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:7c362d6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:7c365774-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7c367f88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:7c36a652-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7c36ce3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:5303 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7c36f512-59f3-11ec-9eaa-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:5304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glasdegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7c371bd2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5304 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 glasdegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7c37429c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.187']} DrugCentral uuid:7c3769b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.092']} DrugCentral uuid:7c37908a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5305 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 larotrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.975']} DrugCentral uuid:7c37b7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7c37deb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7c3807ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7c383224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7c3858d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c387f7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c38a718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c38cdec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5306 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gilteritinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:7c38f4a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5307 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evocalcet is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:7c391b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04275 biolink:molecularly_interacts_with DrugCentral:5308 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 caplacizumab is antibody binding of Unclassified (von Willebrand factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.509']} DrugCentral uuid:7c394272-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5309 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lanadelumab is antibody binding of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:7c396914-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:7c3990ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:O02662 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c39b770-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q28524 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7c39e06a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:5311 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vibegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:7c3a0856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5312 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 omidenepag isopropyl is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:7c3a2f16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5313 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 patisiran is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:7c3a51da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5314 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 moxetumomab pasudotox is binding agent of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7c3a7926-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5315 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fremanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:7c3a9ffa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5316 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 galcanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7c3ac6e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5317 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cemiplimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.102']} DrugCentral uuid:7c3aedb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5319 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inotersen is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:7c3b10ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:5320 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 emapalumab is antibody binding of Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:7c3b37a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:5322 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ravulizumab is antibody binding of Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.357']} DrugCentral uuid:7c3b61ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:7c3b61ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:7c3b8f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:7c3bbea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7c3bbea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7c3bbea8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:7c3c03fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:7c3c03fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:7c3c03fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:7c3c49d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:7c3c49d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:7c3c49d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:7c3c886a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.088']} DrugCentral uuid:7c3cb060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:7c3cd72a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5325 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.848']} DrugCentral uuid:7c3cfe6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:7c3d2504-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3']} DrugCentral uuid:7c3d4bc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:7c3d7270-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.409']} DrugCentral uuid:7c3d9b4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5326 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.009']} DrugCentral uuid:7c3dc1e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7c3de890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:7c3e1086-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.434']} DrugCentral uuid:7c3e37c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:7c3e5e88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.921']} DrugCentral uuid:7c3e8566-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:7c3ead0c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5327 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:7c3ed444-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7c3efb04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c3f21ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7c3f487a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Z1L0 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c3f7282-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5328 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 alpelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:7c3f9942-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:7c3fc03e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:7c3fe758-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.02']} DrugCentral uuid:7c400e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:7c4030fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5329 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:7c4058c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14980 biolink:molecularly_interacts_with DrugCentral:5330 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selinexor is inhibitor of Nuclear other (Exportin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:7c407f9c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5331 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 prabotulinumtoxinA is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c40bd72-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c4134b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40259 biolink:molecularly_interacts_with DrugCentral:5333 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 polatuzumab vedotin is antibody binding of Tumour-associated antigen (B-cell antigen receptor complex-associated protein beta chain) DrugCentral uuid:7c415782-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c417e56-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is antagonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:7c41a124-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5334 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 darolutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.187']} DrugCentral uuid:7c41c852-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02656 biolink:molecularly_interacts_with DrugCentral:5335 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 volanesorsen is antisense inhibitor of RNA (apolipoprotein C-III (apoC-III) mRNA) DrugCentral uuid:7c41eb2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5337 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 risankizumab is inhibitor of Cytokine (Interleukin-23 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:7c421564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7c421564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:7c4242a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:7c4269c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5339 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.444']} DrugCentral uuid:7c429106-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c42b79e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7c42de54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c430618-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c432cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c43537a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7c437b52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:7c43a398-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:7c43ca4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c43f104-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c4417a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7c443ec0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c446562-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c448c18-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c44b2ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:7c44db78-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7c450508-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c452eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7c4555a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7c457d12-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7c45a3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:7c45ca6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:7c45f10c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7c461830-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7c463ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c466592-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7c468c3e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:7c46b47a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7c46db26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c4701c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7c47287e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7c474fd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7c477798-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c479e4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7c47c4e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7c47ec0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c4812c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7c483980-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5341 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 quizartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.796']} DrugCentral uuid:7c486040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8RL90 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7c48893a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2PUH3 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:7c48b2ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9X5A7 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7c48d9bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q93LQ9 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7c490086-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q93DC4 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:7c4927e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:B1PL86 biolink:molecularly_interacts_with DrugCentral:5342 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7c494ea6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c497552-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7c499bf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:7c49c304-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:7c49e9b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c4a11a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.56']} DrugCentral uuid:7c4a3866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:7c4a61f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5343 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pexidartinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.88']} DrugCentral uuid:7c4a89ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7c4ab05c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:7c4ad6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7c4afe4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:7c4b24e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7c4b4c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c4b7334-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:7c4b9a30-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:7c4bc0d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7c4be7ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7c4c0e8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7c4c381e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7c4c5ede-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7c4c858a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:7c4cac5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c4cd3b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:7c4cfa74-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5345 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 entrectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7c4d212a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c4d47e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:7c4d6ef0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:7c4d963c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5346 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c4dbcd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7c4de38a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7c4e0d10-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:7c4e33b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7c4e5a54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:7c4e8100-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7c4ea856-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c4eceee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:7c4ef59a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c4f1d4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:7c4f4464-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7c4f6afc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7c4f91b2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7c4fb854-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c4fe004-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c5006a6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7c502d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7c5053ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c507cb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c50a35e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7c50ca0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c50f0a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:7c5117a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c513e4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:7c5164f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c518b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c51b30c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7c51d9b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c520064-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7c522706-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c524e5c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7c5274fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:7c529bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7c52c256-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c52ea60-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7c531102-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7c5337b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7c535e5a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:7c5385c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c53ac66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:7c53d31c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:7c53fa36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7c5421a0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c544842-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c546f02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7c5495a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c54bcb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c54e356-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:7c5509e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c5530ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c555976-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7c55804a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:7c55a6ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:7c55cda2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c55f4ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:7c561ba4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7c5642dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c56699c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7c5690a2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:7c56b85c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7c56df08-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:7c5706f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7c572f4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7c575622-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7c577cc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:7c57a37a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c57cada-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c57f186-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7c581832-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:7c583ed4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c5865da-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c588c9a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7c58b33c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:7c58d9f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7c5901d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:7c59288a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c594f2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c5975ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c599d4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:7c59c402-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7c59eaae-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c5a115a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:7c5a384c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c5a5eee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:7c5a86a8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:7c5aade0-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c5ad69e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7c5b0074-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c5b2720-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:7c5b4dd6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:7c5b7518-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:7c5b9bd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c5bc27a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7c5be926-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7c5c1036-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c5c36e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c5c5d70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c5c8426-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:7c5cad16-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c5cd3ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7c5cfa82-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7c5d212e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c5d487a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c5d7066-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:7c5d9708-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c5dbdbe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7c5de4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c5e0b98-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:7c5e323a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c5e59ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c5e830c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c5ea9fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c5ed096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7c5ef742-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c5f1ea2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c5f4558-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7c5f6c0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c5f92c4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:7c5fb9d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c5fe094-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c600736-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:7c602e00-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:7c6056c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7c607f72-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7c60a628-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7c60ccd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c60f416-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:7c611b44-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7c6141e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7c616892-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c618fa2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c61b662-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7c61dcf0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7c62039c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c622c0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c6252c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7c62794e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7c62a00e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7c62c75a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c62ee1a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7c6314bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c633b72-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7c63628c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:7c638938-59f3-11ec-9eaa-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7c63afc6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7c63d67c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7c63ff1c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c6425dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c644c74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7c64732a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c649a80-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c64c12c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7c64e7ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:7c650e84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:7c653576-59f3-11ec-9eaa-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7c655c36-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c6582d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7c65a984-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c65d22e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:7c65fa2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:7c6620d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7c66477c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7c666ebe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7c66957e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7c66bc2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c66e2ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7c6709dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c673092-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:7c675734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:7c677e62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7c67a64e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c67cd04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7c67f39c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:7c681a52-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:7c684194-59f3-11ec-9eaa-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7c68684a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7c688f00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7c68b5ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:7c68dcd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c690390-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7c692a3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c6950f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7c69797e-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:7c69a322-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7c69cae6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7c69f19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:7c6a18fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c6a3fa8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7c6a6794-59f3-11ec-9eaa-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c6a8e54-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c6ab564-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:7c6adc24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:7c6b02c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7c6b297c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:7c6b5244-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c6b7bc0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c6ba532-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:7c6bce90-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:7c6bf5e6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7c6c1c92-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c6c432a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7c6c69e0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:7c6c90f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:7c6cb7b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:7c6cde52-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:7c6d0512-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:7c6d2eb6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:7c6d5580-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c6d7c22-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7c6da3d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:7c6dcb28-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7c6df256-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c6e190c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7c6e3fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c6e66d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c6e8d92-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c6eb420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7c6edb76-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7c6f02ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7c6f29aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c6f5060-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c6f770c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c6f9e76-59f3-11ec-9eaa-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:7c6fc52c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:7c6febc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:7c70127a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:7c703994-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c706040-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c7086ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:7c70ad84-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:7c70d5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:7c70fdac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c71243a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7c714b04-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:7c71737c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c719a28-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:7c71c0c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7c71e776-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:7c720e86-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7c72353c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c725bd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:7c728280-59f3-11ec-9eaa-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7c72ac06-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7c72d2c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:7c72f9d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c73208c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c7347ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c736eac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:7c739562-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7c73bc18-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:7c73e328-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:7c7409e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:7c74308a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7c7457c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:7c74813e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7c74a8e4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:7c74cf68-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7c74f614-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:7c751d74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c754538-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c756bda-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c759286-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7c75b9aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:7c75e060-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:7c760702-59f3-11ec-9eaa-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:7c762dcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:7c765770-59f3-11ec-9eaa-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:7c768132-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:7c76a9dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:7c76d09c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51957 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:7c76f810-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q58F21 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Unclassified (Bromodomain testis-specific protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7c771eb2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96PY6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7c774572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:7c776d54-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7c77945a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7c77bb24-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:7c77e1da-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5347 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c78089a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P26433 biolink:molecularly_interacts_with DrugCentral:5349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenapanor targets Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:7c7831da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48764 biolink:molecularly_interacts_with DrugCentral:5349 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tenapanor is inhibitor of Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:7c785890-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7c787f3c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:7c78a5f2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:5350 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7c78cd48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:5351 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lasmiditan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:7c78f4f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7c791bcc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c794278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7c796a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7c79912e-59f3-11ec-9eaa-0242ac110003 UniProtKB:G1C775 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:7c79b802-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6T4V3 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:7c79dec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:H4I819 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c7a0956-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A0W8ASI8 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:7c7a307a-59f3-11ec-9eaa-0242ac110003 UniProtKB:A6T4M7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7c7a5758-59f3-11ec-9eaa-0242ac110003 UniProtKB:G3XD46 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:7c7a7e0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:D0CCM7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:7c7aa578-59f3-11ec-9eaa-0242ac110003 UniProtKB:A0A5E6DR09 biolink:molecularly_interacts_with DrugCentral:5352 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:7c7acc4c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5353 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 zanubrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:7c7af30c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13196 biolink:molecularly_interacts_with DrugCentral:5354 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 givosiran is antisense inhibitor of RNA (aminolevulinate synthase1 (ALAS1) mRNA) DrugCentral uuid:7c7b15d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7c7b3cf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7c7b63b4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:7c7b8a74-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:7c7bb120-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:7c7bdb64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:7c7c0224-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:7c7c2920-59f3-11ec-9eaa-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:5356 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 voxelotor is inhibitor of Transporter (hemoglobin subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:7c7c4fb8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5357 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 golodirsen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:7c7c72fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:7c7c99be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:7c7cc18c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:7c7ce860-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:7c7d0f66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7c7d3644-59f3-11ec-9eaa-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:7c7d5d0e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:7c7d83d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:7c7dae12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:7c7dd630-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5358 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumateperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:7c7dfcfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99572 biolink:molecularly_interacts_with DrugCentral:5359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brilliant Blue G is antagonist of Ion channel (P2X purinoceptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7c7e23b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P37840 biolink:molecularly_interacts_with DrugCentral:5359 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brilliant Blue G targets Transporter (Alpha-synuclein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7c7e4af2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7c7e71bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7c7e989a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:5360 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c7ebf64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5361 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ubrogepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:7c7ee688-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9BQB4 biolink:molecularly_interacts_with DrugCentral:5362 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 romosozumab is binding agent of Glycoprotein (Sclerostin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.7']} DrugCentral uuid:7c7f0d48-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5363 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 brolucizumab is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c7f3408-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95390 biolink:molecularly_interacts_with DrugCentral:5364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.13']} DrugCentral uuid:7c7f5adc-59f3-11ec-9eaa-0242ac110003 UniProtKB:O14793 biolink:molecularly_interacts_with DrugCentral:5364 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.69']} DrugCentral uuid:7c7f846c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16109 biolink:molecularly_interacts_with DrugCentral:5365 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 crizanlizumab is inhibitor of Adhesion (P-selectin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c7fc5c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:7c803d94-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96NY8 biolink:molecularly_interacts_with DrugCentral:5366 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Nectin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:7c80647c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab deruxtecan is binding agent of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7c808b64-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5367 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trastuzumab deruxtecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:7c80b292-59f3-11ec-9eaa-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5368 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 botulinum toxin type A is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:7c80d560-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:7c80fc16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7c8122fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c814b62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:7c817218-59f3-11ec-9eaa-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5372 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 elexacaftor targets Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:7c8198ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c81bf8e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine is inhibitor of Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) DrugCentral uuid:7c81e2e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:5375 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cepharanthine is inhibitor of Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) DrugCentral uuid:7c820638-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:5376 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remdesivir is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c822ce4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c8253a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5378 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:7c827abe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P05532 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:7c82a192-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:7c82c866-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5379 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 avapritinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:7c82ef26-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7c831758-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92800 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:7c833e2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15910 biolink:molecularly_interacts_with DrugCentral:5380 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c8364ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5381 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 rimegepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.56']} DrugCentral uuid:7c838d00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P53396 biolink:molecularly_interacts_with DrugCentral:5382 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bempedoic acid is inhibitor of Enzyme (ATP-citrate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:7c83b532-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7c83dbca-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:7c840280-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:7c842936-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7c845096-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5383 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c84772e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:7c849dd0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:7c84c468-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:7c84ebfa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:7c85129c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7c853948-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:5384 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:7c85601c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5385 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 isatuximab is binding agent of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c858718-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.82']} DrugCentral uuid:7c85adec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10092 biolink:molecularly_interacts_with DrugCentral:5386 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:7c85d4c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5387 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 teprotumumab is antagonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7c85fb80-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:7c862376-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7c864a4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5388 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:7c8670f6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:7c8697ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:7c86c2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:7c86c2b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:7c86f558-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:7c871c2c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7c8743f0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:7c876b0a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5390 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:7c8791c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is antibody binding of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.71']} DrugCentral uuid:7c87b88a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is binding agent of Enzyme (DNA topoisomerase 1) DrugCentral uuid:7c87dbbc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09758 biolink:molecularly_interacts_with DrugCentral:5391 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sacituzumab govitecan is antibody binding of Tumour-associated antigen (Tumor-associated calcium signal transducer 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.58']} DrugCentral uuid:7c88033a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5392 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 capmatinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.88']} DrugCentral uuid:7c8829fa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selpercatinib is inhibitor of Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:7c8850b0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5393 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 selpercatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:7c887784-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7c88a0ec-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:7c88c7b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:7c88ee62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:7c891518-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c893c28-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5394 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:7c8962fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5395 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fluoroestradiol F 18 is binding agent of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.07']} DrugCentral uuid:7c8989d0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:5396 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 flortaucipir F 18 is binding agent of Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:7c89b090-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inebilizumab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7c89d93a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5397 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inebilizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:7c8a06c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7c8a06c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7c8a06c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:7c8a4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c8a4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c8a4c8a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:7c8a9550-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7c8a9550-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7c8a9550-59f3-11ec-9eaa-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:7c8ada92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7c8ada92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7c8ada92-59f3-11ec-9eaa-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b2d62-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:7c8b9c66-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:5401 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fostemsavir is inhibitor of Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:7c8bc34e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32320 biolink:molecularly_interacts_with DrugCentral:5402 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 inqovi is inhibitor of Enzyme (Cytidine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:7c8bea04-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c8c10ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7c8c3888-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:7c8c624a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7c8c891e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51685 biolink:molecularly_interacts_with DrugCentral:5403 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c8cafd4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5404 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tafasitamab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7c8cd716-59f3-11ec-9eaa-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:7c8cfdea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12314 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (High affinity immunoglobulin gamma Fc receptor I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:7c8d24dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7c8d4cc8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02223 biolink:molecularly_interacts_with DrugCentral:5405 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 belantamab mafodotin is binding agent of Tumour-associated antigen (Tumor necrosis factor receptor superfamily member 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:7c8d740a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c8d9ac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7c8dc176-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:7c8de82c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:7c8e0fa0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:7c8e3660-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7c8e5d02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine is agonist of GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:7c8e83b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5406 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 oliceridine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7c8eaafa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5408 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 viltolarsen is binding agent of RNA (exon 53 of dystrophin pre-mRNA) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:7c8ed5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7c8ed5ac-59f3-11ec-9eaa-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7c8f09c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5410 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 clascoterone is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7c8f3092-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5411 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 copper dotatate Cu-64 is binding agent of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:7c8f5806-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:7c8f7ebc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7c8fa572-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7c8fcc32-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:7c8ff568-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7c901c32-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7c9042e8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:7c90699e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:7c9090cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:7c90b7aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5412 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pralsetinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:7c90df50-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5413 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 somapacitan targets GPCR (Growth hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:7c910610-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c912d70-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7c91541c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01111 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase NRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7c917ad2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c91a17e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:7c91cc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c91cc6c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:7c91ff02-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UJM8 biolink:molecularly_interacts_with DrugCentral:5415 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 lumasiran is antisense inhibitor of RNA (Hydroxyacid oxidase 1 (HAO1) mRNA) DrugCentral uuid:7c9221bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7c92487c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7c926faa-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:7c929660-59f3-11ec-9eaa-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:7c92bd2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:7c92e3d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:7c930b4a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5416 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:7c93323c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:5417 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bulevirtide is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:7c9362fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:7c9362fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:7c9362fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:7c9362fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:7c93a910-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7c93d278-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7c93fbea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:7c942340-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7c9449ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:7c947188-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:7c9498de-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:7c94c034-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:7c94e6ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:7c950ec2-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:7c95358c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7c955d46-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5419 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:7c9586f4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c95ade6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7c95d4e2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:7c95fbe8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8N543 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Prolyl 3-hydroxylase OGFOD1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7c96229e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat targets Unclassified (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:7c96494a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:7c967000-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.93']} DrugCentral uuid:7c969760-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:7c96be16-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:7c96e4d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:7c970bb4-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:7c97335a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:5422 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 borofalan (10B) is substrate of Transporter (L-type amino acid transporter 1) DrugCentral uuid:7c9756c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7c977e6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c97a542-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c97ccfc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:7c97f3c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:7c981a7c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:7c98424a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:7c9869be-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:7c989074-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7c98b734-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5423 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:7c98ddfe-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tepotinib is inhibitor of Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:7c990590-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5424 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tepotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:7c992cdc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7c995392-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:7c997a70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:7c99a180-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:7c99c84a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5425 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:7c99eef6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:7c9a15ca-59f3-11ec-9eaa-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:7c9a3d2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7c9a6408-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:7c9a8ac8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5426 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 delgocitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:7c9ab19c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7c9ad910-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:7c9b02d2-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:7c9b2c76-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5428 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sofpironium bromide is inhibitor of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:7c9b521e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07288 biolink:molecularly_interacts_with DrugCentral:5429 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 gallium (68Ga) gozetotide is binding agent of Surface antigen (Prostate-specific antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:7c9b796a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5430 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 berotralstat is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:7c9ba174-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:7c9bc80c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7c9beeea-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:7c9c1730-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:7c9c3df0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:7c9c649c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:7c9c8b66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5432 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:7c9cb366-59f3-11ec-9eaa-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5433 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ansuvimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:7c9cdd00-59f3-11ec-9eaa-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 margetuximab is antagonist of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.55']} DrugCentral uuid:7c9d03d4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5434 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 margetuximab is antagonist of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:7c9d2ad0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atoltivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:7c9d51fe-59f3-11ec-9eaa-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5436 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 atoltivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:7c9d78dc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5437 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 maftivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:7c9d9fd8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 odesivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:7c9dc6c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5438 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 odesivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:7c9dee2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P20595 biolink:molecularly_interacts_with DrugCentral:5439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:7c9e14ea-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:5439 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) DrugCentral uuid:7c9e37b8-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c9e5e64-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c9e8632-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5440 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 cabotegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:7c9ead88-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7c9ed452-59f3-11ec-9eaa-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:7c9efb12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:7c9f22d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:7c9f49aa-59f3-11ec-9eaa-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5441 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 umbralisib is inhibitor of Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7c9f7060-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7c9f970c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7c9fbf66-59f3-11ec-9eaa-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7c9fe61c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:7ca00ce6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:7ca0339c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:7ca05b24-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:7ca081ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6ZWH5 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Serine/threonine-protein kinase Nek10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.57']} DrugCentral uuid:7ca0a8ae-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:7ca0cf78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5442 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:7ca0f692-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5443 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casimersen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:7ca11938-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9NZB8 biolink:molecularly_interacts_with DrugCentral:5444 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 fosdenopterin targets Enzyme (Molybdenum cofactor biosynthesis protein 1) DrugCentral uuid:7ca13bde-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:7ca1628a-59f3-11ec-9eaa-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7ca1892c-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:7ca1b096-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5446 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:7ca1d724-59f3-11ec-9eaa-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:5447 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dasiglucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:7ca1ff38-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9Y5C1 biolink:molecularly_interacts_with DrugCentral:5449 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 evinacumab is inhibitor of Secreted (Angiopoietin-related protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:7ca2260c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:7ca24f6a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:5450 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:7ca276fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5451 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 dostarlimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:7ca29db2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5452 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 loncastuximab tesirine is antibody binding of Surface antigen (B-lymphocyte antigen CD19) DrugCentral uuid:7ca2c080-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5453 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 bamlanivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:7ca2e7a4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5454 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 etesevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:7ca30e78-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5455 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 casirivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.34']} DrugCentral uuid:7ca33524-59f3-11ec-9eaa-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5456 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 imdevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.33']} DrugCentral uuid:7ca35c02-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01024 biolink:molecularly_interacts_with DrugCentral:5457 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 pegcetacoplan is inhibitor of Unclassified (Complement C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:7ca384c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04609 biolink:molecularly_interacts_with DrugCentral:5458 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 piflufolastat F-18 is binding agent of Enzyme (Glutamate carboxypeptidase 2) DrugCentral uuid:7ca3a766-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ca3cdf4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ca3f48c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7ca41d90-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7ca4443c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7ca46ac0-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7ca4916c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7ca4b87c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7ca4df14-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ca505b6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca52c62-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7ca553c2-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7ca57a6e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7ca5a110-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7ca5c7bc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca5f138-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ca619ba-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7ca64066-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:7ca66726-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ca68e22-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7ca6b4ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca6db7a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7ca70230-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ca7299a-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7ca7512c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7ca777d8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ca79e70-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:7ca7c5f8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca7eca4-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7ca8133c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:7ca839de-59f3-11ec-9eaa-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7ca860da-59f3-11ec-9eaa-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:7ca888c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca8af5e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:7ca8d682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:7ca8fdce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:7ca9247a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:7ca94b12-59f3-11ec-9eaa-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7ca971c8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7ca99b4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7ca9c420-59f3-11ec-9eaa-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:7ca9eacc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:7caa1182-59f3-11ec-9eaa-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:7caa3888-59f3-11ec-9eaa-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:7caa5f2a-59f3-11ec-9eaa-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:7caa85cc-59f3-11ec-9eaa-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:7caaac82-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:7caad3ce-59f3-11ec-9eaa-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:7caafb7e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:7cab2234-59f3-11ec-9eaa-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:7cab48d6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:7cab72c0-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:7cab99c6-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:7cabc05e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:7cabe714-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:7cac0e2e-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:7cac34ee-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) DrugCentral uuid:7cac5794-59f3-11ec-9eaa-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:7cac7a4e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) DrugCentral uuid:7cac9d9e-59f3-11ec-9eaa-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5459 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) DrugCentral uuid:7cacc06c-59f3-11ec-9eaa-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:7cace722-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:7cad0df6-59f3-11ec-9eaa-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5460 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 samidorphan is partial agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:7cad3682-59f3-11ec-9eaa-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5461 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 sotorasib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:7cad5dc4-59f3-11ec-9eaa-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:7cad84fc-59f3-11ec-9eaa-0242ac110003 UniProtKB:Q6FTN8 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:7cadaba8-59f3-11ec-9eaa-0242ac110003 UniProtKB:P87204 biolink:molecularly_interacts_with DrugCentral:5462 biolink:Association|biolink:DrugToGeneAssociation RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral